Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines



   lung cancer
  

Disease ID 846
Disease lung cancer
Definition

Lung cancer is one of the most common cancers in the world. It is a leading cause of cancer death in men and women in the United States. Cigarette smoking causes most lung cancers. The more cigarettes you smoke per day and the earlier you started smoking, the greater your risk of lung cancer. High levels of pollution, radiation and asbestos exposure may also increase risk.

Common symptoms of lung cancer include

  • A cough that doesn't go away and gets worse over time
  • Constant chest pain
  • Coughing up blood
  • Shortness of breath, wheezing, or hoarseness
  • Repeated problems with pneumonia or bronchitis
  • Swelling of the neck and face
  • Loss of appetite or weight loss
  • Fatigue

Doctors diagnose lung cancer using a physical exam, imaging, and lab tests. Treatment depends on the type, stage, and how advanced it is. Treatments include surgery, chemotherapy, radiation therapy, and targeted therapy. Targeted therapy uses substances that attack cancer cells without harming normal cells.

NIH: National Cancer Institute


Synonym
ca - lung cancer
cancer of lung
cancer of the lung
cancer pulmonary
cancer, lung
cancer, pulmonary
cancers lungs
cancers, lung
cancers, pulmonary
lung cancers
lung malignancies
lung malignancy
lung malignant tumors
lung malignant tumours
lungs cancer
lungs--cancer
malignant lung neoplasm
malignant lung tumor
malignant neoplasm lung
malignant neoplasm of lung
malignant neoplasm of lung, nos
malignant neoplasm of the lung
malignant tumor of lung
malignant tumor of lung (disorder)
malignant tumor of the lung
malignant tumour of lung
pulmonary cancer
pulmonary cancers
OMIM
DOID
UMLS
C0242379
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:347)
C0220650  |  brain metastases  |  91
C0007131  |  nsclc  |  62
C0001418  |  adenocarcinoma  |  59
C0220650  |  brain metastasis  |  42
C0024115  |  lung disease  |  36
C0024117  |  chronic obstructive pulmonary disease  |  33
C0080032  |  malignant pleural effusion  |  31
C0600260  |  obstructive pulmonary disease  |  29
C0024115  |  pulmonary disease  |  28
C0206062  |  interstitial lung disease  |  25
C0034069  |  pulmonary fibrosis  |  24
C0007137  |  squamous cell carcinoma  |  21
C0032285  |  pneumonitis  |  20
C0011847  |  diabetes  |  20
C0011570  |  depression  |  19
C0032285  |  pneumonia  |  19
C1800706  |  idiopathic pulmonary fibrosis  |  18
C0152013  |  lung adenocarcinoma  |  15
C0013990  |  emphysema  |  14
C0041296  |  tuberculosis  |  14
C0024299  |  lymphoma  |  14
C0024117  |  chronic obstructive pulmonary disease (copd)  |  14
C0006142  |  breast cancer  |  14
C0149925  |  small cell lung cancer  |  13
C0080032  |  malignant effusion  |  9
C0080032  |  malignant pleural effusions  |  9
C0003949  |  asbestosis  |  9
C0014038  |  encephalitis  |  9
C0011860  |  type 2 diabetes  |  9
C0854178  |  adrenal metastases  |  9
C0085786  |  idiopathic interstitial pneumonia  |  8
C0007131  |  non-small cell lung cancer  |  8
C0686619  |  lymph node metastases  |  8
C0024115  |  lung diseases  |  8
C0040053  |  thrombosis  |  8
C0027947  |  neutropenia  |  7
C0004030  |  aspergillosis  |  7
C0042373  |  vascular disease  |  7
C0376358  |  prostate cancer  |  7
C0034065  |  pulmonary embolism  |  7
C0022972  |  myasthenic syndrome  |  6
C0031039  |  pericardial effusion  |  6
C0149925  |  small cell carcinoma  |  6
C0028754  |  obesity  |  6
C0684249  |  lung carcinoma  |  6
C0003467  |  anxiety  |  6
C0002871  |  anemia  |  5
C0006625  |  cachexia  |  5
C0022972  |  lambert-eaton myasthenic syndrome  |  5
C0014868  |  esophagitis  |  5
C0015230  |  rash  |  5
C0011849  |  diabetes mellitus  |  5
C0001418  |  adenocarcinomas  |  5
C0004096  |  asthma  |  5
C0007222  |  cardiovascular disease  |  5
C0032273  |  pneumoconiosis  |  5
C0026896  |  myasthenia gravis  |  4
C0024623  |  gastric cancer  |  4
C1140680  |  ovarian ca  |  4
C0020437  |  hypercalcemia  |  4
C0029412  |  hypertrophic pulmonary osteoarthropathy  |  4
C0206062  |  interstitial lung diseases  |  4
C0153676  |  pulmonary metastasis  |  4
C0037116  |  silicosis  |  4
C2350236  |  idiopathic interstitial pneumonias  |  4
C0006277  |  bronchitis  |  4
C0494165  |  liver metastasis  |  4
C0041327  |  pulmonary tuberculosis  |  4
C0398623  |  hypercoagulability  |  4
C0153676  |  lung metastases  |  4
C0035204  |  respiratory disease  |  3
C0037317  |  sleep disturbance  |  3
C0027051  |  myocardial infarct  |  3
C0162429  |  malnutrition  |  3
C0032326  |  pneumothorax  |  3
C0018801  |  heart failure  |  3
C0030805  |  bullous pemphigoid  |  3
C0027051  |  myocardial infarction  |  3
C0032285  |  pulmonary inflammation  |  3
C0032226  |  pleural disease  |  3
C0153687  |  skin metastases  |  3
C0032231  |  pleuritis  |  3
C0153676  |  pulmonary metastases  |  3
C0836924  |  thrombocytosis  |  3
C0003864  |  arthritis  |  3
C0032285  |  pneumonias  |  3
C0153676  |  lung metastasis  |  3
C0024110  |  lung abscess  |  3
C0036202  |  sarcoidosis  |  3
C0153687  |  skin metastasis  |  3
C0036421  |  systemic sclerosis  |  3
C0011860  |  type 2 diabetes mellitus  |  3
C0018799  |  heart disease  |  3
C0029925  |  ovarian carcinoma  |  3
C0023418  |  leukemia  |  2
C0149925  |  small cell lung carcinoma  |  2
C0042373  |  vascular diseases  |  2
C0085110  |  severe combined immunodefic  |  2
C0036341  |  schizophrenia  |  2
C1704231  |  leptomeningeal metastasis  |  2
C0024117  |  chronic obstructive lung disease  |  2
C0041327  |  pulmonary tb  |  2
C0376545  |  hematological malignancy  |  2
C0010481  |  cushing's syndrome  |  2
C0042384  |  vasculitis  |  2
C0034050  |  alveolar proteinosis  |  2
C0007115  |  thyroid ca  |  2
C1704231  |  leptomeningeal metastases  |  2
C0003873  |  rheumatoid arthritis  |  2
C0009402  |  colorectal cancer  |  2
C0041696  |  major depression  |  2
C1377913  |  pleural mesothelioma  |  2
C0220654  |  carcinomatous meningitis  |  2
C0025289  |  meningitis  |  2
C0035309  |  retinopathy  |  2
C0684249  |  pulmonary carcinoma  |  2
C0007113  |  rectal cancer  |  2
C0021843  |  bowel obstruction  |  2
C0021053  |  immune disease  |  2
C0494165  |  liver metastases  |  2
C0020538  |  hypertension  |  2
C0040188  |  tic disorders  |  2
C0034150  |  purpura  |  2
C0024299  |  malignant lymphoma  |  2
C0600260  |  obstructive lung disease  |  2
C0042769  |  virus infection  |  2
C0007099  |  carcinoma in situ  |  2
C1261473  |  sarcoma  |  2
C0007134  |  renal cell carcinoma  |  2
C0035078  |  renal failure  |  2
C0037317  |  sleep disturbances  |  2
C0030805  |  pemphigoid  |  2
C0034050  |  pulmonary alveolar proteinosis  |  2
C0010068  |  coronary artery disease  |  2
C0036202  |  sarcoid  |  2
C0003165  |  anthracosis  |  1
C0027708  |  wilms tumor  |  1
C0020437  |  hypercalcaemia  |  1
C0010481  |  cushing syndrome  |  1
C0040100  |  thymomas  |  1
C0149782  |  squamous cell carcinoma of the lung  |  1
C0686619  |  metastases to lymph nodes  |  1
C0032533  |  polymyalgia rheumatica  |  1
C0085113  |  neurofibromatosis  |  1
C0011860  |  type ii diabetes  |  1
C0015469  |  facial paralysis  |  1
C0027819  |  neuroblastoma  |  1
C0242647  |  mucosa-associated lymphoid tissue lymphoma  |  1
C0002871  |  anaemia  |  1
C0026277  |  pleomorphic adenoma  |  1
C0009324  |  ulcerative colitis  |  1
C0026718  |  mucormycosis  |  1
C0013395  |  dyspepsia  |  1
C0023903  |  liver tumor  |  1
C0004153  |  atherosclerotic vascular disease  |  1
C0022661  |  chronic renal failure  |  1
C0007785  |  cerebral infarction  |  1
C1800706  |  usual interstitial pneumonia  |  1
C0035229  |  respiratory insufficiency  |  1
C0003165  |  coal worker's pneumoconiosis  |  1
C0026846  |  muscle wasting  |  1
C0007120  |  bronchioloalveolar carcinoma  |  1
C0004031  |  allergic bronchopulmonary aspergillosis  |  1
C1140680  |  ovarian cancer  |  1
C0030424  |  paragonimiasis  |  1
C0005940  |  bone disease  |  1
C0278678  |  metastatic renal cell carcinoma  |  1
C0021845  |  bowel perforation  |  1
C0028754  |  adiposity  |  1
C0302592  |  cervical ca  |  1
C0023448  |  lymphocytic leukemia  |  1
C0339962  |  pulmonary mucormycosis  |  1
C0021400  |  influenza  |  1
C0023895  |  liver diseases  |  1
C0007102  |  colon cancer  |  1
C0870082  |  hyperkeratosis  |  1
C0007137  |  squamous carcinoma  |  1
C0152018  |  esophageal carcinoma  |  1
C0007131  |  non-small cell lung carcinoma  |  1
C0403416  |  crescentic glomerulonephritis  |  1
C0024314  |  lymphoproliferative disorders  |  1
C0035204  |  respiratory diseases  |  1
C0015645  |  fasciitis  |  1
C0740457  |  renal cancers  |  1
C0442874  |  neuropathy  |  1
C0007758  |  cerebellar ataxia  |  1
C0032285  |  pneumoniae  |  1
C0022521  |  kartagener's syndrome  |  1
C0037274  |  dermatoses  |  1
C0206704  |  large cell carcinoma  |  1
C0162429  |  malnourished  |  1
C0221348  |  yellow nail syndrome  |  1
C1261473  |  sarcomas  |  1
C0020757  |  ichthyosis  |  1
C0025202  |  malignant melanoma  |  1
C0023895  |  liver disease  |  1
C0346976  |  pancreatic metastasis  |  1
C0009319  |  colitis  |  1
C0004134  |  ataxia  |  1
C0001261  |  actinomycosis  |  1
C0007131  |  non-small-cell lung carcinoma  |  1
C0149925  |  small cell carcinoma of lung  |  1
C0043119  |  werner syndrome  |  1
C0700251  |  brachial plexopathy  |  1
C0018552  |  hamartoma  |  1
C0008148  |  chlamydia  |  1
C0022116  |  ischemia  |  1
C0040558  |  toxoplasma gondii infection  |  1
C0017609  |  neovascular glaucoma  |  1
C0023267  |  leiomyoma  |  1
C0040147  |  thyroiditis  |  1
C0033860  |  psoriasis  |  1
C0034735  |  raynaud's phenomenon  |  1
C0085084  |  motor neuron disease  |  1
C0023890  |  liver cirrhosis  |  1
C1527336  |  sjogren's syndrome  |  1
C0085655  |  polymyositis  |  1
C0022521  |  kartagener syndrome  |  1
C0022116  |  ischaemia  |  1
C0013595  |  eczema  |  1
C0000889  |  acanthosis nigricans  |  1
C0007121  |  bronchial cancer  |  1
C0006384  |  bundle branch block  |  1
C0206623  |  adenosquamous carcinoma  |  1
C0021053  |  immune dysfunction  |  1
C0024225  |  lymphangitis  |  1
C0221757  |  aat deficiency  |  1
C0024110  |  lung abscesses  |  1
C0014013  |  pyothorax  |  1
C0007847  |  cervical cancer  |  1
C0032305  |  pneumocystis jiroveci pneumonia  |  1
C0026764  |  myeloma  |  1
C0030920  |  peptic ulcer  |  1
C0206695  |  neuroendocrine carcinoma  |  1
C0036205  |  pulmonary sarcoidosis  |  1
C0041341  |  tuberous sclerosis complex  |  1
C0032266  |  pneumatosis cystoides intestinalis  |  1
C0026272  |  sharp syndrome  |  1
C0003028  |  anhidrosis  |  1
C0001420  |  papillary adenocarcinoma  |  1
C0001430  |  adenoma  |  1
C0039978  |  thoracic disease  |  1
C0017658  |  glomerulonephritis  |  1
C0852949  |  arterial disease  |  1
C0015523  |  factor xi deficiency  |  1
C0281373  |  respiratory papilloma  |  1
C0003537  |  aphasia  |  1
C0151332  |  active tuberculosis  |  1
C0030312  |  pancytopenia  |  1
C0025202  |  melanoma  |  1
C0022408  |  arthropathy  |  1
C0686377  |  cns metastasis  |  1
C0346010  |  birt-hogg-dube syndrome  |  1
C0023434  |  chronic lymphocytic leukemia  |  1
C0011991  |  diarrhea  |  1
C0152227  |  epiphora  |  1
C0022972  |  lambert-eaton syndrome  |  1
C0085786  |  fibrosing alveolitis  |  1
C0026986  |  myelodysplastic syndrome  |  1
C0011608  |  dermatitis herpetiformis  |  1
C0024115  |  pulmonary diseases  |  1
C1266119  |  solitary fibrous tumor  |  1
C0221773  |  hyperamylasemia  |  1
C0206754  |  neuroendocrine tumor  |  1
C0034067  |  pulmonary emphysema  |  1
C0025286  |  meningioma  |  1
C0948303  |  peritoneal carcinoma  |  1
C1335437  |  plexopathy  |  1
C0004096  |  bronchial asthma  |  1
C0497327  |  dementia  |  1
C0677607  |  hashimoto's thyroiditis  |  1
C0264716  |  chronic heart failure  |  1
C0272286  |  immune thrombocytopenia  |  1
C0242647  |  mucosa-associated lymphoid tissue  |  1
C0027726  |  nephrotic syndrome  |  1
C0155626  |  acute myocardial infarction  |  1
C0275566  |  pulmonary actinomycosis  |  1
C0007177  |  pericardial tamponade  |  1
C0149931  |  migraine  |  1
C0555198  |  malignant glioma  |  1
C0376358  |  prostate cancers  |  1
C0011334  |  cavities  |  1
C0020542  |  pulmonary hypertension  |  1
C0007130  |  mucinous adenocarcinoma  |  1
C0494165  |  hepatic metastasis  |  1
C0040156  |  thyrotoxicosis  |  1
C0040034  |  thrombocytopenia  |  1
C0279130  |  cns metastases  |  1
C0024623  |  stomach cancer  |  1
C0037933  |  spinal disease  |  1
C0006264  |  bronchial tumor  |  1
C0206754  |  neuroendocrine tumors  |  1
C0031046  |  pericarditis  |  1
C1565489  |  renal insufficiency  |  1
C0003507  |  aortic stenosis  |  1
C0740457  |  renal cancer  |  1
C0019064  |  haemopericardium  |  1
C0740457  |  kidney cancer  |  1
C0149782  |  squamous cell lung cancer  |  1
C0007785  |  cerebral infarct  |  1
C0016057  |  fibrosarcoma  |  1
C0007115  |  thyroid cancer  |  1
C0032319  |  pneumopericardium  |  1
C0017636  |  glioblastoma  |  1
C1140680  |  ovarian cancers  |  1
C0206698  |  cholangiocarcinoma  |  1
C0007570  |  celiac disease  |  1
C0152177  |  trigeminal neuropathy  |  1
C0014070  |  encephalomyelitis  |  1
C0032231  |  pleurisy  |  1
C0011633  |  dermatomyositis  |  1
C0242350  |  erectile dysfunction  |  1
C0494165  |  hepatic metastases  |  1
C0259749  |  autonomic neuropathy  |  1
C0026764  |  multiple myeloma  |  1
C0153685  |  metastasis to the kidney  |  1
C1145670  |  respiratory failure  |  1
C0040053  |  thrombus  |  1
C0007107  |  laryngeal cancer  |  1
C0030305  |  pancreatitis  |  1
C0007177  |  cardiac tamponade  |  1
C0334276  |  adenocarcinoma in situ  |  1
C0024314  |  lymphoproliferative disorder  |  1
C0034152  |  henoch-schonlein purpura  |  1
C0034069  |  lung fibrosis  |  1
C0011644  |  scleroderma  |  1
C0014859  |  esophageal cancer  |  1
C0007137  |  squamous cell cancer  |  1
C0015469  |  facial nerve paralysis  |  1
C0006267  |  bronchiectasis  |  1
C0026769  |  multiple sclerosis  |  1
C0040558  |  toxoplasmosis  |  1
C0012739  |  disseminated intravascular coagulation  |  1
C0007117  |  basal cell carcinoma  |  1
C0007222  |  cardiovascular diseases  |  1
C0023890  |  cirrhosis  |  1
C0024586  |  serotonin syndrome  |  1
C0014084  |  ollier disease  |  1
C0031511  |  pheochromocytoma  |  1
C0001339  |  acute pancreatitis  |  1
C0040100  |  thymoma  |  1
C0024291  |  hemophagocytic syndrome  |  1
C0031269  |  peutz-jeghers syndrome  |  1
C0001623  |  adrenal insufficiency  |  1
C0040583  |  tracheal stenosis  |  1
C0007134  |  renal cell carcinomas  |  1
C0079419  |  li-fraumeni syndrome  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:16)
BRCA2  |  675  |  GWASCAT
ERCC2  |  2068  |  GWASCAT
TERT  |  7015  |  GWASCAT
CHEK2  |  11200  |  GWASCAT
ACTA2  |  59  |  GWASCAT
CHRNA3  |  1136  |  GWASCAT
TP63  |  8626  |  GWASCAT
CLPTM1L  |  81037  |  GWASCAT
BAG6  |  7917  |  GWASCAT
HYKK  |  123688  |  GWASCAT
MTMR3  |  8897  |  GWASCAT
VTI1A  |  143187  |  GWASCAT
TGM5  |  9333  |  GWASCAT
RAD52  |  5893  |  GWASCAT
APOM  |  55937  |  GWASCAT
KLC3  |  147700  |  GWASCAT
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:632)
19  |  ABCA1  |  infer
23461  |  ABCA5  |  infer
23460  |  ABCA6  |  infer
10347  |  ABCA7  |  infer
5243  |  ABCB1  |  infer
8647  |  ABCB11  |  infer
4363  |  ABCC1  |  infer
1244  |  ABCC2  |  infer
8714  |  ABCC3  |  infer
10257  |  ABCC4  |  infer
9429  |  ABCG2  |  infer
64241  |  ABCG8  |  infer
1636  |  ACE  |  infer
126  |  ADH1C  |  infer
183  |  AGT  |  infer
196  |  AHR  |  infer
57491  |  AHRR  |  infer
10142  |  AKAP9  |  infer
10327  |  AKR1A1  |  infer
1645  |  AKR1C1  |  infer
1646  |  AKR1C2  |  infer
8644  |  AKR1C3  |  infer
1109  |  AKR1C4  |  infer
207  |  AKT1  |  infer
208  |  AKT2  |  infer
210  |  ALAD  |  infer
10840  |  ALDH1L1  |  infer
217  |  ALDH2  |  infer
239  |  ALOX12  |  infer
246  |  ALOX15  |  infer
240  |  ALOX5  |  infer
23600  |  AMACR  |  infer
275  |  AMT  |  infer
290  |  ANPEP  |  infer
317  |  APAF1  |  infer
324  |  APC  |  infer
328  |  APEX1  |  infer
336  |  APOA2  |  infer
337  |  APOA4  |  infer
338  |  APOB  |  infer
348  |  APOE  |  infer
397  |  ARHGDIB  |  infer
9826  |  ARHGEF11  |  infer
405  |  ARNT  |  infer
472  |  ATM  |  infer
482  |  ATP1B2  |  infer
545  |  ATR  |  infer
6790  |  AURKA  |  infer
8313  |  AXIN2  |  infer
578  |  BAK1  |  infer
580  |  BARD1  |  infer
581  |  BAX  |  infer
604  |  BCL6  |  infer
613  |  BCR  |  infer
635  |  BHMT  |  infer
329  |  BIRC2  |  infer
330  |  BIRC3  |  infer
332  |  BIRC5  |  infer
641  |  BLM  |  infer
673  |  BRAF  |  infer
672  |  BRCA1  |  infer
675  |  BRCA2  |  infer
83990  |  BRIP1  |  infer
22903  |  BTBD3  |  infer
799  |  CALCR  |  infer
84254  |  CAMKK1  |  infer
55259  |  CASC1  |  infer
843  |  CASP10  |  infer
836  |  CASP3  |  infer
839  |  CASP6  |  infer
840  |  CASP7  |  infer
841  |  CASP8  |  infer
842  |  CASP9  |  infer
846  |  CASR  |  infer
847  |  CAT  |  infer
857  |  CAV1  |  infer
873  |  CBR1  |  infer
874  |  CBR3  |  infer
875  |  CBS  |  infer
6347  |  CCL2  |  infer
6352  |  CCL5  |  infer
890  |  CCNA2  |  infer
595  |  CCND1  |  infer
896  |  CCND3  |  infer
902  |  CCNH  |  infer
1232  |  CCR3  |  infer
1234  |  CCR5  |  infer
929  |  CD14  |  infer
10849  |  CD3EAP  |  infer
920  |  CD4  |  infer
958  |  CD40  |  infer
941  |  CD80  |  infer
975  |  CD81  |  infer
942  |  CD86  |  infer
978  |  CDA  |  infer
993  |  CDC25A  |  infer
994  |  CDC25B  |  infer
995  |  CDC25C  |  infer
999  |  CDH1  |  infer
1019  |  CDK4  |  infer
1020  |  CDK5  |  infer
1022  |  CDK7  |  infer
1026  |  CDKN1A  |  infer
1027  |  CDKN1B  |  infer
1028  |  CDKN1C  |  infer
1029  |  CDKN2A  |  infer
1071  |  CETP  |  infer
3075  |  CFH  |  infer
8837  |  CFLAR  |  infer
1080  |  CFTR  |  infer
1081  |  CGA  |  infer
1111  |  CHEK1  |  infer
11200  |  CHEK2  |  infer
1136  |  CHRNA3  |  infer
1138  |  CHRNA5  |  infer
1143  |  CHRNB4  |  infer
81037  |  CLPTM1L  |  infer
80781  |  COL18A1  |  infer
1312  |  COMT  |  infer
1401  |  CRP  |  infer
1436  |  CSF1R  |  infer
1437  |  CSF2  |  infer
1440  |  CSF3  |  infer
1477  |  CSTF1  |  infer
1491  |  CTH  |  infer
1493  |  CTLA4  |  infer
1499  |  CTNNB1  |  infer
1512  |  CTSH  |  infer
1524  |  CX3CR1  |  infer
6387  |  CXCL12  |  infer
1536  |  CYBB  |  infer
1583  |  CYP11A1  |  infer
1586  |  CYP17A1  |  infer
1588  |  CYP19A1  |  infer
1543  |  CYP1A1  |  infer
1544  |  CYP1A2  |  infer
1545  |  CYP1B1  |  infer
1591  |  CYP24A1  |  infer
1594  |  CYP27B1  |  infer
1553  |  CYP2A13  |  infer
1548  |  CYP2A6  |  infer
1557  |  CYP2C19  |  infer
1559  |  CYP2C9  |  infer
1565  |  CYP2D6  |  infer
1571  |  CYP2E1  |  infer
1572  |  CYP2F1  |  infer
1576  |  CYP3A4  |  infer
1577  |  CYP3A5  |  infer
1551  |  CYP3A7  |  infer
57834  |  CYP4F11  |  infer
9420  |  CYP7B1  |  infer
1643  |  DDB2  |  infer
8886  |  DDX18  |  infer
54487  |  DGCR8  |  infer
1718  |  DHCR24  |  infer
27294  |  DHDH  |  infer
1719  |  DHFR  |  infer
23405  |  DICER1  |  infer
1733  |  DIO1  |  infer
202052  |  DNAJC18  |  infer
1789  |  DNMT3B  |  infer
1812  |  DRD1  |  infer
1813  |  DRD2  |  infer
1815  |  DRD4  |  infer
1843  |  DUSP1  |  infer
79659  |  DYNC2H1  |  infer
1906  |  EDN1  |  infer
1949  |  EFNB3  |  infer
1950  |  EGF  |  infer
1956  |  EGFR  |  infer
2022  |  ENG  |  infer
2052  |  EPHX1  |  infer
2053  |  EPHX2  |  infer
2064  |  ERBB2  |  infer
2065  |  ERBB3  |  infer
2066  |  ERBB4  |  infer
2067  |  ERCC1  |  infer
2068  |  ERCC2  |  infer
2071  |  ERCC3  |  infer
2072  |  ERCC4  |  infer
2073  |  ERCC5  |  infer
2074  |  ERCC6  |  infer
2099  |  ESR1  |  infer
2100  |  ESR2  |  infer
9156  |  EXO1  |  infer
7430  |  EZR  |  infer
2175  |  FANCA  |  infer
2189  |  FANCG  |  infer
355  |  FAS  |  infer
356  |  FASLG  |  infer
55294  |  FBXW7  |  infer
2208  |  FCER2  |  infer
2230  |  FDX1  |  infer
2264  |  FGFR4  |  infer
2272  |  FHIT  |  infer
2335  |  FN1  |  infer
2353  |  FOS  |  infer
2296  |  FOXC1  |  infer
2356  |  FPGS  |  infer
2512  |  FTL  |  infer
8324  |  FZD7  |  infer
2625  |  GATA3  |  infer
2638  |  GC  |  infer
2729  |  GCLC  |  infer
2730  |  GCLM  |  infer
9518  |  GDF15  |  infer
50628  |  GEMIN4  |  infer
8836  |  GGH  |  infer
2690  |  GHR  |  infer
2262  |  GPC5  |  infer
2876  |  GPX1  |  infer
2877  |  GPX2  |  infer
2878  |  GPX3  |  infer
2879  |  GPX4  |  infer
2880  |  GPX5  |  infer
257202  |  GPX6  |  infer
2882  |  GPX7  |  infer
2925  |  GRPR  |  infer
2932  |  GSK3B  |  infer
2936  |  GSR  |  infer
2937  |  GSS  |  infer
2938  |  GSTA1  |  infer
2939  |  GSTA2  |  infer
2940  |  GSTA3  |  infer
2941  |  GSTA4  |  infer
221357  |  GSTA5  |  infer
2944  |  GSTM1  |  infer
2946  |  GSTM2  |  infer
2947  |  GSTM3  |  infer
2948  |  GSTM4  |  infer
2949  |  GSTM5  |  infer
9446  |  GSTO1  |  infer
119391  |  GSTO2  |  infer
2950  |  GSTP1  |  infer
2952  |  GSTT1  |  infer
2953  |  GSTT2  |  infer
2954  |  GSTZ1  |  infer
3030  |  HADHA  |  infer
3077  |  HFE  |  infer
3091  |  HIF1A  |  infer
55662  |  HIF1AN  |  infer
3105  |  HLA-A  |  infer
3106  |  HLA-B  |  infer
3107  |  HLA-C  |  infer
3117  |  HLA-DQA1  |  infer
3123  |  HLA-DRB1  |  infer
3156  |  HMGCR  |  infer
3162  |  HMOX1  |  infer
3248  |  HPGD  |  infer
3251  |  HPRT1  |  infer
3265  |  HRAS  |  infer
3292  |  HSD17B1  |  infer
3294  |  HSD17B2  |  infer
3295  |  HSD17B4  |  infer
3283  |  HSD3B1  |  infer
3284  |  HSD3B2  |  infer
51182  |  HSPA14  |  infer
3303  |  HSPA1A  |  infer
3304  |  HSPA1B  |  infer
3305  |  HSPA1L  |  infer
3312  |  HSPA8  |  infer
3315  |  HSPB1  |  infer
26353  |  HSPB8  |  infer
3351  |  HTR1B  |  infer
3352  |  HTR1D  |  infer
3364  |  HUS1  |  infer
3383  |  ICAM1  |  infer
3454  |  IFNAR1  |  infer
3455  |  IFNAR2  |  infer
3458  |  IFNG  |  infer
3459  |  IFNGR1  |  infer
3460  |  IFNGR2  |  infer
7866  |  IFRD2  |  infer
3479  |  IGF1  |  infer
3480  |  IGF1R  |  infer
3481  |  IGF2  |  infer
3482  |  IGF2R  |  infer
3483  |  IGFALS  |  infer
3484  |  IGFBP1  |  infer
3485  |  IGFBP2  |  infer
3486  |  IGFBP3  |  infer
3488  |  IGFBP5  |  infer
3489  |  IGFBP6  |  infer
3586  |  IL10  |  infer
3587  |  IL10RA  |  infer
3588  |  IL10RB  |  infer
3592  |  IL12A  |  infer
3593  |  IL12B  |  infer
3594  |  IL12RB1  |  infer
3596  |  IL13  |  infer
3600  |  IL15  |  infer
3601  |  IL15RA  |  infer
3603  |  IL16  |  infer
3552  |  IL1A  |  infer
3553  |  IL1B  |  infer
3554  |  IL1R1  |  infer
3556  |  IL1RAP  |  infer
3557  |  IL1RN  |  infer
3558  |  IL2  |  infer
3560  |  IL2RB  |  infer
3562  |  IL3  |  infer
3565  |  IL4  |  infer
3566  |  IL4R  |  infer
3568  |  IL5RA  |  infer
3569  |  IL6  |  infer
3570  |  IL6R  |  infer
3575  |  IL7R  |  infer
3643  |  INSR  |  infer
3658  |  IREB2  |  infer
3659  |  IRF1  |  infer
3661  |  IRF3  |  infer
3667  |  IRS1  |  infer
3718  |  JAK3  |  infer
9817  |  KEAP1  |  infer
1316  |  KLF6  |  infer
3845  |  KRAS  |  infer
25984  |  KRT23  |  infer
55353  |  LAPTM4B  |  infer
3931  |  LCAT  |  infer
3949  |  LDLR  |  infer
3952  |  LEP  |  infer
3953  |  LEPR  |  infer
3978  |  LIG1  |  infer
3980  |  LIG3  |  infer
3981  |  LIG4  |  infer
3990  |  LIPC  |  infer
9516  |  LITAF  |  infer
4005  |  LMO2  |  infer
25802  |  LMOD1  |  infer
4015  |  LOX  |  infer
4023  |  LPL  |  infer
4033  |  LRMP  |  infer
4041  |  LRP5  |  infer
4040  |  LRP6  |  infer
7940  |  LST1  |  infer
4049  |  LTA  |  infer
8379  |  MAD1L1  |  infer
4085  |  MAD2L1  |  infer
4097  |  MAFG  |  infer
4128  |  MAOA  |  infer
5604  |  MAP2K1  |  infer
6416  |  MAP2K4  |  infer
5648  |  MASP1  |  infer
9782  |  MATR3  |  infer
4152  |  MBD1  |  infer
8932  |  MBD2  |  infer
8930  |  MBD4  |  infer
4153  |  MBL2  |  infer
4193  |  MDM2  |  infer
4199  |  ME1  |  infer
4232  |  MEST  |  infer
4233  |  MET  |  infer
10988  |  METAP2  |  infer
4255  |  MGMT  |  infer
4282  |  MIF  |  infer
406973  |  MIR196A2  |  infer
4292  |  MLH1  |  infer
4300  |  MLLT3  |  infer
4312  |  MMP1  |  infer
4321  |  MMP12  |  infer
4313  |  MMP2  |  infer
4314  |  MMP3  |  infer
4318  |  MMP9  |  infer
4331  |  MNAT1  |  infer
9526  |  MPDU1  |  infer
4350  |  MPG  |  infer
4353  |  MPO  |  infer
4436  |  MSH2  |  infer
4437  |  MSH3  |  infer
4439  |  MSH5  |  infer
2956  |  MSH6  |  infer
4481  |  MSR1  |  infer
4482  |  MSRA  |  infer
4522  |  MTHFD1  |  infer
10797  |  MTHFD2  |  infer
4524  |  MTHFR  |  infer
4536  |  MT-ND2  |  infer
4548  |  MTR  |  infer
4552  |  MTRR  |  infer
4567  |  MT-TL1  |  infer
4582  |  MUC1  |  infer
4595  |  MUTYH  |  infer
4599  |  MX1  |  infer
4605  |  MYBL2  |  infer
4609  |  MYC  |  infer
55892  |  MYNN  |  infer
4644  |  MYO5A  |  infer
9  |  NAT1  |  infer
10  |  NAT2  |  infer
4683  |  NBN  |  infer
4688  |  NCF2  |  infer
8202  |  NCOA3  |  infer
23054  |  NCOA6  |  infer
79661  |  NEIL1  |  infer
4790  |  NFKB1  |  infer
4792  |  NFKBIA  |  infer
4794  |  NFKBIE  |  infer
4814  |  NINJ1  |  infer
4830  |  NME1  |  infer
4846  |  NOS3  |  infer
1728  |  NQO1  |  infer
9971  |  NR1H4  |  infer
4893  |  NRAS  |  infer
4682  |  NUBP1  |  infer
10101  |  NUBP2  |  infer
4521  |  NUDT1  |  infer
4948  |  OCA2  |  infer
4968  |  OGG1  |  infer
4985  |  OPRD1  |  infer
4988  |  OPRM1  |  infer
5027  |  P2RX7  |  infer
56924  |  PAK6  |  infer
142  |  PARP1  |  infer
143  |  PARP4  |  infer
5111  |  PCNA  |  infer
58488  |  PCTP  |  infer
9141  |  PDCD5  |  infer
5241  |  PGR  |  infer
5245  |  PHB  |  infer
5290  |  PIK3CA  |  infer
5292  |  PIM1  |  infer
5300  |  PIN1  |  infer
143689  |  PIWIL4  |  infer
5320  |  PLA2G2A  |  infer
8398  |  PLA2G6  |  infer
5328  |  PLAU  |  infer
5329  |  PLAUR  |  infer
5347  |  PLK1  |  infer
5378  |  PMS1  |  infer
5395  |  PMS2  |  infer
5423  |  POLB  |  infer
5424  |  POLD1  |  infer
5426  |  POLE  |  infer
11201  |  POLI  |  infer
5444  |  PON1  |  infer
25913  |  POT1  |  infer
5465  |  PPARA  |  infer
5467  |  PPARD  |  infer
5468  |  PPARG  |  infer
4659  |  PPP1R12A  |  infer
10848  |  PPP1R13L  |  infer
5519  |  PPP2R1B  |  infer
7799  |  PRDM2  |  infer
5685  |  PSMA4  |  infer
5728  |  PTEN  |  infer
5742  |  PTGS1  |  infer
5743  |  PTGS2  |  infer
5741  |  PTH  |  infer
376267  |  RAB15  |  infer
5879  |  RAC1  |  infer
56852  |  RAD18  |  infer
5887  |  RAD23B  |  infer
5888  |  RAD51  |  infer
5893  |  RAD52  |  infer
8438  |  RAD54L  |  infer
5896  |  RAG1  |  infer
5901  |  RAN  |  infer
5921  |  RASA1  |  infer
11186  |  RASSF1  |  infer
11228  |  RASSF8  |  infer
9821  |  RB1CC1  |  infer
85004  |  RERG  |  infer
5979  |  RET  |  infer
26575  |  RGS17  |  infer
5997  |  RGS2  |  infer
8490  |  RGS5  |  infer
9628  |  RGS6  |  infer
6041  |  RNASEL  |  infer
6098  |  ROS1  |  infer
29935  |  RPA4  |  infer
6240  |  RRM1  |  infer
50484  |  RRM2B  |  infer
6256  |  RXRA  |  infer
6257  |  RXRB  |  infer
112483  |  SAT2  |  infer
949  |  SCARB1  |  infer
57758  |  SCUBE2  |  infer
23541  |  SEC14L2  |  infer
6401  |  SELE  |  infer
7869  |  SEMA3B  |  infer
5265  |  SERPINA1  |  infer
23544  |  SEZ6L  |  infer
653509  |  SFTPA1  |  infer
6439  |  SFTPB  |  infer
6441  |  SFTPD  |  infer
6462  |  SHBG  |  infer
6470  |  SHMT1  |  infer
6504  |  SLAMF1  |  infer
6573  |  SLC19A1  |  infer
9963  |  SLC23A1  |  infer
9962  |  SLC23A2  |  infer
55315  |  SLC29A3  |  infer
6513  |  SLC2A1  |  infer
6517  |  SLC2A4  |  infer
7779  |  SLC30A1  |  infer
7780  |  SLC30A2  |  infer
64924  |  SLC30A5  |  infer
29986  |  SLC39A2  |  infer
6522  |  SLC4A2  |  infer
6531  |  SLC6A3  |  infer
10599  |  SLCO1B1  |  infer
8435  |  SOAT2  |  infer
6647  |  SOD1  |  infer
6648  |  SOD2  |  infer
6649  |  SOD3  |  infer
10011  |  SRA1  |  infer
8082  |  SSPN  |  infer
6753  |  SSTR3  |  infer
6772  |  STAT1  |  infer
6794  |  STK11  |  infer
134957  |  STXBP5  |  infer
6817  |  SULT1A1  |  infer
79723  |  SUV39H2  |  infer
6996  |  TDG  |  infer
7011  |  TEP1  |  infer
7013  |  TERF1  |  infer
7014  |  TERF2  |  infer
7015  |  TERT  |  infer
7031  |  TFF1  |  infer
7033  |  TFF3  |  infer
7980  |  TFPI2  |  infer
7037  |  TFRC  |  infer
7040  |  TGFB1  |  infer
7046  |  TGFBR1  |  infer
7051  |  TGM1  |  infer
9333  |  TGM5  |  infer
7097  |  TLR2  |  infer
7124  |  TNF  |  infer
8797  |  TNFRSF10A  |  infer
7132  |  TNFRSF1A  |  infer
7133  |  TNFRSF1B  |  infer
10318  |  TNIP1  |  infer
8658  |  TNKS  |  infer
7157  |  TP53  |  infer
7158  |  TP53BP1  |  infer
9540  |  TP53I3  |  infer
7161  |  TP73  |  infer
1787  |  TRDMT1  |  infer
54802  |  TRIT1  |  infer
7251  |  TSG101  |  infer
706  |  TSPO  |  infer
7298  |  TYMS  |  infer
7299  |  TYR  |  infer
7352  |  UCP3  |  infer
54658  |  UGT1A1  |  infer
54657  |  UGT1A4  |  infer
54577  |  UGT1A7  |  infer
54600  |  UGT1A9  |  infer
7367  |  UGT2B17  |  infer
7412  |  VCAM1  |  infer
7421  |  VDR  |  infer
7422  |  VEGFA  |  infer
7486  |  WRN  |  infer
7494  |  XBP1  |  infer
7507  |  XPA  |  infer
7508  |  XPC  |  infer
57510  |  XPO5  |  infer
7515  |  XRCC1  |  infer
7516  |  XRCC2  |  infer
7517  |  XRCC3  |  infer
7518  |  XRCC4  |  infer
7520  |  XRCC5  |  infer
2547  |  XRCC6  |  infer
10413  |  YAP1  |  infer
161882  |  ZFPM1  |  infer
7773  |  ZNF230  |  infer
59348  |  ZNF350  |  infer
238  |  ALK  |  infer
383  |  ARG1  |  infer
384  |  ARG2  |  infer
596  |  BCL2  |  infer
701  |  BUB1B  |  infer
728  |  C5AR1  |  infer
29775  |  CARD10  |  infer
838  |  CASP5  |  infer
729230  |  CCR2  |  infer
9350  |  CER1  |  infer
1134  |  CHRNA1  |  infer
1139  |  CHRNA7  |  infer
1490  |  CTGF  |  infer
1558  |  CYP2C8  |  infer
64816  |  CYP3A43  |  infer
1672  |  DEFB1  |  infer
8667  |  EIF3H  |  infer
1996  |  ELAVL4  |  infer
2139  |  EYA2  |  infer
2146  |  EZH2  |  infer
2237  |  FEN1  |  infer
1647  |  GADD45A  |  infer
2965  |  GTF2H1  |  infer
84868  |  HAVCR2  |  infer
3119  |  HLA-DQB1  |  infer
3606  |  IL18  |  infer
3567  |  IL5  |  infer
22801  |  ITGA11  |  infer
3690  |  ITGB3  |  infer
3791  |  KDR  |  infer
27030  |  MLH3  |  infer
4322  |  MMP13  |  infer
4316  |  MMP7  |  infer
4317  |  MMP8  |  infer
4586  |  MUC5AC  |  infer
24142  |  NAT6  |  infer
64127  |  NOD2  |  infer
4843  |  NOS2  |  infer
8856  |  NR1I2  |  infer
5099  |  PCDH7  |  infer
5591  |  PRKDC  |  infer
5732  |  PTGER2  |  infer
5740  |  PTGIS  |  infer
5829  |  PXN  |  infer
5925  |  RB1  |  infer
51455  |  REV1  |  infer
5981  |  RFC1  |  infer
6273  |  S100A2  |  infer
7356  |  SCGB1A1  |  infer
12  |  SERPINA3  |  infer
5055  |  SERPINB2  |  infer
5054  |  SERPINE1  |  infer
5270  |  SERPINE2  |  infer
6581  |  SLC22A3  |  infer
9154  |  SLC28A1  |  infer
7782  |  SLC30A4  |  infer
6774  |  STAT3  |  infer
27347  |  STK39  |  infer
7341  |  SUMO1  |  infer
54386  |  TERF2IP  |  infer
54106  |  TLR9  |  infer
8771  |  TNFRSF6B  |  infer
8626  |  TP63  |  infer
222642  |  TSPO2  |  infer
7329  |  UBE2I  |  infer
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:2219)
100132116  |  ACTA2-AS1  |  DISEASES
84740  |  AFAP1-AS1  |  DISEASES
100130776  |  AGAP2-AS1  |  DISEASES
100885775  |  BANCR  |  DISEASES
101805488  |  CCAT2  |  DISEASES
100048912  |  CDKN2B-AS1  |  DISEASES
6405  |  SEMA3F  |  DISEASES
1595  |  CYP51A1  |  DISEASES
6362  |  CCL18  |  DISEASES
5898  |  RALA  |  DISEASES
55971  |  BAIAP2L1  |  DISEASES
1856  |  DVL2  |  DISEASES
3207  |  HOXA11  |  DISEASES
3675  |  ITGA3  |  DISEASES
928  |  CD9  |  DISEASES
972  |  CD74  |  DISEASES
4830  |  NME1  |  DISEASES
2067  |  ERCC1  |  DISEASES
9052  |  GPRC5A  |  DISEASES
10928  |  RALBP1  |  DISEASES
6591  |  SNAI2  |  DISEASES
1015  |  CDH17  |  DISEASES
84245  |  MRI1  |  DISEASES
65078  |  RTN4R  |  DISEASES
5685  |  PSMA4  |  DISEASES
7984  |  ARHGEF5  |  DISEASES
4826  |  NNAT  |  DISEASES
6515  |  SLC2A3  |  DISEASES
55359  |  STYK1  |  DISEASES
53615  |  MBD3  |  DISEASES
84254  |  CAMKK1  |  DISEASES
634  |  CEACAM1  |  DISEASES
7132  |  TNFRSF1A  |  DISEASES
57595  |  PDZD4  |  DISEASES
9319  |  TRIP13  |  DISEASES
3861  |  KRT14  |  DISEASES
54474  |  KRT20  |  DISEASES
9817  |  KEAP1  |  DISEASES
7145  |  TNS1  |  DISEASES
7216  |  TRO  |  DISEASES
30009  |  TBX21  |  DISEASES
771  |  CA12  |  DISEASES
51208  |  CLDN18  |  DISEASES
4680  |  CEACAM6  |  DISEASES
3691  |  ITGB4  |  DISEASES
4504  |  MT3  |  DISEASES
28954  |  REM1  |  DISEASES
23368  |  PPP1R13B  |  DISEASES
3902  |  LAG3  |  DISEASES
7066  |  THPO  |  DISEASES
10683  |  DLL3  |  DISEASES
2099  |  ESR1  |  DISEASES
26575  |  RGS17  |  DISEASES
990  |  CDC6  |  DISEASES
7414  |  VCL  |  DISEASES
23411  |  SIRT1  |  DISEASES
7049  |  TGFBR3  |  DISEASES
5714  |  PSMD8  |  DISEASES
513  |  ATP5D  |  DISEASES
4616  |  GADD45B  |  DISEASES
4320  |  MMP11  |  DISEASES
4282  |  MIF  |  DISEASES
2953  |  GSTT2  |  DISEASES
5008  |  OSM  |  DISEASES
5594  |  MAPK1  |  DISEASES
25776  |  CBY1  |  DISEASES
7494  |  XBP1  |  DISEASES
638  |  BIK  |  DISEASES
3162  |  HMOX1  |  DISEASES
23551  |  RASD2  |  DISEASES
49  |  ACR  |  DISEASES
9978  |  RBX1  |  DISEASES
3002  |  GZMB  |  DISEASES
1113  |  CHGA  |  DISEASES
6554  |  SLC10A1  |  DISEASES
328  |  APEX1  |  DISEASES
4792  |  NFKBIA  |  DISEASES
84312  |  BRMS1L  |  DISEASES
1591  |  CYP24A1  |  DISEASES
6790  |  AURKA  |  DISEASES
10544  |  PROCR  |  DISEASES
4605  |  MYBL2  |  DISEASES
57167  |  SALL4  |  DISEASES
79444  |  BIRC7  |  DISEASES
1917  |  EEF1A2  |  DISEASES
55612  |  FERMT1  |  DISEASES
5173  |  PDYN  |  DISEASES
9352  |  TXNL1  |  DISEASES
25878  |  MXRA5  |  DISEASES
10857  |  PGRMC1  |  DISEASES
51311  |  TLR8  |  DISEASES
7076  |  TIMP1  |  DISEASES
54  |  ACP5  |  DISEASES
10562  |  OLFM4  |  DISEASES
4313  |  MMP2  |  DISEASES
6367  |  CCL22  |  DISEASES
50855  |  PARD6A  |  DISEASES
4324  |  MMP15  |  DISEASES
55512  |  SMPD3  |  DISEASES
7249  |  TSC2  |  DISEASES
10273  |  STUB1  |  DISEASES
123263  |  MTFMT  |  DISEASES
2137  |  EXTL3  |  DISEASES
2222  |  FDFT1  |  DISEASES
7038  |  TG  |  DISEASES
10404  |  CPQ  |  DISEASES
1666  |  DECR1  |  DISEASES
6422  |  SFRP1  |  DISEASES
5327  |  PLAT  |  DISEASES
83988  |  NCALD  |  DISEASES
8797  |  TNFRSF10A  |  DISEASES
7991  |  TUSC3  |  DISEASES
54623  |  PAF1  |  DISEASES
27294  |  DHDH  |  DISEASES
3191  |  HNRNPL  |  DISEASES
5971  |  RELB  |  DISEASES
166  |  AES  |  DISEASES
7040  |  TGFB1  |  DISEASES
973  |  CD79A  |  DISEASES
1048  |  CEACAM5  |  DISEASES
9545  |  RAB3D  |  DISEASES
2057  |  EPOR  |  DISEASES
5296  |  PIK3R2  |  DISEASES
7392  |  USF2  |  DISEASES
3082  |  HGF  |  DISEASES
7980  |  TFPI2  |  DISEASES
858  |  CAV2  |  DISEASES
3202  |  HOXA5  |  DISEASES
83451  |  ABHD11  |  DISEASES
1577  |  CYP3A5  |  DISEASES
7965  |  AIMP2  |  DISEASES
5054  |  SERPINE1  |  DISEASES
7431  |  VIM  |  DISEASES
2662  |  GDF10  |  DISEASES
6348  |  CCL3  |  DISEASES
4353  |  MPO  |  DISEASES
1440  |  CSF3  |  DISEASES
6198  |  RPS6KB1  |  DISEASES
51655  |  RASD1  |  DISEASES
708  |  C1QBP  |  DISEASES
218  |  ALDH3A1  |  DISEASES
6347  |  CCL2  |  DISEASES
6346  |  CCL1  |  DISEASES
51225  |  ABI3  |  DISEASES
5957  |  RCVRN  |  DISEASES
7448  |  VTN  |  DISEASES
7126  |  TNFAIP1  |  DISEASES
27346  |  TMEM97  |  DISEASES
8456  |  FOXN1  |  DISEASES
3381  |  IBSP  |  DISEASES
4790  |  NFKB1  |  DISEASES
3558  |  IL2  |  DISEASES
3732  |  CD82  |  DISEASES
3312  |  HSPA8  |  DISEASES
595  |  CCND1  |  DISEASES
329  |  BIRC2  |  DISEASES
4254  |  KITLG  |  DISEASES
5829  |  PXN  |  DISEASES
969  |  CD69  |  DISEASES
1594  |  CYP27B1  |  DISEASES
2735  |  GLI1  |  DISEASES
1027  |  CDKN1B  |  DISEASES
397  |  ARHGDIB  |  DISEASES
3458  |  IFNG  |  DISEASES
2597  |  GAPDH  |  DISEASES
7167  |  TPI1  |  DISEASES
2026  |  ENO2  |  DISEASES
113246  |  C12orf57  |  DISEASES
79923  |  NANOG  |  DISEASES
3945  |  LDHB  |  DISEASES
55907  |  CMAS  |  DISEASES
2729  |  GCLC  |  DISEASES
80329  |  ULBP1  |  DISEASES
1432  |  MAPK14  |  DISEASES
51053  |  GMNN  |  DISEASES
1611  |  DAP  |  DISEASES
1839  |  HBEGF  |  DISEASES
4015  |  LOX  |  DISEASES
6678  |  SPARC  |  DISEASES
3565  |  IL4  |  DISEASES
3567  |  IL5  |  DISEASES
6500  |  SKP1  |  DISEASES
2908  |  NR3C1  |  DISEASES
5917  |  RARS  |  DISEASES
4292  |  MLH1  |  DISEASES
1894  |  ECT2  |  DISEASES
2779  |  GNAT1  |  DISEASES
11334  |  TUSC2  |  DISEASES
10641  |  NPRL2  |  DISEASES
4820  |  NKTR  |  DISEASES
9168  |  TMSB10  |  DISEASES
4436  |  MSH2  |  DISEASES
374291  |  NDUFS7  |  DISEASES
3485  |  IGFBP2  |  DISEASES
3488  |  IGFBP5  |  DISEASES
4953  |  ODC1  |  DISEASES
2023  |  ENO1  |  DISEASES
9068  |  ANGPTL1  |  DISEASES
79084  |  WDR77  |  DISEASES
7799  |  PRDM2  |  DISEASES
6402  |  SELL  |  DISEASES
1509  |  CTSD  |  DISEASES
4317  |  MMP8  |  DISEASES
7276  |  TTR  |  DISEASES
9519  |  TBPL1  |  DISEASES
6943  |  TCF21  |  DISEASES
2691  |  GHRH  |  DISEASES
9429  |  ABCG2  |  DISEASES
9525  |  VPS4B  |  DISEASES
5273  |  SERPINB10  |  DISEASES
7043  |  TGFB3  |  DISEASES
1843  |  DUSP1  |  DISEASES
8600  |  TNFSF11  |  DISEASES
1958  |  EGR1  |  DISEASES
5217  |  PFN2  |  DISEASES
1748  |  DLX4  |  DISEASES
10342  |  TFG  |  DISEASES
2703  |  GJA8  |  DISEASES
847  |  CAT  |  DISEASES
8743  |  TNFSF10  |  DISEASES
2946  |  GSTM2  |  DISEASES
51426  |  POLK  |  DISEASES
2322  |  FLT3  |  DISEASES
7291  |  TWIST1  |  DISEASES
79365  |  BHLHE41  |  DISEASES
140690  |  CTCFL  |  DISEASES
5740  |  PTGIS  |  DISEASES
6615  |  SNAI1  |  DISEASES
4109  |  MAGEA10  |  DISEASES
27076  |  LYPD3  |  DISEASES
1088  |  CEACAM8  |  DISEASES
8339  |  HIST1H2BG  |  DISEASES
1026  |  CDKN1A  |  DISEASES
6659  |  SOX4  |  DISEASES
6745  |  SSR1  |  DISEASES
2069  |  EREG  |  DISEASES
583  |  BBS2  |  DISEASES
56848  |  SPHK2  |  DISEASES
9271  |  PIWIL1  |  DISEASES
1948  |  EFNB2  |  DISEASES
652  |  BMP4  |  DISEASES
6662  |  SOX9  |  DISEASES
51081  |  MRPS7  |  DISEASES
8744  |  TNFSF9  |  DISEASES
718  |  C3  |  DISEASES
994  |  CDC25B  |  DISEASES
11034  |  DSTN  |  DISEASES
826  |  CAPNS1  |  DISEASES
1236  |  CCR7  |  DISEASES
6945  |  MLX  |  DISEASES
7355  |  SLC35A2  |  DISEASES
9787  |  DLGAP5  |  DISEASES
30848  |  CTAG2  |  DISEASES
29085  |  PHPT1  |  DISEASES
10365  |  KLF2  |  DISEASES
9002  |  F2RL3  |  DISEASES
3315  |  HSPB1  |  DISEASES
2678  |  GGT1  |  DISEASES
23544  |  SEZ6L  |  DISEASES
2952  |  GSTT1  |  DISEASES
10738  |  RFPL3  |  DISEASES
5880  |  RAC2  |  DISEASES
611  |  OPN1SW  |  DISEASES
22933  |  SIRT2  |  DISEASES
3232  |  HOXD3  |  DISEASES
8554  |  PIAS1  |  DISEASES
54567  |  DLL4  |  DISEASES
8930  |  MBD4  |  DISEASES
968  |  CD68  |  DISEASES
6351  |  CCL4  |  DISEASES
8840  |  WISP1  |  DISEASES
599  |  BCL2L2  |  DISEASES
10038  |  PARP2  |  DISEASES
3169  |  FOXA1  |  DISEASES
1036  |  CDO1  |  DISEASES
3630  |  INS  |  DISEASES
9717  |  SEC14L5  |  DISEASES
57488  |  ESYT2  |  DISEASES
5157  |  PDGFRL  |  DISEASES
50484  |  RRM2B  |  DISEASES
5894  |  RAF1  |  DISEASES
7251  |  TSG101  |  DISEASES
1890  |  TYMP  |  DISEASES
2006  |  ELN  |  DISEASES
653857  |  ACTR3C  |  DISEASES
3852  |  KRT5  |  DISEASES
3854  |  KRT6B  |  DISEASES
1264  |  CNN1  |  DISEASES
10912  |  GADD45G  |  DISEASES
81  |  ACTN4  |  DISEASES
2056  |  EPO  |  DISEASES
9518  |  GDF15  |  DISEASES
3727  |  JUND  |  DISEASES
1571  |  CYP2E1  |  DISEASES
140628  |  GATA5  |  DISEASES
10155  |  TRIM28  |  DISEASES
83667  |  SESN2  |  DISEASES
9590  |  AKAP12  |  DISEASES
9113  |  LATS1  |  DISEASES
55902  |  ACSS2  |  DISEASES
51659  |  GINS2  |  DISEASES
9476  |  NAPSA  |  DISEASES
47  |  ACLY  |  DISEASES
3866  |  KRT15  |  DISEASES
8431  |  NR0B2  |  DISEASES
79727  |  LIN28A  |  DISEASES
55860  |  ACTR10  |  DISEASES
3958  |  LGALS3  |  DISEASES
6382  |  SDC1  |  DISEASES
84674  |  CARD6  |  DISEASES
5176  |  SERPINF1  |  DISEASES
182  |  JAG1  |  DISEASES
6754  |  SSTR4  |  DISEASES
1401  |  CRP  |  DISEASES
325  |  APCS  |  DISEASES
1116  |  CHI3L1  |  DISEASES
8900  |  CCNA1  |  DISEASES
23640  |  HSPBP1  |  DISEASES
5920  |  RARRES3  |  DISEASES
57180  |  ACTR3B  |  DISEASES
4922  |  NTS  |  DISEASES
3845  |  KRAS  |  DISEASES
10526  |  IPO8  |  DISEASES
759  |  CA1  |  DISEASES
10894  |  LYVE1  |  DISEASES
157310  |  PEBP4  |  DISEASES
891  |  CCNB1  |  DISEASES
1022  |  CDK7  |  DISEASES
8553  |  BHLHE40  |  DISEASES
10752  |  CHL1  |  DISEASES
83998  |  REG4  |  DISEASES
2947  |  GSTM3  |  DISEASES
4853  |  NOTCH2  |  DISEASES
10468  |  FST  |  DISEASES
10595  |  ERN2  |  DISEASES
2922  |  GRP  |  DISEASES
902  |  CCNH  |  DISEASES
91768  |  CABLES1  |  DISEASES
1643  |  DDB2  |  DISEASES
2346  |  FOLH1  |  DISEASES
1830  |  DSG3  |  DISEASES
5156  |  PDGFRA  |  DISEASES
11095  |  ADAMTS8  |  DISEASES
301  |  ANXA1  |  DISEASES
6927  |  HNF1A  |  DISEASES
967  |  CD63  |  DISEASES
1019  |  CDK4  |  DISEASES
4829  |  NMBR  |  DISEASES
1593  |  CYP27A1  |  DISEASES
9392  |  TGFBRAP1  |  DISEASES
10643  |  IGF2BP3  |  DISEASES
3569  |  IL6  |  DISEASES
26257  |  NKX2-8  |  DISEASES
3658  |  IREB2  |  DISEASES
6426  |  SRSF1  |  DISEASES
9936  |  CD302  |  DISEASES
6366  |  CCL21  |  DISEASES
2295  |  FOXF2  |  DISEASES
5460  |  POU5F1  |  DISEASES
7097  |  TLR2  |  DISEASES
8836  |  GGH  |  DISEASES
81796  |  SLCO5A1  |  DISEASES
4316  |  MMP7  |  DISEASES
2230  |  FDX1  |  DISEASES
4322  |  MMP13  |  DISEASES
7057  |  THBS1  |  DISEASES
3706  |  ITPKA  |  DISEASES
1588  |  CYP19A1  |  DISEASES
1545  |  CYP1B1  |  DISEASES
6496  |  SIX3  |  DISEASES
1559  |  CYP2C9  |  DISEASES
3832  |  KIF11  |  DISEASES
11073  |  TOPBP1  |  DISEASES
53836  |  GPR87  |  DISEASES
2660  |  MSTN  |  DISEASES
9360  |  PPIG  |  DISEASES
1134  |  CHRNA1  |  DISEASES
9194  |  SLC16A7  |  DISEASES
6857  |  SYT1  |  DISEASES
4659  |  PPP1R12A  |  DISEASES
894  |  CCND2  |  DISEASES
4069  |  LYZ  |  DISEASES
5037  |  PEBP1  |  DISEASES
9956  |  HS3ST2  |  DISEASES
9891  |  NUAK1  |  DISEASES
7450  |  VWF  |  DISEASES
3093  |  UBE2K  |  DISEASES
5687  |  PSMA6  |  DISEASES
23326  |  USP22  |  DISEASES
6095  |  RORA  |  DISEASES
9097  |  USP14  |  DISEASES
8140  |  SLC7A5  |  DISEASES
217  |  ALDH2  |  DISEASES
1143  |  CHRNB4  |  DISEASES
999  |  CDH1  |  DISEASES
5159  |  PDGFRB  |  DISEASES
2196  |  FAT2  |  DISEASES
2324  |  FLT4  |  DISEASES
57472  |  CNOT6  |  DISEASES
9043  |  SPAG9  |  DISEASES
3690  |  ITGB3  |  DISEASES
4223  |  MEOX2  |  DISEASES
1975  |  EIF4B  |  DISEASES
23531  |  MMD  |  DISEASES
4481  |  MSR1  |  DISEASES
4173  |  MCM4  |  DISEASES
57045  |  TWSG1  |  DISEASES
5934  |  RBL2  |  DISEASES
4092  |  SMAD7  |  DISEASES
4087  |  SMAD2  |  DISEASES
3757  |  KCNH2  |  DISEASES
7528  |  YY1  |  DISEASES
945  |  CD33  |  DISEASES
81671  |  VMP1  |  DISEASES
55771  |  PRR11  |  DISEASES
8312  |  AXIN1  |  DISEASES
1387  |  CREBBP  |  DISEASES
2294  |  FOXF1  |  DISEASES
23406  |  COTL1  |  DISEASES
6416  |  MAP2K4  |  DISEASES
6558  |  SLC12A2  |  DISEASES
1459  |  CSNK2A2  |  DISEASES
898  |  CCNE1  |  DISEASES
9878  |  TOX4  |  DISEASES
84962  |  AJUBA  |  DISEASES
8503  |  PIK3R3  |  DISEASES
5052  |  PRDX1  |  DISEASES
7077  |  TIMP2  |  DISEASES
3959  |  LGALS3BP  |  DISEASES
25939  |  SAMHD1  |  DISEASES
7515  |  XRCC1  |  DISEASES
1871  |  E2F3  |  DISEASES
10552  |  ARPC1A  |  DISEASES
51588  |  PIAS4  |  DISEASES
5595  |  MAPK3  |  DISEASES
1326  |  MAP3K8  |  DISEASES
9422  |  ZNF264  |  DISEASES
8030  |  CCDC6  |  DISEASES
6598  |  SMARCB1  |  DISEASES
1109  |  AKR1C4  |  DISEASES
54487  |  DGCR8  |  DISEASES
6855  |  SYP  |  DISEASES
2033  |  EP300  |  DISEASES
3978  |  LIG1  |  DISEASES
3552  |  IL1A  |  DISEASES
3553  |  IL1B  |  DISEASES
23476  |  BRD4  |  DISEASES
4854  |  NOTCH3  |  DISEASES
29099  |  COMMD9  |  DISEASES
330  |  BIRC3  |  DISEASES
1991  |  ELANE  |  DISEASES
6403  |  SELP  |  DISEASES
2034  |  EPAS1  |  DISEASES
4072  |  EPCAM  |  DISEASES
4722  |  NDUFS3  |  DISEASES
7301  |  TYRO3  |  DISEASES
4058  |  LTK  |  DISEASES
10000  |  AKT3  |  DISEASES
3574  |  IL7  |  DISEASES
390  |  RND3  |  DISEASES
3791  |  KDR  |  DISEASES
5317  |  PKP1  |  DISEASES
5290  |  PIK3CA  |  DISEASES
10664  |  CTCF  |  DISEASES
1001  |  CDH3  |  DISEASES
867  |  CBL  |  DISEASES
4162  |  MCAM  |  DISEASES
60482  |  SLC5A7  |  DISEASES
10382  |  TUBB4A  |  DISEASES
4175  |  MCM6  |  DISEASES
10874  |  NMU  |  DISEASES
941  |  CD80  |  DISEASES
54940  |  OCIAD1  |  DISEASES
10144  |  FAM13A  |  DISEASES
590  |  BCHE  |  DISEASES
8452  |  CUL3  |  DISEASES
1475  |  CSTA  |  DISEASES
374  |  AREG  |  DISEASES
2247  |  FGF2  |  DISEASES
27338  |  UBE2S  |  DISEASES
3589  |  IL11  |  DISEASES
9759  |  HDAC4  |  DISEASES
1356  |  CP  |  DISEASES
7474  |  WNT5A  |  DISEASES
7067  |  THRA  |  DISEASES
6774  |  STAT3  |  DISEASES
23415  |  KCNH4  |  DISEASES
2255  |  FGF10  |  DISEASES
4552  |  MTRR  |  DISEASES
5443  |  POMC  |  DISEASES
1788  |  DNMT3A  |  DISEASES
8626  |  TP63  |  DISEASES
3680  |  ITGA9  |  DISEASES
7297  |  TYK2  |  DISEASES
3383  |  ICAM1  |  DISEASES
306  |  ANXA3  |  DISEASES
56852  |  RAD18  |  DISEASES
10016  |  PDCD6  |  DISEASES
11063  |  SOX30  |  DISEASES
3827  |  KNG1  |  DISEASES
4171  |  MCM2  |  DISEASES
1004  |  CDH6  |  DISEASES
1462  |  VCAN  |  DISEASES
4437  |  MSH3  |  DISEASES
80315  |  CPEB4  |  DISEASES
51121  |  RPL26L1  |  DISEASES
6897  |  TARS  |  DISEASES
839  |  CASP6  |  DISEASES
51176  |  LEF1  |  DISEASES
1950  |  EGF  |  DISEASES
9061  |  PAPSS1  |  DISEASES
54908  |  SPDL1  |  DISEASES
7416  |  VDAC1  |  DISEASES
57510  |  XPO5  |  DISEASES
10371  |  SEMA3A  |  DISEASES
8829  |  NRP1  |  DISEASES
1390  |  CREM  |  DISEASES
7365  |  UGT2B10  |  DISEASES
7472  |  WNT2  |  DISEASES
25824  |  PRDX5  |  DISEASES
23649  |  POLA2  |  DISEASES
51083  |  GAL  |  DISEASES
1119  |  CHKA  |  DISEASES
5243  |  ABCB1  |  DISEASES
6717  |  SRI  |  DISEASES
1021  |  CDK6  |  DISEASES
5218  |  CDK14  |  DISEASES
54443  |  ANLN  |  DISEASES
10863  |  ADAM28  |  DISEASES
11178  |  LZTS1  |  DISEASES
29999  |  FSCN3  |  DISEASES
8379  |  MAD1L1  |  DISEASES
55749  |  CCAR1  |  DISEASES
2965  |  GTF2H1  |  DISEASES
5286  |  PIK3C2A  |  DISEASES
10180  |  RBM6  |  DISEASES
3373  |  HYAL1  |  DISEASES
7078  |  TIMP3  |  DISEASES
939  |  CD27  |  DISEASES
429  |  ASCL1  |  DISEASES
1017  |  CDK2  |  DISEASES
6895  |  TARBP2  |  DISEASES
79035  |  NABP2  |  DISEASES
6601  |  SMARCC2  |  DISEASES
2065  |  ERBB3  |  DISEASES
23344  |  ESYT1  |  DISEASES
5925  |  RB1  |  DISEASES
6751  |  SSTR1  |  DISEASES
6252  |  RTN1  |  DISEASES
2252  |  FGF7  |  DISEASES
54939  |  COMMD4  |  DISEASES
597  |  BCL2A1  |  DISEASES
3480  |  IGF1R  |  DISEASES
5045  |  FURIN  |  DISEASES
8826  |  IQGAP1  |  DISEASES
3687  |  ITGAX  |  DISEASES
85407  |  NKD1  |  DISEASES
81631  |  MAP1LC3B  |  DISEASES
284086  |  NEK8  |  DISEASES
28987  |  NOB1  |  DISEASES
55040  |  EPN3  |  DISEASES
1000  |  CDH2  |  DISEASES
2627  |  GATA6  |  DISEASES
7157  |  TP53  |  DISEASES
396  |  ARHGDIA  |  DISEASES
201292  |  TRIM65  |  DISEASES
2064  |  ERBB2  |  DISEASES
3858  |  KRT10  |  DISEASES
3487  |  IGFBP4  |  DISEASES
10270  |  AKAP8  |  DISEASES
5678  |  PSG9  |  DISEASES
150094  |  SIK1  |  DISEASES
207  |  AKT1  |  DISEASES
114783  |  LMTK3  |  DISEASES
5226  |  PGD  |  DISEASES
58985  |  IL22RA1  |  DISEASES
83540  |  NUF2  |  DISEASES
4209  |  MEF2D  |  DISEASES
6282  |  S100A11  |  DISEASES
9869  |  SETDB1  |  DISEASES
3707  |  ITPKB  |  DISEASES
10637  |  LEFTY1  |  DISEASES
2052  |  EPHX1  |  DISEASES
388  |  RHOB  |  DISEASES
805  |  CALM2  |  DISEASES
5899  |  RALB  |  DISEASES
140739  |  UBE2F  |  DISEASES
5868  |  RAB5A  |  DISEASES
10217  |  CTDSPL  |  DISEASES
9922  |  IQSEC1  |  DISEASES
26018  |  LRIG1  |  DISEASES
890  |  CCNA2  |  DISEASES
6423  |  SFRP2  |  DISEASES
6502  |  SKP2  |  DISEASES
5295  |  PIK3R1  |  DISEASES
5921  |  RASA1  |  DISEASES
81786  |  TRIM7  |  DISEASES
4594  |  MUT  |  DISEASES
23500  |  DAAM2  |  DISEASES
222663  |  SCUBE3  |  DISEASES
55023  |  PHIP  |  DISEASES
319100  |  TAAR6  |  DISEASES
257218  |  SHPRH  |  DISEASES
79017  |  GGCT  |  DISEASES
1956  |  EGFR  |  DISEASES
113130  |  CDCA5  |  DISEASES
3484  |  IGFBP1  |  DISEASES
5723  |  PSPH  |  DISEASES
2041  |  EPHA1  |  DISEASES
10395  |  DLC1  |  DISEASES
4103  |  MAGEA4  |  DISEASES
8973  |  CHRNA6  |  DISEASES
9046  |  DOK2  |  DISEASES
8795  |  TNFRSF10B  |  DISEASES
63978  |  PRDM14  |  DISEASES
7013  |  TERF1  |  DISEASES
1030  |  CDKN2B  |  DISEASES
3439  |  IFNA1  |  DISEASES
4915  |  NTRK2  |  DISEASES
3934  |  LCN2  |  DISEASES
4851  |  NOTCH1  |  DISEASES
7356  |  SCGB1A1  |  DISEASES
6749  |  SSRP1  |  DISEASES
472  |  ATM  |  DISEASES
9219  |  MTA2  |  DISEASES
90952  |  ESAM  |  DISEASES
6876  |  TAGLN  |  DISEASES
5531  |  PPP4C  |  DISEASES
4319  |  MMP10  |  DISEASES
1848  |  DUSP6  |  DISEASES
27250  |  PDCD4  |  DISEASES
7424  |  VEGFC  |  DISEASES
3606  |  IL18  |  DISEASES
5805  |  PTS  |  DISEASES
23657  |  SLC7A11  |  DISEASES
3948  |  LDHC  |  DISEASES
1824  |  DSC2  |  DISEASES
4718  |  NDUFC2  |  DISEASES
4613  |  MYCN  |  DISEASES
5281  |  PIGF  |  DISEASES
120224  |  TMEM45B  |  DISEASES
2180  |  ACSL1  |  DISEASES
7082  |  TJP1  |  DISEASES
55294  |  FBXW7  |  DISEASES
5741  |  PTH  |  DISEASES
83734  |  ATG10  |  DISEASES
90233  |  ZNF551  |  DISEASES
55521  |  TRIM36  |  DISEASES
2321  |  FLT1  |  DISEASES
10413  |  YAP1  |  DISEASES
8404  |  SPARCL1  |  DISEASES
2697  |  GJA1  |  DISEASES
3672  |  ITGA1  |  DISEASES
11228  |  RASSF8  |  DISEASES
64422  |  ATG3  |  DISEASES
79888  |  LPCAT1  |  DISEASES
23250  |  ATP11A  |  DISEASES
50853  |  VILL  |  DISEASES
6317  |  SERPINB3  |  DISEASES
1054  |  CEBPG  |  DISEASES
7070  |  THY1  |  DISEASES
25890  |  ABI3BP  |  DISEASES
7345  |  UCHL1  |  DISEASES
89780  |  WNT3A  |  DISEASES
81559  |  TRIM11  |  DISEASES
221357  |  GSTA5  |  DISEASES
1525  |  CXADR  |  DISEASES
351  |  APP  |  DISEASES
9510  |  ADAMTS1  |  DISEASES
7476  |  WNT7A  |  DISEASES
7508  |  XPC  |  DISEASES
8714  |  ABCC3  |  DISEASES
760  |  CA2  |  DISEASES
2071  |  ERCC3  |  DISEASES
29761  |  USP25  |  DISEASES
389  |  RHOC  |  DISEASES
5018  |  OXA1L  |  DISEASES
9947  |  MAGEC1  |  DISEASES
231  |  AKR1B1  |  DISEASES
9601  |  PDIA4  |  DISEASES
843  |  CASP10  |  DISEASES
130540  |  ALS2CR12  |  DISEASES
1436  |  CSF1R  |  DISEASES
10  |  NAT2  |  DISEASES
11197  |  WIF1  |  DISEASES
132  |  ADK  |  DISEASES
1633  |  DCK  |  DISEASES
9154  |  SLC28A1  |  DISEASES
7074  |  TIAM1  |  DISEASES
2528  |  FUT6  |  DISEASES
4838  |  NODAL  |  DISEASES
25921  |  ZDHHC5  |  DISEASES
9530  |  BAG4  |  DISEASES
29028  |  ATAD2  |  DISEASES
163786  |  SASS6  |  DISEASES
701  |  BUB1B  |  DISEASES
6750  |  SST  |  DISEASES
2177  |  FANCD2  |  DISEASES
5468  |  PPARG  |  DISEASES
3815  |  KIT  |  DISEASES
9133  |  CCNB2  |  DISEASES
673  |  BRAF  |  DISEASES
56896  |  DPYSL5  |  DISEASES
4091  |  SMAD6  |  DISEASES
130106  |  CIB4  |  DISEASES
79623  |  GALNT14  |  DISEASES
3242  |  HPD  |  DISEASES
5291  |  PIK3CB  |  DISEASES
8365  |  HIST1H4H  |  DISEASES
909  |  CD1A  |  DISEASES
50848  |  F11R  |  DISEASES
1142  |  CHRNB3  |  DISEASES
55114  |  ARHGAP17  |  DISEASES
7832  |  BTG2  |  DISEASES
3099  |  HK2  |  DISEASES
4489  |  MT1A  |  DISEASES
653689  |  GSTT2B  |  DISEASES
1636  |  ACE  |  DISEASES
51673  |  TPPP3  |  DISEASES
441459  |  ANKRD18B  |  DISEASES
5304  |  PIP  |  DISEASES
808  |  CALM3  |  DISEASES
8566  |  PDXK  |  DISEASES
54058  |  C21orf58  |  DISEASES
9437  |  NCR1  |  DISEASES
80308  |  FLAD1  |  DISEASES
729230  |  CCR2  |  DISEASES
2264  |  FGFR4  |  DISEASES
10898  |  CPSF4  |  DISEASES
5731  |  PTGER1  |  DISEASES
92304  |  SCGB3A1  |  DISEASES
54165  |  DCUN1D1  |  DISEASES
5130  |  PCYT1A  |  DISEASES
3046  |  HBE1  |  DISEASES
1346  |  COX7A1  |  DISEASES
114757  |  CYGB  |  DISEASES
6352  |  CCL5  |  DISEASES
581  |  BAX  |  DISEASES
3856  |  KRT8  |  DISEASES
6777  |  STAT5B  |  DISEASES
3678  |  ITGA5  |  DISEASES
7471  |  WNT1  |  DISEASES
362  |  AQP5  |  DISEASES
256126  |  SYCE2  |  DISEASES
58191  |  CXCL16  |  DISEASES
1973  |  EIF4A1  |  DISEASES
6755  |  SSTR5  |  DISEASES
9965  |  FGF19  |  DISEASES
23358  |  USP24  |  DISEASES
10630  |  PDPN  |  DISEASES
7412  |  VCAM1  |  DISEASES
2215  |  FCGR3B  |  DISEASES
5937  |  RBMS1  |  DISEASES
5966  |  REL  |  DISEASES
4760  |  NEUROD1  |  DISEASES
2487  |  FRZB  |  DISEASES
27306  |  HPGDS  |  DISEASES
284996  |  RNF149  |  DISEASES
55677  |  IWS1  |  DISEASES
10602  |  CDC42EP3  |  DISEASES
7039  |  TGFA  |  DISEASES
10461  |  MERTK  |  DISEASES
248  |  ALPI  |  DISEASES
9076  |  CLDN1  |  DISEASES
151647  |  FAM19A4  |  DISEASES
3490  |  IGFBP7  |  DISEASES
3577  |  CXCR1  |  DISEASES
57650  |  KIAA1524  |  DISEASES
50852  |  TRAT1  |  DISEASES
5584  |  PRKCI  |  DISEASES
56648  |  EIF5A2  |  DISEASES
152185  |  SPICE1  |  DISEASES
213  |  ALB  |  DISEASES
54502  |  RBM47  |  DISEASES
151613  |  TTC14  |  DISEASES
2921  |  CXCL3  |  DISEASES
6374  |  CXCL5  |  DISEASES
5473  |  PPBP  |  DISEASES
5196  |  PF4  |  DISEASES
64866  |  CDCP1  |  DISEASES
6997  |  TDGF1  |  DISEASES
79753  |  SNIP1  |  DISEASES
4486  |  MST1R  |  DISEASES
4085  |  MAD2L1  |  DISEASES
308  |  ANXA5  |  DISEASES
3248  |  HPGD  |  DISEASES
3600  |  IL15  |  DISEASES
64399  |  HHIP  |  DISEASES
6059  |  ABCE1  |  DISEASES
4724  |  NDUFS4  |  DISEASES
117156  |  SCGB3A2  |  DISEASES
9607  |  CARTPT  |  DISEASES
94234  |  FOXQ1  |  DISEASES
85409  |  NKD2  |  DISEASES
3562  |  IL3  |  DISEASES
1437  |  CSF2  |  DISEASES
4869  |  NPM1  |  DISEASES
285761  |  DCBLD1  |  DISEASES
9265  |  CYTH3  |  DISEASES
63974  |  NEUROD6  |  DISEASES
6469  |  SHH  |  DISEASES
8601  |  RGS20  |  DISEASES
4982  |  TNFRSF11B  |  DISEASES
216  |  ALDH1A1  |  DISEASES
360  |  AQP3  |  DISEASES
9833  |  MELK  |  DISEASES
23588  |  KLHDC2  |  DISEASES
9147  |  NEMF  |  DISEASES
382  |  ARF6  |  DISEASES
3251  |  HPRT1  |  DISEASES
57447  |  NDRG2  |  DISEASES
56339  |  METTL3  |  DISEASES
143689  |  PIWIL4  |  DISEASES
1152  |  CKB  |  DISEASES
27343  |  POLL  |  DISEASES
10818  |  FRS2  |  DISEASES
3611  |  ILK  |  DISEASES
5055  |  SERPINB2  |  DISEASES
1138  |  CHRNA5  |  DISEASES
6236  |  RRAD  |  DISEASES
7184  |  HSP90B1  |  DISEASES
4314  |  MMP3  |  DISEASES
89927  |  C16orf45  |  DISEASES
290  |  ANPEP  |  DISEASES
5347  |  PLK1  |  DISEASES
26585  |  GREM1  |  DISEASES
22974  |  TPX2  |  DISEASES
5245  |  PHB  |  DISEASES
1398  |  CRK  |  DISEASES
5469  |  MED1  |  DISEASES
6240  |  RRM1  |  DISEASES
56547  |  MMP26  |  DISEASES
78994  |  PRR14  |  DISEASES
762  |  CA4  |  DISEASES
29123  |  ANKRD11  |  DISEASES
1548  |  CYP2A6  |  DISEASES
1549  |  CYP2A7  |  DISEASES
558  |  AXL  |  DISEASES
84798  |  C19orf48  |  DISEASES
92162  |  TMEM88  |  DISEASES
332  |  BIRC5  |  DISEASES
7083  |  TK1  |  DISEASES
8772  |  FADD  |  DISEASES
55872  |  PBK  |  DISEASES
4255  |  MGMT  |  DISEASES
4807  |  NHLH1  |  DISEASES
9101  |  USP8  |  DISEASES
5604  |  MAP2K1  |  DISEASES
9839  |  ZEB2  |  DISEASES
699  |  BUB1  |  DISEASES
598  |  BCL2L1  |  DISEASES
8313  |  AXIN2  |  DISEASES
3479  |  IGF1  |  DISEASES
2990  |  GUSB  |  DISEASES
3225  |  HOXC9  |  DISEASES
5734  |  PTGER4  |  DISEASES
3308  |  HSPA4  |  DISEASES
54578  |  UGT1A6  |  DISEASES
255738  |  PCSK9  |  DISEASES
3726  |  JUNB  |  DISEASES
3688  |  ITGB1  |  DISEASES
51181  |  DCXR  |  DISEASES
8988  |  HSPB3  |  DISEASES
1673  |  DEFB4A  |  DISEASES
29104  |  N6AMT1  |  DISEASES
993  |  CDC25A  |  DISEASES
3643  |  INSR  |  DISEASES
1493  |  CTLA4  |  DISEASES
4071  |  TM4SF1  |  DISEASES
10663  |  CXCR6  |  DISEASES
171558  |  PTCRA  |  DISEASES
2194  |  FASN  |  DISEASES
54658  |  UGT1A1  |  DISEASES
3667  |  IRS1  |  DISEASES
3596  |  IL13  |  DISEASES
54538  |  ROBO4  |  DISEASES
1602  |  DACH1  |  DISEASES
9482  |  STX8  |  DISEASES
5579  |  PRKCB  |  DISEASES
1051  |  CEBPB  |  DISEASES
2237  |  FEN1  |  DISEASES
5093  |  PCBP1  |  DISEASES
2525  |  FUT3  |  DISEASES
3627  |  CXCL10  |  DISEASES
8436  |  SDPR  |  DISEASES
8019  |  BRD3  |  DISEASES
214  |  ALCAM  |  DISEASES
3575  |  IL7R  |  DISEASES
2353  |  FOS  |  DISEASES
7532  |  YWHAG  |  DISEASES
51029  |  DESI2  |  DISEASES
4968  |  OGG1  |  DISEASES
8493  |  PPM1D  |  DISEASES
6373  |  CXCL11  |  DISEASES
6383  |  SDC2  |  DISEASES
3799  |  KIF5B  |  DISEASES
112398  |  EGLN2  |  DISEASES
1501  |  CTNND2  |  DISEASES
3622  |  ING2  |  DISEASES
2186  |  BPTF  |  DISEASES
9451  |  EIF2AK3  |  DISEASES
4176  |  MCM7  |  DISEASES
54541  |  DDIT4  |  DISEASES
57599  |  WDR48  |  DISEASES
794  |  CALB2  |  DISEASES
54205  |  CYCS  |  DISEASES
51162  |  EGFL7  |  DISEASES
27087  |  B3GAT1  |  DISEASES
1938  |  EEF2  |  DISEASES
10855  |  HPSE  |  DISEASES
2348  |  FOLR1  |  DISEASES
4323  |  MMP14  |  DISEASES
3213  |  HOXB3  |  DISEASES
197259  |  MLKL  |  DISEASES
6199  |  RPS6KB2  |  DISEASES
991  |  CDC20  |  DISEASES
3872  |  KRT17  |  DISEASES
2147  |  F2  |  DISEASES
9940  |  DLEC1  |  DISEASES
2733  |  GLE1  |  DISEASES
26032  |  SUSD5  |  DISEASES
660  |  BMX  |  DISEASES
6363  |  CCL19  |  DISEASES
6573  |  SLC19A1  |  DISEASES
5340  |  PLG  |  DISEASES
9134  |  CCNE2  |  DISEASES
3219  |  HOXB9  |  DISEASES
7534  |  YWHAZ  |  DISEASES
54923  |  LIME1  |  DISEASES
1808  |  DPYSL2  |  DISEASES
7015  |  TERT  |  DISEASES
3964  |  LGALS8  |  DISEASES
1072  |  CFL1  |  DISEASES
152002  |  XXYLT1  |  DISEASES
29903  |  CCDC106  |  DISEASES
116113  |  FOXP4  |  DISEASES
6169  |  RPL38  |  DISEASES
3265  |  HRAS  |  DISEASES
6868  |  ADAM17  |  DISEASES
947  |  CD34  |  DISEASES
9344  |  TAOK2  |  DISEASES
5708  |  PSMD2  |  DISEASES
8061  |  FOSL1  |  DISEASES
392  |  ARHGAP1  |  DISEASES
2072  |  ERCC4  |  DISEASES
403314  |  APOBEC4  |  DISEASES
8463  |  TEAD2  |  DISEASES
5467  |  PPARD  |  DISEASES
10849  |  CD3EAP  |  DISEASES
5598  |  MAPK7  |  DISEASES
836  |  CASP3  |  DISEASES
1163  |  CKS1B  |  DISEASES
7423  |  VEGFB  |  DISEASES
358  |  AQP1  |  DISEASES
286827  |  TRIM59  |  DISEASES
6578  |  SLCO2A1  |  DISEASES
5519  |  PPP2R1B  |  DISEASES
5883  |  RAD9A  |  DISEASES
57804  |  POLD4  |  DISEASES
2944  |  GSTM1  |  DISEASES
22949  |  PTGR1  |  DISEASES
8658  |  TNKS  |  DISEASES
10290  |  SPEG  |  DISEASES
5655  |  KLK10  |  DISEASES
83858  |  ATAD3B  |  DISEASES
83637  |  ZMIZ2  |  DISEASES
5978  |  REST  |  DISEASES
9156  |  EXO1  |  DISEASES
84868  |  HAVCR2  |  DISEASES
79850  |  FAM57A  |  DISEASES
55279  |  ZNF654  |  DISEASES
5319  |  PLA2G1B  |  DISEASES
344191  |  EVX2  |  DISEASES
91607  |  SLFN11  |  DISEASES
8837  |  CFLAR  |  DISEASES
3642  |  INSM1  |  DISEASES
3952  |  LEP  |  DISEASES
55584  |  CHRNA9  |  DISEASES
835  |  CASP2  |  DISEASES
10645  |  CAMKK2  |  DISEASES
55885  |  LMO3  |  DISEASES
124925  |  SEZ6  |  DISEASES
3172  |  HNF4A  |  DISEASES
2771  |  GNAI2  |  DISEASES
1601  |  DAB2  |  DISEASES
5591  |  PRKDC  |  DISEASES
653499  |  LGALS7B  |  DISEASES
92745  |  SLC38A5  |  DISEASES
81037  |  CLPTM1L  |  DISEASES
354  |  KLK3  |  DISEASES
10009  |  ZBTB33  |  DISEASES
9448  |  MAP4K4  |  DISEASES
998  |  CDC42  |  DISEASES
285  |  ANGPT2  |  DISEASES
27122  |  DKK3  |  DISEASES
56475  |  RPRM  |  DISEASES
5430  |  POLR2A  |  DISEASES
1191  |  CLU  |  DISEASES
6047  |  RNF4  |  DISEASES
8092  |  ALX1  |  DISEASES
284459  |  HKR1  |  DISEASES
1136  |  CHRNA3  |  DISEASES
7298  |  TYMS  |  DISEASES
3234  |  HOXD8  |  DISEASES
3170  |  FOXA2  |  DISEASES
10949  |  HNRNPA0  |  DISEASES
1857  |  DVL3  |  DISEASES
55143  |  CDCA8  |  DISEASES
6440  |  SFTPC  |  DISEASES
1604  |  CD55  |  DISEASES
8239  |  USP9X  |  DISEASES
8560  |  DEGS1  |  DISEASES
23512  |  SUZ12  |  DISEASES
4233  |  MET  |  DISEASES
2744  |  GLS  |  DISEASES
53905  |  DUOX1  |  DISEASES
2529  |  FUT7  |  DISEASES
29057  |  FAM156A  |  DISEASES
115353  |  LRRC42  |  DISEASES
4691  |  NCL  |  DISEASES
4684  |  NCAM1  |  DISEASES
6210  |  RPS15A  |  DISEASES
27319  |  BHLHE22  |  DISEASES
6470  |  SHMT1  |  DISEASES
27086  |  FOXP1  |  DISEASES
63899  |  NSUN3  |  DISEASES
10419  |  PRMT5  |  DISEASES
3579  |  CXCR2  |  DISEASES
83786  |  FRMD8  |  DISEASES
1728  |  NQO1  |  DISEASES
50619  |  DEF6  |  DISEASES
10397  |  NDRG1  |  DISEASES
8834  |  TMEM11  |  DISEASES
80381  |  CD276  |  DISEASES
2146  |  EZH2  |  DISEASES
5315  |  PKM  |  DISEASES
8289  |  ARID1A  |  DISEASES
54556  |  ING3  |  DISEASES
27436  |  EML4  |  DISEASES
811  |  CALR  |  DISEASES
140461  |  ASB8  |  DISEASES
6863  |  TAC1  |  DISEASES
25898  |  RCHY1  |  DISEASES
1351  |  COX8A  |  DISEASES
3996  |  LLGL1  |  DISEASES
131566  |  DCBLD2  |  DISEASES
1400  |  CRMP1  |  DISEASES
995  |  CDC25C  |  DISEASES
6867  |  TACC1  |  DISEASES
50628  |  GEMIN4  |  DISEASES
8347  |  HIST1H2BC  |  DISEASES
54802  |  TRIT1  |  DISEASES
2118  |  ETV4  |  DISEASES
5345  |  SERPINF2  |  DISEASES
6817  |  SULT1A1  |  DISEASES
84289  |  ING5  |  DISEASES
57060  |  PCBP4  |  DISEASES
23552  |  CDK20  |  DISEASES
3039  |  HBA1  |  DISEASES
6478  |  SIAH2  |  DISEASES
4312  |  MMP1  |  DISEASES
587  |  BCAT2  |  DISEASES
84985  |  FAM83A  |  DISEASES
84126  |  ATRIP  |  DISEASES
199699  |  DAND5  |  DISEASES
923  |  CD6  |  DISEASES
10615  |  SPAG5  |  DISEASES
158506  |  ZNF645  |  DISEASES
6657  |  SOX2  |  DISEASES
55818  |  KDM3A  |  DISEASES
51341  |  ZBTB7A  |  DISEASES
57491  |  AHRR  |  DISEASES
223082  |  ZNRF2  |  DISEASES
2  |  A2M  |  DISEASES
285464  |  CRIPAK  |  DISEASES
977  |  CD151  |  DISEASES
2027  |  ENO3  |  DISEASES
3309  |  HSPA5  |  DISEASES
55135  |  WRAP53  |  DISEASES
8408  |  ULK1  |  DISEASES
1555  |  CYP2B6  |  DISEASES
146556  |  C16orf89  |  DISEASES
9235  |  IL32  |  DISEASES
2932  |  GSK3B  |  DISEASES
6794  |  STK11  |  DISEASES
7329  |  UBE2I  |  DISEASES
22820  |  COPG1  |  DISEASES
5520  |  PPP2R2A  |  DISEASES
5241  |  PGR  |  DISEASES
55748  |  CNDP2  |  DISEASES
1272  |  CNTN1  |  DISEASES
400120  |  SERTM1  |  DISEASES
3326  |  HSP90AB1  |  DISEASES
9159  |  PCSK7  |  DISEASES
5366  |  PMAIP1  |  DISEASES
2300  |  FOXL1  |  DISEASES
5663  |  PSEN1  |  DISEASES
2303  |  FOXC2  |  DISEASES
81556  |  VWA9  |  DISEASES
152573  |  SHISA3  |  DISEASES
10460  |  TACC3  |  DISEASES
51330  |  TNFRSF12A  |  DISEASES
121227  |  LRIG3  |  DISEASES
8454  |  CUL1  |  DISEASES
22801  |  ITGA11  |  DISEASES
1435  |  CSF1  |  DISEASES
5034  |  P4HB  |  DISEASES
3714  |  JAG2  |  DISEASES
9241  |  NOG  |  DISEASES
84864  |  MINA  |  DISEASES
346389  |  MACC1  |  DISEASES
8331  |  HIST1H2AJ  |  DISEASES
1789  |  DNMT3B  |  DISEASES
116447  |  TOP1MT  |  DISEASES
5583  |  PRKCH  |  DISEASES
5454  |  POU3F2  |  DISEASES
3855  |  KRT7  |  DISEASES
6667  |  SP1  |  DISEASES
8651  |  SOCS1  |  DISEASES
4733  |  DRG1  |  DISEASES
29110  |  TBK1  |  DISEASES
1915  |  EEF1A1  |  DISEASES
6753  |  SSTR3  |  DISEASES
6656  |  SOX1  |  DISEASES
842  |  CASP9  |  DISEASES
9021  |  SOCS3  |  DISEASES
5155  |  PDGFB  |  DISEASES
9798  |  IST1  |  DISEASES
83479  |  DDX59  |  DISEASES
115908  |  CTHRC1  |  DISEASES
79680  |  C22orf29  |  DISEASES
8519  |  IFITM1  |  DISEASES
4978  |  OPCML  |  DISEASES
2188  |  FANCF  |  DISEASES
7490  |  WT1  |  DISEASES
2520  |  GAST  |  DISEASES
2242  |  FES  |  DISEASES
339883  |  C3orf35  |  DISEASES
83482  |  SCRT1  |  DISEASES
6401  |  SELE  |  DISEASES
3212  |  HOXB2  |  DISEASES
796  |  CALCA  |  DISEASES
2621  |  GAS6  |  DISEASES
942  |  CD86  |  DISEASES
2049  |  EPHB3  |  DISEASES
8338  |  HIST2H2AC  |  DISEASES
10509  |  SEMA4B  |  DISEASES
220  |  ALDH1A3  |  DISEASES
5915  |  RARB  |  DISEASES
5727  |  PTCH1  |  DISEASES
3838  |  KPNA2  |  DISEASES
1485  |  CTAG1B  |  DISEASES
1553  |  CYP2A13  |  DISEASES
2185  |  PTK2B  |  DISEASES
126382  |  NR2C2AP  |  DISEASES
4088  |  SMAD3  |  DISEASES
668  |  FOXL2  |  DISEASES
7318  |  UBA7  |  DISEASES
377630  |  USP17L2  |  DISEASES
348235  |  SKA2  |  DISEASES
266740  |  MAGEA2B  |  DISEASES
1572  |  CYP2F1  |  DISEASES
9112  |  MTA1  |  DISEASES
2139  |  EYA2  |  DISEASES
6472  |  SHMT2  |  DISEASES
5600  |  MAPK11  |  DISEASES
682  |  BSG  |  DISEASES
151888  |  BTLA  |  DISEASES
10057  |  ABCC5  |  DISEASES
10013  |  HDAC6  |  DISEASES
2248  |  FGF3  |  DISEASES
2152  |  F3  |  DISEASES
2009  |  EML1  |  DISEASES
342926  |  ZNF677  |  DISEASES
2626  |  GATA4  |  DISEASES
84700  |  MYO18B  |  DISEASES
199720  |  GGN  |  DISEASES
10076  |  PTPRU  |  DISEASES
196528  |  ARID2  |  DISEASES
5133  |  PDCD1  |  DISEASES
3320  |  HSP90AA1  |  DISEASES
253935  |  ANGPTL5  |  DISEASES
887  |  CCKBR  |  DISEASES
112616  |  CMTM7  |  DISEASES
55727  |  BTBD7  |  DISEASES
2938  |  GSTA1  |  DISEASES
885  |  CCK  |  DISEASES
9075  |  CLDN2  |  DISEASES
30850  |  CDR2L  |  DISEASES
11335  |  CBX3  |  DISEASES
1984  |  EIF5A  |  DISEASES
3984  |  LIMK1  |  DISEASES
283  |  ANG  |  DISEASES
468  |  ATF4  |  DISEASES
64410  |  KLHL25  |  DISEASES
226  |  ALDOA  |  DISEASES
150280  |  HORMAD2  |  DISEASES
1209  |  CLPTM1  |  DISEASES
9547  |  CXCL14  |  DISEASES
4221  |  MEN1  |  DISEASES
2036  |  EPB41L1  |  DISEASES
51548  |  SIRT6  |  DISEASES
219541  |  MED19  |  DISEASES
8372  |  HYAL3  |  DISEASES
2042  |  EPHA3  |  DISEASES
9166  |  EBAG9  |  DISEASES
7095  |  SEC62  |  DISEASES
3932  |  LCK  |  DISEASES
7189  |  TRAF6  |  DISEASES
1576  |  CYP3A4  |  DISEASES
3363  |  HTR7  |  DISEASES
66004  |  LYNX1  |  DISEASES
3091  |  HIF1A  |  DISEASES
1981  |  EIF4G1  |  DISEASES
554  |  AVPR2  |  DISEASES
92140  |  MTDH  |  DISEASES
23462  |  HEY1  |  DISEASES
140823  |  ROMO1  |  DISEASES
6622  |  SNCA  |  DISEASES
2246  |  FGF1  |  DISEASES
23583  |  SMUG1  |  DISEASES
90627  |  STARD13  |  DISEASES
7430  |  EZR  |  DISEASES
203068  |  TUBB  |  DISEASES
2885  |  GRB2  |  DISEASES
6175  |  RPLP0  |  DISEASES
3266  |  ERAS  |  DISEASES
1368  |  CPM  |  DISEASES
9402  |  GRAP2  |  DISEASES
857  |  CAV1  |  DISEASES
359787  |  DPPA3  |  DISEASES
5329  |  PLAUR  |  DISEASES
29894  |  CPSF1  |  DISEASES
1429  |  CRYZ  |  DISEASES
63826  |  SRR  |  DISEASES
4521  |  NUDT1  |  DISEASES
2309  |  FOXO3  |  DISEASES
9541  |  CIR1  |  DISEASES
2261  |  FGFR3  |  DISEASES
29102  |  DROSHA  |  DISEASES
4602  |  MYB  |  DISEASES
966  |  CD59  |  DISEASES
11315  |  PARK7  |  DISEASES
8788  |  DLK1  |  DISEASES
64100  |  ELSPBP1  |  DISEASES
1978  |  EIF4EBP1  |  DISEASES
5781  |  PTPN11  |  DISEASES
2810  |  SFN  |  DISEASES
3167  |  HMX2  |  DISEASES
23136  |  EPB41L3  |  DISEASES
5764  |  PTN  |  DISEASES
5747  |  PTK2  |  DISEASES
6776  |  STAT5A  |  DISEASES
4089  |  SMAD4  |  DISEASES
84335  |  AKT1S1  |  DISEASES
54345  |  SOX18  |  DISEASES
3178  |  HNRNPA1  |  DISEASES
7159  |  TP53BP2  |  DISEASES
1544  |  CYP1A2  |  DISEASES
7518  |  XRCC4  |  DISEASES
1508  |  CTSB  |  DISEASES
6590  |  SLPI  |  DISEASES
2272  |  FHIT  |  DISEASES
8445  |  DYRK2  |  DISEASES
51393  |  TRPV2  |  DISEASES
2066  |  ERBB4  |  DISEASES
2305  |  FOXM1  |  DISEASES
9536  |  PTGES  |  DISEASES
1364  |  CLDN4  |  DISEASES
10979  |  FERMT2  |  DISEASES
3146  |  HMGB1  |  DISEASES
10181  |  RBM5  |  DISEASES
23650  |  TRIM29  |  DISEASES
3716  |  JAK1  |  DISEASES
8360  |  HIST1H4D  |  DISEASES
9474  |  ATG5  |  DISEASES
7517  |  XRCC3  |  DISEASES
9577  |  BRE  |  DISEASES
6318  |  SERPINB4  |  DISEASES
10746  |  MAP3K2  |  DISEASES
864  |  RUNX3  |  DISEASES
7398  |  USP1  |  DISEASES
7874  |  USP7  |  DISEASES
3205  |  HOXA9  |  DISEASES
9771  |  RAPGEF5  |  DISEASES
1809  |  DPYSL3  |  DISEASES
3836  |  KPNA1  |  DISEASES
545  |  ATR  |  DISEASES
23405  |  DICER1  |  DISEASES
10252  |  SPRY1  |  DISEASES
2100  |  ESR2  |  DISEASES
5498  |  PPOX  |  DISEASES
9830  |  TRIM14  |  DISEASES
1003  |  CDH5  |  DISEASES
3605  |  IL17A  |  DISEASES
5170  |  PDPK1  |  DISEASES
53827  |  FXYD5  |  DISEASES
467  |  ATF3  |  DISEASES
389421  |  LIN28B  |  DISEASES
1499  |  CTNNB1  |  DISEASES
875  |  CBS  |  DISEASES
4771  |  NF2  |  DISEASES
7316  |  UBC  |  DISEASES
25797  |  QPCT  |  DISEASES
9232  |  PTTG1  |  DISEASES
81848  |  SPRY4  |  DISEASES
23373  |  CRTC1  |  DISEASES
5606  |  MAP2K3  |  DISEASES
2035  |  EPB41  |  DISEASES
57556  |  SEMA6A  |  DISEASES
1869  |  E2F1  |  DISEASES
2624  |  GATA2  |  DISEASES
538  |  ATP7A  |  DISEASES
22881  |  ANKRD6  |  DISEASES
5213  |  PFKM  |  DISEASES
8326  |  FZD9  |  DISEASES
6677  |  SPAM1  |  DISEASES
23007  |  PLCH1  |  DISEASES
6122  |  RPL3  |  DISEASES
6157  |  RPL27A  |  DISEASES
302  |  ANXA2  |  DISEASES
6189  |  RPS3A  |  DISEASES
3921  |  RPSA  |  DISEASES
9188  |  DDX21  |  DISEASES
51297  |  BPIFA1  |  DISEASES
6275  |  S100A4  |  DISEASES
1399  |  CRKL  |  DISEASES
8294  |  HIST1H4I  |  DISEASES
10533  |  ATG7  |  DISEASES
6925  |  TCF4  |  DISEASES
5154  |  PDGFA  |  DISEASES
80201  |  HKDC1  |  DISEASES
2534  |  FYN  |  DISEASES
3181  |  HNRNPA2B1  |  DISEASES
23481  |  PES1  |  DISEASES
2335  |  FN1  |  DISEASES
7080  |  NKX2-1  |  DISEASES
24142  |  NAT6  |  DISEASES
374882  |  TMEM205  |  DISEASES
8363  |  HIST1H4J  |  DISEASES
8650  |  NUMB  |  DISEASES
2873  |  GPS1  |  DISEASES
100506658  |  OCLN  |  DISEASES
147495  |  APCDD1  |  DISEASES
83593  |  RASSF5  |  DISEASES
2202  |  EFEMP1  |  DISEASES
84450  |  ZNF512  |  DISEASES
80781  |  COL18A1  |  DISEASES
3359  |  HTR3A  |  DISEASES
331  |  XIAP  |  DISEASES
1785  |  DNM2  |  DISEASES
5979  |  RET  |  DISEASES
2073  |  ERCC5  |  DISEASES
355  |  FAS  |  DISEASES
26503  |  SLC17A5  |  DISEASES
5265  |  SERPINA1  |  DISEASES
3240  |  HP  |  DISEASES
89122  |  TRIM4  |  DISEASES
8368  |  HIST1H4L  |  DISEASES
51155  |  HN1  |  DISEASES
5879  |  RAC1  |  DISEASES
10146  |  G3BP1  |  DISEASES
273  |  AMPH  |  DISEASES
23035  |  PHLPP2  |  DISEASES
54892  |  NCAPG2  |  DISEASES
11226  |  GALNT6  |  DISEASES
5906  |  RAP1A  |  DISEASES
5789  |  PTPRD  |  DISEASES
7068  |  THRB  |  DISEASES
11065  |  UBE2C  |  DISEASES
23201  |  FAM168A  |  DISEASES
5284  |  PIGR  |  DISEASES
6288  |  SAA1  |  DISEASES
8344  |  HIST1H2BE  |  DISEASES
114960  |  TSGA13  |  DISEASES
5733  |  PTGER3  |  DISEASES
4100  |  MAGEA1  |  DISEASES
84542  |  KIAA1841  |  DISEASES
55124  |  PIWIL2  |  DISEASES
3084  |  NRG1  |  DISEASES
3981  |  LIG4  |  DISEASES
3482  |  IGF2R  |  DISEASES
801  |  CALM1  |  DISEASES
11186  |  RASSF1  |  DISEASES
1996  |  ELAVL4  |  DISEASES
10445  |  MCRS1  |  DISEASES
83658  |  DYNLRB1  |  DISEASES
8940  |  TOP3B  |  DISEASES
253260  |  RICTOR  |  DISEASES
60  |  ACTB  |  DISEASES
51614  |  ERGIC3  |  DISEASES
9961  |  MVP  |  DISEASES
728378  |  POTEF  |  DISEASES
8362  |  HIST1H4K  |  DISEASES
8087  |  FXR1  |  DISEASES
6752  |  SSTR2  |  DISEASES
79961  |  DENND2D  |  DISEASES
4097  |  MAFG  |  DISEASES
8692  |  HYAL2  |  DISEASES
11148  |  HHLA2  |  DISEASES
10987  |  COPS5  |  DISEASES
4111  |  MAGEA12  |  DISEASES
1644  |  DDC  |  DISEASES
286319  |  TUSC1  |  DISEASES
6597  |  SMARCA4  |  DISEASES
121504  |  HIST4H4  |  DISEASES
1612  |  DAPK1  |  DISEASES
5079  |  PAX5  |  DISEASES
79366  |  HMGN5  |  DISEASES
2050  |  EPHB4  |  DISEASES
6714  |  SRC  |  DISEASES
4763  |  NF1  |  DISEASES
56241  |  SUSD2  |  DISEASES
3698  |  ITIH2  |  DISEASES
1969  |  EPHA2  |  DISEASES
841  |  CASP8  |  DISEASES
5893  |  RAD52  |  DISEASES
8852  |  AKAP4  |  DISEASES
84986  |  ARHGAP19  |  DISEASES
389658  |  FAM150A  |  DISEASES
405  |  ARNT  |  DISEASES
2526  |  FUT4  |  DISEASES
8323  |  FZD6  |  DISEASES
6364  |  CCL20  |  DISEASES
56980  |  PRDM10  |  DISEASES
5980  |  REV3L  |  DISEASES
7415  |  VCP  |  DISEASES
7048  |  TGFBR2  |  DISEASES
389376  |  SFTA2  |  DISEASES
9332  |  CD163  |  DISEASES
5294  |  PIK3CG  |  DISEASES
1995  |  ELAVL3  |  DISEASES
2547  |  XRCC6  |  DISEASES
7516  |  XRCC2  |  DISEASES
6942  |  TCF20  |  DISEASES
1786  |  DNMT1  |  DISEASES
799  |  CALCR  |  DISEASES
57016  |  AKR1B10  |  DISEASES
4192  |  MDK  |  DISEASES
8359  |  HIST1H4A  |  DISEASES
23370  |  ARHGEF18  |  DISEASES
55959  |  SULF2  |  DISEASES
5792  |  PTPRF  |  DISEASES
8343  |  HIST1H2BF  |  DISEASES
51150  |  SDF4  |  DISEASES
79947  |  DHDDS  |  DISEASES
7037  |  TFRC  |  DISEASES
2114  |  ETS2  |  DISEASES
4134  |  MAP4  |  DISEASES
1523  |  CUX1  |  DISEASES
4478  |  MSN  |  DISEASES
3164  |  NR4A1  |  DISEASES
3135  |  HLA-G  |  DISEASES
1366  |  CLDN7  |  DISEASES
5599  |  MAPK8  |  DISEASES
23294  |  ANKS1A  |  DISEASES
8828  |  NRP2  |  DISEASES
1825  |  DSC3  |  DISEASES
8367  |  HIST1H4E  |  DISEASES
9643  |  MORF4L2  |  DISEASES
8682  |  PEA15  |  DISEASES
4311  |  MME  |  DISEASES
10210  |  TOPORS  |  DISEASES
6241  |  RRM2  |  DISEASES
11076  |  TPPP  |  DISEASES
1565  |  CYP2D6  |  DISEASES
25937  |  WWTR1  |  DISEASES
54106  |  TLR9  |  DISEASES
4916  |  NTRK3  |  DISEASES
10848  |  PPP1R13L  |  DISEASES
23151  |  GRAMD4  |  DISEASES
57111  |  RAB25  |  DISEASES
6772  |  STAT1  |  DISEASES
6935  |  ZEB1  |  DISEASES
1312  |  COMT  |  DISEASES
7150  |  TOP1  |  DISEASES
2475  |  MTOR  |  DISEASES
676  |  BRDT  |  DISEASES
23499  |  MACF1  |  DISEASES
2736  |  GLI2  |  DISEASES
22887  |  FOXJ3  |  DISEASES
51438  |  MAGEC2  |  DISEASES
9181  |  ARHGEF2  |  DISEASES
9760  |  TOX  |  DISEASES
4283  |  CXCL9  |  DISEASES
7096  |  TLR1  |  DISEASES
9846  |  GAB2  |  DISEASES
5455  |  POU3F3  |  DISEASES
4536  |  MT-ND2  |  DISEASES
3880  |  KRT19  |  DISEASES
84072  |  HORMAD1  |  DISEASES
9853  |  RUSC2  |  DISEASES
8678  |  BECN1  |  DISEASES
5083  |  PAX9  |  DISEASES
23038  |  WDTC1  |  DISEASES
961  |  CD47  |  DISEASES
9860  |  LRIG2  |  DISEASES
25893  |  TRIM58  |  DISEASES
28514  |  DLL1  |  DISEASES
7058  |  THBS2  |  DISEASES
142  |  PARP1  |  DISEASES
168002  |  DACT2  |  DISEASES
11116  |  FGFR1OP  |  DISEASES
388743  |  CAPN8  |  DISEASES
2058  |  EPRS  |  DISEASES
7042  |  TGFB2  |  DISEASES
4751  |  NEK2  |  DISEASES
3664  |  IRF6  |  DISEASES
6648  |  SOD2  |  DISEASES
722  |  C4BPA  |  DISEASES
64710  |  NUCKS1  |  DISEASES
93273  |  LEMD1  |  DISEASES
4194  |  MDM4  |  DISEASES
5287  |  PIK3C2B  |  DISEASES
7432  |  VIP  |  DISEASES
29089  |  UBE2T  |  DISEASES
5788  |  PTPRC  |  DISEASES
3075  |  CFH  |  DISEASES
5321  |  PLA2G4A  |  DISEASES
5743  |  PTGS2  |  DISEASES
462  |  SERPINC1  |  DISEASES
356  |  FASLG  |  DISEASES
4921  |  DDR2  |  DISEASES
11266  |  DUSP12  |  DISEASES
2214  |  FCGR3A  |  DISEASES
1490  |  CTGF  |  DISEASES
383  |  ARG1  |  DISEASES
8407  |  TAGLN2  |  DISEASES
911  |  CD1C  |  DISEASES
912  |  CD1D  |  DISEASES
2117  |  ETV3  |  DISEASES
3068  |  HDGF  |  DISEASES
1382  |  CRABP2  |  DISEASES
10763  |  NES  |  DISEASES
22889  |  KIAA0907  |  DISEASES
4582  |  MUC1  |  DISEASES
1942  |  EFNA1  |  DISEASES
1944  |  EFNA3  |  DISEASES
57326  |  PBXIP1  |  DISEASES
4121  |  MAN1A1  |  DISEASES
3570  |  IL6R  |  DISEASES
6098  |  ROS1  |  DISEASES
7170  |  TPM3  |  DISEASES
221303  |  FAM162B  |  DISEASES
221302  |  ZUFSP  |  DISEASES
7259  |  TSPYL1  |  DISEASES
4082  |  MARCKS  |  DISEASES
664  |  BNIP3  |  DISEASES
253738  |  EBF3  |  DISEASES
4288  |  MKI67  |  DISEASES
11000  |  SLC27A3  |  DISEASES
8038  |  ADAM12  |  DISEASES
6273  |  S100A2  |  DISEASES
6277  |  S100A6  |  DISEASES
6278  |  S100A7  |  DISEASES
10758  |  TRAF3IP2  |  DISEASES
117145  |  THEM4  |  DISEASES
4942  |  OAT  |  DISEASES
262  |  AMD1  |  DISEASES
1755  |  DMBT1  |  DISEASES
246269  |  LACE1  |  DISEASES
1520  |  CTSS  |  DISEASES
4170  |  MCL1  |  DISEASES
57107  |  PDSS2  |  DISEASES
8661  |  EIF3A  |  DISEASES
8349  |  HIST2H2BE  |  DISEASES
554313  |  HIST2H4B  |  DISEASES
8337  |  HIST2H2AA3  |  DISEASES
8370  |  HIST2H4A  |  DISEASES
2209  |  FCGR1A  |  DISEASES
2018  |  EMX2  |  DISEASES
2045  |  EPHA7  |  DISEASES
10628  |  TXNIP  |  DISEASES
840  |  CASP7  |  DISEASES
26227  |  PHGDH  |  DISEASES
58528  |  RRAGD  |  DISEASES
79679  |  VTCN1  |  DISEASES
4893  |  NRAS  |  DISEASES
6566  |  SLC16A1  |  DISEASES
7162  |  TPBG  |  DISEASES
7272  |  TTK  |  DISEASES
54492  |  NEURL1B  |  DISEASES
2948  |  GSTM4  |  DISEASES
127002  |  ATXN7L2  |  DISEASES
8277  |  TKTL1  |  DISEASES
4791  |  NFKB2  |  DISEASES
50861  |  STMN3  |  DISEASES
1301  |  COL11A1  |  DISEASES
8945  |  BTRC  |  DISEASES
1806  |  DPYD  |  DISEASES
10660  |  LBX1  |  DISEASES
1137  |  CHRNA4  |  DISEASES
4102  |  MAGEA3  |  DISEASES
4101  |  MAGEA2  |  DISEASES
2556  |  GABRA3  |  DISEASES
55510  |  DDX43  |  DISEASES
6319  |  SCD  |  DISEASES
3149  |  HMGB3  |  DISEASES
1369  |  CPN1  |  DISEASES
343472  |  BARHL2  |  DISEASES
1244  |  ABCC2  |  DISEASES
158521  |  FMR1NB  |  DISEASES
4923  |  NTSR1  |  DISEASES
9635  |  CLCA2  |  DISEASES
2258  |  FGF13  |  DISEASES
959  |  CD40LG  |  DISEASES
680  |  BRS3  |  DISEASES
51557  |  LGSN  |  DISEASES
541466  |  CT45A1  |  DISEASES
11080  |  DNAJB4  |  DISEASES
653  |  BMP5  |  DISEASES
1647  |  GADD45A  |  DISEASES
116154  |  PHACTR3  |  DISEASES
10023  |  FRAT1  |  DISEASES
4919  |  ROR1  |  DISEASES
2778  |  GNAS  |  DISEASES
128602  |  C20orf85  |  DISEASES
1791  |  DNTT  |  DISEASES
6005  |  RHAG  |  DISEASES
3725  |  JUN  |  DISEASES
4070  |  TACSTD2  |  DISEASES
1558  |  CYP2C8  |  DISEASES
1557  |  CYP2C19  |  DISEASES
988  |  CDC5L  |  DISEASES
55165  |  CEP55  |  DISEASES
440590  |  ZYG11A  |  DISEASES
80351  |  TNKS2  |  DISEASES
55684  |  RABL6  |  DISEASES
2030  |  SLC29A1  |  DISEASES
9334  |  B4GALT5  |  DISEASES
2060  |  EPS15  |  DISEASES
1580  |  CYP4B1  |  DISEASES
5728  |  PTEN  |  DISEASES
154796  |  AMOT  |  DISEASES
8202  |  NCOA3  |  DISEASES
7422  |  VEGFA  |  DISEASES
4595  |  MUTYH  |  DISEASES
115201  |  ATG4A  |  DISEASES
958  |  CD40  |  DISEASES
6441  |  SFTPD  |  DISEASES
128209  |  KLF17  |  DISEASES
729238  |  SFTPA2  |  DISEASES
4318  |  MMP9  |  DISEASES
25  |  ABL1  |  DISEASES
9682  |  KDM4A  |  DISEASES
7075  |  TIE1  |  DISEASES
89845  |  ABCC10  |  DISEASES
4904  |  YBX1  |  DISEASES
79717  |  PPCS  |  DISEASES
163732  |  CITED4  |  DISEASES
2021  |  ENDOG  |  DISEASES
6385  |  SDC4  |  DISEASES
5328  |  PLAU  |  DISEASES
6789  |  STK4  |  DISEASES
84879  |  MFSD2A  |  DISEASES
51440  |  HPCAL4  |  DISEASES
26508  |  HEYL  |  DISEASES
1678  |  TIMM8A  |  DISEASES
896  |  CCND3  |  DISEASES
9436  |  NCR2  |  DISEASES
2022  |  ENG  |  DISEASES
5464  |  PPA1  |  DISEASES
2356  |  FPGS  |  DISEASES
5230  |  PGK1  |  DISEASES
139596  |  UPRT  |  DISEASES
23452  |  ANGPTL2  |  DISEASES
54577  |  UGT1A7  |  DISEASES
8565  |  YARS  |  DISEASES
3065  |  HDAC1  |  DISEASES
220202  |  ATOH7  |  DISEASES
2833  |  CXCR3  |  DISEASES
2934  |  GSN  |  DISEASES
6732  |  SRPK1  |  DISEASES
22943  |  DKK1  |  DISEASES
7099  |  TLR4  |  DISEASES
51230  |  PHF20  |  DISEASES
9966  |  TNFSF15  |  DISEASES
1317  |  SLC31A1  |  DISEASES
7357  |  UGCG  |  DISEASES
3710  |  ITPR3  |  DISEASES
240  |  ALOX5  |  DISEASES
24137  |  KIF4A  |  DISEASES
7295  |  TXN  |  DISEASES
5774  |  PTPN3  |  DISEASES
3399  |  ID3  |  DISEASES
9314  |  KLF4  |  DISEASES
367  |  AR  |  DISEASES
8325  |  FZD8  |  DISEASES
219771  |  CCNY  |  DISEASES
84557  |  MAP1LC3A  |  DISEASES
7046  |  TGFBR1  |  DISEASES
4855  |  NOTCH4  |  DISEASES
5089  |  PBX2  |  DISEASES
978  |  CDA  |  DISEASES
177  |  AGER  |  DISEASES
7507  |  XPA  |  DISEASES
3014  |  H2AFX  |  DISEASES
7027  |  TFDP1  |  DISEASES
8451  |  CUL4A  |  DISEASES
2159  |  F10  |  DISEASES
2155  |  F7  |  DISEASES
54455  |  FBXO42  |  DISEASES
143903  |  LAYN  |  DISEASES
728239  |  MAGED4  |  DISEASES
3303  |  HSPA1A  |  DISEASES
57819  |  LSM2  |  DISEASES
4439  |  MSH5  |  DISEASES
6850  |  SYK  |  DISEASES
3055  |  HCK  |  DISEASES
3397  |  ID1  |  DISEASES
50943  |  FOXP3  |  DISEASES
100507436  |  MICA  |  DISEASES
3190  |  HNRNPK  |  DISEASES
5355  |  PLP2  |  DISEASES
5794  |  PTPRH  |  DISEASES
29979  |  UBQLN1  |  DISEASES
9656  |  MDC1  |  DISEASES
7088  |  TLE1  |  DISEASES
8428  |  STK24  |  DISEASES
780  |  DDR1  |  DISEASES
4524  |  MTHFR  |  DISEASES
648  |  BMI1  |  DISEASES
5935  |  RBM3  |  DISEASES
3105  |  HLA-A  |  DISEASES
548313  |  SSX4B  |  DISEASES
6759  |  SSX4  |  DISEASES
10257  |  ABCC4  |  DISEASES
1471  |  CST3  |  DISEASES
11166  |  SOX21  |  DISEASES
369  |  ARAF  |  DISEASES
2262  |  GPC5  |  DISEASES
7056  |  THBD  |  DISEASES
442186  |  OR2J3  |  DISEASES
22803  |  XRN2  |  DISEASES
51720  |  UIMC1  |  DISEASES
8366  |  HIST1H4B  |  DISEASES
3604  |  TNFRSF9  |  DISEASES
8241  |  RBM10  |  DISEASES
688  |  KLF5  |  DISEASES
219  |  ALDH1B1  |  DISEASES
8346  |  HIST1H2BI  |  DISEASES
8361  |  HIST1H4F  |  DISEASES
8364  |  HIST1H4C  |  DISEASES
6520  |  SLC3A2  |  DISEASES
8434  |  RECK  |  DISEASES
4609  |  MYC  |  DISEASES
390205  |  LRRC10B  |  DISEASES
7161  |  TP73  |  DISEASES
768  |  CA9  |  DISEASES
353  |  APRT  |  DISEASES
3980  |  LIG3  |  DISEASES
3963  |  LGALS7  |  DISEASES
650  |  BMP2  |  DISEASES
1855  |  DVL1  |  DISEASES
4112  |  MAGEB1  |  DISEASES
4113  |  MAGEB2  |  DISEASES
9308  |  CD83  |  DISEASES
6303  |  SAT1  |  DISEASES
2625  |  GATA3  |  DISEASES
10549  |  PRDX4  |  DISEASES
28984  |  RGCC  |  DISEASES
168400  |  DDX53  |  DISEASES
1906  |  EDN1  |  DISEASES
9770  |  RASSF2  |  DISEASES
9636  |  ISG15  |  DISEASES
4739  |  NEDD9  |  DISEASES
444  |  ASPH  |  DISEASES
165186  |  FAM179A  |  DISEASES
2308  |  FOXO1  |  DISEASES
6197  |  RPS6KA3  |  DISEASES
7020  |  TFAP2A  |  DISEASES
7905  |  REEP5  |  DISEASES
7222  |  TRPC3  |  DISEASES
10527  |  IPO7  |  DISEASES
1543  |  CYP1A1  |  DISEASES
10631  |  POSTN  |  DISEASES
133482  |  SLCO6A1  |  DISEASES
1262  |  CNGA4  |  DISEASES
3559  |  IL2RA  |  DISEASES
3887  |  KRT81  |  DISEASES
7010  |  TEK  |  DISEASES
10799  |  RPP40  |  DISEASES
1993  |  ELAVL2  |  DISEASES
675  |  BRCA2  |  DISEASES
4507  |  MTAP  |  DISEASES
247  |  ALOX15B  |  DISEASES
3440  |  IFNA2  |  DISEASES
3456  |  IFNB1  |  DISEASES
2925  |  GRPR  |  DISEASES
551  |  AVP  |  DISEASES
7280  |  TUBB2A  |  DISEASES
6194  |  RPS6  |  DISEASES
8644  |  AKR1C3  |  DISEASES
6456  |  SH3GL2  |  DISEASES
7114  |  TMSB4X  |  DISEASES
51284  |  TLR7  |  DISEASES
5272  |  SERPINB9  |  DISEASES
6541  |  SLC7A1  |  DISEASES
1646  |  AKR1C2  |  DISEASES
5884  |  RAD17  |  DISEASES
55841  |  WWC3  |  DISEASES
1645  |  AKR1C1  |  DISEASES
4781  |  NFIB  |  DISEASES
57486  |  NLN  |  DISEASES
1045  |  CDX2  |  DISEASES
26609  |  VCX  |  DISEASES
3486  |  IGFBP3  |  DISEASES
5214  |  PFKP  |  DISEASES
8908  |  GYG2  |  DISEASES
11082  |  ESM1  |  DISEASES
6443  |  SGCB  |  DISEASES
162073  |  ITPRIPL2  |  DISEASES
54951  |  COMMD8  |  DISEASES
29126  |  CD274  |  DISEASES
128646  |  SIRPD  |  DISEASES
3717  |  JAK2  |  DISEASES
51378  |  ANGPT4  |  DISEASES
7158  |  TP53BP1  |  DISEASES
10568  |  SLC34A2  |  DISEASES
80023  |  NRSN2  |  DISEASES
2254  |  FGF9  |  DISEASES
6624  |  FSCN1  |  DISEASES
394  |  ARHGAP5  |  DISEASES
9037  |  SEMA5A  |  DISEASES
11200  |  CHEK2  |  DISEASES
26524  |  LATS2  |  DISEASES
5888  |  RAD51  |  DISEASES
5268  |  SERPINB5  |  DISEASES
10232  |  MSLN  |  DISEASES
353497  |  POLN  |  DISEASES
92305  |  TMEM129  |  DISEASES
6736  |  SRY  |  DISEASES
10675  |  CSPG5  |  DISEASES
27303  |  RBMS3  |  DISEASES
131965  |  METTL6  |  DISEASES
28512  |  NKIRAS1  |  DISEASES
3875  |  KRT18  |  DISEASES
64754  |  SMYD3  |  DISEASES
238  |  ALK  |  DISEASES
4017  |  LOXL2  |  DISEASES
53353  |  LRP1B  |  DISEASES
2877  |  GPX2  |  DISEASES
7247  |  TSN  |  DISEASES
8878  |  SQSTM1  |  DISEASES
259290  |  TAS2R31  |  DISEASES
10288  |  LILRB2  |  DISEASES
126119  |  JOSD2  |  DISEASES
11009  |  IL24  |  DISEASES
2068  |  ERCC2  |  DISEASES
147700  |  KLC3  |  DISEASES
208  |  AKT2  |  DISEASES
7520  |  XRCC5  |  DISEASES
2113  |  ETS1  |  DISEASES
7187  |  TRAF3  |  DISEASES
6996  |  TDG  |  DISEASES
2051  |  EPHB6  |  DISEASES
10401  |  PIAS3  |  DISEASES
143187  |  VTI1A  |  DISEASES
12  |  SERPINA3  |  DISEASES
145270  |  PRIMA1  |  DISEASES
838  |  CASP5  |  DISEASES
654364  |  NME1-NME2  |  DISEASES
4831  |  NME2  |  DISEASES
27032  |  ATP2C1  |  DISEASES
10018  |  BCL2L11  |  DISEASES
6439  |  SFTPB  |  DISEASES
3161  |  HMMR  |  DISEASES
5091  |  PC  |  DISEASES
79767  |  ELMO3  |  DISEASES
5627  |  PROS1  |  DISEASES
2719  |  GPC3  |  DISEASES
26468  |  LHX6  |  DISEASES
4828  |  NMB  |  DISEASES
5530  |  PPP3CA  |  DISEASES
2319  |  FLOT2  |  DISEASES
6696  |  SPP1  |  DISEASES
51343  |  FZR1  |  DISEASES
1365  |  CLDN3  |  DISEASES
983  |  CDK1  |  DISEASES
26471  |  NUPR1  |  DISEASES
147166  |  TRIM16L  |  DISEASES
685  |  BTC  |  DISEASES
2919  |  CXCL1  |  DISEASES
174  |  AFP  |  DISEASES
6387  |  CXCL12  |  DISEASES
655  |  BMP7  |  DISEASES
5744  |  PTHLH  |  DISEASES
2737  |  GLI3  |  DISEASES
55259  |  CASC1  |  DISEASES
55233  |  MOB1A  |  DISEASES
79838  |  TMC5  |  DISEASES
144195  |  SLC2A14  |  DISEASES
116135  |  LRRC3B  |  DISEASES
51147  |  ING4  |  DISEASES
11184  |  MAP4K1  |  DISEASES
4780  |  NFE2L2  |  DISEASES
84928  |  TMEM209  |  DISEASES
163051  |  ZNF709  |  DISEASES
80380  |  PDCD1LG2  |  DISEASES
8786  |  RGS11  |  DISEASES
202374  |  STK32A  |  DISEASES
5609  |  MAP2K7  |  DISEASES
2047  |  EPHB1  |  DISEASES
594857  |  NPS  |  DISEASES
729857  |  RGPD2  |  DISEASES
4356  |  MPP3  |  DISEASES
4599  |  MX1  |  DISEASES
2950  |  GSTP1  |  DISEASES
81539  |  SLC38A1  |  DISEASES
23532  |  PRAME  |  DISEASES
10039  |  PARP3  |  DISEASES
1500  |  CTNND1  |  DISEASES
4363  |  ABCC1  |  DISEASES
492307  |  C8orf22  |  DISEASES
253650  |  ANKRD18A  |  DISEASES
6093  |  ROCK1  |  DISEASES
1654  |  DDX3X  |  DISEASES
23028  |  KDM1A  |  DISEASES
57648  |  KIAA1522  |  DISEASES
8091  |  HMGA2  |  DISEASES
8450  |  CUL4B  |  DISEASES
256130  |  TMEM196  |  DISEASES
5970  |  RELA  |  DISEASES
95  |  ACY1  |  DISEASES
51701  |  NLK  |  DISEASES
6654  |  SOS1  |  DISEASES
3098  |  HK1  |  DISEASES
7514  |  XPO1  |  DISEASES
9866  |  TRIM66  |  DISEASES
83874  |  TBC1D10A  |  DISEASES
57504  |  MTA3  |  DISEASES
1994  |  ELAVL1  |  DISEASES
388931  |  MFSD2B  |  DISEASES
728441  |  GGT2  |  DISEASES
164668  |  APOBEC3H  |  DISEASES
2011  |  MARK2  |  DISEASES
7018  |  TF  |  DISEASES
1363  |  CPE  |  DISEASES
29072  |  SETD2  |  DISEASES
7852  |  CXCR4  |  DISEASES
55206  |  SBNO1  |  DISEASES
1385  |  CREB1  |  DISEASES
837  |  CASP4  |  DISEASES
1111  |  CHEK1  |  DISEASES
4776  |  NFATC4  |  DISEASES
5601  |  MAPK9  |  DISEASES
6916  |  TBXAS1  |  DISEASES
6788  |  STK3  |  DISEASES
6336  |  SCN10A  |  DISEASES
10551  |  AGR2  |  DISEASES
9564  |  BCAR1  |  DISEASES
3718  |  JAK3  |  DISEASES
3481  |  IGF2  |  DISEASES
5537  |  PPP6C  |  DISEASES
55743  |  CHFR  |  DISEASES
10553  |  HTATIP2  |  DISEASES
2260  |  FGFR1  |  DISEASES
84448  |  ABLIM2  |  DISEASES
54733  |  SLC35F2  |  DISEASES
57448  |  BIRC6  |  DISEASES
27244  |  SESN1  |  DISEASES
85458  |  DIXDC1  |  DISEASES
4988  |  OPRM1  |  DISEASES
5783  |  PTPN13  |  DISEASES
1029  |  CDKN2A  |  DISEASES
55273  |  TMEM100  |  DISEASES
23705  |  CADM1  |  DISEASES
7849  |  PAX8  |  DISEASES
25855  |  BRMS1  |  DISEASES
1719  |  DHFR  |  DISEASES
390927  |  ZNF793  |  DISEASES
4802  |  NFYC  |  DISEASES
7155  |  TOP2B  |  DISEASES
653509  |  SFTPA1  |  DISEASES
56616  |  DIABLO  |  DISEASES
960  |  CD44  |  DISEASES
7124  |  TNF  |  DISEASES
6474  |  SHOX2  |  DISEASES
3491  |  CYR61  |  DISEASES
196993  |  CT62  |  DISEASES
79669  |  C3orf52  |  DISEASES
387  |  RHOA  |  DISEASES
64785  |  GINS3  |  DISEASES
6464  |  SHC1  |  DISEASES
2081  |  ERN1  |  DISEASES
7465  |  WEE1  |  DISEASES
55353  |  LAPTM4B  |  DISEASES
9236  |  CCPG1  |  DISEASES
4049  |  LTA  |  DISEASES
10178  |  TENM1  |  DISEASES
222068  |  TMED4  |  DISEASES
27113  |  BBC3  |  DISEASES
6892  |  TAPBP  |  DISEASES
117581  |  TWIST2  |  DISEASES
7086  |  TKT  |  DISEASES
388372  |  CCL4L1  |  DISEASES
8318  |  CDC45  |  DISEASES
54845  |  ESRP1  |  DISEASES
84148  |  KAT8  |  DISEASES
23098  |  SARM1  |  DISEASES
54900  |  LAX1  |  DISEASES
374875  |  HSD11B1L  |  DISEASES
2876  |  GPX1  |  DISEASES
149281  |  METTL11B  |  DISEASES
1012  |  CDH13  |  DISEASES
5578  |  PRKCA  |  DISEASES
1154  |  CISH  |  DISEASES
408  |  ARRB1  |  DISEASES
834  |  CASP1  |  DISEASES
2263  |  FGFR2  |  DISEASES
3925  |  STMN1  |  DISEASES
7153  |  TOP2A  |  DISEASES
1028  |  CDKN1C  |  DISEASES
3451  |  IFNA17  |  DISEASES
54458  |  PRR13  |  DISEASES
3586  |  IL10  |  DISEASES
2257  |  FGF12  |  DISEASES
54475  |  NLE1  |  DISEASES
54857  |  GDPD2  |  DISEASES
4485  |  MST1  |  DISEASES
627  |  BDNF  |  DISEASES
3831  |  KLC1  |  DISEASES
8842  |  PROM1  |  DISEASES
5270  |  SERPINE2  |  DISEASES
721  |  C4B  |  DISEASES
56649  |  TMPRSS4  |  DISEASES
6513  |  SLC2A1  |  DISEASES
7045  |  TGFBI  |  DISEASES
9749  |  PHACTR2  |  DISEASES
8314  |  BAP1  |  DISEASES
4193  |  MDM2  |  DISEASES
29803  |  REPIN1  |  DISEASES
4585  |  MUC4  |  DISEASES
23089  |  PEG10  |  DISEASES
28988  |  DBNL  |  DISEASES
9254  |  CACNA2D2  |  DISEASES
79692  |  ZNF322  |  DISEASES
672  |  BRCA1  |  DISEASES
5478  |  PPIA  |  DISEASES
8754  |  ADAM9  |  DISEASES
1020  |  CDK5  |  DISEASES
1316  |  KLF6  |  DISEASES
30816  |  ERVW-1  |  DISEASES
5447  |  POR  |  DISEASES
2939  |  GSTA2  |  DISEASES
6091  |  ROBO1  |  DISEASES
25852  |  ARMC8  |  DISEASES
813  |  CALU  |  DISEASES
573  |  BAG1  |  DISEASES
727866  |  FAM156B  |  DISEASES
641700  |  ECSCR  |  DISEASES
6949  |  TCOF1  |  DISEASES
1452  |  CSNK1A1  |  DISEASES
728373  |  USP17L25  |  DISEASES
131870  |  NUDT16  |  DISEASES
25907  |  TMEM158  |  DISEASES
9353  |  SLIT2  |  DISEASES
51428  |  DDX41  |  DISEASES
728419  |  USP17L30  |  DISEASES
728405  |  USP17L29  |  DISEASES
132299  |  OCIAD2  |  DISEASES
728393  |  USP17L27  |  DISEASES
728400  |  USP17L28  |  DISEASES
83697  |  SLC4A9  |  DISEASES
9140  |  ATG12  |  DISEASES
728369  |  USP17L24  |  DISEASES
285782  |  CAGE1  |  DISEASES
1977  |  EIF4E  |  DISEASES
57113  |  TRPC7  |  DISEASES
2920  |  CXCL2  |  DISEASES
728379  |  USP17L26  |  DISEASES
1050  |  CEBPA  |  DISEASES
27  |  ABL2  |  DISEASES
116328  |  C8orf34  |  DISEASES
23303  |  KIF13B  |  DISEASES
114907  |  FBXO32  |  DISEASES
284  |  ANGPT1  |  DISEASES
56100  |  PCDHGB6  |  DISEASES
4067  |  LYN  |  DISEASES
9788  |  MTSS1  |  DISEASES
11075  |  STMN2  |  DISEASES
10687  |  PNMA2  |  DISEASES
374897  |  SBSN  |  DISEASES
6586  |  SLIT3  |  DISEASES
3066  |  HDAC2  |  DISEASES
3620  |  IDO1  |  DISEASES
3551  |  IKBKB  |  DISEASES
4914  |  NTRK1  |  DISEASES
9776  |  ATG13  |  DISEASES
63970  |  TP53AIP1  |  DISEASES
9793  |  CKAP5  |  DISEASES
22992  |  KDM2A  |  DISEASES
26256  |  CABYR  |  DISEASES
4008  |  LMO7  |  DISEASES
54970  |  TTC12  |  DISEASES
84000  |  TMPRSS13  |  DISEASES
7296  |  TXNRD1  |  DISEASES
996  |  CDC27  |  DISEASES
6195  |  RPS6KA1  |  DISEASES
84107  |  ZIC4  |  DISEASES
4586  |  MUC5AC  |  DISEASES
6207  |  RPS13  |  DISEASES
10658  |  CELF1  |  DISEASES
727897  |  MUC5B  |  DISEASES
399687  |  MYO18A  |  DISEASES
930  |  CD19  |  DISEASES
9820  |  CUL7  |  DISEASES
7694  |  ZNF135  |  DISEASES
3684  |  ITGAM  |  DISEASES
6510  |  SLC1A5  |  DISEASES
3939  |  LDHA  |  DISEASES
5125  |  PCSK5  |  DISEASES
11153  |  FICD  |  DISEASES
4637  |  MYL6  |  DISEASES
7421  |  VDR  |  DISEASES
8972  |  MGAM  |  DISEASES
1649  |  DDIT3  |  DISEASES
317  |  APAF1  |  DISEASES
84525  |  HOPX  |  DISEASES
5228  |  PGF  |  DISEASES
10381  |  TUBB3  |  DISEASES
567  |  B2M  |  DISEASES
54742  |  LY6K  |  DISEASES
101  |  ADAM8  |  DISEASES
51203  |  NUSAP1  |  DISEASES
6642  |  SNX1  |  DISEASES
51741  |  WWOX  |  DISEASES
3316  |  HSPB2  |  DISEASES
1006  |  CDH8  |  DISEASES
63895  |  PIEZO2  |  DISEASES
9212  |  AURKB  |  DISEASES
30837  |  SOCS7  |  DISEASES
388789  |  LINC00493  |  DISEASES
92283  |  ZNF461  |  DISEASES
284424  |  MIR7-3HG  |  DISEASES
5608  |  MAP2K6  |  DISEASES
26085  |  KLK13  |  DISEASES
246734  |  NPCDR1  |  DISEASES
7409  |  VAV1  |  DISEASES
11012  |  KLK11  |  DISEASES
619343  |  ERICH1-AS1  |  DISEASES
400550  |  FENDRR  |  DISEASES
84793  |  FOXD2-AS1  |  DISEASES
100287082  |  GACAT2  |  DISEASES
60674  |  GAS5  |  DISEASES
100506046  |  GAS5-AS1  |  DISEASES
650669  |  GAS6-AS1  |  DISEASES
100128893  |  GATA6-AS1  |  DISEASES
100128811  |  GPR158-AS1  |  DISEASES
414761  |  HCG15  |  DISEASES
283460  |  HNF1A-AS1  |  DISEASES
100124700  |  HOTAIR  |  DISEASES
100316868  |  HOTTIP  |  DISEASES
221883  |  HOXA11-AS  |  DISEASES
104797538  |  KCNMB2-AS1  |  DISEASES
80078  |  LCAL1  |  DISEASES
79854  |  LINC00115  |  DISEASES
349114  |  LINC00265  |  DISEASES
114038  |  LINC00313  |  DISEASES
150759  |  LINC00342  |  DISEASES
90632  |  LINC00473  |  DISEASES
400619  |  LINC00511  |  DISEASES
338002  |  LINC00524  |  DISEASES
100499467  |  LINC00673  |  DISEASES
439990  |  LINC00857  |  DISEASES
170425  |  LINC00858  |  DISEASES
100287314  |  LINC00941  |  DISEASES
158376  |  LINC00961  |  DISEASES
100507632  |  LINC00968  |  DISEASES
100133161  |  LINC01001  |  DISEASES
399844  |  LINC01002  |  DISEASES
100505636  |  LINC01024  |  DISEASES
100505633  |  LINC01133  |  DISEASES
101927574  |  LINC01186  |  DISEASES
348120  |  LINC01193  |  DISEASES
100996490  |  LINC01206  |  DISEASES
100506115  |  LINC01272  |  DISEASES
100996492  |  LINC01314  |  DISEASES
100506385  |  LINC01426  |  DISEASES
728228  |  LINC01433  |  DISEASES
100506791  |  LINC01511  |  DISEASES
100132354  |  LINC01512  |  DISEASES
101927957  |  LINC01572  |  DISEASES
100505994  |  LUCAT1  |  DISEASES
266671  |  MAGI2-IT1  |  DISEASES
378938  |  MALAT1  |  DISEASES
100507257  |  MEG9  |  DISEASES
407975  |  MIR17HG  |  DISEASES
642587  |  MIR205HG  |  DISEASES
84981  |  MIR22HG  |  DISEASES
554202  |  MIR31HG  |  DISEASES
400931  |  MIRLET7BHG  |  DISEASES
152217  |  NCBP2-AS2  |  DISEASES
283131  |  NEAT1  |  DISEASES
374987  |  NEXN-AS1  |  DISEASES
100130557  |  NFYC-AS1  |  DISEASES
100309464  |  OTX2-AS1  |  DISEASES
103611155  |  PAPPA-AS2  |  DISEASES
103164619  |  PCAT2  |  DISEASES
5820  |  PVT1  |  DISEASES
503569  |  RGMB-AS1  |  DISEASES
283104  |  SBF2-AS1  |  DISEASES
100874028  |  SGO1-AS1  |  DISEASES
23642  |  SNHG1  |  DISEASES
283596  |  SNHG10  |  DISEASES
84973  |  SNHG7  |  DISEASES
677844  |  SNORA78  |  DISEASES
677823  |  SNORA80E  |  DISEASES
9300  |  SNORD28  |  DISEASES
692107  |  SNORD66  |  DISEASES
692198  |  SNORD78  |  DISEASES
347689  |  SOX2-OT  |  DISEASES
100642175  |  SPRY4-IT1  |  DISEASES
7012  |  TERC  |  DISEASES
440944  |  THUMPD3-AS1  |  DISEASES
100128191  |  TMPO-AS1  |  DISEASES
252948  |  TTTY16  |  DISEASES
55000  |  TUG1  |  DISEASES
652995  |  UCA1  |  DISEASES
Locus(Waiting for update.)
Disease ID 846
Disease lung cancer
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:223)
HP:0002664  |  Neoplasia  |  284
HP:0002202  |  Pleural effusion  |  60
HP:0030731  |  Carcinoma  |  52
HP:0006510  |  Chronic obstructive pulmonary disease  |  32
HP:0006530  |  Interstitial lung disease  |  25
HP:0002206  |  Pulmonary fibrosis  |  24
HP:0002860  |  Squamous cell carcinoma  |  21
HP:0012531  |  Pain  |  20
HP:0000716  |  Depression  |  19
HP:0002090  |  Pneumonia  |  17
HP:0030078  |  Lung adenocarcinoma  |  15
HP:0030357  |  Small cell lung carcinoma  |  15
HP:0002835  |  Aspiration  |  15
HP:0002097  |  Pulmonary emphysema  |  14
HP:0003002  |  Breast carcinoma  |  14
HP:0002665  |  Lymphoma  |  12
HP:0001907  |  Thromboembolic disease  |  11
HP:0002383  |  Encephalitis  |  9
HP:0030358  |  Non-small cell lung carcinoma  |  9
HP:0012378  |  Fatigue  |  8
HP:0012735  |  Coughing  |  8
HP:0100721  |  Mediastinal lymphadenopathy  |  8
HP:0001824  |  Weight loss  |  7
HP:0012125  |  Prostate cancer  |  7
HP:0002094  |  Dyspnea  |  7
HP:0002716  |  Lymph node hyperplasia  |  7
HP:0001875  |  Neutropenia  |  7
HP:0002105  |  Hemoptysis  |  6
HP:0002204  |  Pulmonary embolism  |  6
HP:0001698  |  Pericardial effusions  |  6
HP:0001513  |  Obesity  |  6
HP:0000739  |  Anxiety  |  6
HP:0002902  |  Hyponatremia  |  6
HP:0001903  |  Anemia  |  6
HP:0000819  |  Diabetes mellitus  |  5
HP:0004326  |  Cachexia  |  5
HP:0002099  |  Asthma  |  5
HP:0100633  |  Inflammation of the esophagus  |  5
HP:0012126  |  Gastric cancer  |  5
HP:0012020  |  Right aortic arch  |  5
HP:0003473  |  Fatigable weakness  |  4
HP:0004469  |  Chronic bronchitis  |  4
HP:0002721  |  Immunodeficiency  |  4
HP:0000718  |  Aggressive behaviour  |  4
HP:0012387  |  Bronchitis  |  4
HP:0003072  |  Hypercalcemia  |  4
HP:0100724  |  Hypercoagulability  |  4
HP:0002102  |  Pleuritis  |  4
HP:0012223  |  Ruptured spleen  |  3
HP:0001369  |  Arthritis  |  3
HP:0003470  |  Inability to move  |  3
HP:0002360  |  Sleep disturbance  |  3
HP:0001658  |  Myocardial infarction  |  3
HP:0004395  |  Malnutrition  |  3
HP:0002960  |  Autoimmune condition  |  3
HP:0001894  |  Thrombocytosis  |  3
HP:0001279  |  Syncope  |  3
HP:0002107  |  Collapsed lung  |  3
HP:0001635  |  Congestive heart failure  |  3
HP:0000083  |  Renal insufficiency  |  3
HP:0001945  |  Fever  |  3
HP:0100033  |  Tic disorder  |  2
HP:0001287  |  Meningitis  |  2
HP:0002015  |  Swallowing difficulty  |  2
HP:0006517  |  Alveolar proteinosis  |  2
HP:0001370  |  Rheumatoid arthritis  |  2
HP:0001696  |  Situs inversus totalis  |  2
HP:0002039  |  Anorexia  |  2
HP:0030692  |  Brain tumor  |  2
HP:0006536  |  Obstructive lung disease  |  2
HP:0002027  |  Abdominal pain  |  2
HP:0005584  |  Renal cell carcinoma  |  2
HP:0100753  |  Schizophrenia  |  2
HP:0000822  |  Hypertension  |  2
HP:0001909  |  Leukemia  |  2
HP:0002321  |  Vertigo  |  2
HP:0001324  |  Muscular weakness  |  2
HP:0000979  |  Purpura  |  2
HP:0000365  |  Hearing impairment  |  2
HP:0100526  |  Neoplasm of the lung  |  2
HP:0005214  |  Bowel obstruction  |  2
HP:0001974  |  Leukocytosis  |  2
HP:0002633  |  Vasculitis  |  2
HP:0100002  |  Pleural mesothelioma  |  2
HP:0004936  |  Blood clot in vein  |  2
HP:0001677  |  Coronary artery disease  |  2
HP:0002140  |  Ischemic stroke  |  2
HP:0100242  |  Sarcoma  |  2
HP:0100750  |  Pulmonary atelectasis  |  2
HP:0006528  |  Chronic lung disease  |  2
HP:0003073  |  Hypoalbuminaemia  |  2
HP:0000969  |  Dropsy  |  2
HP:0000488  |  Noninflammatory retina disease  |  2
HP:0100806  |  Sepsis  |  2
HP:0001297  |  Cerebral vascular events  |  2
HP:0000282  |  Facial puffiness  |  1
HP:0010772  |  Anomalous pulmonary venous return  |  1
HP:0002267  |  Exaggerated startle response  |  1
HP:0000100  |  Nephrosis  |  1
HP:0100843  |  Glioblastoma  |  1
HP:0000726  |  Dementia  |  1
HP:0000970  |  Lack of sweating  |  1
HP:0002113  |  Pulmonary infiltrates  |  1
HP:0000846  |  Hypoadrenalism  |  1
HP:0005550  |  Chronic lymphatic leukemia  |  1
HP:0002617  |  Aneurysmal dilatation  |  1
HP:0003418  |  Back pain  |  1
HP:0002013  |  Emesis  |  1
HP:0002667  |  Wilms tumor  |  1
HP:0003765  |  Psoriasis  |  1
HP:0002093  |  progressive respiratory failure  |  1
HP:0002583  |  Colitis  |  1
HP:0100522  |  Thymoma  |  1
HP:0012444  |  Brain wasting  |  1
HP:0002878  |  Respiratory failure  |  1
HP:0002861  |  Melanoma  |  1
HP:0001873  |  Low platelet count  |  1
HP:0002017  |  Nausea and vomiting  |  1
HP:0006775  |  Multiple myeloma  |  1
HP:0000962  |  Hyperkeratosis  |  1
HP:0001973  |  Autoimmune thrombocytopenia  |  1
HP:0000956  |  Keratosis nigricans  |  1
HP:0001733  |  Pancreatic inflammation  |  1
HP:0100279  |  Ulcerative colitis  |  1
HP:0006824  |  Cranial nerve palsy  |  1
HP:0001217  |  Digital clubbing  |  1
HP:0100570  |  Carcinoid tumor  |  1
HP:0002092  |  Pulmonary artery hypertension  |  1
HP:0001510  |  Growth deficiency  |  1
HP:0030834  |  Shoulder pain  |  1
HP:0010310  |  Chylothorax  |  1
HP:0011675  |  Arrhythmias  |  1
HP:0000107  |  Renal cyst  |  1
HP:0005521  |  Disseminated intravascular coagulation  |  1
HP:0100244  |  Fibrosarcoma  |  1
HP:0001263  |  Developmental retardation  |  1
HP:0001876  |  Low blood cell count  |  1
HP:0002089  |  Hypoplastic lungs  |  1
HP:0100749  |  Thoracic pain  |  1
HP:0000099  |  Glomerular nephritis  |  1
HP:0001701  |  Pericarditis  |  1
HP:0002315  |  Headaches  |  1
HP:0001067  |  Neurofibromas  |  1
HP:0012398  |  Peripheral edema  |  1
HP:0012118  |  Cancer of the larynx  |  1
HP:0002381  |  Aphasia  |  1
HP:0002910  |  Elevated transaminases  |  1
HP:0002527  |  Falls  |  1
HP:0002777  |  Tracheal stenosis  |  1
HP:0001735  |  Acute pancreatitis  |  1
HP:0010773  |  Partial anomalous pulmonary venous return  |  1
HP:0002110  |  Bronchiectasis  |  1
HP:0002076  |  Migraine headaches  |  1
HP:0001278  |  Orthostatic hypotension  |  1
HP:0002858  |  Mengiomia  |  1
HP:0002239  |  Gastrointestinal hemorrhage  |  1
HP:0011710  |  Bundle-branch block  |  1
HP:0000872  |  Hashimoto's thyroiditis  |  1
HP:0008064  |  Ichthyosis  |  1
HP:0005110  |  Atrial fibrillation  |  1
HP:0012035  |  Steatocystoma multiplex  |  1
HP:0001948  |  Alkalosis  |  1
HP:0000790  |  Hematuria  |  1
HP:0003774  |  End-stage renal failure  |  1
HP:0001336  |  Myoclonic jerks  |  1
HP:0002653  |  Bone pain  |  1
HP:0002018  |  Nausea  |  1
HP:0002608  |  Celiac disease  |  1
HP:0001650  |  Valvular aortic stenosis  |  1
HP:0000855  |  Insulin resistance  |  1
HP:0001548  |  Overgrowth  |  1
HP:0002615  |  Low blood pressure  |  1
HP:0002671  |  Basalioma  |  1
HP:0002575  |  Tracheoesophageal fistula  |  1
HP:0001394  |  Hepatic cirrhosis  |  1
HP:0100699  |  Scarring  |  1
HP:0200058  |  Angiosarcoma  |  1
HP:0009926  |  Epiphora  |  1
HP:0030880  |  Raynaud phenomenon  |  1
HP:0001249  |  Mental retardation  |  1
HP:0006532  |  Pneumonia, recurrent episodes  |  1
HP:0001251  |  Ataxia  |  1
HP:0005523  |  Lymphoproliferative disorder  |  1
HP:0011852  |  Chylopericardium  |  1
HP:0010543  |  Opsoclonus  |  1
HP:0003006  |  Neuroblastoma  |  1
HP:0003287  |  Abnormality of mitochondrial metabolism  |  1
HP:0007209  |  Facial paresis  |  1
HP:0030153  |  Cholangiocarcinoma  |  1
HP:0002829  |  Arthralgias  |  1
HP:0000802  |  Erectile dysfunction  |  1
HP:0002666  |  Pheochromocytoma  |  1
HP:0005301  |  Persistent left superior vena cava  |  1
HP:0010622  |  Neoplasm of the skeletal system  |  1
HP:0002863  |  Myelodysplastic syndrome  |  1
HP:0004448  |  Fulminant hepatic failure  |  1
HP:0100646  |  Thyroiditis  |  1
HP:0004398  |  Peptic ulcer  |  1
HP:0002176  |  Spinal cord compression  |  1
HP:0002896  |  Liver cancer  |  1
HP:0011713  |  Left bundle branch block  |  1
HP:0011459  |  Esophageal carcinoma  |  1
HP:0009733  |  Glioma  |  1
HP:0001250  |  Seizures  |  1
HP:0100537  |  Inflammation of the fascia  |  1
HP:0003003  |  Colon cancer  |  1
HP:0200029  |  Cutaneous vasculitis  |  1
HP:0100543  |  Cognitive deficits  |  1
HP:0001578  |  Hypercortisolism  |  1
HP:0000964  |  Eczema  |  1
HP:0002014  |  Diarrhea  |  1
HP:0010566  |  Hamartoma  |  1
HP:0010628  |  Facial palsy, unilateral or bilateral  |  1
HP:0001880  |  Eosinophilia  |  1
HP:0200114  |  Metabolic alkalosis  |  1
HP:0012151  |  Hemothorax  |  1
HP:0008653  |  Crescentic glomerulonephritis  |  1
HP:0003040  |  Arthropathy  |  1
HP:0001399  |  Liver failure  |  1
HP:0001919  |  Acute renal failure  |  1
HP:0003202  |  Neurogenic muscle atrophy, especially in the lower limbs  |  1
HP:0100324  |  Progressive systemic scleroderma  |  1
HP:0002584  |  Intestinal hemorrhage  |  1
Disease ID 846
Disease lung cancer
Manually Symptom(Waiting for update.)
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:153)
C0220650  |  brain metastases  |  89
C0001418  |  adenocarcinoma  |  59
C0032227  |  pleural effusion  |  48
C0153690  |  bone metastases  |  48
C0220650  |  brain metastasis  |  42
C0024115  |  lung disease  |  30
C0080032  |  malignant pleural effusion  |  29
C0153690  |  bone metastasis  |  29
C0206062  |  interstitial lung disease  |  25
C0009450  |  infection  |  24
C0034069  |  pulmonary fibrosis  |  24
C0030193  |  pain  |  20
C0032285  |  pneumonitis  |  20
C0011570  |  depression  |  19
C1800706  |  idiopathic pulmonary fibrosis  |  18
C0032285  |  pneumonia  |  17
C0231303  |  distress  |  17
C0030472  |  paraneoplastic syndrome  |  15
C0041296  |  tuberculosis  |  14
C0032227  |  pleural effusions  |  13
C0001883  |  airway obstruction  |  10
C0153685  |  renal metastasis  |  10
C0854178  |  adrenal metastases  |  9
C0003949  |  asbestosis  |  9
C0686619  |  lymph node metastases  |  8
C0080032  |  malignant effusion  |  8
C0015672  |  fatigue  |  8
C0010200  |  cough  |  8
C0520743  |  mediastinal lymphadenopathy  |  8
C0040053  |  thrombosis  |  8
C0013404  |  dyspnea  |  7
C0024228  |  lymphadenopathy  |  7
C2119038  |  pleural metastasis  |  7
C0027947  |  neutropenia  |  7
C0040038  |  thromboembolism  |  7
C0263661  |  osteoarthropathy  |  7
C0031039  |  pericardial effusion  |  6
C0003467  |  anxiety  |  6
C0085786  |  idiopathic interstitial pneumonia  |  6
C0024115  |  lung diseases  |  6
C0013404  |  breathlessness  |  6
C0034065  |  pulmonary embolism  |  6
C0342500  |  adrenal mass  |  6
C1839611  |  n syndrome  |  6
C0746883  |  febrile neutropenia  |  6
C0019079  |  hemoptysis  |  6
C0019080  |  hemorrhage  |  5
C0030472  |  paraneoplastic syndromes  |  5
C1519670  |  tumor angiogenesis  |  5
C0038833  |  superior vena cava syndrome  |  5
C0006625  |  cachexia  |  5
C0021311  |  infections  |  5
C0007222  |  cardiovascular disease  |  5
C0009814  |  stenosis  |  5
C0153687  |  cutaneous metastasis  |  5
C0002871  |  anemia  |  5
C0014868  |  esophagitis  |  5
C0153676  |  pulmonary metastasis  |  4
C0008677  |  chronic bronchitis  |  4
C0006277  |  bronchitis  |  4
C0037116  |  silicosis  |  4
C0041327  |  pulmonary tuberculosis  |  4
C0178703  |  hypertrophic osteoarthropathy  |  4
C0684550  |  spinal metastases  |  4
C0747690  |  obstructive pneumonia  |  4
C0020437  |  hypercalcemia  |  4
C0398623  |  hypercoagulability  |  4
C0022972  |  myasthenic syndrome  |  4
C2350236  |  idiopathic interstitial pneumonias  |  4
C0024232  |  lymphatic metastases  |  3
C0149882  |  acute esophagitis  |  3
C0024110  |  lung abscess  |  3
C0032231  |  pleuritis  |  3
C0153687  |  skin metastases  |  3
C0032285  |  pulmonary inflammation  |  3
C0153676  |  pulmonary metastases  |  3
C0035204  |  respiratory disease  |  3
C2350529  |  pulmonary aspergillosis  |  3
C0162429  |  malnutrition  |  3
C0836924  |  thrombocytosis  |  3
C0016169  |  fistula  |  3
C0220655  |  malignant pericardial effusion  |  3
C0032326  |  pneumothorax  |  3
C0037284  |  skin lesions  |  2
C0014009  |  empyema  |  2
C0036690  |  sepsis  |  2
C1393529  |  vascular complications  |  2
C0037317  |  sleep disturbances  |  2
C0494165  |  liver metastases  |  2
C0347016  |  spinal cord metastasis  |  2
C0003123  |  anorexia  |  2
C0034050  |  pulmonary alveolar proteinosis  |  2
C0747690  |  obstructive pneumonitis  |  2
C0022972  |  lambert-eaton myasthenic syndrome  |  2
C0153687  |  skin metastasis  |  2
C0011168  |  dysphagia  |  2
C0086132  |  depressive symptoms  |  2
C1704231  |  leptomeningeal metastasis  |  2
C0010481  |  cushing's syndrome  |  2
C0042487  |  venous thrombosis  |  2
C0555278  |  cerebral metastases  |  2
C0019079  |  haemoptysis  |  2
C0037090  |  respiratory symptoms  |  2
C0011608  |  dermatitis herpetiformis  |  1
C0494165  |  hepatic metastasis  |  1
C0027726  |  nephrotic syndrome  |  1
C0025286  |  meningioma  |  1
C0001339  |  acute pancreatitis  |  1
C1332128  |  peritoneal carcinomatosis  |  1
C0442874  |  neuropathy  |  1
C0153677  |  mediastinal metastases  |  1
C0026918  |  mycobacteriosis  |  1
C0007758  |  cerebellar ataxia  |  1
C0940937  |  precancerous lesions  |  1
C0005940  |  bone disease  |  1
C0006118  |  brain tumor  |  1
C0039978  |  thoracic disease  |  1
C0040100  |  thymomas  |  1
C1145670  |  respiratory failure  |  1
C0040034  |  thrombocytopenia  |  1
C0031046  |  pericarditis  |  1
C0007177  |  cardiac tamponade  |  1
C1279386  |  postoperative pneumonia  |  1
C0275566  |  pulmonary actinomycosis  |  1
C0037926  |  spinal cord compression  |  1
C0406351  |  malignant acanthosis nigricans  |  1
C0596240  |  cancer pain  |  1
C0279130  |  cns metastases  |  1
C0006118  |  brain tumors  |  1
C0008733  |  chylothorax  |  1
C0022116  |  ischemia  |  1
C0035204  |  respiratory disorders  |  1
C0022408  |  arthropathy  |  1
C0038833  |  svc syndrome  |  1
C0040583  |  tracheal stenosis  |  1
C0021079  |  immunosuppression  |  1
C0262471  |  ent problem  |  1
C0040588  |  tracheoesophageal fistula  |  1
C0034065  |  pulmonary emboli  |  1
C0042963  |  vomiting  |  1
C0034067  |  pulmonary emphysema  |  1
C0023501  |  leukemoid reaction  |  1
C0002871  |  anaemia  |  1
C0032285  |  pneumoniae  |  1
C0686645  |  intrathoracic lymph nodes  |  1
C0220654  |  meningeal carcinomatosis  |  1
C0024115  |  pulmonary diseases  |  1
C0080032  |  malignant pleural effusions  |  1
C0346976  |  pancreatic metastasis  |  1
C0494165  |  hepatic metastases  |  1
C0014457  |  eosinophilia  |  1
C0422833  |  ent symptoms  |  1
C0030200  |  intractable pain  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:912)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs10079250251442418626TP63umls:C0242379BeFreeAmong 16 SNPs, three SNPs (colony-stimulating factor 1 receptor [CSF1R] rs10079250A>G, tumor protein p63 [TP63] rs7631358G>A, and corepressor interacting with RBPJ 1 [CIR1] rs13009079T>C) were found to be significantly associated with lung cancer in the same direction as the discovery set.0.1253528932015CSF1R5150070569TC
rs10079250251442419541CIR1umls:C0242379BeFreeAmong 16 SNPs, three SNPs (colony-stimulating factor 1 receptor [CSF1R] rs10079250A>G, tumor protein p63 [TP63] rs7631358G>A, and corepressor interacting with RBPJ 1 [CIR1] rs13009079T>C) were found to be significantly associated with lung cancer in the same direction as the discovery set.0.0002714422015CSF1R5150070569TC
rs10115703197891909350CER1umls:C0242379GAD[When numeric scores were assigned to both the SNP and demographic data, and sequentially combined by a simple algorithm in a risk model, the composite score was found to be linearly related to lung cancer risk with a bimodal distribution.]0.0047340642009CER1914722618GA,C
rs10244817192857507014TERF2umls:C0242379BeFreePOT1 rs10244817, TERT rs2075786, and TERF2 rs251796 were significantly associated with lung cancer (p(trend)< or =0.05).0.0050055062009POT17124827416TC
rs102448171928575025913POT1umls:C0242379BeFreeWhen stratified by genotype, there was a suggestion of a dose-response relationship between tertiles of telomere length and risk of lung cancer among the POT1 rs10244817 common variant carriers (OR (95% CI)=1.33 (0.47-3.75), 3.30 (1.14-9.56), respectively) but not among variant genotype carriers (p(interaction)=0.05).0.0052769482009POT17124827416TC
rs10244817192857507015TERTumls:C0242379BeFreePOT1 rs10244817, TERT rs2075786, and TERF2 rs251796 were significantly associated with lung cancer (p(trend)< or =0.05).0.1554182652009POT17124827416TC
rs10254120239815787157TP53umls:C0242379BeFreeWe further demonstrate that P53 V157D and/or PMS2 R20Q mutant promotes lung cancer cell proliferation.0.162013PMS276005996CA,T
rs10254120239815785395PMS2umls:C0242379BeFreeWe further demonstrate that P53 V157D and/or PMS2 R20Q mutant promotes lung cancer cell proliferation.0.0026384742013PMS276005996CA,T
rs1042522196236497157TP53umls:C0242379BeFreeTP53 Arg72Pro polymorphism and lung cancer risk: a meta-analysis.0.162009TP53177676154GT,C
rs1042522169122097157TP53umls:C0242379BeFreeTherefore, we hypothesized that the genetic variants in these three genes influence the predisposition of lung cancer (i.e., CCND1 G870A, CDKN2A Ala(148)Thr, TP53 Arg(72)Pro, and 16-bp repeat in intron 3) and that the effect of X-ray on lung cancer risk can be modified by the presence of these genetic variations.0.162006TP53177676154GT,C
rs1042522181810447157TP53umls:C0242379BeFreeCox regression analysis showed p53 Arg72Pro heterozygous genotype was overall an independent prognostic factor (Risk ratio of death, 2.2; P = 0.02), suggesting Pro72Pro genotype to be a potential risk factor favoring the development of lung carcinoma and that Arg72Pro genotype is independently associated with a poorer prognosis of lung cancer.0.162008TP53177676154GT,C
rs1042522189907482068ERCC2umls:C0242379BeFreeFour of the variants were found to be weakly associated with lung cancer risk with borderline significance: these were XRCC3 T241M [heterozygote odds ratio (OR), 0.89; 95% confidence interval (95% CI), 0.79-0.99 and homozygote OR, 0.84; 95% CI, 0.71-1.00] based on 3,467 cases and 5,021 controls from 8 studies, XPD K751Q (heterozygote OR, 0.99; 95% CI, 0.89-1.10 and homozygote OR, 1.19; 95% CI, 1.02-1.39) based on 6,463 cases and 6,603 controls from 9 studies, and TP53 R72P (heterozygote OR, 1.14; 95% CI, 1.00-1.29 and homozygote OR, 1.20; 95% CI, 1.02-1.42) based on 3,610 cases and 5,293 controls from 6 studies.0.2138435352008TP53177676154GT,C
rs1042522189907487517XRCC3umls:C0242379BeFreeFour of the variants were found to be weakly associated with lung cancer risk with borderline significance: these were XRCC3 T241M [heterozygote odds ratio (OR), 0.89; 95% confidence interval (95% CI), 0.79-0.99 and homozygote OR, 0.84; 95% CI, 0.71-1.00] based on 3,467 cases and 5,021 controls from 8 studies, XPD K751Q (heterozygote OR, 0.99; 95% CI, 0.89-1.10 and homozygote OR, 1.19; 95% CI, 1.02-1.39) based on 6,463 cases and 6,603 controls from 9 studies, and TP53 R72P (heterozygote OR, 1.14; 95% CI, 1.00-1.29 and homozygote OR, 1.20; 95% CI, 1.02-1.42) based on 3,610 cases and 5,293 controls from 6 studies.0.0443871172008TP53177676154GT,C
rs1042522170598535063PAK3umls:C0242379BeFreeWe therefore investigated the combined effects of polymorphisms in TP53 (Arg72Pro) and p21/CDKN1A (Ser31Arg) and smoking on lung cancer risk.0.0002714422007TP53177676154GT,C
rs1042522233174147157TP53umls:C0242379BeFreePresent report evaluated the association of polymorphism in exon 4 Arg72Pro (G>C) of the p53 gene with lung cancer susceptibility using 175 cancer cases and 202 controls from the North Indian population.0.162013TP53177676154GT,C
rs1042522189907487157TP53umls:C0242379BeFreeFour of the variants were found to be weakly associated with lung cancer risk with borderline significance: these were XRCC3 T241M [heterozygote odds ratio (OR), 0.89; 95% confidence interval (95% CI), 0.79-0.99 and homozygote OR, 0.84; 95% CI, 0.71-1.00] based on 3,467 cases and 5,021 controls from 8 studies, XPD K751Q (heterozygote OR, 0.99; 95% CI, 0.89-1.10 and homozygote OR, 1.19; 95% CI, 1.02-1.39) based on 6,463 cases and 6,603 controls from 9 studies, and TP53 R72P (heterozygote OR, 1.14; 95% CI, 1.00-1.29 and homozygote OR, 1.20; 95% CI, 1.02-1.42) based on 3,610 cases and 5,293 controls from 6 studies.0.162008TP53177676154GT,C
rs1042522235956587157TP53umls:C0242379BeFreeThe association between TP53 Arg72Pro polymorphism and lung cancer susceptibility: evidence from 30,038 subjects.0.162013TP53177676154GT,C
rs1042522183369517157TP53umls:C0242379BeFreeThe TP53 Arg72Pro polymorphism and lung cancer risk in a population of Northern Spain.0.162008TP53177676154GT,C
rs1042522169122091029CDKN2Aumls:C0242379BeFreeTherefore, we hypothesized that the genetic variants in these three genes influence the predisposition of lung cancer (i.e., CCND1 G870A, CDKN2A Ala(148)Thr, TP53 Arg(72)Pro, and 16-bp repeat in intron 3) and that the effect of X-ray on lung cancer risk can be modified by the presence of these genetic variations.0.0383169112006TP53177676154GT,C
rs1042522238127257157TP53umls:C0242379BeFreeThe updated meta-analysis suggests that the p53 codon 72 Arg/Pro polymorphism is a risk factor for lung cancer in the Asian population.0.162013TP53177676154GT,C
rs1042522174003327157TP53umls:C0242379BeFreeLack of evidence that p53 Arg72Pro influences lung cancer prognosis: an analysis of survival in 619 female patients.0.162007TP53177676154GT,C
rs1045642246873445243ABCB1umls:C0242379BeFreeIn regard to the clinical implications of MDR1 SNPs, it was found in large meta-analysis that C3435T SNP was associated with a slight increase in the susceptibility to ulcerative colitis and cancer and was related with slight modifications in tacrolimus pharmacokinetics and platinum-based chemotherapy response in lung cancer.0.0410102622013ABCB1787509329AT,G
rs10462822414046010848PPP1R13Lumls:C0242379BeFreeThe haplotype ERCC2 rs3916874(G) and rs238415(C) [OR (95% CI)=1.26 (1.02-1.57), P=0.03] in block 1 and the haplotype PPP1R13L rs4803817(A), CD3EAP rs1046282(T), rs735482(C), ERCC1 rs3212980(A), rs3212964(G) [OR (95% CI)=3.56 (1.55-8.18), P=0.005] in block 3 were associated with lung cancer risk.0.0071770412013ERCC1;PPP1R13L;CD3EAP1945407414AG
rs10475407233726584524MTHFRumls:C0242379BeFreeSNPs in MTRR (rs13162612; OR = 0.25; 95% CI: 0.11-0.58; rs10512948; OR = 0.61; 95% CI: 0.41-0.90; rs2924471; OR = 3.31; 95% CI: 1.66-6.59), and MTHFR (rs9651118; OR = 0.63; 95% CI: 0.43-0.95) and three SNP*nutrient interactions (choline*rs10475407; OR = 1.62; 95% CI: 1.11-2.42; choline*rs11134290; OR = 0.51; 95% CI: 0.27-0.92; and riboflavin*rs8767412; OR = 0.40; 95% CI: 0.15-0.95) were associated with lung cancer risk in never smokers.0.056765162013NA58092964CT
rs10475407233726584552MTRRumls:C0242379BeFreeSNPs in MTRR (rs13162612; OR = 0.25; 95% CI: 0.11-0.58; rs10512948; OR = 0.61; 95% CI: 0.41-0.90; rs2924471; OR = 3.31; 95% CI: 1.66-6.59), and MTHFR (rs9651118; OR = 0.63; 95% CI: 0.43-0.95) and three SNP*nutrient interactions (choline*rs10475407; OR = 1.62; 95% CI: 1.11-2.42; choline*rs11134290; OR = 0.51; 95% CI: 0.27-0.92; and riboflavin*rs8767412; OR = 0.40; 95% CI: 0.15-0.95) were associated with lung cancer risk in never smokers.0.0105538952013NA58092964CT
rs1047972251545116790AURKAumls:C0242379BeFreeIn summary, this meta-analysis suggests that STK15 F31I polymorphism is associated with increased breast cancer and ovarian cancer risk among Caucasians, F31I polymorphism is associated with decreased lung cancer risk among Caucasians, and V57I polymorphism is associated with decreased breast cancer risk among Caucasians.0.0087297472014AURKA2056386407TC
rs104894396107911543CYP1A1umls:C0242379BeFreeWe examined an Ile462Val polymorphism (CYP1A1*2 allele) of cytochrome P450 IA1 in a hospital-based case-control study of lung cancer patients (247 cases and 185 controls) in Okinawa to ascertain the association of this variant with lung cancer.0.1237021411998CYP1A11574720644TG,C,A
rs1048943225255587517XRCC3umls:C0242379BeFreeCYP1A1 rs4646903 (OR = 1.72, 95% CI = 1.25-2.38), rs1048943 (OR = 1.40, 95% CI = 1.02-1.92), the GSTM1 deletion polymorphism (OR = 1.38, 95% CI = 1.01-1.89), GSTP1 rs1695 (OR =1.48, 95% CI = 1.04-2.11), ERCC2 rs13181 (OR = 1.89, 95% CI = 1.28-2.78), and Chinese hamster 1 rs25487 (OR = 1.54, 95% CI = 1.12-2.13) were associated with lung cancer risk whereas the GSTT1 deletion polymorphism and XRCC3 rs861539 were not.0.0443871172012CYP1A11574720644TG,C,A
rs1048943110089202944GSTM1umls:C0242379BeFreeIn this Chinese cohort, with CYP1A1 valine allele frequency intermediate between Japanese and Caucasian populations, the I462V polymorphism is not related to lung cancer overall, but it might play a role at lower levels of cigarette smoking among subjects with impaired carcinogen detoxification as assessed by the GSTM1-null genotype.0.126416562000CYP1A11574720644TG,C,A
rs1048943179809331545CYP1B1umls:C0242379BeFreeFurthermore, the combination of risk genotypes of CYP1B1 Leu432Val with CYP1A1 Ile462Val was associated with the risk of lung adenocarcinoma (adjusted OR=2.16; 95% CI, 1.02-4.57) as well as overall lung cancer (adjusted OR=2.23; 95% CI 1.01-4.89).0.0332903372008CYP1A11574720644TG,C,A
rs1048943220251361543CYP1A1umls:C0242379BeFreeCYP1A1 Ile462Val polymorphism and susceptibility to lung cancer: a meta-analysis based on 32 studies.0.1237021412011CYP1A11574720644TG,C,A
rs1048943225255582950GSTP1umls:C0242379BeFreeCYP1A1 rs4646903 (OR = 1.72, 95% CI = 1.25-2.38), rs1048943 (OR = 1.40, 95% CI = 1.02-1.92), the GSTM1 deletion polymorphism (OR = 1.38, 95% CI = 1.01-1.89), GSTP1 rs1695 (OR =1.48, 95% CI = 1.04-2.11), ERCC2 rs13181 (OR = 1.89, 95% CI = 1.28-2.78), and Chinese hamster 1 rs25487 (OR = 1.54, 95% CI = 1.12-2.13) were associated with lung cancer risk whereas the GSTT1 deletion polymorphism and XRCC3 rs861539 were not.0.0924863262012CYP1A11574720644TG,C,A
rs1048943225255582952GSTT1umls:C0242379BeFreeCYP1A1 rs4646903 (OR = 1.72, 95% CI = 1.25-2.38), rs1048943 (OR = 1.40, 95% CI = 1.02-1.92), the GSTM1 deletion polymorphism (OR = 1.38, 95% CI = 1.01-1.89), GSTP1 rs1695 (OR =1.48, 95% CI = 1.04-2.11), ERCC2 rs13181 (OR = 1.89, 95% CI = 1.28-2.78), and Chinese hamster 1 rs25487 (OR = 1.54, 95% CI = 1.12-2.13) were associated with lung cancer risk whereas the GSTT1 deletion polymorphism and XRCC3 rs861539 were not.0.100358142012CYP1A11574720644TG,C,A
rs1048943110089201543CYP1A1umls:C0242379BeFreeCYP1A1 I462V genetic polymorphism and lung cancer risk in a cohort of men in Shanghai, China.0.1237021412000CYP1A11574720644TG,C,A
rs1048943171744381543CYP1A1umls:C0242379BeFreeIn Caucasians, those with the IIe/Val genotype at CYP1A1 Ile(462)Val locus were at decreased risk of having lung cancer compared to those with the lle/lle genotype, after adjusting for age at diagnosis, sex, pack years of smoking and family history of cancer (OR=0.41 95% Cl 0.19-0.90).0.1237021412007CYP1A11574720644TG,C,A
rs1048943199631141543CYP1A1umls:C0242379BeFreeThe polymorphic frequency of 10 genetic susceptibility genes and their association with lung cancer were examined in a northern Thai population: CYP1A1 (MspI), CYP1A1 (Ile462Val), CYP2E1 (PstI), CYP2E1 (DraI), GSTM1, GSTT1, MPO (AciI), OGG1 (Ser326Cys), TP53 (Arg72Pro), and MMP1(AluI).0.1237021412009CYP1A11574720644TG,C,A
rs1048943179809331543CYP1A1umls:C0242379BeFreeTheses results suggest that the CYP1A1 Ile462Val polymorphism is associated with a reduced risk of lung adenocarcinoma in never-smoking Korean women, whereas specific combinations of variant genotypes for metabolic enzymes increase lung cancer risk considerably.0.1237021412008CYP1A11574720644TG,C,A
rs1048943229526731543CYP1A1umls:C0242379BeFreeCYP1A1 Ile462Val polymorphism contributes to lung cancer susceptibility among lung squamous carcinoma and smokers: a meta-analysis.0.1237021412012CYP1A11574720644TG,C,A
rs1050450175486726648SOD2umls:C0242379BeFreeWe evaluated potential associations between gene variants that result in reduced neutralization of reactive oxygen species (ROS; MnSOD Ala-16Val, CAT -262 C>T, and GPX1 Pro200Leu) and prostate cancer risk among 724 men with incident prostate cancer who participated in the Carotene and Retinol Efficacy Trial (CARET) cohort, a randomized trial for the prevention of lung cancer among men with a history of smoking and/or asbestos exposure.0.0219221162007GPX1349357401GA
rs1050450182988062876GPX1umls:C0242379BeFreeHowever, this study provides some support for the T-Allel of GPX1(Pro200Leu) and the C-Allele of EPHX1(His113Tyr) to play a protective role in early onset lung cancer susceptibility.0.0258418552008GPX1349357401GA
rs1050450182988062052EPHX1umls:C0242379BeFreeHowever, this study provides some support for the T-Allel of GPX1(Pro200Leu) and the C-Allele of EPHX1(His113Tyr) to play a protective role in early onset lung cancer susceptibility.0.0660377912008GPX1349357401GA
rs1050450175486722876GPX1umls:C0242379BeFreeWe evaluated potential associations between gene variants that result in reduced neutralization of reactive oxygen species (ROS; MnSOD Ala-16Val, CAT -262 C>T, and GPX1 Pro200Leu) and prostate cancer risk among 724 men with incident prostate cancer who participated in the Carotene and Retinol Efficacy Trial (CARET) cohort, a randomized trial for the prevention of lung cancer among men with a history of smoking and/or asbestos exposure.0.0258418552007GPX1349357401GA
rs10511729252396441993ELAVL2umls:C0242379BeFreeASSET analyses identified four SNPs significantly associated with multiple cancers: rs3731239 (CDKN2A intronic) with ESCC, GC and BC (P = 3.96 × 10(-) (4)); rs10811474 (3' of IFNW1) with RCC and BrC (P = 0.001); rs12683422 (LINGO2 intronic) with RCC and BC (P = 5.93 × 10(-) (4)) and rs10511729 (3' of ELAVL2) with LC and BrC (P = 8.63 × 10(-) (4)).0.0013572092015LOC101929563923557229TG
rs10511729252396441029CDKN2Aumls:C0242379BeFreeASSET analyses identified four SNPs significantly associated with multiple cancers: rs3731239 (CDKN2A intronic) with ESCC, GC and BC (P = 3.96 × 10(-) (4)); rs10811474 (3' of IFNW1) with RCC and BrC (P = 0.001); rs12683422 (LINGO2 intronic) with RCC and BC (P = 5.93 × 10(-) (4)) and rs10511729 (3' of ELAVL2) with LC and BrC (P = 8.63 × 10(-) (4)).0.0383169112015LOC101929563923557229TG
rs10512948233726584552MTRRumls:C0242379BeFreeSNPs in MTRR (rs13162612; OR = 0.25; 95% CI: 0.11-0.58; rs10512948; OR = 0.61; 95% CI: 0.41-0.90; rs2924471; OR = 3.31; 95% CI: 1.66-6.59), and MTHFR (rs9651118; OR = 0.63; 95% CI: 0.43-0.95) and three SNP*nutrient interactions (choline*rs10475407; OR = 1.62; 95% CI: 1.11-2.42; choline*rs11134290; OR = 0.51; 95% CI: 0.27-0.92; and riboflavin*rs8767412; OR = 0.40; 95% CI: 0.15-0.95) were associated with lung cancer risk in never smokers.0.0105538952013NA58233238TC
rs10512948233726584524MTHFRumls:C0242379BeFreeSNPs in MTRR (rs13162612; OR = 0.25; 95% CI: 0.11-0.58; rs10512948; OR = 0.61; 95% CI: 0.41-0.90; rs2924471; OR = 3.31; 95% CI: 1.66-6.59), and MTHFR (rs9651118; OR = 0.63; 95% CI: 0.43-0.95) and three SNP*nutrient interactions (choline*rs10475407; OR = 1.62; 95% CI: 1.11-2.42; choline*rs11134290; OR = 0.51; 95% CI: 0.27-0.92; and riboflavin*rs8767412; OR = 0.40; 95% CI: 0.15-0.95) were associated with lung cancer risk in never smokers.0.056765162013NA58233238TC
rs1051730205549421136CHRNA3umls:C0242379BeFreeAssociations of SNPs in LOC123688 (rs10519203; odds ratio [OR] = 1.60, 95% confidence interval [CI] = 1.25 to 2.05, P = .00016), CHRNA5 (rs2036527; OR = 1.67, 95% CI = 1.26 to 2.21, P = .00031), and CHRNA3 (rs1051730; OR = 1.81, 95% CI = 1.26 to 2.59, P = .00137) genes with lung cancer risk reached Bonferroni-corrected levels of statistical significance (all statistical tests were two-sided).0.1792081372010CHRNA31578601997GA
rs1051730216459421136CHRNA3umls:C0242379BeFreeWe also investigated the relationship between the rs1051730 SNP in an intron of the CHRNA3 gene (the polymorphism most significantly associated with lung cancer risk and smoking behavior) and TSD.0.1792081372011CHRNA31578601997GA
rs1051730243378551136CHRNA3umls:C0242379BeFreeAssociation between CHRNA3 rs1051730 genotype and lung cancer risk in Chinese Han population: a case-control study.0.1792081372014CHRNA31578601997GA
rs105173020554942123688HYKKumls:C0242379BeFreeAssociations of SNPs in LOC123688 (rs10519203; odds ratio [OR] = 1.60, 95% confidence interval [CI] = 1.25 to 2.05, P = .00016), CHRNA5 (rs2036527; OR = 1.67, 95% CI = 1.26 to 2.21, P = .00031), and CHRNA3 (rs1051730; OR = 1.81, 95% CI = 1.26 to 2.59, P = .00137) genes with lung cancer risk reached Bonferroni-corrected levels of statistical significance (all statistical tests were two-sided).0.1337352532010CHRNA31578601997GA
rs1051730192474741362CPDumls:C0242379BeFreeIn the chr15q25.1 region spanning the nicotinic receptors CHRNA3 and CHRNA5, we identified multiple SNPs associated with CPD (p<10(-3)), including rs1051730, which has been associated with nicotine dependence, smoking intensity and lung cancer risk.0.0002714422009CHRNA31578601997GA
rs1051730192474741136CHRNA3umls:C0242379BeFreeIn the chr15q25.1 region spanning the nicotinic receptors CHRNA3 and CHRNA5, we identified multiple SNPs associated with CPD (p<10(-3)), including rs1051730, which has been associated with nicotine dependence, smoking intensity and lung cancer risk.0.1792081372009CHRNA31578601997GA
rs1051730192474741138CHRNA5umls:C0242379BeFreeIn the chr15q25.1 region spanning the nicotinic receptors CHRNA3 and CHRNA5, we identified multiple SNPs associated with CPD (p<10(-3)), including rs1051730, which has been associated with nicotine dependence, smoking intensity and lung cancer risk.0.0598269662009CHRNA31578601997GA
rs1051730200680851136CHRNA3umls:C0242379BeFreeSimilarly, neither CHRNA3 rs8034191 nor rs1051730 were associated with lung cancer risk.0.1792081372010CHRNA31578601997GA
rs1051730189787901136CHRNA3umls:C0242379GWASCATLung cancer susceptibility locus at 5p15.33.0.1792081372008CHRNA31578601997GA
rs105173022701590123688HYKKumls:C0242379BeFreeOur findings demonstrated that CHRNA3 gene rs1051730-A allele and AGPHD1 gene rs8034191-T allele might be risk-conferring factors for the development of lung cancer in Caucasians, but not in East-Asians.0.1337352532012CHRNA31578601997GA
rs1051730227015901136CHRNA3umls:C0242379BeFreeOur findings demonstrated that CHRNA3 gene rs1051730-A allele and AGPHD1 gene rs8034191-T allele might be risk-conferring factors for the development of lung cancer in Caucasians, but not in East-Asians.0.1792081372012CHRNA31578601997GA
rs1051740222060166817SULT1A1umls:C0242379BeFreeMDR analysis identified two distinct predictor models for the risk of lung cancer in smokers (tobacco chewing, EPHX1 Tyr113His, and SULT1A1 Arg213His) and non-smokers (CYP1A1*2A, GSTP1 Ile105Val and SULT1A1 Arg213His) with testing balance accuracy (TBA) of 0.6436 and 0.6677 respectively.0.0134638112011EPHX11225831932TC
rs1051740182988062052EPHX1umls:C0242379BeFreeHowever, this study provides some support for the T-Allel of GPX1(Pro200Leu) and the C-Allele of EPHX1(His113Tyr) to play a protective role in early onset lung cancer susceptibility.0.0660377912008EPHX11225831932TC
rs1051740222060162052EPHX1umls:C0242379BeFreeMDR analysis identified two distinct predictor models for the risk of lung cancer in smokers (tobacco chewing, EPHX1 Tyr113His, and SULT1A1 Arg213His) and non-smokers (CYP1A1*2A, GSTP1 Ile105Val and SULT1A1 Arg213His) with testing balance accuracy (TBA) of 0.6436 and 0.6677 respectively.0.0660377912011EPHX11225831932TC
rs1051740182988062876GPX1umls:C0242379BeFreeHowever, this study provides some support for the T-Allel of GPX1(Pro200Leu) and the C-Allele of EPHX1(His113Tyr) to play a protective role in early onset lung cancer susceptibility.0.0258418552008EPHX11225831932TC
rs10519203205549421136CHRNA3umls:C0242379BeFreeAssociations of SNPs in LOC123688 (rs10519203; odds ratio [OR] = 1.60, 95% confidence interval [CI] = 1.25 to 2.05, P = .00016), CHRNA5 (rs2036527; OR = 1.67, 95% CI = 1.26 to 2.21, P = .00031), and CHRNA3 (rs1051730; OR = 1.81, 95% CI = 1.26 to 2.59, P = .00137) genes with lung cancer risk reached Bonferroni-corrected levels of statistical significance (all statistical tests were two-sided).0.1792081372010HYKK1578521704GA
rs1051920320554942123688HYKKumls:C0242379BeFreeAssociations of SNPs in LOC123688 (rs10519203; odds ratio [OR] = 1.60, 95% confidence interval [CI] = 1.25 to 2.05, P = .00016), CHRNA5 (rs2036527; OR = 1.67, 95% CI = 1.26 to 2.21, P = .00031), and CHRNA3 (rs1051730; OR = 1.81, 95% CI = 1.26 to 2.59, P = .00137) genes with lung cancer risk reached Bonferroni-corrected levels of statistical significance (all statistical tests were two-sided).0.1337352532010HYKK1578521704GA
rs1052133239719714968OGG1umls:C0242379BeFreeAssociation between the hOGG1 Ser326Cys polymorphism and lung cancer susceptibility: a meta-analysis based on 22,475 subjects.0.0722050092013OGG1;CAMK139757089CG
rs1052133220446604968OGG1umls:C0242379BeFreeIn a nested case-cohort design we examined associations between urinary excretion of 8-oxoGua and risk of lung cancer as well as potential interaction with the OGG1 Ser326Cys polymorphism in a population-based cohort of 25,717 men and 27,972 women aged 50-64 years with 3-7 years follow-up.0.0722050092012OGG1;CAMK139757089CG
rs1052133225400134968OGG1umls:C0242379BeFreeThe association between OGG1 Ser326Cys polymorphism and lung cancer susceptibility: a meta-analysis of 27 studies.0.0722050092012OGG1;CAMK139757089CG
rs1052133119275024968OGG1umls:C0242379BeFreeAssociation of the hOGG1 Ser326Cys polymorphism with lung cancer risk.0.0722050092002OGG1;CAMK139757089CG
rs1052133230652114968OGG1umls:C0242379BeFreeAssociation between the OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and lung cancer risk: a meta-analysis.0.0722050092012OGG1;CAMK139757089CG
rs1052133158964614968OGG1umls:C0242379BeFreeGSTP1 Ile105Val and hOGG1 Ser326Cys polymorphisms were not found to be risk factors of lung cancer in this study.0.0722050092005OGG1;CAMK139757089CG
rs1052133170152674968OGG1umls:C0242379BeFreeInteractions between the OGG1 Ser326Cys polymorphism and intake of fruit and vegetables in relation to lung cancer.0.0722050092006OGG1;CAMK139757089CG
rs1052133240853574968OGG1umls:C0242379BeFreeSmoking and hOGG1 Ser326Cys polymorphism contribute to lung cancer risk: evidence from a meta-analysis.0.0722050092013OGG1;CAMK139757089CG
rs1052133181552534968OGG1umls:C0242379BeFreeOGG1 expression and OGG1 Ser326Cys polymorphism and risk of lung cancer in a prospective study.0.0722050092008OGG1;CAMK139757089CG
rs1052133175315254968OGG1umls:C0242379BeFreeBoth the XRCC1 Arg194Trp and Arg280His as well as the OGG1 Ser326Cys heterozygous genotypes were associated with a significantly reduced risk for lung cancer (OR=0.32, p=0.024; OR=0.25, p=0.028; OR=0.51, p=0.033, respectively).0.0722050092007OGG1;CAMK139757089CG
rs1052133228557044968OGG1umls:C0242379BeFreeWe demonstrated a novel, significant correlation between the hOGG1 Ser326Cys polymorphism and increased lung cancer susceptibility in Caucasians.0.0722050092012OGG1;CAMK139757089CG
rs1052133186284264968OGG1umls:C0242379BeFreeThe hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis.0.0722050092008OGG1;CAMK139757089CG
rs1052133167716924595MUTYHumls:C0242379BeFreeCase-control studies of genetic polymorphisms in DNA repair enzymes suggest that the common variant Ser326Cys in OGG1 may be a risk factor for lung cancer, whereas a rare variant in OGG1 and germ line mutations in the corresponding mismatch repair gene MYH are risk factors for hereditary colon cancer.0.0087297472006OGG1;CAMK139757089CG
rs1052133230230284968OGG1umls:C0242379BeFreeFor example, there was a positive association between the OGG1 Ser326Cys variant and gastric and lung cancer, while the XRCC1 Arg399Gln variant was associated with reduced cancer risk.0.0722050092012OGG1;CAMK139757089CG
rs1052133189907484968OGG1umls:C0242379BeFreeOGG1 S326C homozygote was suggested to be associated with lung cancer risk in Caucasians (homozygote OR, 1.34; 95% CI, 1.01-1.79) based on 2,569 cases and 4,178 controls from 4 studies but not in Asians.0.0722050092008OGG1;CAMK139757089CG
rs1052133230230287515XRCC1umls:C0242379BeFreeFor example, there was a positive association between the OGG1 Ser326Cys variant and gastric and lung cancer, while the XRCC1 Arg399Gln variant was associated with reduced cancer risk.0.0998152572012OGG1;CAMK139757089CG
rs1052133190643614968OGG1umls:C0242379BeFreeThe association of OGG1 Ser326Cys polymorphism and urinary 8-OHdG levels with lung cancer susceptibility: a hospital-based case-control study in Turkey.0.0722050092008OGG1;CAMK139757089CG
rs1052133175315257507XPAumls:C0242379BeFreeWe investigated the association of 10 base-excision and nucleotide-excision repair gene polymorphisms (XRCC1 -77 T/C, Arg194Trp, Arg280His and Arg399Gln; APE1 Asp148Glu; OGG1 Ser326Cys; XPA -4 G/A; XPC PAT; XPD Asp312Asn and Lys751Gln) with lung cancer risk in Caucasians.0.0361243082007OGG1;CAMK139757089CG
rs1052133158964612950GSTP1umls:C0242379BeFreeGSTP1 Ile105Val and hOGG1 Ser326Cys polymorphisms were not found to be risk factors of lung cancer in this study.0.0924863262005OGG1;CAMK139757089CG
rs1052133244359784968OGG1umls:C0242379BeFreehOGG1 Ser326Cys polymorphism and lung cancer susceptibility: a meta-analysis.0.0722050092014OGG1;CAMK139757089CG
rs105213323065211328APEX1umls:C0242379BeFreeAssociation between the OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and lung cancer risk: a meta-analysis.0.0489256842012OGG1;CAMK139757089CG
rs1052133217902534968OGG1umls:C0242379BeFreeAssociation of the hOGG1 Ser326Cys polymorphism with increased lung cancer susceptibility in Asians: a meta-analysis of 18 studies including 7592 cases and 8129 controls.0.0722050092011OGG1;CAMK139757089CG
rs1052133107441264968OGG1umls:C0242379BeFreehOGG1 Ser326Cys polymorphism and lung cancer susceptibility.0.0722050091999OGG1;CAMK139757089CG
rs1052133167716924968OGG1umls:C0242379BeFreeCase-control studies of genetic polymorphisms in DNA repair enzymes suggest that the common variant Ser326Cys in OGG1 may be a risk factor for lung cancer, whereas a rare variant in OGG1 and germ line mutations in the corresponding mismatch repair gene MYH are risk factors for hereditary colon cancer.0.0722050092006OGG1;CAMK139757089CG
rs1052133175315257508XPCumls:C0242379BeFreeWe investigated the association of 10 base-excision and nucleotide-excision repair gene polymorphisms (XRCC1 -77 T/C, Arg194Trp, Arg280His and Arg399Gln; APE1 Asp148Glu; OGG1 Ser326Cys; XPA -4 G/A; XPC PAT; XPD Asp312Asn and Lys751Gln) with lung cancer risk in Caucasians.0.0443111722007OGG1;CAMK139757089CG
rs1052486249899257917BAG6umls:C0242379BeFreeBAT3 rs1052486 and rs3117582 polymorphisms are associated with lung cancer risk: a meta-analysis.0.1326494862014BAG6631642909AG
rs1056836171744381545CYP1B1umls:C0242379BeFreeNo association was seen between lung cancer risk and polymorphisms in CYP1A1 Msp1 or CYP1B1 Leu(432)Val for Caucasians or African Americans, after adjusting for age at diagnosis, sex, pack years of smoking and family history of lung cancer.0.0332903372007CYP1B1238071060GC
rs1056836179809331545CYP1B1umls:C0242379BeFreeFurthermore, the combination of risk genotypes of CYP1B1 Leu432Val with CYP1A1 Ile462Val was associated with the risk of lung adenocarcinoma (adjusted OR=2.16; 95% CI, 1.02-4.57) as well as overall lung cancer (adjusted OR=2.23; 95% CI 1.01-4.89).0.0332903372008CYP1B1238071060GC
rs1056836249891131545CYP1B1umls:C0242379BeFreeImpacts on the catalytic activity of the CYP1B1 enzyme, as well as an association of the Leu432Val polymorphism with the risk of lung cancer, have been described; however, the results remain controversial.0.0332903372014CYP1B1238071060GC
rs1056836160516421728NQO1umls:C0242379BeFreeThe combination of CYP1B1 Leu(432)Val and NQO1 C(609)T appeared to be associated with the highest risk of lung cancer (OR = 4.14, 95% CI 1.60-10.74), although no combinations differed significantly from the risk associated with CYP1B1 Leu(432)Val alone.0.060217962005CYP1B1238071060GC
rs1056836160516422651GCNT2umls:C0242379BeFreeWhen individuals were stratified by household ETS exposure (yes/no), CYP1B1 Leu(432)Val alone and in combination with Phase II enzyme polymorphisms was more strongly associated with increased lung cancer susceptibility among those with at least some household ETS exposure.0.0040716282005CYP1B1238071060GC
rs10811474252396441029CDKN2Aumls:C0242379BeFreeASSET analyses identified four SNPs significantly associated with multiple cancers: rs3731239 (CDKN2A intronic) with ESCC, GC and BC (P = 3.96 × 10(-) (4)); rs10811474 (3' of IFNW1) with RCC and BrC (P = 0.001); rs12683422 (LINGO2 intronic) with RCC and BC (P = 5.93 × 10(-) (4)) and rs10511729 (3' of ELAVL2) with LC and BrC (P = 8.63 × 10(-) (4)).0.0383169112015NA921114238AG
rs10811474252396441993ELAVL2umls:C0242379BeFreeASSET analyses identified four SNPs significantly associated with multiple cancers: rs3731239 (CDKN2A intronic) with ESCC, GC and BC (P = 3.96 × 10(-) (4)); rs10811474 (3' of IFNW1) with RCC and BrC (P = 0.001); rs12683422 (LINGO2 intronic) with RCC and BC (P = 5.93 × 10(-) (4)) and rs10511729 (3' of ELAVL2) with LC and BrC (P = 8.63 × 10(-) (4)).0.0013572092015NA921114238AG
rs10849605228996535893RAD52umls:C0242379GWASCATSeveral other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.0.1229099162012RAD5212955272TC
rs1102080221739480472ATMumls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0211837362012MRE11A;ANKRD491194493959CA,T
rs11020802217394802068ERCC2umls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.2138435352012MRE11A;ANKRD491194493959CA,T
rs11020802217394807515XRCC1umls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0998152572012MRE11A;ANKRD491194493959CA,T
rs11020802217394808930MBD4umls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0102824542012MRE11A;ANKRD491194493959CA,T
rs11020802217394805378PMS1umls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0026384742012MRE11A;ANKRD491194493959CA,T
rs11020802217394804361MRE11Aumls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0002714422012MRE11A;ANKRD491194493959CA,T
rs110484131719449879365BHLHE41umls:C0242379BeFreeA replication study in an independent Norwegian lung cancer population of multiple cancer histotypes failed to replicate the significant association of BHLHB3 Ala298Val with survival; such association, however, was confirmed by analysis of ADCA only from both populations.0.0005428842007SSPN;BHLHE411226122622GA
rs11134290233726584552MTRRumls:C0242379BeFreeSNPs in MTRR (rs13162612; OR = 0.25; 95% CI: 0.11-0.58; rs10512948; OR = 0.61; 95% CI: 0.41-0.90; rs2924471; OR = 3.31; 95% CI: 1.66-6.59), and MTHFR (rs9651118; OR = 0.63; 95% CI: 0.43-0.95) and three SNP*nutrient interactions (choline*rs10475407; OR = 1.62; 95% CI: 1.11-2.42; choline*rs11134290; OR = 0.51; 95% CI: 0.27-0.92; and riboflavin*rs8767412; OR = 0.40; 95% CI: 0.15-0.95) were associated with lung cancer risk in never smokers.0.0105538952013NA58202423CT
rs11134290233726584524MTHFRumls:C0242379BeFreeSNPs in MTRR (rs13162612; OR = 0.25; 95% CI: 0.11-0.58; rs10512948; OR = 0.61; 95% CI: 0.41-0.90; rs2924471; OR = 3.31; 95% CI: 1.66-6.59), and MTHFR (rs9651118; OR = 0.63; 95% CI: 0.43-0.95) and three SNP*nutrient interactions (choline*rs10475407; OR = 1.62; 95% CI: 1.11-2.42; choline*rs11134290; OR = 0.51; 95% CI: 0.27-0.92; and riboflavin*rs8767412; OR = 0.40; 95% CI: 0.15-0.95) were associated with lung cancer risk in never smokers.0.056765162013NA58202423CT
rs11169748217755331613DAPK3umls:C0242379BeFreeKnockdown of DAPK3 and METTL6, for which expression levels were correlated with the rs11169748 and rs2440915 SNPs, significantly decreased cisplatin sensitivity in lung cancer cells.0.0002714422011NA1251185388AG
rs1116974821775533131965METTL6umls:C0242379BeFreeKnockdown of DAPK3 and METTL6, for which expression levels were correlated with the rs11169748 and rs2440915 SNPs, significantly decreased cisplatin sensitivity in lung cancer cells.0.0002714422011NA1251185388AG
rs1126579254809453576CXCL8umls:C0242379BeFreeMoreover, analysis of rs1126579 with serum levels of IL8, its endogenous ligand, supported an interaction whereby rs1126579-T and high serum IL8 conferred synergistic protection from lung cancer.0.0290232122015CXCR22218136011TC
rs1130409175315252068ERCC2umls:C0242379BeFreeIn conclusion, the APE1 Asp148Glu polymorphism is highly predictive for lung cancer, and cumulative cigarette smoking modifies the associations between the XRCC1 Arg399Gln and the XPD Lys751Gln polymorphisms and lung cancer risk.0.2138435352007APEX1;OSGEP1420456995TA,G
rs113040917531525328APEX1umls:C0242379BeFreeIn conclusion, the APE1 Asp148Glu polymorphism is highly predictive for lung cancer, and cumulative cigarette smoking modifies the associations between the XRCC1 Arg399Gln and the XPD Lys751Gln polymorphisms and lung cancer risk.0.0489256842007APEX1;OSGEP1420456995TA,G
rs1130409175315257508XPCumls:C0242379BeFreeWe investigated the association of 10 base-excision and nucleotide-excision repair gene polymorphisms (XRCC1 -77 T/C, Arg194Trp, Arg280His and Arg399Gln; APE1 Asp148Glu; OGG1 Ser326Cys; XPA -4 G/A; XPC PAT; XPD Asp312Asn and Lys751Gln) with lung cancer risk in Caucasians.0.0443111722007APEX1;OSGEP1420456995TA,G
rs1130409175315257507XPAumls:C0242379BeFreeWe investigated the association of 10 base-excision and nucleotide-excision repair gene polymorphisms (XRCC1 -77 T/C, Arg194Trp, Arg280His and Arg399Gln; APE1 Asp148Glu; OGG1 Ser326Cys; XPA -4 G/A; XPC PAT; XPD Asp312Asn and Lys751Gln) with lung cancer risk in Caucasians.0.0361243082007APEX1;OSGEP1420456995TA,G
rs1130409150443287515XRCC1umls:C0242379BeFreeThese results suggest that APE1 Asp148Glu and XRCC1 Arg399Gln polymorphisms might modify the risk of lung cancer attributable to cigarette smoking exposure.0.0998152572004APEX1;OSGEP1420456995TA,G
rs113040921132382328APEX1umls:C0242379BeFreeAPE1 Asp148Glu gene polymorphism and lung cancer risk: a meta-analysis.0.0489256842011APEX1;OSGEP1420456995TA,G
rs1130409175315257515XRCC1umls:C0242379BeFreeIn conclusion, the APE1 Asp148Glu polymorphism is highly predictive for lung cancer, and cumulative cigarette smoking modifies the associations between the XRCC1 Arg399Gln and the XPD Lys751Gln polymorphisms and lung cancer risk.0.0998152572007APEX1;OSGEP1420456995TA,G
rs113040924310503328APEX1umls:C0242379BeFreeThe association of APE1 Asp148Glu gene polymorphisms and lung cancer risk: an updated meta-analysis.0.0489256842013APEX1;OSGEP1420456995TA,G
rs1130409230652114968OGG1umls:C0242379BeFreeAssociation between the OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and lung cancer risk: a meta-analysis.0.0722050092012APEX1;OSGEP1420456995TA,G
rs113040924523018328APEX1umls:C0242379BeFreeAPE1 Asp148Glu polymorphism and lung cancer susceptibility.0.0489256842014APEX1;OSGEP1420456995TA,G
rs113040924705777328APEX1umls:C0242379BeFreeGenetic polymorphism of APE1 rs1130409 can contribute to the risk of lung cancer.0.0489256842014APEX1;OSGEP1420456995TA,G
rs113040923065211328APEX1umls:C0242379BeFreeAssociation between the OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and lung cancer risk: a meta-analysis.0.0489256842012APEX1;OSGEP1420456995TA,G
rs113040916425270328APEX1umls:C0242379BeFreeA common APE1 polymorphism, a T-->G transversion (Asp 148 Glu), was previously shown to be associated with risk of lung cancer, an association that was modified by cigarette smoking.0.0489256842006APEX1;OSGEP1420456995TA,G
rs113040921198260328APEX1umls:C0242379BeFreeAPEX1 Asp148Glu gene polymorphism is a risk factor for lung cancer in relation to smoking in Japanese.0.0489256842010APEX1;OSGEP1420456995TA,G
rs113040915044328328APEX1umls:C0242379BeFreeThese results suggest that APE1 Asp148Glu and XRCC1 Arg399Gln polymorphisms might modify the risk of lung cancer attributable to cigarette smoking exposure.0.0489256842004APEX1;OSGEP1420456995TA,G
rs113040923749940328APEX1umls:C0242379BeFreeOur results provide evidence that the non-synonymous polymorphism of APEX1 Asp(148)Glu may not be directly associated with lung cancer risk, nor enhance the effects of smoking habit on lung cancer development.0.0489256842013APEX1;OSGEP1420456995TA,G
rs11348802223370429673BRAFumls:C0242379BeFreeColorectal and lung cancers associated with the BRAF V600E mutation often demonstrated mucinous morphology.0.0151684072013BRAF7140753336AT,G,C
rs113488022238255893845KRASumls:C0242379BeFreeAlthough oncogenic KRAS mutations are frequent, BRAF mutations (BRAF(V600E)) are found in 3% of human non-small cell lung cancers.0.113387352013BRAF7140753336AT,G,C
rs11348802221483012673BRAFumls:C0242379BeFreeThe incidence of BRAF mutations other than V600E is significantly higher in lung cancer than in melanoma.0.0151684072011BRAF7140753336AT,G,C
rs11348802223825589673BRAFumls:C0242379BeFreeAlthough oncogenic KRAS mutations are frequent, BRAF mutations (BRAF(V600E)) are found in 3% of human non-small cell lung cancers.0.0151684072013BRAF7140753336AT,G,C
rs11348802226386083673BRAFumls:C0242379BeFreeThe three most common BRAF mutations in lung cancers accounted for only 41% of the observed BRAF mutations (p.D594G [18%], p.V600E [14%], and p.G469A [9%]).0.0151684072015BRAF7140753336AT,G,C
rs11348802216376942673BRAFumls:C0242379BeFreeUncommon V599E BRAF mutations in Japanese patients with lung cancer.0.0151684072006BRAF7140753336AT,G,C
rs11348802224035431673BRAFumls:C0242379BeFreeBRAF V600E is an emerging drug target in lung cancer, but the clinical significance of non-V600 BRAF mutations in lung cancer and other malignancies is less clear.0.0151684072013BRAF7140753336AT,G,C
rs11364102517983725976TIPARPumls:C0242379BeFreeThe aim of this study was to investigate the relationship of the PARP-1 Val762Ala (rs1136410 T>C) polymorphism and the risk of lung cancer.0.0005428842014PARP11226367601AG
rs113641024853559142PARP1umls:C0242379BeFreeThe present meta-analysis provides evidence that the PARP-1 Val762Ala may be involved in cancer development at least in some ethnic groups (Asian) or some specific cancer types (gastric, cervical, and lung cancers, and glioma).0.0153639042014PARP11226367601AG
rs113641025179837142PARP1umls:C0242379BeFreeCorrelation between PARP-1 Val762Ala polymorphism and the risk of lung cancer in a Chinese population.0.0153639042014PARP11226367601AG
rs1138272150696852947GSTM3umls:C0242379BeFreeIn a population-based case-cohort study where cases and the subcohort sample were matched on duration of smoking, we investigated the occurrence of lung cancer and histological subtypes of lung cancer in relation to deletion polymorphism in both GSTM1 and GSTT1, single nucleotide polymorphisms (SNPs) in GSTP1 (Ile105Val and Ala114Val) and a 3 base pair deletion polymorphism in GSTM3.0.0158308432004GSTP11167586108CT
rs1138272165097652947GSTM3umls:C0242379BeFreeThe risk of lung cancer is not strongly associated with the I105V and A114V polymorphisms in the GSTP1 gene or with GSTM3 intron 6 polymorphism.0.0158308432006GSTP11167586108CT
rs1138272165097652950GSTP1umls:C0242379BeFreeThe risk of lung cancer is not strongly associated with the I105V and A114V polymorphisms in the GSTP1 gene or with GSTM3 intron 6 polymorphism.0.0924863262006GSTP11167586108CT
rs1138272150696852950GSTP1umls:C0242379BeFreeIn a population-based case-cohort study where cases and the subcohort sample were matched on duration of smoking, we investigated the occurrence of lung cancer and histological subtypes of lung cancer in relation to deletion polymorphism in both GSTM1 and GSTT1, single nucleotide polymorphisms (SNPs) in GSTP1 (Ile105Val and Ala114Val) and a 3 base pair deletion polymorphism in GSTM3.0.0924863262004GSTP11167586108CT
rs1139417197891907132TNFRSF1Aumls:C0242379GAD[When numeric scores were assigned to both the SNP and demographic data, and sequentially combined by a simple algorithm in a risk model, the composite score was found to be linearly related to lung cancer risk with a bimodal distribution.]0.0147450762009NANANANANA
rs1143634255972813553IL1Bumls:C0242379BeFreeCART analyses did not yield a tree structure for overall survival; separate CART tree structures were identified for recurrence, based on three SNPs (IL13:rs1881457, IL1B:rs1143634, and IL12A:rs662959), and for disease-free survival, based on two SNPs (IL12A:rs662959 and IL16:rs7170924), which may suggest that these candidate IL SNPs have a specific impact on lung cancer progression and recurrence.0.0443111722014IL1B2112832813GA
rs1143634200352393553IL1Bumls:C0242379GAD[IL1B rs1143634 polymorphism, cigarette smoking, alcohol use, and lung cancer risk in a Japanese population.]0.0443111722010IL1B2112832813GA
rs1143634255972813592IL12Aumls:C0242379BeFreeCART analyses did not yield a tree structure for overall survival; separate CART tree structures were identified for recurrence, based on three SNPs (IL13:rs1881457, IL1B:rs1143634, and IL12A:rs662959), and for disease-free survival, based on two SNPs (IL12A:rs662959 and IL16:rs7170924), which may suggest that these candidate IL SNPs have a specific impact on lung cancer progression and recurrence.0.0079154222014IL1B2112832813GA
rs1143634255972813603IL16umls:C0242379BeFreeCART analyses did not yield a tree structure for overall survival; separate CART tree structures were identified for recurrence, based on three SNPs (IL13:rs1881457, IL1B:rs1143634, and IL12A:rs662959), and for disease-free survival, based on two SNPs (IL12A:rs662959 and IL16:rs7170924), which may suggest that these candidate IL SNPs have a specific impact on lung cancer progression and recurrence.0.0050055062014IL1B2112832813GA
rs1143634200352393553IL1Bumls:C0242379BeFreeIL1B rs1143634 polymorphism, cigarette smoking, alcohol use, and lung cancer risk in a Japanese population.0.0443111722010IL1B2112832813GA
rs1143634255972813596IL13umls:C0242379BeFreeCART analyses did not yield a tree structure for overall survival; separate CART tree structures were identified for recurrence, based on three SNPs (IL13:rs1881457, IL1B:rs1143634, and IL12A:rs662959), and for disease-free survival, based on two SNPs (IL12A:rs662959 and IL16:rs7170924), which may suggest that these candidate IL SNPs have a specific impact on lung cancer progression and recurrence.0.0100110122014IL1B2112832813GA
rs11540652211876517157TP53umls:C0242379BeFreeMutant p53 R248Q but not R248W enhances in vitro invasiveness of human lung cancer NCI-H1299 cells.0.162010TP53177674220CT
rs11540654233174147157TP53umls:C0242379BeFreePresent report evaluated the association of polymorphism in exon 4 Arg72Pro (G>C) of the p53 gene with lung cancer susceptibility using 175 cancer cases and 202 controls from the North Indian population.0.162013TP53177676040CT,G,A
rs11540654189907487517XRCC3umls:C0242379BeFreeFour of the variants were found to be weakly associated with lung cancer risk with borderline significance: these were XRCC3 T241M [heterozygote odds ratio (OR), 0.89; 95% confidence interval (95% CI), 0.79-0.99 and homozygote OR, 0.84; 95% CI, 0.71-1.00] based on 3,467 cases and 5,021 controls from 8 studies, XPD K751Q (heterozygote OR, 0.99; 95% CI, 0.89-1.10 and homozygote OR, 1.19; 95% CI, 1.02-1.39) based on 6,463 cases and 6,603 controls from 9 studies, and TP53 R72P (heterozygote OR, 1.14; 95% CI, 1.00-1.29 and homozygote OR, 1.20; 95% CI, 1.02-1.42) based on 3,610 cases and 5,293 controls from 6 studies.0.0443871172008TP53177676040CT,G,A
rs11540654189907482068ERCC2umls:C0242379BeFreeFour of the variants were found to be weakly associated with lung cancer risk with borderline significance: these were XRCC3 T241M [heterozygote odds ratio (OR), 0.89; 95% confidence interval (95% CI), 0.79-0.99 and homozygote OR, 0.84; 95% CI, 0.71-1.00] based on 3,467 cases and 5,021 controls from 8 studies, XPD K751Q (heterozygote OR, 0.99; 95% CI, 0.89-1.10 and homozygote OR, 1.19; 95% CI, 1.02-1.39) based on 6,463 cases and 6,603 controls from 9 studies, and TP53 R72P (heterozygote OR, 1.14; 95% CI, 1.00-1.29 and homozygote OR, 1.20; 95% CI, 1.02-1.42) based on 3,610 cases and 5,293 controls from 6 studies.0.2138435352008TP53177676040CT,G,A
rs11540654181810447157TP53umls:C0242379BeFreeCox regression analysis showed p53 Arg72Pro heterozygous genotype was overall an independent prognostic factor (Risk ratio of death, 2.2; P = 0.02), suggesting Pro72Pro genotype to be a potential risk factor favoring the development of lung carcinoma and that Arg72Pro genotype is independently associated with a poorer prognosis of lung cancer.0.162008TP53177676040CT,G,A
rs11540654238127257157TP53umls:C0242379BeFreeThe updated meta-analysis suggests that the p53 codon 72 Arg/Pro polymorphism is a risk factor for lung cancer in the Asian population.0.162013TP53177676040CT,G,A
rs11540654189907487157TP53umls:C0242379BeFreeFour of the variants were found to be weakly associated with lung cancer risk with borderline significance: these were XRCC3 T241M [heterozygote odds ratio (OR), 0.89; 95% confidence interval (95% CI), 0.79-0.99 and homozygote OR, 0.84; 95% CI, 0.71-1.00] based on 3,467 cases and 5,021 controls from 8 studies, XPD K751Q (heterozygote OR, 0.99; 95% CI, 0.89-1.10 and homozygote OR, 1.19; 95% CI, 1.02-1.39) based on 6,463 cases and 6,603 controls from 9 studies, and TP53 R72P (heterozygote OR, 1.14; 95% CI, 1.00-1.29 and homozygote OR, 1.20; 95% CI, 1.02-1.42) based on 3,610 cases and 5,293 controls from 6 studies.0.162008TP53177676040CT,G,A
rs11540654235956587157TP53umls:C0242379BeFreeThe association between TP53 Arg72Pro polymorphism and lung cancer susceptibility: evidence from 30,038 subjects.0.162013TP53177676040CT,G,A
rs11540654170598535063PAK3umls:C0242379BeFreeWe therefore investigated the combined effects of polymorphisms in TP53 (Arg72Pro) and p21/CDKN1A (Ser31Arg) and smoking on lung cancer risk.0.0002714422007TP53177676040CT,G,A
rs11540654169122097157TP53umls:C0242379BeFreeTherefore, we hypothesized that the genetic variants in these three genes influence the predisposition of lung cancer (i.e., CCND1 G870A, CDKN2A Ala(148)Thr, TP53 Arg(72)Pro, and 16-bp repeat in intron 3) and that the effect of X-ray on lung cancer risk can be modified by the presence of these genetic variations.0.162006TP53177676040CT,G,A
rs11540654174003327157TP53umls:C0242379BeFreeLack of evidence that p53 Arg72Pro influences lung cancer prognosis: an analysis of survival in 619 female patients.0.162007TP53177676040CT,G,A
rs11540654169122091029CDKN2Aumls:C0242379BeFreeTherefore, we hypothesized that the genetic variants in these three genes influence the predisposition of lung cancer (i.e., CCND1 G870A, CDKN2A Ala(148)Thr, TP53 Arg(72)Pro, and 16-bp repeat in intron 3) and that the effect of X-ray on lung cancer risk can be modified by the presence of these genetic variations.0.0383169112006TP53177676040CT,G,A
rs11540654196236497157TP53umls:C0242379BeFreeTP53 Arg72Pro polymorphism and lung cancer risk: a meta-analysis.0.162009TP53177676040CT,G,A
rs11540654183369517157TP53umls:C0242379BeFreeThe TP53 Arg72Pro polymorphism and lung cancer risk in a population of Northern Spain.0.162008TP53177676040CT,G,A
rs1157183324880342675BRCA2umls:C0242379GWASCATRare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.0.1329209272014BRCA21332398489AT
rs11614913235933855018OXA1Lumls:C0242379BeFreeEffects of common polymorphism rs11614913 in Hsa-miR-196a2 on lung cancer risk.0.0016286512013MIR196A21253991815CT
rs11614913231436265018OXA1Lumls:C0242379BeFreeOur study confirmed that rs11614913 in hsa-miR-196a2 was associated with severe toxicity in lung cancer patients, and might help to improve individualized therapy in the future.0.0016286512012MIR196A21253991815CT
rs1161491325077922406938MIR146Aumls:C0242379BeFreeOur study suggested that the miR-196a2 gene rs11614913 polymorphism and the miR-146a gene rs2910164 polymorphism might associate with lung cancer risk.0.0013572092014MIR196A21253991815CT
rs1161491320188135406973MIR196A2umls:C0242379BeFreeRecent studies have implicated that the rs11614913 SNP in MIR196A2 was associated with susceptibility of lung cancer, congenital heart disease, breast cancer and shortened survival time of nonsmall cell lung cancer.0.0026384742010MIR196A21253991815CT
rs1161491325077922406941MIR149umls:C0242379BeFreeNo clear consensus has been reached on the four single nucleotide polymorphisms (miR-196a2 gene rs11614913, miR-146a gene rs2910164, miR-149 gene rs2292832, and miR-499 gene rs3746444) in microRNA-coding genes and lung cancer risk.0.0008143262014MIR196A21253991815CT
rs11614913236137714610MYCLumls:C0242379BeFreePolymorphisms of miRNA-196a2 rs11614913 and MYCL1 rs3134615 could be potential biomarkers of lung cancer.0.0105538952013MIR196A21253991815CT
rs1161491325077922574501MIR499Aumls:C0242379BeFreeNo clear consensus has been reached on the four single nucleotide polymorphisms (miR-196a2 gene rs11614913, miR-146a gene rs2910164, miR-149 gene rs2292832, and miR-499 gene rs3746444) in microRNA-coding genes and lung cancer risk.0.0008143262014MIR196A21253991815CT
rs11614913185211895018OXA1Lumls:C0242379BeFreeIn the genotype-phenotype correlation analysis of 23 human lung cancer tissue samples, rs11614913 CC was associated with a statistically significant increase in mature hsa-mir-196a expression but not with changes in levels of the precursor, suggesting enhanced processing of the pre-miRNA to its mature form.0.0016286512008MIR196A21253991815CT
rs116152233588810849CD3EAPumls:C0242379BeFreeA specific diplotype defined by PPP1R13L rs1970764, CD3EAP rs967591 and ERCC1 rs11615 and lung cancer risk in a Chinese population.0.0039956832012ERCC11945420395AG
rs11615217394802067ERCC1umls:C0242379BeFreeFurthermore, a significant effect of SNPs in nucleotide excision repair pathway on lung cancer survival was observed among 185 stages III-IV patients treated with platinum-based chemotherapy without surgical operation: XPC rs2228000 (Ala499Val; P = 0.002) and ERCC1 rs11615 (Asn118Asn; P = 0.012).0.0670476142012ERCC11945420395AG
rs116152233588810848PPP1R13Lumls:C0242379BeFreeA specific diplotype defined by PPP1R13L rs1970764, CD3EAP rs967591 and ERCC1 rs11615 and lung cancer risk in a Chinese population.0.0071770412012ERCC11945420395AG
rs11615217394807508XPCumls:C0242379BeFreeFurthermore, a significant effect of SNPs in nucleotide excision repair pathway on lung cancer survival was observed among 185 stages III-IV patients treated with platinum-based chemotherapy without surgical operation: XPC rs2228000 (Ala499Val; P = 0.002) and ERCC1 rs11615 (Asn118Asn; P = 0.012).0.0443111722012ERCC11945420395AG
rs11615223358882067ERCC1umls:C0242379BeFreeA specific diplotype defined by PPP1R13L rs1970764, CD3EAP rs967591 and ERCC1 rs11615 and lung cancer risk in a Chinese population.0.0670476142012ERCC11945420395AG
rs11637635205876041136CHRNA3umls:C0242379BeFreeA four-SNP haplotype spanning CHRNA5 (rs11637635 C, rs17408276 T, rs16969968 G) and CHRNA3 (rs578776 G) was associated with increased lung cancer risk (P = 0.002).0.1792081372010CHRNA51578584808AG
rs11637635205876041138CHRNA5umls:C0242379BeFreeA four-SNP haplotype spanning CHRNA5 (rs11637635 C, rs17408276 T, rs16969968 G) and CHRNA3 (rs578776 G) was associated with increased lung cancer risk (P = 0.002).0.0598269662010CHRNA51578584808AG
rs11878644187096421081CGAumls:C0242379BeFreeAmong Latinos, ERCC2 haplotype CGA (rs238406, rs11878644, rs6966) was associated with reduced lung cancer risk [odds ratio (OR) of 0.65 and 95% confidence interval (CI): 0.44-0.97], especially among nonsmokers (OR = 0.29; 95% CI: 0.12-0.67).0.0026384742008NA1945373709TC
rs12072037217367094610MYCLumls:C0242379BeFreeSNP rs12072037 modulates MFSD2A promoter activity and thus might affect MFSD2A levels in normal lung and in lung tumors, representing a candidate ethnically specific genetic factor underlying the association between the MYCL1 locus and lung cancer patients' survival.0.0105538952011MFSD2A139954534CA
rs121434568215310841956EGFRumls:C0242379BeFreeRecently, frequent mutations in the epidermal growth factor receptor (EGFR) have been detected in lung cancer, mainly deletions in exon 19 and L858R mutation in exon 21.0.162011EGFR755191822TG
rs121434568197264541956EGFRumls:C0242379BeFreeFour novel mutations (E709K, V765G, Ins770G, and G1022S) and one mutation well-known in lung cancer (L858R) were identified in six HNSCC samples (7%), but we could not find any mutations in the extracellular domain of EGFR, such as EGFRvIII, in this study.0.162009EGFR755191822TG
rs121434568239377171956EGFRumls:C0242379BeFreeGefitinib greatly enhanced NK cell cytotoxicity to lung cancer cells with EGFR L858R + T790M resistance mutation.0.162013EGFR755191822TG
rs121434568168903221956EGFRumls:C0242379BeFreeL858R EGFR mutation status correlated with clinico-pathological features of Japanese lung cancer.0.162006EGFR755191822TG
rs121434568253203601956EGFRumls:C0242379BeFreeNext, we examined the role of RhoB in lung cancer progression in transgenic mice that express inducible EGFR(L858R) crossed with Rhob null mice.0.162015EGFR755191822TG
rs121434568264963081956EGFRumls:C0242379BeFreeAdvanced lung cancers with epidermal growth factor receptor (EGFR) exon 19 deletions (Ex19s) and EGFR exon 21 L858R point mutations (Ex21s) exhibit different clinical behavior.0.162016EGFR755191822TG
rs121434568192762591956EGFRumls:C0242379BeFreeWe aim to develop a digital PCR-based method for the quantitative detection of the two common epidermal growth factor receptor (EGFR) mutations (in-frame deletion at exon 19 and L858R at exon 21) in the plasma and tumor tissues of patients suffering from non-small cell lung cancers.0.162009EGFR755191822TG
rs121434568176859311956EGFRumls:C0242379BeFreeAn in situ LAMP method was used, along with an amplification refractory mutation system (ARMS) to directly detect a specific point mutation, L858R, which is a mutation of epidermal growth factor receptor (EGFR), useful for the prediction of the effects of the anti-lung cancer drug gefitinib.0.162007EGFR755191822TG
rs121434568227335941956EGFRumls:C0242379BeFreeGenetic analysis suggested that the specific EGFR mutation L858R in exon 21 might be the main factor contributing to lung carcinogenesis in multiple lung cancers.0.162012EGFR755191822TG
rs121434568205749561956EGFRumls:C0242379BeFreeDenaturing capillary electrophoresis for automated detection of L858R mutation in exon 21 of the epidermal growth factor receptor gene in prediction of the outcome of lung cancer therapy.0.162010EGFR755191822TG
rs121434568217419591956EGFRumls:C0242379BeFreeThe loop-hybrid mobility shift assay (LH-MSA) was previously developed for the rapid detection of the EGFR mutation L858R for predicting clinical responses to gefitinib in lung cancer.0.162011EGFR755191822TG
rs121434568190156411956EGFRumls:C0242379BeFreeWe have recently identified an EGFR mutation E884K, in combination with L858R, in a patient with advanced lung cancer who progressed on erlotinib maintenance therapy, and subsequently had leptomeningeal metastases that responded to gefitinib.0.162009EGFR755191822TG
rs121434569228993581956EGFRumls:C0242379BeFreeHighly sensitive detection of EGFR T790M mutation using colony hybridization predicts favorable prognosis of patients with lung cancer harboring activating EGFR mutation.0.162012EGFR;EGFR-AS1755181378CT
rs121434569200088401956EGFRumls:C0242379BeFreeHepatocyte growth factor reduces susceptibility to an irreversible epidermal growth factor receptor inhibitor in EGFR-T790M mutant lung cancer.0.162010EGFR;EGFR-AS1755181378CT
rs121434569254864091956EGFRumls:C0242379BeFreeWe investigated the effect of CK2 inhibition in lung cancer cells with T790M-mediated resistance to the EGFR-TK inhibitor.0.162014EGFR;EGFR-AS1755181378CT
rs121434569240291201956EGFRumls:C0242379BeFreeEGFR-mutated lung cancer with T790M-acquired resistance in the brain and histologic transformation in the lung.0.162014EGFR;EGFR-AS1755181378CT
rs121434569235924461956EGFRumls:C0242379BeFreeClinical resistance to gefitinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), in patients with lung cancer has been linked to acquisition of the T790M resistance mutation in activated EGFR or amplification of MET.0.162012EGFR;EGFR-AS1755181378CT
rs121434569175103921956EGFRumls:C0242379BeFreeEGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity.0.162007EGFR;EGFR-AS1755181378CT
rs121434569200088408731RNMTumls:C0242379BeFreeIt will be clinically valuable to investigate the involvement of HGF-MET-mediated signaling in de novo and acquired resistance to irreversible EGFR-TKIs in lung cancer harboring T790M mutation in EGFR.0.0108576752010EGFR;EGFR-AS1755181378CT
rs1214345691935183479811SLTMumls:C0242379BeFreeClinical resistance to epidermal growth factor receptor (EGFR) inhibition in lung cancer has been linked to the emergence of the EGFR T790M resistance mutation or amplification of MET.0.0108576752009EGFR;EGFR-AS1755181378CT
rs121434569235924464233METumls:C0242379BeFreeClinical resistance to gefitinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), in patients with lung cancer has been linked to acquisition of the T790M resistance mutation in activated EGFR or amplification of MET.0.0230402222012EGFR;EGFR-AS1755181378CT
rs121434569200088404233METumls:C0242379BeFreeIt will be clinically valuable to investigate the involvement of HGF-MET-mediated signaling in de novo and acquired resistance to irreversible EGFR-TKIs in lung cancer harboring T790M mutation in EGFR.0.0230402222010EGFR;EGFR-AS1755181378CT
rs121434569254508751956EGFRumls:C0242379BeFreeClinical likelihood of sporadic primary EGFR T790M mutation in EGFR-mutant lung cancer.0.162014EGFR;EGFR-AS1755181378CT
rs121434569230452735293PIK3CDumls:C0242379BeFreeHere, we focused on Akt kinase-interacting protein1 (Aki1), a scaffold protein of PI3K (phosphoinositide 3-kinase)/PDK1 (3-phosphoinositide-dependent protein kinase)/Akt that determines receptor signal selectivity for non-mutated EGFR, and assessed its role in EGFR mutant lung cancer with or without gatekeeper T790M mutation.0.0089575822013EGFR;EGFR-AS1755181378CT
rs121434569244783191956EGFRumls:C0242379BeFreeTo define the incidence of EGFR T790M, we reviewed 2774 sequentially tested patients with lung cancer who underwent molecular testing using a mass spectrometry-based assay, and 11 (0.5%) had baseline EGFR T790M.0.162015EGFR;EGFR-AS1755181378CT
rs121434569230452735291PIK3CBumls:C0242379BeFreeHere, we focused on Akt kinase-interacting protein1 (Aki1), a scaffold protein of PI3K (phosphoinositide 3-kinase)/PDK1 (3-phosphoinositide-dependent protein kinase)/Akt that determines receptor signal selectivity for non-mutated EGFR, and assessed its role in EGFR mutant lung cancer with or without gatekeeper T790M mutation.0.0092290242013EGFR;EGFR-AS1755181378CT
rs121434569230452735163PDK1umls:C0242379BeFreeHere, we focused on Akt kinase-interacting protein1 (Aki1), a scaffold protein of PI3K (phosphoinositide 3-kinase)/PDK1 (3-phosphoinositide-dependent protein kinase)/Akt that determines receptor signal selectivity for non-mutated EGFR, and assessed its role in EGFR mutant lung cancer with or without gatekeeper T790M mutation.0.0005428842013EGFR;EGFR-AS1755181378CT
rs1214345692304527354862CC2D1Aumls:C0242379BeFreeCell line-based assays showed that Aki1 constitutively associates with mutant EGFR in lung cancer cells with (H1975) or without (PC-9 and HCC827) T790M gatekeeper mutation.0.0005428842013EGFR;EGFR-AS1755181378CT
rs121434569220522308731RNMTumls:C0242379BeFreeHigh-level HGF expression was detected more frequently than EGFR T790M secondary mutation or MET amplification in tumors with intrinsic and acquired EGFR-TKI resistance in EGFR mutant lung cancer in Japanese patients.0.0108576752011EGFR;EGFR-AS1755181378CT
rs121434569230452735294PIK3CGumls:C0242379BeFreeHere, we focused on Akt kinase-interacting protein1 (Aki1), a scaffold protein of PI3K (phosphoinositide 3-kinase)/PDK1 (3-phosphoinositide-dependent protein kinase)/Akt that determines receptor signal selectivity for non-mutated EGFR, and assessed its role in EGFR mutant lung cancer with or without gatekeeper T790M mutation.0.0089575822013EGFR;EGFR-AS1755181378CT
rs121434569253827051956EGFRumls:C0242379BeFreeThe combination of irreversible EGFR TKIs and SAHA induces apoptosis and autophagy-mediated cell death to overcome acquired resistance in EGFR T790M-mutated lung cancer.0.162014EGFR;EGFR-AS1755181378CT
rs121434569248425951956EGFRumls:C0242379BeFreeCombination of BIBW2992 and ARQ 197 is effective against erlotinib-resistant human lung cancer cells with the EGFR T790M mutation.0.162014EGFR;EGFR-AS1755181378CT
rs121434569176711473098HK1umls:C0242379BeFreeHKI-272 is an irreversible EGFR/HER/ErbB inhibitor that has been shown to inhibit the growth of T790M mutant cells in vitro in human lung cancer cell lines and in murine cells transfected with sensitizing EGFR mutations.0.0008143262007EGFR;EGFR-AS1755181378CT
rs121434569220522304233METumls:C0242379BeFreeHigh-level HGF expression was detected more frequently than EGFR T790M secondary mutation or MET amplification in tumors with intrinsic and acquired EGFR-TKI resistance in EGFR mutant lung cancer in Japanese patients.0.0230402222011EGFR;EGFR-AS1755181378CT
rs121434569230452735290PIK3CAumls:C0242379BeFreeHere, we focused on Akt kinase-interacting protein1 (Aki1), a scaffold protein of PI3K (phosphoinositide 3-kinase)/PDK1 (3-phosphoinositide-dependent protein kinase)/Akt that determines receptor signal selectivity for non-mutated EGFR, and assessed its role in EGFR mutant lung cancer with or without gatekeeper T790M mutation.0.0214875152013EGFR;EGFR-AS1755181378CT
rs121434569199618251956EGFRumls:C0242379BeFreeQuantification of epidermal growth factor receptor T790M mutant transcripts in lung cancer cells by real-time reverse transcriptase-quantitative polymerase chain reaction.0.162010EGFR;EGFR-AS1755181378CT
rs121434569230452735170PDPK1umls:C0242379BeFreeHere, we focused on Akt kinase-interacting protein1 (Aki1), a scaffold protein of PI3K (phosphoinositide 3-kinase)/PDK1 (3-phosphoinositide-dependent protein kinase)/Akt that determines receptor signal selectivity for non-mutated EGFR, and assessed its role in EGFR mutant lung cancer with or without gatekeeper T790M mutation.0.0008143262013EGFR;EGFR-AS1755181378CT
rs121434569193518348731RNMTumls:C0242379BeFreeClinical resistance to epidermal growth factor receptor (EGFR) inhibition in lung cancer has been linked to the emergence of the EGFR T790M resistance mutation or amplification of MET.0.0108576752009EGFR;EGFR-AS1755181378CT
rs121434569228440751950EGFumls:C0242379BeFreeAlthough the EGF receptor tyrosine kinase inhibitors (EGFR-TKI) erlotinib and gefitinib have shown dramatic effects against EGFR mutant lung cancer, patients become resistant by various mechanisms, including gatekeeper EGFR-T790M mutation, Met amplification, and HGF overexpression, thereafter relapsing.0.0242019342012EGFR;EGFR-AS1755181378CT
rs121434569210629334233METumls:C0242379BeFreeReciprocal and complementary role of MET amplification and EGFR T790M mutation in acquired resistance to kinase inhibitors in lung cancer.0.0230402222010EGFR;EGFR-AS1755181378CT
rs121434569260580741956EGFRumls:C0242379BeFreeThe T790M mutation in EGFR accounts for approximately half of all lung cancer cases with acquired resistance to the current clinical EGFR tyrosine kinase inhibitors.0.162015EGFR;EGFR-AS1755181378CT
rs121434569259235491956EGFRumls:C0242379BeFreeAZD9291 was highly active in patients with lung cancer with the EGFR T790M mutation who had had disease progression during prior therapy with EGFR tyrosine kinase inhibitors.0.162015EGFR;EGFR-AS1755181378CT
rs1214345692000884079811SLTMumls:C0242379BeFreeIt will be clinically valuable to investigate the involvement of HGF-MET-mediated signaling in de novo and acquired resistance to irreversible EGFR-TKIs in lung cancer harboring T790M mutation in EGFR.0.0108576752010EGFR;EGFR-AS1755181378CT
rs121434569162585411956EGFRumls:C0242379BeFreeInherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR.0.162005EGFR;EGFR-AS1755181378CT
rs121434569235924468731RNMTumls:C0242379BeFreeClinical resistance to gefitinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), in patients with lung cancer has been linked to acquisition of the T790M resistance mutation in activated EGFR or amplification of MET.0.0108576752012EGFR;EGFR-AS1755181378CT
rs121434569216355471956EGFRumls:C0242379BeFreeDetection of low-level EGFR T790M mutation in lung cancer tissues.0.162011EGFR;EGFR-AS1755181378CT
rs121434569157370141956EGFRumls:C0242379BeFreeBiochemical analyses of transfected cells and growth inhibition studies with lung cancer cell lines demonstrate that the T790M mutation confers resistance to EGFR mutants usually sensitive to either gefitinib or erlotinib.0.162005EGFR;EGFR-AS1755181378CT
rs121434569239377171956EGFRumls:C0242379BeFreeGefitinib greatly enhanced NK cell cytotoxicity to lung cancer cells with EGFR L858R + T790M resistance mutation.0.162013EGFR;EGFR-AS1755181378CT
rs121434569190962991956EGFRumls:C0242379BeFreeEGFR T790M mutation: a double role in lung cancer cell survival?0.162009EGFR;EGFR-AS1755181378CT
rs121434569212483001956EGFRumls:C0242379BeFreeThe epidermal growth factor receptor (EGFR) mutation T790M is reported in approximately 50% of lung cancers with acquired resistance to EGFR inhibitors and is a potential prognostic and predictive biomarker.0.162011EGFR;EGFR-AS1755181378CT
rs121434569176711471956EGFRumls:C0242379BeFreeHKI-272 is an irreversible EGFR/HER/ErbB inhibitor that has been shown to inhibit the growth of T790M mutant cells in vitro in human lung cancer cell lines and in murine cells transfected with sensitizing EGFR mutations.0.162007EGFR;EGFR-AS1755181378CT
rs1214345692359244679811SLTMumls:C0242379BeFreeClinical resistance to gefitinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), in patients with lung cancer has been linked to acquisition of the T790M resistance mutation in activated EGFR or amplification of MET.0.0108576752012EGFR;EGFR-AS1755181378CT
rs1214345692205223079811SLTMumls:C0242379BeFreeHigh-level HGF expression was detected more frequently than EGFR T790M secondary mutation or MET amplification in tumors with intrinsic and acquired EGFR-TKI resistance in EGFR mutant lung cancer in Japanese patients.0.0108576752011EGFR;EGFR-AS1755181378CT
rs121434569243864071956EGFRumls:C0242379BeFreeLung cancer cell lines made resistant to EGFR-TKIs by the gatekeeper EGFR-T790M mutation, Met amplification, and HGF overexpression and mice with tumors induced by these cells were treated with crizotinib and a new generation EGFR-TKI.0.162013EGFR;EGFR-AS1755181378CT
rs121434569235882211956EGFRumls:C0242379BeFreeKnockdown of the Bcl-2 gene increases sensitivity to EGFR tyrosine kinase inhibitors in the H1975 lung cancer cell line harboring T790M mutation.0.162013EGFR;EGFR-AS1755181378CT
rs121434569247360661956EGFRumls:C0242379BeFreeHereditary lung cancer syndrome targets never smokers with germline EGFR gene T790M mutations.0.162015EGFR;EGFR-AS1755181378CT
rs121434569210629331956EGFRumls:C0242379BeFreeReciprocal and complementary role of MET amplification and EGFR T790M mutation in acquired resistance to kinase inhibitors in lung cancer.0.162010EGFR;EGFR-AS1755181378CT
rs121434569200088403082HGFumls:C0242379BeFreeHepatocyte growth factor reduces susceptibility to an irreversible epidermal growth factor receptor inhibitor in EGFR-T790M mutant lung cancer.0.0059717212010EGFR;EGFR-AS1755181378CT
rs1214345692106293379811SLTMumls:C0242379BeFreeReciprocal and complementary role of MET amplification and EGFR T790M mutation in acquired resistance to kinase inhibitors in lung cancer.0.0108576752010EGFR;EGFR-AS1755181378CT
rs121434569210629338731RNMTumls:C0242379BeFreeReciprocal and complementary role of MET amplification and EGFR T790M mutation in acquired resistance to kinase inhibitors in lung cancer.0.0108576752010EGFR;EGFR-AS1755181378CT
rs121434569240337221956EGFRumls:C0242379BeFreeLower gefitinib dose led to earlier resistance acquisition before emergence of T790M mutation in epidermal growth factor receptor-mutated lung cancer model.0.162013EGFR;EGFR-AS1755181378CT
rs121434569193518344233METumls:C0242379BeFreeClinical resistance to epidermal growth factor receptor (EGFR) inhibition in lung cancer has been linked to the emergence of the EGFR T790M resistance mutation or amplification of MET.0.0230402222009EGFR;EGFR-AS1755181378CT
rs121434569247375991956EGFRumls:C0242379BeFreeClinical outcome according to the level of preexisting epidermal growth factor receptor T790M mutation in patients with lung cancer harboring sensitive epidermal growth factor receptor mutations.0.162014EGFR;EGFR-AS1755181378CT
rs12143459219491896207AKT1umls:C0242379BeFreeThe AKT1 (E17K) mutation has been reported in some tumour types (breast, colorectal, ovarian and lung cancers), and it is of interest which tumour types other than those possess the E17K mutation.0.0189685932009AKT114104780214CT
rs12143459218256540207AKT1umls:C0242379BeFreeOur data provide evidence that, although AKT1 mutations are apparently rare in lung cancer (1.9%), the oncogenic properties of E17K-AKT1 may contribute to the development of a fraction of lung carcinoma with squamous histotype (5.5%).0.0189685932008AKT114104780214CT
rs121912651211876517157TP53umls:C0242379BeFreeMutant p53 R248Q but not R248W enhances in vitro invasiveness of human lung cancer NCI-H1299 cells.0.162010TP53177674221GA
rs12191333826386083673BRAFumls:C0242379BeFreeThe three most common BRAF mutations in lung cancers accounted for only 41% of the observed BRAF mutations (p.D594G [18%], p.V600E [14%], and p.G469A [9%]).0.0151684072015BRAF7140753354TC,A
rs12191335526386083673BRAFumls:C0242379BeFreeThe three most common BRAF mutations in lung cancers accounted for only 41% of the observed BRAF mutations (p.D594G [18%], p.V600E [14%], and p.G469A [9%]).0.0151684072015BRAF7140781602CT,G,A
rs121913469256204232064ERBB2umls:C0242379BeFreeAtomistic insights into the lung cancer-associated L755P mutation in HER2 resistance to lapatinib: a molecular dynamics study.0.0448427862015NANANANANA
rs121913529239174873845KRASumls:C0242379BeFreeThis case suggests possible eradication of the G12D KRAS lung cancer clones by concurrent chemoradiation with panitumumab.0.113387352014KRAS1225245350CT,G,A
rs121913529219944687839LEPQTL1umls:C0242379BeFreeUsing an inducible LSL-KRAS(G12D) model of lung cancer in vivo, we show a transient upregulation of Notch pathway activity in early tumor precursor lesions.0.0005428842011KRAS1225245350CT,G,A
rs121913529219944683845KRASumls:C0242379BeFreeUsing an inducible LSL-KRAS(G12D) model of lung cancer in vivo, we show a transient upregulation of Notch pathway activity in early tumor precursor lesions.0.113387352011KRAS1225245350CT,G,A
rs121913530251706383845KRASumls:C0242379BeFreeGene-expression profiles in lung cancer cell lines and surgically resected lung AC revealed that KRAS-G12C mutants had an epithelial to mesenchymal transition and a KRAS-independent phenotype.0.113387352015KRAS1225245351CT,G,A
rs1226884017957803442459XRCC6P5umls:C0242379BeFreeThe association between lung cancer risk and 2 polymorphisms, rs12268840 and rs2308327 (codon K178R), in the DNA repair protein, O(6)-alkylguanine-DNA alkyltransferase, which are associated with interindividual differences in activity, have been investigated in 3 hospital-based case-control studies.0.0005428842008MGMT10129527035CT
rs1241560723315881842CASP9umls:C0242379BeFreeMeta-analysis results showed positive associations between heterozygote (A/G) of rs507879 in the CASP-5 gene, the T allele of rs12415607 in the CASP-7 gene, and the T allele and T carrier (C/T+T/T) of rs4645981 in the CASP-9 gene with lung cancer susceptibility [odds ratio (OR) = 1.83, 95% confidence interval (95%CI) = 1.07-3.12, P = 0.03; OR = 1.18, 95%CI = 1.02-1.37, P = 0.03; OR = 1.43, 95%CI = 1.12-1.81, P = 0.004; OR = 1.46, 95%CI = 1.10-1.93, P = 0.009; respectively].0.0140066952014CASP710113678445CA
rs125555162843664152MBD1umls:C0242379BeFreeThese results suggest that the MBD1 -634G>A, -501delT, and Pro(401)Ala polymorphisms and their haplotypes contribute to the genetic susceptibility for lung cancer and particularly for adenocarcinoma.0.005548392005MBD11850273809GC,A
rs12683422252396441993ELAVL2umls:C0242379BeFreeASSET analyses identified four SNPs significantly associated with multiple cancers: rs3731239 (CDKN2A intronic) with ESCC, GC and BC (P = 3.96 × 10(-) (4)); rs10811474 (3' of IFNW1) with RCC and BrC (P = 0.001); rs12683422 (LINGO2 intronic) with RCC and BC (P = 5.93 × 10(-) (4)) and rs10511729 (3' of ELAVL2) with LC and BrC (P = 8.63 × 10(-) (4)).0.0013572092015LINGO2927969442CT
rs12683422252396441029CDKN2Aumls:C0242379BeFreeASSET analyses identified four SNPs significantly associated with multiple cancers: rs3731239 (CDKN2A intronic) with ESCC, GC and BC (P = 3.96 × 10(-) (4)); rs10811474 (3' of IFNW1) with RCC and BrC (P = 0.001); rs12683422 (LINGO2 intronic) with RCC and BC (P = 5.93 × 10(-) (4)) and rs10511729 (3' of ELAVL2) with LC and BrC (P = 8.63 × 10(-) (4)).0.0383169112015LINGO2927969442CT
rs12917243906654255MGMTumls:C0242379BeFreeMGMT Leu84Phe gene polymorphism and lung cancer risk: a meta-analysis.0.0280893352013MGMT10129708019CT
rs13009079251442418626TP63umls:C0242379BeFreeAmong 16 SNPs, three SNPs (colony-stimulating factor 1 receptor [CSF1R] rs10079250A>G, tumor protein p63 [TP63] rs7631358G>A, and corepressor interacting with RBPJ 1 [CIR1] rs13009079T>C) were found to be significantly associated with lung cancer in the same direction as the discovery set.0.1253528932015CIR1;SCRN32174396420TC
rs13009079251442419541CIR1umls:C0242379BeFreeAmong 16 SNPs, three SNPs (colony-stimulating factor 1 receptor [CSF1R] rs10079250A>G, tumor protein p63 [TP63] rs7631358G>A, and corepressor interacting with RBPJ 1 [CIR1] rs13009079T>C) were found to be significantly associated with lung cancer in the same direction as the discovery set.0.0002714422015CIR1;SCRN32174396420TC
rs13162612233726584552MTRRumls:C0242379BeFreeSNPs in MTRR (rs13162612; OR = 0.25; 95% CI: 0.11-0.58; rs10512948; OR = 0.61; 95% CI: 0.41-0.90; rs2924471; OR = 3.31; 95% CI: 1.66-6.59), and MTHFR (rs9651118; OR = 0.63; 95% CI: 0.43-0.95) and three SNP*nutrient interactions (choline*rs10475407; OR = 1.62; 95% CI: 1.11-2.42; choline*rs11134290; OR = 0.51; 95% CI: 0.27-0.92; and riboflavin*rs8767412; OR = 0.40; 95% CI: 0.15-0.95) were associated with lung cancer risk in never smokers.0.0105538952013NA58042908AG
rs13162612233726584524MTHFRumls:C0242379BeFreeSNPs in MTRR (rs13162612; OR = 0.25; 95% CI: 0.11-0.58; rs10512948; OR = 0.61; 95% CI: 0.41-0.90; rs2924471; OR = 3.31; 95% CI: 1.66-6.59), and MTHFR (rs9651118; OR = 0.63; 95% CI: 0.43-0.95) and three SNP*nutrient interactions (choline*rs10475407; OR = 1.62; 95% CI: 1.11-2.42; choline*rs11134290; OR = 0.51; 95% CI: 0.27-0.92; and riboflavin*rs8767412; OR = 0.40; 95% CI: 0.15-0.95) were associated with lung cancer risk in never smokers.0.056765162013NA58042908AG
rs1318117531525328APEX1umls:C0242379BeFreeIn conclusion, the APE1 Asp148Glu polymorphism is highly predictive for lung cancer, and cumulative cigarette smoking modifies the associations between the XRCC1 Arg399Gln and the XPD Lys751Gln polymorphisms and lung cancer risk.0.0489256842007ERCC2;KLC31945351661TA,G
rs13181189907487517XRCC3umls:C0242379BeFreeFour of the variants were found to be weakly associated with lung cancer risk with borderline significance: these were XRCC3 T241M [heterozygote odds ratio (OR), 0.89; 95% confidence interval (95% CI), 0.79-0.99 and homozygote OR, 0.84; 95% CI, 0.71-1.00] based on 3,467 cases and 5,021 controls from 8 studies, XPD K751Q (heterozygote OR, 0.99; 95% CI, 0.89-1.10 and homozygote OR, 1.19; 95% CI, 1.02-1.39) based on 6,463 cases and 6,603 controls from 9 studies, and TP53 R72P (heterozygote OR, 1.14; 95% CI, 1.00-1.29 and homozygote OR, 1.20; 95% CI, 1.02-1.42) based on 3,610 cases and 5,293 controls from 6 studies.0.0443871172008ERCC2;KLC31945351661TA,G
rs13181253006877515XRCC1umls:C0242379BeFreeIn the present study, we investigated the polymorphisms of the following selected members of the base and nucleotide excision repair genes: XPC (Lys939Gln), XPD (Lys751Gln), XRCC1(Arg399Gln), and hOGG1(Ser326Ser), and the risk they present toward the development of lung cancer, with emphasis on the effect of chromium exposure.0.0998152572015ERCC2;KLC31945351661TA,G
rs13181189907487157TP53umls:C0242379BeFreeFour of the variants were found to be weakly associated with lung cancer risk with borderline significance: these were XRCC3 T241M [heterozygote odds ratio (OR), 0.89; 95% confidence interval (95% CI), 0.79-0.99 and homozygote OR, 0.84; 95% CI, 0.71-1.00] based on 3,467 cases and 5,021 controls from 8 studies, XPD K751Q (heterozygote OR, 0.99; 95% CI, 0.89-1.10 and homozygote OR, 1.19; 95% CI, 1.02-1.39) based on 6,463 cases and 6,603 controls from 9 studies, and TP53 R72P (heterozygote OR, 1.14; 95% CI, 1.00-1.29 and homozygote OR, 1.20; 95% CI, 1.02-1.42) based on 3,610 cases and 5,293 controls from 6 studies.0.162008ERCC2;KLC31945351661TA,G
rs13181177058147508XPCumls:C0242379BeFreeWe investigated the relationship between polymorphisms in two NER genes, XPC (poly (AT) insertion/deletion: PAT-/+) and XPD (Asp312Asn and Lys751Gln), the BER gene XRCC1 (Arg399Gln), and the DSBR gene XRCC3 (Thr241Met) and the risk of developing lung cancer.0.0443111722007ERCC2;KLC31945351661TA,G
rs13181218645464683NBNumls:C0242379BeFreeThese associations were: two SNPs rs1799793 and rs13181 in the ERCC2 gene and lung cancer (recessive model) and rs1805794 in the NBN gene and bladder cancer (dominant model).0.0134638112012ERCC2;KLC31945351661TA,G
rs13181179524682068ERCC2umls:C0242379BeFreeTwo of the genetic polymorphisms, XRCC1Arg399Gln and XPD Lys751Gln have been extensively studied in the association with lung cancer risk, although published studies have been inconclusive.0.2138435352008ERCC2;KLC31945351661TA,G
rs13181225255582950GSTP1umls:C0242379BeFreeCYP1A1 rs4646903 (OR = 1.72, 95% CI = 1.25-2.38), rs1048943 (OR = 1.40, 95% CI = 1.02-1.92), the GSTM1 deletion polymorphism (OR = 1.38, 95% CI = 1.01-1.89), GSTP1 rs1695 (OR =1.48, 95% CI = 1.04-2.11), ERCC2 rs13181 (OR = 1.89, 95% CI = 1.28-2.78), and Chinese hamster 1 rs25487 (OR = 1.54, 95% CI = 1.12-2.13) were associated with lung cancer risk whereas the GSTT1 deletion polymorphism and XRCC3 rs861539 were not.0.0924863262012ERCC2;KLC31945351661TA,G
rs13181231081452068ERCC2umls:C0242379GWASCATGenome-wide association study reveals novel genetic determinants of DNA repair capacity in lung cancer.0.2138435352013ERCC2;KLC31945351661TA,G
rs13181175315257515XRCC1umls:C0242379BeFreeIn conclusion, the APE1 Asp148Glu polymorphism is highly predictive for lung cancer, and cumulative cigarette smoking modifies the associations between the XRCC1 Arg399Gln and the XPD Lys751Gln polymorphisms and lung cancer risk.0.0998152572007ERCC2;KLC31945351661TA,G
rs13181189907482068ERCC2umls:C0242379BeFreeFour of the variants were found to be weakly associated with lung cancer risk with borderline significance: these were XRCC3 T241M [heterozygote odds ratio (OR), 0.89; 95% confidence interval (95% CI), 0.79-0.99 and homozygote OR, 0.84; 95% CI, 0.71-1.00] based on 3,467 cases and 5,021 controls from 8 studies, XPD K751Q (heterozygote OR, 0.99; 95% CI, 0.89-1.10 and homozygote OR, 1.19; 95% CI, 1.02-1.39) based on 6,463 cases and 6,603 controls from 9 studies, and TP53 R72P (heterozygote OR, 1.14; 95% CI, 1.00-1.29 and homozygote OR, 1.20; 95% CI, 1.02-1.42) based on 3,610 cases and 5,293 controls from 6 studies.0.2138435352008ERCC2;KLC31945351661TA,G
rs13181206277042068ERCC2umls:C0242379BeFreeERCC2 Lys751Gln polymorphism is associated with lung cancer among Caucasians.0.2138435352010ERCC2;KLC31945351661TA,G
rs13181225255582944GSTM1umls:C0242379BeFreeA pertinent combination of multiple at-risk genotypes of CYP1A1 rs4646903, the GSTM1 deletion polymorphism and ERCC2 rs13181 was at a 5.94-fold (95% CI = 2.77-12.7) increased risk of lung cancer.0.126416562012ERCC2;KLC31945351661TA,G
rs13181112454332068ERCC2umls:C0242379BeFreeWe therefore examined XPD polymorphisms at Lys751Gln and Asp312Asn in 341 white lung cancer cases and 360 age-, sex-, ethnicity-, and smoking-matched controls accrued in a hospital-based molecular epidemiological study of susceptibility markers for lung cancer.0.2138435352001ERCC2;KLC31945351661TA,G
rs13181175049862068ERCC2umls:C0242379BeFreeProspective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer.0.2138435352007ERCC2;KLC31945351661TA,G
rs13181225255587517XRCC3umls:C0242379BeFreeCYP1A1 rs4646903 (OR = 1.72, 95% CI = 1.25-2.38), rs1048943 (OR = 1.40, 95% CI = 1.02-1.92), the GSTM1 deletion polymorphism (OR = 1.38, 95% CI = 1.01-1.89), GSTP1 rs1695 (OR =1.48, 95% CI = 1.04-2.11), ERCC2 rs13181 (OR = 1.89, 95% CI = 1.28-2.78), and Chinese hamster 1 rs25487 (OR = 1.54, 95% CI = 1.12-2.13) were associated with lung cancer risk whereas the GSTT1 deletion polymorphism and XRCC3 rs861539 were not.0.0443871172012ERCC2;KLC31945351661TA,G
rs13181225255582952GSTT1umls:C0242379BeFreeCYP1A1 rs4646903 (OR = 1.72, 95% CI = 1.25-2.38), rs1048943 (OR = 1.40, 95% CI = 1.02-1.92), the GSTM1 deletion polymorphism (OR = 1.38, 95% CI = 1.01-1.89), GSTP1 rs1695 (OR =1.48, 95% CI = 1.04-2.11), ERCC2 rs13181 (OR = 1.89, 95% CI = 1.28-2.78), and Chinese hamster 1 rs25487 (OR = 1.54, 95% CI = 1.12-2.13) were associated with lung cancer risk whereas the GSTT1 deletion polymorphism and XRCC3 rs861539 were not.0.100358142012ERCC2;KLC31945351661TA,G
rs13181197891902068ERCC2umls:C0242379GAD[When numeric scores were assigned to both the SNP and demographic data, and sequentially combined by a simple algorithm in a risk model, the composite score was found to be linearly related to lung cancer risk with a bimodal distribution.]0.2138435352009ERCC2;KLC31945351661TA,G
rs13181147571942068ERCC2umls:C0242379BeFreeAmong men, carriers of the variant allele of XPD Lys751Gln had a non-significantly increased risk of lung cancer in the youngest age interval (RR=6.38, 95% CI=0.74-54.90).0.2138435352004ERCC2;KLC31945351661TA,G
rs13181225255581543CYP1A1umls:C0242379BeFreeA pertinent combination of multiple at-risk genotypes of CYP1A1 rs4646903, the GSTM1 deletion polymorphism and ERCC2 rs13181 was at a 5.94-fold (95% CI = 2.77-12.7) increased risk of lung cancer.0.1237021412012ERCC2;KLC31945351661TA,G
rs13181225255582068ERCC2umls:C0242379BeFreeA pertinent combination of multiple at-risk genotypes of CYP1A1 rs4646903, the GSTM1 deletion polymorphism and ERCC2 rs13181 was at a 5.94-fold (95% CI = 2.77-12.7) increased risk of lung cancer.0.2138435352012ERCC2;KLC31945351661TA,G
rs13181175049867515XRCC1umls:C0242379BeFreeProspective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer.0.0998152572007ERCC2;KLC31945351661TA,G
rs13181174985572068ERCC2umls:C0242379BeFreeA haplotype encompassing the variant allele of DNA repair gene polymorphism ERCC2/XPD Lys751Gln but not the variant allele of Asp312Asn is associated with risk of lung cancer in a northeastern Chinese population.0.2138435352007ERCC2;KLC31945351661TA,G
rs13181175315257507XPAumls:C0242379BeFreeWe investigated the association of 10 base-excision and nucleotide-excision repair gene polymorphisms (XRCC1 -77 T/C, Arg194Trp, Arg280His and Arg399Gln; APE1 Asp148Glu; OGG1 Ser326Cys; XPA -4 G/A; XPC PAT; XPD Asp312Asn and Lys751Gln) with lung cancer risk in Caucasians.0.0361243082007ERCC2;KLC31945351661TA,G
rs13181218645462068ERCC2umls:C0242379BeFreeThese associations were: two SNPs rs1799793 and rs13181 in the ERCC2 gene and lung cancer (recessive model) and rs1805794 in the NBN gene and bladder cancer (dominant model).0.2138435352012ERCC2;KLC31945351661TA,G
rs13181253006874968OGG1umls:C0242379BeFreeIn the present study, we investigated the polymorphisms of the following selected members of the base and nucleotide excision repair genes: XPC (Lys939Gln), XPD (Lys751Gln), XRCC1(Arg399Gln), and hOGG1(Ser326Ser), and the risk they present toward the development of lung cancer, with emphasis on the effect of chromium exposure.0.0722050092015ERCC2;KLC31945351661TA,G
rs13181245561682068ERCC2umls:C0242379BeFreeAssociation between ERCC2 Lys751Gln polymorphism and lung cancer risk: a meta-analysis involving 23,370 subjects.0.2138435352014ERCC2;KLC31945351661TA,G
rs13181168759332068ERCC2umls:C0242379BeFreePolymorphism of the DNA repair gene ERCC2 Lys751Gln and risk of lung cancer in a northeastern Chinese population.0.2138435352006ERCC2;KLC31945351661TA,G
rs13181174985572067ERCC1umls:C0242379BeFreeHaplotype analysis including three previously studied polymorphisms (ERCC1 Asn118Asn, ERCC2 Arg156Arg, and ERCC2 Lys751Gln) revealed that a haplotype consisting of ERCC1Asn118Asn(G)-ERCC2 Arg156Arg(C)-ERCC2 Asp312Asn(G)-ERCC2 Lys751Gln(C) was marginally associated with an increased risk of lung cancer (OR = 3.61, 95% CI = 1.00-13.06, P = 0.04).0.0670476142007ERCC2;KLC31945351661TA,G
rs13181175315252068ERCC2umls:C0242379BeFreeIn conclusion, the APE1 Asp148Glu polymorphism is highly predictive for lung cancer, and cumulative cigarette smoking modifies the associations between the XRCC1 Arg399Gln and the XPD Lys751Gln polymorphisms and lung cancer risk.0.2138435352007ERCC2;KLC31945351661TA,G
rs13181243683302068ERCC2umls:C0242379BeFreeIn conclusion, Lys751Gln in ERCC2 is associated with lung cancer, and the risk effect probably exists in Caucasians.0.2138435352013ERCC2;KLC31945351661TA,G
rs1318123108145147700KLC3umls:C0242379GWASCATGenome-wide association study reveals novel genetic determinants of DNA repair capacity in lung cancer.0.122013ERCC2;KLC31945351661TA,G
rs13181206516122068ERCC2umls:C0242379BeFreeERCC2/XPD Lys751Gln and Asp312Asn gene polymorphism and lung cancer risk: a meta-analysis involving 22 case-control studies.0.2138435352010ERCC2;KLC31945351661TA,G
rs13181175315257508XPCumls:C0242379BeFreeWe investigated the association of 10 base-excision and nucleotide-excision repair gene polymorphisms (XRCC1 -77 T/C, Arg194Trp, Arg280His and Arg399Gln; APE1 Asp148Glu; OGG1 Ser326Cys; XPA -4 G/A; XPC PAT; XPD Asp312Asn and Lys751Gln) with lung cancer risk in Caucasians.0.0443111722007ERCC2;KLC31945351661TA,G
rs13314271248803428626TP63umls:C0242379GWASCATRare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.0.1253528932014TP633189639813TC
rs140693217394804361MRE11Aumls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0002714422012MBD43129436608CT
rs140693217394807515XRCC1umls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0998152572012MBD43129436608CT
rs140693217394805378PMS1umls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0026384742012MBD43129436608CT
rs140693168038458930MBD4umls:C0242379BeFreeTo test this hypothesis, we examined the potential association between the MBD4 Glu346Lys polymorphism and the risk of lung cancer in a Korean population.0.0102824542006MBD43129436608CT
rs140693217394802068ERCC2umls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.2138435352012MBD43129436608CT
rs140693217394808930MBD4umls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0102824542012MBD43129436608CT
rs14069321739480472ATMumls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0211837362012MBD43129436608CT
rs142616668237276062067ERCC1umls:C0242379BeFreeAssociation of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: a pooled analysis based on 39 reports.0.0670476142013ERCC1;PPP1R13L;CD3EAP1945407183CT
rs146795390233802241956EGFRumls:C0242379BeFreeA dramatic lung cancer course in a patient with a rare EGFR germline mutation exon 21 V843I: Is EGFR TKI resistance predictable?0.162013EGFR755191776GA
rs146795390183555441956EGFRumls:C0242379BeFreeNovel germline mutation: EGFR V843I in patient with multiple lung adenocarcinomas and family members with lung cancer.0.162008EGFR755191776GA
rs146795390250579401956EGFRumls:C0242379BeFreeV843I, a lung cancer predisposing EGFR mutation, is responsible for resistance to EGFR tyrosine kinase inhibitors.0.162015EGFR755191776GA
rs156641187096422073ERCC5umls:C0242379BeFreeAmong African Americans, His/His genotype of ERCC5 His1104Asp (rs17655) was associated with increased lung cancer risk (OR = 1.78; 95% CI: 1.09-2.91), and LIG1 haplotype GGGAA (rs20581, rs156641, rs3730931, rs20579 and rs439132) was associated with reduced lung cancer risk (OR = 0.61; 95% CI: 0.42-0.88).0.0300330352008LIG11948128151CT
rs1566411870964226018LRIG1umls:C0242379BeFreeAmong African Americans, His/His genotype of ERCC5 His1104Asp (rs17655) was associated with increased lung cancer risk (OR = 1.78; 95% CI: 1.09-2.91), and LIG1 haplotype GGGAA (rs20581, rs156641, rs3730931, rs20579 and rs439132) was associated with reduced lung cancer risk (OR = 0.61; 95% CI: 0.42-0.88).0.0010857672008LIG11948128151CT
rs1625895179089955715PSMD9umls:C0242379BeFreeWhen individuals with variant-containing genotypes were compared with homozygous wild-type carriers, a significantly increased lung cancer risk was identified for polymorphisms in p53 intron 6 [rs1625895; odds ratio (OR), 1.29; 95% confidence interval (95% CI), 1.08-1.55] and in p27 5' untranslated region (UTR; rs34330; OR, 1.27; 95% CI, 1.01-1.60).0.0024429772007TP53177674797TG,C
rs1625895179089957157TP53umls:C0242379BeFreeWhen individuals with variant-containing genotypes were compared with homozygous wild-type carriers, a significantly increased lung cancer risk was identified for polymorphisms in p53 intron 6 [rs1625895; odds ratio (OR), 1.29; 95% confidence interval (95% CI), 1.08-1.55] and in p27 5' untranslated region (UTR; rs34330; OR, 1.27; 95% CI, 1.01-1.60).0.162007TP53177674797TG,C
rs1663689227977252625GATA3umls:C0242379BeFreeWe found genome-wide significant (P < 5.0 × 10(-8)) evidence for three additional lung cancer susceptibility loci at 10p14 (rs1663689, close to GATA3, P = 2.84 × 10(-10)), 5q32 (rs2895680 in PPP2R2B-STK32A-DPYSL3, P = 6.60 × 10(-9)) and 20q13.2 (rs4809957 in CYP24A1, P = 1.20 × 10(-8)).0.0026384742012LOC105376400108983232TC
rs1663689227977251591CYP24A1umls:C0242379BeFreeWe found genome-wide significant (P < 5.0 × 10(-8)) evidence for three additional lung cancer susceptibility loci at 10p14 (rs1663689, close to GATA3, P = 2.84 × 10(-10)), 5q32 (rs2895680 in PPP2R2B-STK32A-DPYSL3, P = 6.60 × 10(-9)) and 20q13.2 (rs4809957 in CYP24A1, P = 1.20 × 10(-8)).0.0039956832012LOC105376400108983232TC
rs1663689227977255521PPP2R2Bumls:C0242379BeFreeWe found genome-wide significant (P < 5.0 × 10(-8)) evidence for three additional lung cancer susceptibility loci at 10p14 (rs1663689, close to GATA3, P = 2.84 × 10(-10)), 5q32 (rs2895680 in PPP2R2B-STK32A-DPYSL3, P = 6.60 × 10(-9)) and 20q13.2 (rs4809957 in CYP24A1, P = 1.20 × 10(-8)).0.0002714422012LOC105376400108983232TC
rs1663689227977251809DPYSL3umls:C0242379BeFreeWe found genome-wide significant (P < 5.0 × 10(-8)) evidence for three additional lung cancer susceptibility loci at 10p14 (rs1663689, close to GATA3, P = 2.84 × 10(-10)), 5q32 (rs2895680 in PPP2R2B-STK32A-DPYSL3, P = 6.60 × 10(-9)) and 20q13.2 (rs4809957 in CYP24A1, P = 1.20 × 10(-8)).0.0002714422012LOC105376400108983232TC
rs166368922797725202374STK32Aumls:C0242379BeFreeWe found genome-wide significant (P < 5.0 × 10(-8)) evidence for three additional lung cancer susceptibility loci at 10p14 (rs1663689, close to GATA3, P = 2.84 × 10(-10)), 5q32 (rs2895680 in PPP2R2B-STK32A-DPYSL3, P = 6.60 × 10(-9)) and 20q13.2 (rs4809957 in CYP24A1, P = 1.20 × 10(-8)).0.0002714422012LOC105376400108983232TC
rs16944241392384353MPOumls:C0242379BeFreeWe evaluated the role of tumor necrosis factor α (TNFA) rs1799724, interleukin 1β (IL1B) rs16944, IL6 rs1800796, myeloperoxidase (MPO) rs2333227 and C-reactive protein (CRP) rs2794520 in a case-control study comprised of 462 lung cancer cases and 379 controls in a Japanese population.0.0778729512013IL1B2112837290AG
rs16944197891903553IL1Bumls:C0242379GAD[When numeric scores were assigned to both the SNP and demographic data, and sequentially combined by a simple algorithm in a risk model, the composite score was found to be linearly related to lung cancer risk with a bimodal distribution.]0.0443111722009IL1B2112837290AG
rs1695225255582950GSTP1umls:C0242379BeFreeCYP1A1 rs4646903 (OR = 1.72, 95% CI = 1.25-2.38), rs1048943 (OR = 1.40, 95% CI = 1.02-1.92), the GSTM1 deletion polymorphism (OR = 1.38, 95% CI = 1.01-1.89), GSTP1 rs1695 (OR =1.48, 95% CI = 1.04-2.11), ERCC2 rs13181 (OR = 1.89, 95% CI = 1.28-2.78), and Chinese hamster 1 rs25487 (OR = 1.54, 95% CI = 1.12-2.13) were associated with lung cancer risk whereas the GSTT1 deletion polymorphism and XRCC3 rs861539 were not.0.0924863262012GSTP11167585218AG
rs1695165097652950GSTP1umls:C0242379BeFreeThe risk of lung cancer is not strongly associated with the I105V and A114V polymorphisms in the GSTP1 gene or with GSTM3 intron 6 polymorphism.0.0924863262006GSTP11167585218AG
rs1695150696852950GSTP1umls:C0242379BeFreeIn a population-based case-cohort study where cases and the subcohort sample were matched on duration of smoking, we investigated the occurrence of lung cancer and histological subtypes of lung cancer in relation to deletion polymorphism in both GSTM1 and GSTT1, single nucleotide polymorphisms (SNPs) in GSTP1 (Ile105Val and Ala114Val) and a 3 base pair deletion polymorphism in GSTM3.0.0924863262004GSTP11167585218AG
rs1695100269932950GSTP1umls:C0242379BeFreeA polymorphic site of GSTP1 (valine to isoleucine at codon 104) decreases activity to several carcinogenic diol epoxides and was associated with testicular, bladder and lung cancer.0.0924863261998GSTP11167585218AG
rs1695245666902950GSTP1umls:C0242379BeFreeGSTP1 Ile105Val polymorphism is associated with lung cancer risk among Asian population and smokers: an updated meta-analysis.0.0924863262014GSTP11167585218AG
rs1695225255582952GSTT1umls:C0242379BeFreeCYP1A1 rs4646903 (OR = 1.72, 95% CI = 1.25-2.38), rs1048943 (OR = 1.40, 95% CI = 1.02-1.92), the GSTM1 deletion polymorphism (OR = 1.38, 95% CI = 1.01-1.89), GSTP1 rs1695 (OR =1.48, 95% CI = 1.04-2.11), ERCC2 rs13181 (OR = 1.89, 95% CI = 1.28-2.78), and Chinese hamster 1 rs25487 (OR = 1.54, 95% CI = 1.12-2.13) were associated with lung cancer risk whereas the GSTT1 deletion polymorphism and XRCC3 rs861539 were not.0.100358142012GSTP11167585218AG
rs1695207297932950GSTP1umls:C0242379BeFreeThe objective of this report is to evaluate the literature on the association of common glutathione S-transferase (GST) variants (GSTM1 null, GSTT1 null and GSTP1 Ile105Val polymorphism) and lung cancer, and to assess the credibility of the associations using the newly proposed cumulative evidence guidelines.0.0924863262010GSTP11167585218AG
rs1695165097652947GSTM3umls:C0242379BeFreeThe risk of lung cancer is not strongly associated with the I105V and A114V polymorphisms in the GSTP1 gene or with GSTM3 intron 6 polymorphism.0.0158308432006GSTP11167585218AG
rs1695158964612950GSTP1umls:C0242379BeFreeGSTP1 Ile105Val and hOGG1 Ser326Cys polymorphisms were not found to be risk factors of lung cancer in this study.0.0924863262005GSTP11167585218AG
rs1695158964614968OGG1umls:C0242379BeFreeGSTP1 Ile105Val and hOGG1 Ser326Cys polymorphisms were not found to be risk factors of lung cancer in this study.0.0722050092005GSTP11167585218AG
rs1695225255587517XRCC3umls:C0242379BeFreeCYP1A1 rs4646903 (OR = 1.72, 95% CI = 1.25-2.38), rs1048943 (OR = 1.40, 95% CI = 1.02-1.92), the GSTM1 deletion polymorphism (OR = 1.38, 95% CI = 1.01-1.89), GSTP1 rs1695 (OR =1.48, 95% CI = 1.04-2.11), ERCC2 rs13181 (OR = 1.89, 95% CI = 1.28-2.78), and Chinese hamster 1 rs25487 (OR = 1.54, 95% CI = 1.12-2.13) were associated with lung cancer risk whereas the GSTT1 deletion polymorphism and XRCC3 rs861539 were not.0.0443871172012GSTP11167585218AG
rs1695247862341421CRYGDumls:C0242379BeFreeWhen Phase 2 software was used to reconstruct the haplotype for GSTP1, the haplotype CACA (rs749174+rs1695 + rs762803+rs4891) exhibited an increased risk of lung cancer among smokers (adjust odds ratio 1.53; 95%CI 1.04-2.25, P=0.033).0.0008143262014GSTP11167585218AG
rs1695150696852947GSTM3umls:C0242379BeFreeIn a population-based case-cohort study where cases and the subcohort sample were matched on duration of smoking, we investigated the occurrence of lung cancer and histological subtypes of lung cancer in relation to deletion polymorphism in both GSTM1 and GSTT1, single nucleotide polymorphisms (SNPs) in GSTP1 (Ile105Val and Ala114Val) and a 3 base pair deletion polymorphism in GSTM3.0.0158308432004GSTP11167585218AG
rs1695230135351543CYP1A1umls:C0242379BeFreeWe investigated if the individual and/or combined modifying effects of the CYP1A1 MspI T6235C, GSTM1 present/null, GSTT1 present/null and GSTP1 Ile105Val polymorphisms are related to the risk of developing lung cancer in relation to tobacco consumption and occupation in Asturias, Northern Spain.0.1237021412012GSTP11167585218AG
rs1696698205549421138CHRNA5umls:C0242379BeFreeThe functional A variant of rs1696698 in CHRNA5 had the strongest association with lung cancer (OR = 1.98, 95% CI = 1.25 to 3.11, P = .003).0.0598269662010NANANANANA
rs16969968262823301138CHRNA5umls:C0242379BeFreeSliding window haplotype analysis within chromosome 15, evaluating 4722250 haplotypes and pair-wise haplotype analysis identified that CHRNA5 rs588765-rs16969968 was the most significant haplotype associated with lung cancer risk (omnibus P = 8.35×10(-15) in discovery and 7.26×10(-14) in replication), and improved the prediction of case status over that provided by the individual SNPs rs16969968 or rs588765 (likelihood ratio test P = 0.006 for rs16969968 and 3.83×10(-14) for rs588765 in discovery, 0.009 for rs16969968 and 4.62×10(-13) for rs588765 in replication, compared with rs588765-rs16969968).0.0598269662015CHRNA51578590583GA
rs16969968205876041138CHRNA5umls:C0242379BeFreeA four-SNP haplotype spanning CHRNA5 (rs11637635 C, rs17408276 T, rs16969968 G) and CHRNA3 (rs578776 G) was associated with increased lung cancer risk (P = 0.002).0.0598269662010CHRNA51578590583GA
rs16969968231784471138CHRNA5umls:C0242379BeFreeNo association with lung cancer risk was found for CHRNA5 rs16969968.0.0598269662013CHRNA51578590583GA
rs16969968218626241138CHRNA5umls:C0242379BeFreeTwo variants in the nicotinic acetylcholine receptor subunit genes CHRNA5 and CHRNA3 on 15q25, rs16969968 and rs578776, were associated with cotinine (P = 0.001 and 0.03, respectively) in current smokers and with lung cancer risk (P < 0.001 and P = 0.001, respectively).0.0598269662011CHRNA51578590583GA
rs16969968205876041136CHRNA3umls:C0242379BeFreeA four-SNP haplotype spanning CHRNA5 (rs11637635 C, rs17408276 T, rs16969968 G) and CHRNA3 (rs578776 G) was associated with increased lung cancer risk (P = 0.002).0.1792081372010CHRNA51578590583GA
rs16969968218626241136CHRNA3umls:C0242379BeFreeTwo variants in the nicotinic acetylcholine receptor subunit genes CHRNA5 and CHRNA3 on 15q25, rs16969968 and rs578776, were associated with cotinine (P = 0.001 and 0.03, respectively) in current smokers and with lung cancer risk (P < 0.001 and P = 0.001, respectively).0.1792081372011CHRNA51578590583GA
rs171140187096422068ERCC2umls:C0242379BeFreeFrom MDR analysis, in Latinos, smoking and 3 SNPs (ERCC2 rs171140, ERCC5 rs17655 and LIG1 rs20581) together had a prediction accuracy of 67.4% (p = 0.001) for lung cancer.0.2138435352008ERCC21945361744CA
rs17408276205876041138CHRNA5umls:C0242379BeFreeA four-SNP haplotype spanning CHRNA5 (rs11637635 C, rs17408276 T, rs16969968 G) and CHRNA3 (rs578776 G) was associated with increased lung cancer risk (P = 0.002).0.0598269662010CHRNA51578589276TC
rs17408276205876041136CHRNA3umls:C0242379BeFreeA four-SNP haplotype spanning CHRNA5 (rs11637635 C, rs17408276 T, rs16969968 G) and CHRNA3 (rs578776 G) was associated with increased lung cancer risk (P = 0.002).0.1792081372010CHRNA51578589276TC
rs17486278205876041143CHRNB4umls:C0242379BeFreeCHRNA5 rs17486278 G had OR = 1.28, 95% CI 1.07-1.54 and P = 0.008, whereas CHRNB4 rs7178270 G had OR = 0.78, 95% CI 0.66-0.94 and P = 0.008 for lung cancer risk.0.018273822010CHRNA51578575140AC
rs176094421429202328APEX1umls:C0242379BeFreeRecently, the APE1/Ref-1 promoter -141T/G variant (rs1760944) has been reported to be associated with lung cancer risk.0.0489256842011APEX1;OSGEP1420454990TG
rs1760944214292027003TEAD1umls:C0242379BeFreeRecently, the APE1/Ref-1 promoter -141T/G variant (rs1760944) has been reported to be associated with lung cancer risk.0.0008143262011APEX1;OSGEP1420454990TG
rs17655187096422073ERCC5umls:C0242379BeFreeAmong African Americans, His/His genotype of ERCC5 His1104Asp (rs17655) was associated with increased lung cancer risk (OR = 1.78; 95% CI: 1.09-2.91), and LIG1 haplotype GGGAA (rs20581, rs156641, rs3730931, rs20579 and rs439132) was associated with reduced lung cancer risk (OR = 0.61; 95% CI: 0.42-0.88).0.0300330352008ERCC5;BIVM-ERCC513102875652GC
rs17655245960322073ERCC5umls:C0242379BeFreeGenetic association between ERCC5 rs17655 polymorphism and lung cancer risk: evidence based on a meta-analysis.0.0300330352014ERCC5;BIVM-ERCC513102875652GC
rs176551870964226018LRIG1umls:C0242379BeFreeAmong African Americans, His/His genotype of ERCC5 His1104Asp (rs17655) was associated with increased lung cancer risk (OR = 1.78; 95% CI: 1.09-2.91), and LIG1 haplotype GGGAA (rs20581, rs156641, rs3730931, rs20579 and rs439132) was associated with reduced lung cancer risk (OR = 0.61; 95% CI: 0.42-0.88).0.0010857672008ERCC5;BIVM-ERCC513102875652GC
rs17655128694232073ERCC5umls:C0242379BeFreeWe investigated the relationship between the His1104Asp polymorphism in the XPG gene and the risk of lung cancer.0.0300330352003ERCC5;BIVM-ERCC513102875652GC
rs17655187096422068ERCC2umls:C0242379BeFreeFrom MDR analysis, in Latinos, smoking and 3 SNPs (ERCC2 rs171140, ERCC5 rs17655 and LIG1 rs20581) together had a prediction accuracy of 67.4% (p = 0.001) for lung cancer.0.2138435352008ERCC5;BIVM-ERCC513102875652GC
rs177284612172530881037CLPTM1Lumls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.1428883322011HORMAD2;LOC1053729882230202563CG
rs17728461217253083976LIFumls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.0002714422011HORMAD2;LOC1053729882230202563CG
rs1772846121725308150280HORMAD2umls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.0005428842011HORMAD2;LOC1053729882230202563CG
rs17728461217253084285MIPEPumls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.0002714422011HORMAD2;LOC1053729882230202563CG
rs17728461217253087015TERTumls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.1554182652011HORMAD2;LOC1053729882230202563CG
rs17728461217253088897MTMR3umls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.1205428842011HORMAD2;LOC1053729882230202563CG
rs17728461217253088626TP63umls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.1253528932011HORMAD2;LOC1053729882230202563CG
rs177284612172530855504TNFRSF19umls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.0002714422011HORMAD2;LOC1053729882230202563CG
rs178799612488034211200CHEK2umls:C0242379GWASCATRare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.0.1298155152014CHEK22228725099AG
rs1799724241392387124TNFumls:C0242379BeFreeAs TNFA triggers a cytokine cascade, the modifying effect of the TNFA rs1799724 genotypes on the association of any of the remaining polymorphisms with lung cancer risk was also examined.0.0423674712013LTA;TNF631574705CT
rs1799724241392384353MPOumls:C0242379BeFreeWe evaluated the role of tumor necrosis factor α (TNFA) rs1799724, interleukin 1β (IL1B) rs16944, IL6 rs1800796, myeloperoxidase (MPO) rs2333227 and C-reactive protein (CRP) rs2794520 in a case-control study comprised of 462 lung cancer cases and 379 controls in a Japanese population.0.0778729512013LTA;TNF631574705CT
rs1799732197891901813DRD2umls:C0242379GAD[When numeric scores were assigned to both the SNP and demographic data, and sequentially combined by a simple algorithm in a risk model, the composite score was found to be linearly related to lung cancer risk with a bimodal distribution.]0.0168406662009DRD2;LOC10536950011113475529-G
rs1799750163112444321MMP12umls:C0242379BeFreeWe investigated the associations between polymorphisms of MMP-1 (-1607 1G/2G, rs1799750), MMP-3 (-1171 5A/6A, rs3025058), and MMP-12 (-82AG, rs2276109, and 1082A/G, rs652438) and the risk of lung cancer in 2014 Caucasian lung cancer patients and 1323 healthy controls.0.0090011892006MMP1;WTAPP111102799765C-
rs1799750163112444314MMP3umls:C0242379BeFreeWe investigated the associations between polymorphisms of MMP-1 (-1607 1G/2G, rs1799750), MMP-3 (-1171 5A/6A, rs3025058), and MMP-12 (-82AG, rs2276109, and 1082A/G, rs652438) and the risk of lung cancer in 2014 Caucasian lung cancer patients and 1323 healthy controls.0.0155594012006MMP1;WTAPP111102799765C-
rs1799782158408794968OGG1umls:C0242379BeFreeThe associations between the OGG1 Cys/Cys genotype and adenocarcinoma risk and between XRCC1 Arg194Trp polymorphism and lung cancer risk among heavy smokers remained robust given prior probabilities of 25% (FPRP = 0.238) and 10% (FPRP = 0.276), respectively.0.0722050092005XRCC11943553422GA
rs1799782175315254968OGG1umls:C0242379BeFreeBoth the XRCC1 Arg194Trp and Arg280His as well as the OGG1 Ser326Cys heterozygous genotypes were associated with a significantly reduced risk for lung cancer (OR=0.32, p=0.024; OR=0.25, p=0.028; OR=0.51, p=0.033, respectively).0.0722050092007XRCC11943553422GA
rs1799782236533787515XRCC1umls:C0242379BeFreeTherefore, this meta-analysis suggests that XRCC1 Arg194Trp polymorphism is associated with increased risk of lung cancer in Chinese Han population.0.0998152572013XRCC11943553422GA
rs1799782245902657515XRCC1umls:C0242379BeFreeNo association between XRCC1 gene Arg194Trp polymorphism and risk of lung cancer: evidence based on an updated cumulative meta-analysis.0.0998152572014XRCC11943553422GA
rs1799782174179477515XRCC1umls:C0242379BeFreeContrasting impact of DNA repair gene XRCC1 polymorphisms Arg399Gln and Arg194Trp on the risk of lung cancer in the north-Indian population.0.0998152572007XRCC11943553422GA
rs1799782158408797515XRCC1umls:C0242379BeFreeThe associations between the OGG1 Cys/Cys genotype and adenocarcinoma risk and between XRCC1 Arg194Trp polymorphism and lung cancer risk among heavy smokers remained robust given prior probabilities of 25% (FPRP = 0.238) and 10% (FPRP = 0.276), respectively.0.0998152572005XRCC11943553422GA
rs1799782209753747515XRCC1umls:C0242379BeFreeHomozygous Trp/Trp variant genotype of XRCC1 Arg194Trp polymorphism could increase lung cancer risk in total population, especially in Asians.0.0998152572010XRCC11943553422GA
rs1799793217394802068ERCC2umls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.2138435352012ERCC21945364001CT
rs1799793175315257507XPAumls:C0242379BeFreeWe investigated the association of 10 base-excision and nucleotide-excision repair gene polymorphisms (XRCC1 -77 T/C, Arg194Trp, Arg280His and Arg399Gln; APE1 Asp148Glu; OGG1 Ser326Cys; XPA -4 G/A; XPC PAT; XPD Asp312Asn and Lys751Gln) with lung cancer risk in Caucasians.0.0361243082007ERCC21945364001CT
rs1799793217394807515XRCC1umls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0998152572012ERCC21945364001CT
rs1799793217394808930MBD4umls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0102824542012ERCC21945364001CT
rs1799793112454332068ERCC2umls:C0242379BeFreeWe therefore examined XPD polymorphisms at Lys751Gln and Asp312Asn in 341 white lung cancer cases and 360 age-, sex-, ethnicity-, and smoking-matched controls accrued in a hospital-based molecular epidemiological study of susceptibility markers for lung cancer.0.2138435352001ERCC21945364001CT
rs179979321739480472ATMumls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0211837362012ERCC21945364001CT
rs1799793206516122068ERCC2umls:C0242379BeFreeERCC2/XPD Lys751Gln and Asp312Asn gene polymorphism and lung cancer risk: a meta-analysis involving 22 case-control studies.0.2138435352010ERCC21945364001CT
rs1799793217394804361MRE11Aumls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0002714422012ERCC21945364001CT
rs1799793240835502068ERCC2umls:C0242379BeFreePolymorphism of ERCC2 Asp312Asn with lung cancer risk: evidence from 20,101 subjects.0.2138435352014ERCC21945364001CT
rs1799793211955042068ERCC2umls:C0242379BeFreeERCC2 Asp/Asn (rs1799793) polymorphism may also affect lung cancer risk among nonsmokers.0.2138435352011ERCC21945364001CT
rs1799793177058147508XPCumls:C0242379BeFreeWe investigated the relationship between polymorphisms in two NER genes, XPC (poly (AT) insertion/deletion: PAT-/+) and XPD (Asp312Asn and Lys751Gln), the BER gene XRCC1 (Arg399Gln), and the DSBR gene XRCC3 (Thr241Met) and the risk of developing lung cancer.0.0443111722007ERCC21945364001CT
rs1799793217394805378PMS1umls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0026384742012ERCC21945364001CT
rs1799793175315257508XPCumls:C0242379BeFreeWe investigated the association of 10 base-excision and nucleotide-excision repair gene polymorphisms (XRCC1 -77 T/C, Arg194Trp, Arg280His and Arg399Gln; APE1 Asp148Glu; OGG1 Ser326Cys; XPA -4 G/A; XPC PAT; XPD Asp312Asn and Lys751Gln) with lung cancer risk in Caucasians.0.0443111722007ERCC21945364001CT
rs1799793174985572068ERCC2umls:C0242379BeFreeA haplotype encompassing the variant allele of DNA repair gene polymorphism ERCC2/XPD Lys751Gln but not the variant allele of Asp312Asn is associated with risk of lung cancer in a northeastern Chinese population.0.2138435352007ERCC21945364001CT
rs1799793218645462068ERCC2umls:C0242379BeFreeThese associations were: two SNPs rs1799793 and rs13181 in the ERCC2 gene and lung cancer (recessive model) and rs1805794 in the NBN gene and bladder cancer (dominant model).0.2138435352012ERCC21945364001CT
rs1799793218645464683NBNumls:C0242379BeFreeThese associations were: two SNPs rs1799793 and rs13181 in the ERCC2 gene and lung cancer (recessive model) and rs1805794 in the NBN gene and bladder cancer (dominant model).0.0134638112012ERCC21945364001CT
rs1799895197891906649SOD3umls:C0242379GAD[When numeric scores were assigned to both the SNP and demographic data, and sequentially combined by a simple algorithm in a risk model, the composite score was found to be linearly related to lung cancer risk with a bimodal distribution.]0.0071010962009SOD3;LOC105374533424800212CG
rs17999301978919010NAT2umls:C0242379GAD[When numeric scores were assigned to both the SNP and demographic data, and sequentially combined by a simple algorithm in a risk model, the composite score was found to be linearly related to lung cancer risk with a bimodal distribution.]0.0564937182009NAT2818400593GA
rs1799964201123373586IL10umls:C0242379BeFreeBayesian correction for multiple comparisons suggests that chance is unlikely to explain our findings (although epigenetic mechanisms may be in effect), which support our hypotheses, suggesting that IL10 rs1800871 is a susceptibility marker for oropharyngeal and lung cancers, and that TNF rs1799964 is associated with smoking-related cancers among never smokers.0.024560592010LTA;TNF;LOC100287329631574531TC
rs1799964201123377124TNFumls:C0242379BeFreeBayesian correction for multiple comparisons suggests that chance is unlikely to explain our findings (although epigenetic mechanisms may be in effect), which support our hypotheses, suggesting that IL10 rs1800871 is a susceptibility marker for oropharyngeal and lung cancers, and that TNF rs1799964 is associated with smoking-related cancers among never smokers.0.0423674712010LTA;TNF;LOC100287329631574531TC
rs1800067252920412072ERCC4umls:C0242379BeFreeFor subgroup of lung cancer, A allele of ERCC4 rs1800067 A/G polymorphism was significantly associated with decreased risk of lung cancer compared with G allele (OR=0.806, 95%CI=0.697-0.931, P=0.003).0.0197505812015ERCC41613935176GA
rs1800470254098907040TGFB1umls:C0242379BeFreeTransforming growth factor-β1 rs1800470 polymorphism is associated with lung cancer risk: a meta-analysis.0.0199024712015TGFB11941353016GC,A
rs1800566167023801728NQO1umls:C0242379BeFreeIn stratified analyses, the NQO1 Pro187Ser variant genotypes were associated with slightly increased lung cancer risk in white ever smokers but not in white never smokers and were mainly associated with a reduced risk of lung adenocarcinoma but not squamous cell carcinoma in Asians.0.060217962006NQO11669711242GA
rs1800566231101371429CRYZumls:C0242379BeFreeThe association between NAD(P)H:quinone oxidoreductase 1 (NQO1) gene C609T polymorphism (rs1800566) and lung cancer has been widely evaluated, and a definitive answer so far is lacking.0.0038001862012NQO11669711242GA
rs1800734252529094292MLH1umls:C0242379BeFreeIn the present case-control study, we investigated the promoter polymorphisms of selected mismatch repair genes: hMLH1 (rs1800734) and hMSH2 (rs2303425), and the risk they present regarding the development of lung cancer in the Slovak population.0.0190122012015MLH1;EPM2AIP1336993455GA
rs1800734252529094436MSH2umls:C0242379BeFreeIn the present case-control study, we investigated the promoter polymorphisms of selected mismatch repair genes: hMLH1 (rs1800734) and hMSH2 (rs2303425), and the risk they present regarding the development of lung cancer in the Slovak population.0.0140066952015MLH1;EPM2AIP1336993455GA
rs1800796249846103569IL6umls:C0242379BeFreeLack of association between a functional polymorphism (rs1800796) in the interleukin-6 gene promoter and lung cancer.0.0403478262014IL6;LOC541472722726627GC
rs180079624139238140913PPIAP10umls:C0242379BeFreeCRP rs2794520 (OR=1.64, 95% CI=1.19-2.26) and IL6 rs1800796 (OR=1.41, 95% CI=1.02-1.96) were associated with lung cancer risk.0.0008143262013IL6;LOC541472722726627GC
rs1800796241392383569IL6umls:C0242379BeFreeCRP rs2794520 (OR=1.64, 95% CI=1.19-2.26) and IL6 rs1800796 (OR=1.41, 95% CI=1.02-1.96) were associated with lung cancer risk.0.0403478262013IL6;LOC541472722726627GC
rs1800796241392384353MPOumls:C0242379BeFreeWe evaluated the role of tumor necrosis factor α (TNFA) rs1799724, interleukin 1β (IL1B) rs16944, IL6 rs1800796, myeloperoxidase (MPO) rs2333227 and C-reactive protein (CRP) rs2794520 in a case-control study comprised of 462 lung cancer cases and 379 controls in a Japanese population.0.0778729512013IL6;LOC541472722726627GC
rs1800871201123373586IL10umls:C0242379BeFreeBayesian correction for multiple comparisons suggests that chance is unlikely to explain our findings (although epigenetic mechanisms may be in effect), which support our hypotheses, suggesting that IL10 rs1800871 is a susceptibility marker for oropharyngeal and lung cancers, and that TNF rs1799964 is associated with smoking-related cancers among never smokers.0.024560592010IL101206773289AG
rs1800871201123377124TNFumls:C0242379BeFreeBayesian correction for multiple comparisons suggests that chance is unlikely to explain our findings (although epigenetic mechanisms may be in effect), which support our hypotheses, suggesting that IL10 rs1800871 is a susceptibility marker for oropharyngeal and lung cancers, and that TNF rs1799964 is associated with smoking-related cancers among never smokers.0.0423674712010IL101206773289AG
rs1800975246962587507XPAumls:C0242379BeFreeXPA gene rs1800975 single nucleotide polymorphism and lung cancer risk: a meta-analysis.0.0361243082014XPA997697296TG,C
rs1801131221440476648SOD2umls:C0242379BeFreeA review was conducted of 136 patients treated with radiation therapy for lung cancer between 2001 and 2007, and who had prior genotyping of functional single-nucleotide polymorphisms in oxidative stress genes including superoxide dismutase 2 (SOD2; rs4880) and methylene tetrahydrofolate reductase (MTHFR; rs1801131, rs1801133).0.0219221162012MTHFR111794419TG
rs1801133221440476648SOD2umls:C0242379BeFreeA review was conducted of 136 patients treated with radiation therapy for lung cancer between 2001 and 2007, and who had prior genotyping of functional single-nucleotide polymorphisms in oxidative stress genes including superoxide dismutase 2 (SOD2; rs4880) and methylene tetrahydrofolate reductase (MTHFR; rs1801131, rs1801133).0.0219221162012MTHFR111796321GA
rs1801270170598535063PAK3umls:C0242379BeFreeWe therefore investigated the combined effects of polymorphisms in TP53 (Arg72Pro) and p21/CDKN1A (Ser31Arg) and smoking on lung cancer risk.0.0002714422007CDKN1A636684194CA,T
rs1801394174685114524MTHFRumls:C0242379BeFreeIn addition, we found interactions between the MTRR A66G polymorphism and smoking (P = 0.015) and the MTHFR A1,298C polymorphism and alcohol consumption (P = 0.025) for risk of lung cancer overall.0.056765162007MTRR;FASTKD357870860AG
rs1801394174685114548MTRumls:C0242379BeFreeFunctional polymorphisms in genes encoding one-carbon metabolism enzymes, methylenetetrahydrofolate reductase (MTHFR C677T and A1,298C), methionine synthase (MTR A2,756G), methionine synthase reductase (MTRR A66G) and thymidylate synthase, influence folate metabolism and thus might be suspected of impacting on lung cancer risk.0.0105538952007MTRR;FASTKD357870860AG
rs1801394174685114552MTRRumls:C0242379BeFreeIn addition, we found interactions between the MTRR A66G polymorphism and smoking (P = 0.015) and the MTHFR A1,298C polymorphism and alcohol consumption (P = 0.025) for risk of lung cancer overall.0.0105538952007MTRR;FASTKD357870860AG
rs1801394174685117298TYMSumls:C0242379BeFreeFunctional polymorphisms in genes encoding one-carbon metabolism enzymes, methylenetetrahydrofolate reductase (MTHFR C677T and A1,298C), methionine synthase (MTR A2,756G), methionine synthase reductase (MTRR A66G) and thymidylate synthase, influence folate metabolism and thus might be suspected of impacting on lung cancer risk.0.016178232007MTRR;FASTKD357870860AG
rs1805077170598535063PAK3umls:C0242379BeFreeWe therefore investigated the combined effects of polymorphisms in TP53 (Arg72Pro) and p21/CDKN1A (Ser31Arg) and smoking on lung cancer risk.0.0002714422007PAK3X111123196CA
rs1805794218645462068ERCC2umls:C0242379BeFreeThese associations were: two SNPs rs1799793 and rs13181 in the ERCC2 gene and lung cancer (recessive model) and rs1805794 in the NBN gene and bladder cancer (dominant model).0.2138435352012NBN889978251CG
rs1805794218645464683NBNumls:C0242379BeFreeThese associations were: two SNPs rs1799793 and rs13181 in the ERCC2 gene and lung cancer (recessive model) and rs1805794 in the NBN gene and bladder cancer (dominant model).0.0134638112012NBN889978251CG
rs18057942577187155655NLRP2umls:C0242379BeFreeThese findings suggest that the rs1805794G>C of NBS1 may be a functional genetic biomarker for lung cancer.0.0010857672014NBN889978251CG
rs1805794257718714683NBNumls:C0242379BeFreeThe functional polymorphism of NBS1 p.Glu185Gln is associated with an increased risk of lung cancer in Chinese populations: case-control and a meta-analysis.0.0134638112014NBN889978251CG
rs1805794232751904683NBNumls:C0242379BeFreeAssociation between the NBS1 Glu185Gln polymorphism and lung cancer risk: a systemic review and meta-analysis.0.0134638112012NBN889978251CG
rs1881457255972813596IL13umls:C0242379BeFreeCART analyses did not yield a tree structure for overall survival; separate CART tree structures were identified for recurrence, based on three SNPs (IL13:rs1881457, IL1B:rs1143634, and IL12A:rs662959), and for disease-free survival, based on two SNPs (IL12A:rs662959 and IL16:rs7170924), which may suggest that these candidate IL SNPs have a specific impact on lung cancer progression and recurrence.0.0100110122014IL13;LOC1019277615132656717AC
rs1881457255972813603IL16umls:C0242379BeFreeCART analyses did not yield a tree structure for overall survival; separate CART tree structures were identified for recurrence, based on three SNPs (IL13:rs1881457, IL1B:rs1143634, and IL12A:rs662959), and for disease-free survival, based on two SNPs (IL12A:rs662959 and IL16:rs7170924), which may suggest that these candidate IL SNPs have a specific impact on lung cancer progression and recurrence.0.0050055062014IL13;LOC1019277615132656717AC
rs1881457255972813553IL1Bumls:C0242379BeFreeCART analyses did not yield a tree structure for overall survival; separate CART tree structures were identified for recurrence, based on three SNPs (IL13:rs1881457, IL1B:rs1143634, and IL12A:rs662959), and for disease-free survival, based on two SNPs (IL12A:rs662959 and IL16:rs7170924), which may suggest that these candidate IL SNPs have a specific impact on lung cancer progression and recurrence.0.0443111722014IL13;LOC1019277615132656717AC
rs1881457255972813592IL12Aumls:C0242379BeFreeCART analyses did not yield a tree structure for overall survival; separate CART tree structures were identified for recurrence, based on three SNPs (IL13:rs1881457, IL1B:rs1143634, and IL12A:rs662959), and for disease-free survival, based on two SNPs (IL12A:rs662959 and IL16:rs7170924), which may suggest that these candidate IL SNPs have a specific impact on lung cancer progression and recurrence.0.0079154222014IL13;LOC1019277615132656717AC
rs189037217394805378PMS1umls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0026384742012ATM;NPAT11108223106GA
rs189037217394804361MRE11Aumls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0002714422012ATM;NPAT11108223106GA
rs18903721739480472ATMumls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0211837362012ATM;NPAT11108223106GA
rs189037217394808930MBD4umls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0102824542012ATM;NPAT11108223106GA
rs189037217394802068ERCC2umls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.2138435352012ATM;NPAT11108223106GA
rs189037217394807515XRCC1umls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0998152572012ATM;NPAT11108223106GA
rs19262031965430359ACTA2umls:C0242379GWASCATDeciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study.0.122009ACTA21088967577CA
rs1948229456517015TERTumls:C0242379BeFreeSingle-nucleotide polymorphisms rs421629 on 5p15.33 and rs1948, rs660652, rs8040868 and rs2036527 on 15q25.1, previously identified as lung cancer risk or nicotine-addiction modifiers, were associated with tumor DNA methylation levels in the promoters of TERT and CHRNB4 (P<0.001), respectively, in two independent sample sets (n=82; n=150).0.1554182652013CHRNB41578625057AG
rs19707642233588810849CD3EAPumls:C0242379BeFreeA specific diplotype defined by PPP1R13L rs1970764, CD3EAP rs967591 and ERCC1 rs11615 and lung cancer risk in a Chinese population.0.0039956832012PPP1R13L1945387615TC
rs1970764223358882067ERCC1umls:C0242379BeFreeA specific diplotype defined by PPP1R13L rs1970764, CD3EAP rs967591 and ERCC1 rs11615 and lung cancer risk in a Chinese population.0.0670476142012PPP1R13L1945387615TC
rs19707642233588810848PPP1R13Lumls:C0242379BeFreeA specific diplotype defined by PPP1R13L rs1970764, CD3EAP rs967591 and ERCC1 rs11615 and lung cancer risk in a Chinese population.0.0071770412012PPP1R13L1945387615TC
rs1982073193804417040TGFB1umls:C0242379GAD[Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy.]0.0199024712009NANANANANA
rs200100285172596549NAT1umls:C0242379BeFreeHeterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.0.0116396632007MTHFR111796313TC,G
rs200100285172596545243ABCB1umls:C0242379BeFreeHeterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.0.0410102622007MTHFR111796313TC,G
rs200100285172596542939GSTA2umls:C0242379BeFreeHeterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.0.0050055062007MTHFR111796313TC,G
rs200100285172596544524MTHFRumls:C0242379BeFreeHeterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.0.056765162007MTHFR111796313TC,G
rs200100285172596541548CYP2A6umls:C0242379BeFreeHeterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.0.0333662822007MTHFR111796313TC,G
rs200100285172596542947GSTM3umls:C0242379BeFreeHeterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.0.0158308432007MTHFR111796313TC,G
rs200847762259374447916PRRC2Aumls:C0242379BeFreeWe identified three low-frequency missense variants in BAT2 (rs9469031, c.1544C>T [p.Pro515Leu]; odds ratio [OR] = 0.55, p = 1.28 × 10(-10)), FKBPL (rs200847762, c.410C>T [p.Pro137Leu]; OR = 0.25, p = 9.79 × 10(-12)), and BPIFB1 (rs6141383, c.850G>A [p.Val284Met]; OR = 1.72, p = 1.79 × 10(-7)); these variants were associated with lung cancer risk. rs9469031 in BAT2 and rs6141383 in BPIFB1 were also associated with the age of onset of lung cancer (p = 0.001 and 0.006, respectively).0.0002714422015ATF6B;FKBPL632129371GA
rs2008477622593744492747BPIFB1umls:C0242379BeFreeWe identified three low-frequency missense variants in BAT2 (rs9469031, c.1544C>T [p.Pro515Leu]; odds ratio [OR] = 0.55, p = 1.28 × 10(-10)), FKBPL (rs200847762, c.410C>T [p.Pro137Leu]; OR = 0.25, p = 9.79 × 10(-12)), and BPIFB1 (rs6141383, c.850G>A [p.Val284Met]; OR = 1.72, p = 1.79 × 10(-7)); these variants were associated with lung cancer risk. rs9469031 in BAT2 and rs6141383 in BPIFB1 were also associated with the age of onset of lung cancer (p = 0.001 and 0.006, respectively).0.0002714422015ATF6B;FKBPL632129371GA
rs2010963241462757422VEGFAumls:C0242379BeFreeVascular endothelial growth factor -634G/C and vascular endothelial growth factor -2578C/A polymorphisms and lung cancer risk: a case-control study and meta-analysis.0.0429426932013VEGFA643770613CG
rs2031920197891901571CYP2E1umls:C0242379GAD[When numeric scores were assigned to both the SNP and demographic data, and sequentially combined by a simple algorithm in a risk model, the composite score was found to be linearly related to lung cancer risk with a bimodal distribution.]0.0552883992009CYP2E110133526341CT
rs2032582171201995243ABCB1umls:C0242379BeFreeAdenosine triphosphate-binding cassette B1 (ABCB1) (multidrug resistance 1) G2677T/A gene polymorphism is associated with high risk of lung cancer.0.0410102622006ABCB1787531302AT,C
rs203652720554942123688HYKKumls:C0242379BeFreeAssociations of SNPs in LOC123688 (rs10519203; odds ratio [OR] = 1.60, 95% confidence interval [CI] = 1.25 to 2.05, P = .00016), CHRNA5 (rs2036527; OR = 1.67, 95% CI = 1.26 to 2.21, P = .00031), and CHRNA3 (rs1051730; OR = 1.81, 95% CI = 1.26 to 2.59, P = .00137) genes with lung cancer risk reached Bonferroni-corrected levels of statistical significance (all statistical tests were two-sided).0.1337352532010NA1578559273GA
rs2036527205549421136CHRNA3umls:C0242379BeFreeAssociations of SNPs in LOC123688 (rs10519203; odds ratio [OR] = 1.60, 95% confidence interval [CI] = 1.25 to 2.05, P = .00016), CHRNA5 (rs2036527; OR = 1.67, 95% CI = 1.26 to 2.21, P = .00031), and CHRNA3 (rs1051730; OR = 1.81, 95% CI = 1.26 to 2.59, P = .00137) genes with lung cancer risk reached Bonferroni-corrected levels of statistical significance (all statistical tests were two-sided).0.1792081372010NA1578559273GA
rs2036527229456517015TERTumls:C0242379BeFreeSingle-nucleotide polymorphisms rs421629 on 5p15.33 and rs1948, rs660652, rs8040868 and rs2036527 on 15q25.1, previously identified as lung cancer risk or nicotine-addiction modifiers, were associated with tumor DNA methylation levels in the promoters of TERT and CHRNB4 (P<0.001), respectively, in two independent sample sets (n=82; n=150).0.1554182652013NA1578559273GA
rs20579187096422073ERCC5umls:C0242379BeFreeAmong African Americans, His/His genotype of ERCC5 His1104Asp (rs17655) was associated with increased lung cancer risk (OR = 1.78; 95% CI: 1.09-2.91), and LIG1 haplotype GGGAA (rs20581, rs156641, rs3730931, rs20579 and rs439132) was associated with reduced lung cancer risk (OR = 0.61; 95% CI: 0.42-0.88).0.0300330352008LIG11948165573GC,A
rs20579180590211421CRYGDumls:C0242379BeFreeFor lung cancer, when compared to the most common haplotype (rs20581-rs20580-rs20579-rs439132 = T-C-C-A), the adjusted odds ratio (OR) is 1.2 (95% confidence limits (CL) = 0.95, 1.5) for the CACA haplotype, 1.4 (1.0, 1.9) for the CATA haplotype and 1.8 (1.1, 2.8) for the CCCG haplotype, after controlling for age, gender, race/ethnicity, education and tobacco smoking.0.0008143262008LIG11948165573GC,A
rs205791870964226018LRIG1umls:C0242379BeFreeAmong African Americans, His/His genotype of ERCC5 His1104Asp (rs17655) was associated with increased lung cancer risk (OR = 1.78; 95% CI: 1.09-2.91), and LIG1 haplotype GGGAA (rs20581, rs156641, rs3730931, rs20579 and rs439132) was associated with reduced lung cancer risk (OR = 0.61; 95% CI: 0.42-0.88).0.0010857672008LIG11948165573GC,A
rs20580180590211421CRYGDumls:C0242379BeFreeFor lung cancer, when compared to the most common haplotype (rs20581-rs20580-rs20579-rs439132 = T-C-C-A), the adjusted odds ratio (OR) is 1.2 (95% confidence limits (CL) = 0.95, 1.5) for the CACA haplotype, 1.4 (1.0, 1.9) for the CATA haplotype and 1.8 (1.1, 2.8) for the CCCG haplotype, after controlling for age, gender, race/ethnicity, education and tobacco smoking.0.0008143262008LIG11948151296GT
rs205811870964226018LRIG1umls:C0242379BeFreeAmong African Americans, His/His genotype of ERCC5 His1104Asp (rs17655) was associated with increased lung cancer risk (OR = 1.78; 95% CI: 1.09-2.91), and LIG1 haplotype GGGAA (rs20581, rs156641, rs3730931, rs20579 and rs439132) was associated with reduced lung cancer risk (OR = 0.61; 95% CI: 0.42-0.88).0.0010857672008LIG11948119170AG
rs20581187096422068ERCC2umls:C0242379BeFreeFrom MDR analysis, in Latinos, smoking and 3 SNPs (ERCC2 rs171140, ERCC5 rs17655 and LIG1 rs20581) together had a prediction accuracy of 67.4% (p = 0.001) for lung cancer.0.2138435352008LIG11948119170AG
rs20581180590211421CRYGDumls:C0242379BeFreeFor lung cancer, when compared to the most common haplotype (rs20581-rs20580-rs20579-rs439132 = T-C-C-A), the adjusted odds ratio (OR) is 1.2 (95% confidence limits (CL) = 0.95, 1.5) for the CACA haplotype, 1.4 (1.0, 1.9) for the CATA haplotype and 1.8 (1.1, 2.8) for the CCCG haplotype, after controlling for age, gender, race/ethnicity, education and tobacco smoking.0.0008143262008LIG11948119170AG
rs20581187096422073ERCC5umls:C0242379BeFreeAmong African Americans, His/His genotype of ERCC5 His1104Asp (rs17655) was associated with increased lung cancer risk (OR = 1.78; 95% CI: 1.09-2.91), and LIG1 haplotype GGGAA (rs20581, rs156641, rs3730931, rs20579 and rs439132) was associated with reduced lung cancer risk (OR = 0.61; 95% CI: 0.42-0.88).0.0300330352008LIG11948119170AG
rs207060026011358101669765LINC00914umls:C0242379BeFreeThe polymorphism of rs2070600 in the RAGE gene may increase the susceptibility to several human cancers, especially to lung cancer and to Asians.0.0005428842015AGER632183666CT
rs2071203158315297869SEMA3Bumls:C0242379BeFreeThe race associated allele of Semaphorin 3B (SEMA3B) T415I and its role in lung cancer in African-Americans and Latino-Americans.0.0039956832005SEMA3B350274469CT
rs20734982487077911186RASSF1umls:C0242379BeFreeThis meta-analysis suggests, for the first time, that RASSF1A Ala133Ser polymorphism may contribute to cancer susceptibility, especially for lung cancer.0.0209446312015RASSF1350332115CA
rs20734981612530111186RASSF1umls:C0242379BeFreeThese results suggest that the RASSF1 Ala133Ser SNP is associated with development of lung cancer, especially of lung adenocarcinoma.0.0209446312006RASSF1350332115CA
rs207553321292647944TNFSF8umls:C0242379BeFreeAssociation of a novel functional promoter variant (rs2075533 C>T) in the apoptosis gene TNFSF8 with risk of lung cancer--a finding from Texas lung cancer genome-wide association study.0.0002714422011TNFSF89114931351GA
rs2075786192857507014TERF2umls:C0242379BeFreePOT1 rs10244817, TERT rs2075786, and TERF2 rs251796 were significantly associated with lung cancer (p(trend)< or =0.05).0.0050055062009TERT51266195AG
rs2075786192857507015TERTumls:C0242379BeFreePOT1 rs10244817, TERT rs2075786, and TERF2 rs251796 were significantly associated with lung cancer (p(trend)< or =0.05).0.1554182652009TERT51266195AG
rs2180314172596544524MTHFRumls:C0242379BeFreeHeterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.0.056765162007GSTA2652752933CG
rs2180314172596541548CYP2A6umls:C0242379BeFreeHeterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.0.0333662822007GSTA2652752933CG
rs2180314172596549NAT1umls:C0242379BeFreeHeterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.0.0116396632007GSTA2652752933CG
rs2180314172596542939GSTA2umls:C0242379BeFreeHeterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.0.0050055062007GSTA2652752933CG
rs2180314172596542947GSTM3umls:C0242379BeFreeHeterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.0.0158308432007GSTA2652752933CG
rs2180314172596545243ABCB1umls:C0242379BeFreeHeterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.0.0410102622007GSTA2652752933CG
rs222731020661084840CASP7umls:C0242379BeFreeIn individual polymorphism analysis, the CASP7 rs2227310C>G and CASP9 rs4645981C>T were associated with 1.40-fold and 1.28-fold increased risk of lung cancer under recessive and dominant models for the variant allele of each polymorphism, respectively.0.0079154222010CASP710113729393CG
rs222731023315881840CASP7umls:C0242379BeFreeHowever, we found that homozygote (G/G) of rs2227310 in the CASP-7 gene, del allele, heterozygote (ins/del), and del carrier (ins/del + del/del) of rs3834129 in CASP-8 could be protective factors for lung cancer (OR = 0.17, 95%CI = 0.14-0.21, P = 0.0003; OR = 0.83, 95%CI = 0.72-0.97, P = 0.02; OR = 0.74, 95%CI = 0.64-0.85, P < 0.0001; OR = 0.81, 95%CI = 0.71-0.93, P = 0.002; respectively).0.0079154222014CASP710113729393CG
rs222731023315881841CASP8umls:C0242379BeFreeHowever, we found that homozygote (G/G) of rs2227310 in the CASP-7 gene, del allele, heterozygote (ins/del), and del carrier (ins/del + del/del) of rs3834129 in CASP-8 could be protective factors for lung cancer (OR = 0.17, 95%CI = 0.14-0.21, P = 0.0003; OR = 0.83, 95%CI = 0.72-0.97, P = 0.02; OR = 0.74, 95%CI = 0.64-0.85, P < 0.0001; OR = 0.81, 95%CI = 0.71-0.93, P = 0.002; respectively).0.0142781372014CASP710113729393CG
rs222731020661084842CASP9umls:C0242379BeFreeIn individual polymorphism analysis, the CASP7 rs2227310C>G and CASP9 rs4645981C>T were associated with 1.40-fold and 1.28-fold increased risk of lung cancer under recessive and dominant models for the variant allele of each polymorphism, respectively.0.0140066952010CASP710113729393CG
rs2228000217394807508XPCumls:C0242379BeFreeFurthermore, a significant effect of SNPs in nucleotide excision repair pathway on lung cancer survival was observed among 185 stages III-IV patients treated with platinum-based chemotherapy without surgical operation: XPC rs2228000 (Ala499Val; P = 0.002) and ERCC1 rs11615 (Asn118Asn; P = 0.012).0.0443111722012XPC314158387GA
rs2228000217394802067ERCC1umls:C0242379BeFreeFurthermore, a significant effect of SNPs in nucleotide excision repair pathway on lung cancer survival was observed among 185 stages III-IV patients treated with platinum-based chemotherapy without surgical operation: XPC rs2228000 (Ala499Val; P = 0.002) and ERCC1 rs11615 (Asn118Asn; P = 0.012).0.0670476142012XPC314158387GA
rs2228001253006877515XRCC1umls:C0242379BeFreeIn the present study, we investigated the polymorphisms of the following selected members of the base and nucleotide excision repair genes: XPC (Lys939Gln), XPD (Lys751Gln), XRCC1(Arg399Gln), and hOGG1(Ser326Ser), and the risk they present toward the development of lung cancer, with emphasis on the effect of chromium exposure.0.0998152572015XPC314145949GT
rs2228001253006874968OGG1umls:C0242379BeFreeIn the present study, we investigated the polymorphisms of the following selected members of the base and nucleotide excision repair genes: XPC (Lys939Gln), XPD (Lys751Gln), XRCC1(Arg399Gln), and hOGG1(Ser326Ser), and the risk they present toward the development of lung cancer, with emphasis on the effect of chromium exposure.0.0722050092015XPC314145949GT
rs2229388228782804481MSR1umls:C0242379BeFreeThe relationship of three potentially functional polymorphisms (T-365C, T+25C, and Ala275Pro) in the SR-A gene with lung cancer risk was evaluated in 1287 lung cancer case subjects and 1261 control subjects from the Chinese population.0.0029099162012MSR1816155139GC,A
rs2231142191079369429ABCG2umls:C0242379BeFreeIn conclusion, this study prioritizes ABCC3 C-211T and ABCG2 C421A as candidate transporter SNPs to be further investigated as possible predictors of the clinical outcome of chemotherapy in lung cancer patients.0.0117156082009ABCG2488131171GT
rs2234922182586092052EPHX1umls:C0242379BeFreeHowever, only four of the previously reported associations with polymorphisms in the GSTP1 (Ala14Val), SOD2 (Val16Ala), EPHX1 (His139Arg) genes and the NAT1 fast acetylator phenotype remained significantly associated with lung cancer.0.0660377912008EPHX11225838705AG,T
rs223492218258609145389SLC38A6umls:C0242379BeFreeHowever, only four of the previously reported associations with polymorphisms in the GSTP1 (Ala14Val), SOD2 (Val16Ala), EPHX1 (His139Arg) genes and the NAT1 fast acetylator phenotype remained significantly associated with lung cancer.0.0019000932008EPHX11225838705AG,T
rs2234922182586091982EIF4G2umls:C0242379BeFreeHowever, only four of the previously reported associations with polymorphisms in the GSTP1 (Ala14Val), SOD2 (Val16Ala), EPHX1 (His139Arg) genes and the NAT1 fast acetylator phenotype remained significantly associated with lung cancer.0.0019000932008EPHX11225838705AG,T
rs22349221825860910991SLC38A3umls:C0242379BeFreeHowever, only four of the previously reported associations with polymorphisms in the GSTP1 (Ala14Val), SOD2 (Val16Ala), EPHX1 (His139Arg) genes and the NAT1 fast acetylator phenotype remained significantly associated with lung cancer.0.0019000932008EPHX11225838705AG,T
rs2234922182586096530SLC6A2umls:C0242379BeFreeHowever, only four of the previously reported associations with polymorphisms in the GSTP1 (Ala14Val), SOD2 (Val16Ala), EPHX1 (His139Arg) genes and the NAT1 fast acetylator phenotype remained significantly associated with lung cancer.0.0021715352008EPHX11225838705AG,T
rs2234922182586099NAT1umls:C0242379BeFreeHowever, only four of the previously reported associations with polymorphisms in the GSTP1 (Ala14Val), SOD2 (Val16Ala), EPHX1 (His139Arg) genes and the NAT1 fast acetylator phenotype remained significantly associated with lung cancer.0.0116396632008EPHX11225838705AG,T
rs2234922182586092950GSTP1umls:C0242379BeFreeHowever, only four of the previously reported associations with polymorphisms in the GSTP1 (Ala14Val), SOD2 (Val16Ala), EPHX1 (His139Arg) genes and the NAT1 fast acetylator phenotype remained significantly associated with lung cancer.0.0924863262008EPHX11225838705AG,T
rs2234922182586096648SOD2umls:C0242379BeFreeHowever, only four of the previously reported associations with polymorphisms in the GSTP1 (Ala14Val), SOD2 (Val16Ala), EPHX1 (His139Arg) genes and the NAT1 fast acetylator phenotype remained significantly associated with lung cancer.0.0219221162008EPHX11225838705AG,T
rs2240308250915768313AXIN2umls:C0242379BeFreeThe Axin2 rs2240308 polymorphism and susceptibility to lung cancer in a Chinese population.0.0031813582014AXIN21765558473GA
rs2273535251545116790AURKAumls:C0242379BeFreeIn summary, this meta-analysis suggests that STK15 F31I polymorphism is associated with increased breast cancer and ovarian cancer risk among Caucasians, F31I polymorphism is associated with decreased lung cancer risk among Caucasians, and V57I polymorphism is associated with decreased breast cancer risk among Caucasians.0.0087297472014AURKA2056386485AT
rs227353517908995595CCND1umls:C0242379BeFreeCompared with homozygous wild-types, the homozygous variant genotypes of STK15 F31I and CCND1 G870A were associated with a significantly altered lung cancer risk with ORs of 0.58 (95% CI, 0.37-0.90) and 1.26 (95% CI, 1.03-1.53), respectively.0.0240500442007AURKA2056386485AT
rs2273535179089956790AURKAumls:C0242379BeFreeCompared with homozygous wild-types, the homozygous variant genotypes of STK15 F31I and CCND1 G870A were associated with a significantly altered lung cancer risk with ORs of 0.58 (95% CI, 0.37-0.90) and 1.26 (95% CI, 1.03-1.53), respectively.0.0087297472007AURKA2056386485AT
rs2273953197891907161TP73umls:C0242379GAD[When numeric scores were assigned to both the SNP and demographic data, and sequentially combined by a simple algorithm in a risk model, the composite score was found to be linearly related to lung cancer risk with a bimodal distribution.]0.0232793262009TP7313682336GT,A
rs2276109163112444321MMP12umls:C0242379BeFreeWe investigated the associations between polymorphisms of MMP-1 (-1607 1G/2G, rs1799750), MMP-3 (-1171 5A/6A, rs3025058), and MMP-12 (-82AG, rs2276109, and 1082A/G, rs652438) and the risk of lung cancer in 2014 Caucasian lung cancer patients and 1323 healthy controls.0.0090011892006MMP1211102875061TC
rs2276109163112444314MMP3umls:C0242379BeFreeWe investigated the associations between polymorphisms of MMP-1 (-1607 1G/2G, rs1799750), MMP-3 (-1171 5A/6A, rs3025058), and MMP-12 (-82AG, rs2276109, and 1082A/G, rs652438) and the risk of lung cancer in 2014 Caucasian lung cancer patients and 1323 healthy controls.0.0155594012006MMP1211102875061TC
rs227911519789190596BCL2umls:C0242379GAD[When numeric scores were assigned to both the SNP and demographic data, and sequentially combined by a simple algorithm in a risk model, the composite score was found to be linearly related to lung cancer risk with a bimodal distribution.]0.0183061582009BCL21863319604GT
rs229283225077922406941MIR149umls:C0242379BeFreeNo clear consensus has been reached on the four single nucleotide polymorphisms (miR-196a2 gene rs11614913, miR-146a gene rs2910164, miR-149 gene rs2292832, and miR-499 gene rs3746444) in microRNA-coding genes and lung cancer risk.0.0008143262014GPC1;MIR149;PP145712240456086TC
rs229283225077922574501MIR499Aumls:C0242379BeFreeNo clear consensus has been reached on the four single nucleotide polymorphisms (miR-196a2 gene rs11614913, miR-146a gene rs2910164, miR-149 gene rs2292832, and miR-499 gene rs3746444) in microRNA-coding genes and lung cancer risk.0.0008143262014GPC1;MIR149;PP145712240456086TC
rs2298881241404602067ERCC1umls:C0242379BeFreeMDR (multifactor dimensionality reduction) analysis demonstrated the best significant model of two-attributes containing smoking duration and rs2298881 in ERCC1 (P=0.004-0.005) and suggested that the effects of high-order interactions among smoking duration and ERCC2, PPP1R13, ERCC1 htSNPs could modulate lung cancer risk.0.0670476142013ERCC11945423658CA
rs2298881241404602068ERCC2umls:C0242379BeFreeMDR (multifactor dimensionality reduction) analysis demonstrated the best significant model of two-attributes containing smoking duration and rs2298881 in ERCC1 (P=0.004-0.005) and suggested that the effects of high-order interactions among smoking duration and ERCC2, PPP1R13, ERCC1 htSNPs could modulate lung cancer risk.0.2138435352013ERCC11945423658CA
rs2303425252529094436MSH2umls:C0242379BeFreeIn the present case-control study, we investigated the promoter polymorphisms of selected mismatch repair genes: hMLH1 (rs1800734) and hMSH2 (rs2303425), and the risk they present regarding the development of lung cancer in the Slovak population.0.0140066952015MSH2247403074TC
rs2303425252529094292MLH1umls:C0242379BeFreeIn the present case-control study, we investigated the promoter polymorphisms of selected mismatch repair genes: hMLH1 (rs1800734) and hMSH2 (rs2303425), and the risk they present regarding the development of lung cancer in the Slovak population.0.0190122012015MSH2247403074TC
rs23060221978919022801ITGA11umls:C0242379GAD[When numeric scores were assigned to both the SNP and demographic data, and sequentially combined by a simple algorithm in a risk model, the composite score was found to be linearly related to lung cancer risk with a bimodal distribution.]0.0047340642009ITGA111568335825CT
rs230832717957803442459XRCC6P5umls:C0242379BeFreeThe association between lung cancer risk and 2 polymorphisms, rs12268840 and rs2308327 (codon K178R), in the DNA repair protein, O(6)-alkylguanine-DNA alkyltransferase, which are associated with interindividual differences in activity, have been investigated in 3 hospital-based case-control studies.0.0005428842008MGMT;LOC10537855910129766906AG
rs2317676197891903690ITGB3umls:C0242379GAD[When numeric scores were assigned to both the SNP and demographic data, and sequentially combined by a simple algorithm in a risk model, the composite score was found to be linearly related to lung cancer risk with a bimodal distribution.]0.0052769482009ITGB3;LOC1027245081747310917AG
rs2333227241392384353MPOumls:C0242379BeFreeWe evaluated the role of tumor necrosis factor α (TNFA) rs1799724, interleukin 1β (IL1B) rs16944, IL6 rs1800796, myeloperoxidase (MPO) rs2333227 and C-reactive protein (CRP) rs2794520 in a case-control study comprised of 462 lung cancer cases and 379 controls in a Japanese population.0.0778729512013MPO1758281401CT
rs23470920600216102724560LOC102724560umls:C0242379BeFreeAlthough the study size was too small for a definitive conclusion, there was an indication that lung cancer risks might be highest in those with a high %MMA who also carried cystathionine beta-synthase (CBS) rs234709 and rs4920037 variant alleles.0.0005428842010CBS2143066854CT
rs2352028222361852262GPC5umls:C0242379BeFreeGPC5 rs2352028 polymorphism and risk of lung cancer in Han Chinese.0.0058198312012GPC51391792975CT
rs2352028206882702262GPC5umls:C0242379GAD[GPC5 rs2352028 variant and risk of lung cancer in never smokers.]0.0058198312010GPC51391792975CT
rs238406187096421081CGAumls:C0242379BeFreeAmong Latinos, ERCC2 haplotype CGA (rs238406, rs11878644, rs6966) was associated with reduced lung cancer risk [odds ratio (OR) of 0.65 and 95% confidence interval (CI): 0.44-0.97], especially among nonsmokers (OR = 0.29; 95% CI: 0.12-0.67).0.0026384742008ERCC21945365051TG
rs2384152414046010848PPP1R13Lumls:C0242379BeFreeThe haplotype ERCC2 rs3916874(G) and rs238415(C) [OR (95% CI)=1.26 (1.02-1.57), P=0.03] in block 1 and the haplotype PPP1R13L rs4803817(A), CD3EAP rs1046282(T), rs735482(C), ERCC1 rs3212980(A), rs3212964(G) [OR (95% CI)=3.56 (1.55-8.18), P=0.005] in block 3 were associated with lung cancer risk.0.0071770412013ERCC21945353977CG
rs2440915217755331613DAPK3umls:C0242379BeFreeKnockdown of DAPK3 and METTL6, for which expression levels were correlated with the rs11169748 and rs2440915 SNPs, significantly decreased cisplatin sensitivity in lung cancer cells.0.0002714422011NA1059914014GA
rs244091521775533131965METTL6umls:C0242379BeFreeKnockdown of DAPK3 and METTL6, for which expression levels were correlated with the rs11169748 and rs2440915 SNPs, significantly decreased cisplatin sensitivity in lung cancer cells.0.0002714422011NA1059914014GA
rs251796192857507015TERTumls:C0242379BeFreePOT1 rs10244817, TERT rs2075786, and TERF2 rs251796 were significantly associated with lung cancer (p(trend)< or =0.05).0.1554182652009TERF21669361531AG
rs251796192857507014TERF2umls:C0242379BeFreePOT1 rs10244817, TERT rs2075786, and TERF2 rs251796 were significantly associated with lung cancer (p(trend)< or =0.05).0.0050055062009TERF21669361531AG
rs2522137247879494440MSI1umls:C0242379BeFreeCancer stem cell marker Musashi-1 rs2522137 genotype is associated with an increased risk of lung cancer.0.0005428842014MSI112120342128TG
rs25487241758137515XRCC1umls:C0242379BeFreeThe codon 399 Arg/Gln XRCC1 polymorphism is associated with lung cancer in Indians.0.0998152572014XRCC11943551574TC
rs2548717531525328APEX1umls:C0242379BeFreeIn conclusion, the APE1 Asp148Glu polymorphism is highly predictive for lung cancer, and cumulative cigarette smoking modifies the associations between the XRCC1 Arg399Gln and the XPD Lys751Gln polymorphisms and lung cancer risk.0.0489256842007XRCC11943551574TC
rs25487175049867515XRCC1umls:C0242379BeFreeProspective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer.0.0998152572007XRCC11943551574TC
rs25487179524687515XRCC1umls:C0242379BeFreeThese findings suggest that genetic polymorphisms in the DNA repair genes may modulate overall lung cancer susceptibility and that pathological stage and XRCC1 Arg399Gln independently predicted overall survival among Indian lung cancer patients.0.0998152572008XRCC11943551574TC
rs25487253006874968OGG1umls:C0242379BeFreeIn the present study, we investigated the polymorphisms of the following selected members of the base and nucleotide excision repair genes: XPC (Lys939Gln), XPD (Lys751Gln), XRCC1(Arg399Gln), and hOGG1(Ser326Ser), and the risk they present toward the development of lung cancer, with emphasis on the effect of chromium exposure.0.0722050092015XRCC11943551574TC
rs25487217394807515XRCC1umls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0998152572012XRCC11943551574TC
rs2548721739480472ATMumls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0211837362012XRCC11943551574TC
rs25487230230284968OGG1umls:C0242379BeFreeFor example, there was a positive association between the OGG1 Ser326Cys variant and gastric and lung cancer, while the XRCC1 Arg399Gln variant was associated with reduced cancer risk.0.0722050092012XRCC11943551574TC
rs25487217394805378PMS1umls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0026384742012XRCC11943551574TC
rs2548715044328328APEX1umls:C0242379BeFreeThese results suggest that APE1 Asp148Glu and XRCC1 Arg399Gln polymorphisms might modify the risk of lung cancer attributable to cigarette smoking exposure.0.0489256842004XRCC11943551574TC
rs25487256844777515XRCC1umls:C0242379BeFreeUpdated assessment of the association of the XRCC1 Arg399Gln polymorphism with lung cancer risk in the Chinese population.0.0998152572015XRCC11943551574TC
rs25487169821137515XRCC1umls:C0242379BeFreeThe 399Gln/Gln genotype of the XRCC1 Arg399Gln polymorphism was associated with an increased risk of lung cancer among Asians (OR=1.34, 95% CI=1.16-1.54) but not among Caucasians.0.0998152572006XRCC11943551574TC
rs25487177058147508XPCumls:C0242379BeFreeWe investigated the relationship between polymorphisms in two NER genes, XPC (poly (AT) insertion/deletion: PAT-/+) and XPD (Asp312Asn and Lys751Gln), the BER gene XRCC1 (Arg399Gln), and the DSBR gene XRCC3 (Thr241Met) and the risk of developing lung cancer.0.0443111722007XRCC11943551574TC
rs25487253006877515XRCC1umls:C0242379BeFreeIn the present study, we investigated the polymorphisms of the following selected members of the base and nucleotide excision repair genes: XPC (Lys939Gln), XPD (Lys751Gln), XRCC1(Arg399Gln), and hOGG1(Ser326Ser), and the risk they present toward the development of lung cancer, with emphasis on the effect of chromium exposure.0.0998152572015XRCC11943551574TC
rs25487225255587517XRCC3umls:C0242379BeFreeCYP1A1 rs4646903 (OR = 1.72, 95% CI = 1.25-2.38), rs1048943 (OR = 1.40, 95% CI = 1.02-1.92), the GSTM1 deletion polymorphism (OR = 1.38, 95% CI = 1.01-1.89), GSTP1 rs1695 (OR =1.48, 95% CI = 1.04-2.11), ERCC2 rs13181 (OR = 1.89, 95% CI = 1.28-2.78), and Chinese hamster 1 rs25487 (OR = 1.54, 95% CI = 1.12-2.13) were associated with lung cancer risk whereas the GSTT1 deletion polymorphism and XRCC3 rs861539 were not.0.0443871172012XRCC11943551574TC
rs25487217394802068ERCC2umls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.2138435352012XRCC11943551574TC
rs25487217394808930MBD4umls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0102824542012XRCC11943551574TC
rs25487230230287515XRCC1umls:C0242379BeFreeFor example, there was a positive association between the OGG1 Ser326Cys variant and gastric and lung cancer, while the XRCC1 Arg399Gln variant was associated with reduced cancer risk.0.0998152572012XRCC11943551574TC
rs25487175315257515XRCC1umls:C0242379BeFreeIn conclusion, the APE1 Asp148Glu polymorphism is highly predictive for lung cancer, and cumulative cigarette smoking modifies the associations between the XRCC1 Arg399Gln and the XPD Lys751Gln polymorphisms and lung cancer risk.0.0998152572007XRCC11943551574TC
rs25487225255582950GSTP1umls:C0242379BeFreeCYP1A1 rs4646903 (OR = 1.72, 95% CI = 1.25-2.38), rs1048943 (OR = 1.40, 95% CI = 1.02-1.92), the GSTM1 deletion polymorphism (OR = 1.38, 95% CI = 1.01-1.89), GSTP1 rs1695 (OR =1.48, 95% CI = 1.04-2.11), ERCC2 rs13181 (OR = 1.89, 95% CI = 1.28-2.78), and Chinese hamster 1 rs25487 (OR = 1.54, 95% CI = 1.12-2.13) were associated with lung cancer risk whereas the GSTT1 deletion polymorphism and XRCC3 rs861539 were not.0.0924863262012XRCC11943551574TC
rs25487175315252068ERCC2umls:C0242379BeFreeIn conclusion, the APE1 Asp148Glu polymorphism is highly predictive for lung cancer, and cumulative cigarette smoking modifies the associations between the XRCC1 Arg399Gln and the XPD Lys751Gln polymorphisms and lung cancer risk.0.2138435352007XRCC11943551574TC
rs25487238846047515XRCC1umls:C0242379BeFreeAssessment of the association between XRCC1 Arg399Gln polymorphism and lung cancer in Chinese.0.0998152572013XRCC11943551574TC
rs25487217394804361MRE11Aumls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0002714422012XRCC11943551574TC
rs25487174179477515XRCC1umls:C0242379BeFreeContrasting impact of DNA repair gene XRCC1 polymorphisms Arg399Gln and Arg194Trp on the risk of lung cancer in the north-Indian population.0.0998152572007XRCC11943551574TC
rs25487175049862068ERCC2umls:C0242379BeFreeProspective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer.0.2138435352007XRCC11943551574TC
rs25487225255582952GSTT1umls:C0242379BeFreeCYP1A1 rs4646903 (OR = 1.72, 95% CI = 1.25-2.38), rs1048943 (OR = 1.40, 95% CI = 1.02-1.92), the GSTM1 deletion polymorphism (OR = 1.38, 95% CI = 1.01-1.89), GSTP1 rs1695 (OR =1.48, 95% CI = 1.04-2.11), ERCC2 rs13181 (OR = 1.89, 95% CI = 1.28-2.78), and Chinese hamster 1 rs25487 (OR = 1.54, 95% CI = 1.12-2.13) were associated with lung cancer risk whereas the GSTT1 deletion polymorphism and XRCC3 rs861539 were not.0.100358142012XRCC11943551574TC
rs25487155879887515XRCC1umls:C0242379BeFreeNo associations were found between the polymorphisms OGG1 Ser326Cys, XRCC1 Arg280His, and XRCCI Arg399Gln and risk of lung cancer.0.0998152572004XRCC11943551574TC
rs25487150443287515XRCC1umls:C0242379BeFreeThese results suggest that APE1 Asp148Glu and XRCC1 Arg399Gln polymorphisms might modify the risk of lung cancer attributable to cigarette smoking exposure.0.0998152572004XRCC11943551574TC
rs25489155879887515XRCC1umls:C0242379BeFreeNo associations were found between the polymorphisms OGG1 Ser326Cys, XRCC1 Arg280His, and XRCCI Arg399Gln and risk of lung cancer.0.0998152572004XRCC11943552260CT,G
rs25489175315254968OGG1umls:C0242379BeFreeBoth the XRCC1 Arg194Trp and Arg280His as well as the OGG1 Ser326Cys heterozygous genotypes were associated with a significantly reduced risk for lung cancer (OR=0.32, p=0.024; OR=0.25, p=0.028; OR=0.51, p=0.033, respectively).0.0722050092007XRCC11943552260CT,G
rs2606345194790631543CYP1A1umls:C0242379BeFreeMoreover, the association between CYP1A1 rs2606345 genotype and lung cancer was significantly modified by intensity of cigarette smoking, suggesting an underlying dose-response mechanism.0.1237021412009CYP1A11574724835CA
rs2736098242600997015TERTumls:C0242379BeFreeA common genetic variant, telomerase reverse transcriptase (TERT) rs2736098, was recently reported to be associated with lung cancer risk in Caucasians.0.1554182652013TERT51293971CT
rs2736100217253087015TERTumls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.1554182652011TERT51286401CA
rs2736100255164427015TERTumls:C0242379BeFreeWe then found that GRSs used as instrumental variables to predict longer telomere length were associated with increased lung cancer risk (OR = 1.51 (95% CI = 1.34-1.69) for upper vs. lower quartile of the weighted GRS, p value = 4.54 × 10(-14) ) even after removing rs2736100 (p value = 4.81 × 10(-3) ), a SNP in the TERT locus robustly associated with lung cancer risk in prior association studies.0.1554182652014TERT51286401CA
rs2736100233682787015TERTumls:C0242379BeFreeAfter the 2nd stage validation (975 cases versus 1022 controls), the study clarified the association that rs2736100 of the TERT gene conferred the highest significant risk of lung cancer (P=4×10(-3) in the 1st stage association, P=4×10(-4) in the 2nd stage validation, and P=1×10(-5), odds ratio=1.24 in the combined population).0.1554182652013TERT51286401CA
rs2736100217253087015TERTumls:C0242379GWASCATThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.1554182652011TERT51286401CA
rs2736100235556367015TERTumls:C0242379BeFreeLonger telomere length in peripheral white blood cells is associated with risk of lung cancer and the rs2736100 (CLPTM1L-TERT) polymorphism in a prospective cohort study among women in China.0.1554182652013TERT51286401CA
rs2736100242835847015TERTumls:C0242379BeFreeTERT genetic polymorphism rs2736100 was associated with lung cancer: a meta-analysis based on 14,492 subjects.0.1554182652014TERT51286401CA
rs2736100233705452053EPHX2umls:C0242379BeFreeWe identified one novel variant at the level corrected for multiple comparisons (rs2741354 in EPHX2 at 8q21.1 with p value = 7.4 × 10(-6)), and confirmed the associations between TERT (rs2736100) and the HLA region and lung cancer risk.0.0026384742013TERT51286401CA
rs2736100245357787015TERTumls:C0242379BeFreeTERT rs2736100 polymorphism contributes to lung cancer risk: a meta-analysis including 49,869 cases and 73,464 controls.0.1554182652014TERT51286401CA
rs2736100217253084285MIPEPumls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.0002714422011TERT51286401CA
rs2736100250375747015TERTumls:C0242379BeFreeTERT polymorphism (rs2736100) might be a genetic susceptibility factor for lung cancer in non-smoking females in China.0.1554182652014TERT51286401CA
rs27361002172530881037CLPTM1Lumls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.1428883322011TERT51286401CA
rs2736100217253083976LIFumls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.0002714422011TERT51286401CA
rs2736100217253088897MTMR3umls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.1205428842011TERT51286401CA
rs2736100231436017015TERTumls:C0242379GWASCATGenome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia.0.1554182652012TERT51286401CA
rs2736100217253088626TP63umls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.1253528932011TERT51286401CA
rs27361002355563681037CLPTM1Lumls:C0242379BeFreeLonger telomere length in peripheral white blood cells is associated with risk of lung cancer and the rs2736100 (CLPTM1L-TERT) polymorphism in a prospective cohort study among women in China.0.1428883322013TERT51286401CA
rs273610021725308150280HORMAD2umls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.0005428842011TERT51286401CA
rs27361002172530855504TNFRSF19umls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.0002714422011TERT51286401CA
rs2736100233705457015TERTumls:C0242379BeFreeWe identified one novel variant at the level corrected for multiple comparisons (rs2741354 in EPHX2 at 8q21.1 with p value = 7.4 × 10(-6)), and confirmed the associations between TERT (rs2736100) and the HLA region and lung cancer risk.0.1554182652013TERT51286401CA
rs2736100243906167015TERTumls:C0242379BeFreeAssociation between TERT rs2736100 polymorphism and lung cancer susceptibility: evidence from 22 case-control studies.0.1554182652013TERT51286401CA
rs2736100245902687015TERTumls:C0242379BeFreeIncreased lung cancer risk associated with the TERT rs2736100 polymorphism: an updated meta-analysis.0.1554182652014TERT51286401CA
rs2736100200613637015TERTumls:C0242379BeFreeDQA1*03 and the minor allele for a polymorphism, rs2736100, in TERT, another lung cancer susceptibility locus identified in recent GWASs on Europeans and Americans, were indicated to independently contribute to ADC risk with per allele OR of 1.43 (95% CI = 1.31-1.56, P = 7.8 x 10(-16)).0.1554182652010TERT51286401CA
rs2741354233705457015TERTumls:C0242379BeFreeWe identified one novel variant at the level corrected for multiple comparisons (rs2741354 in EPHX2 at 8q21.1 with p value = 7.4 × 10(-6)), and confirmed the associations between TERT (rs2736100) and the HLA region and lung cancer risk.0.1554182652013NA827557959CT
rs2741354233705452053EPHX2umls:C0242379BeFreeWe identified one novel variant at the level corrected for multiple comparisons (rs2741354 in EPHX2 at 8q21.1 with p value = 7.4 × 10(-6)), and confirmed the associations between TERT (rs2736100) and the HLA region and lung cancer risk.0.0026384742013NA827557959CT
rs2794520241392384353MPOumls:C0242379BeFreeWe evaluated the role of tumor necrosis factor α (TNFA) rs1799724, interleukin 1β (IL1B) rs16944, IL6 rs1800796, myeloperoxidase (MPO) rs2333227 and C-reactive protein (CRP) rs2794520 in a case-control study comprised of 462 lung cancer cases and 379 controls in a Japanese population.0.0778729512013NA1159709026CT
rs279452024139238140913PPIAP10umls:C0242379BeFreeCRP rs2794520 (OR=1.64, 95% CI=1.19-2.26) and IL6 rs1800796 (OR=1.41, 95% CI=1.02-1.96) were associated with lung cancer risk.0.0008143262013NA1159709026CT
rs2794520241392383569IL6umls:C0242379BeFreeCRP rs2794520 (OR=1.64, 95% CI=1.19-2.26) and IL6 rs1800796 (OR=1.41, 95% CI=1.02-1.96) were associated with lung cancer risk.0.0403478262013NA1159709026CT
rs2808630183856761401CRPumls:C0242379GAD[Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.]0.0090011892008NA1159711078CT
rs283526724976539873CBR1umls:C0242379BeFreeOne SNP in CBR1 (rs2835267) was significantly associated with overall risk of lung cancer, but did not pass multiple testing adjustment (OR: 0.76 95% CI: 0.58-0.99, P = 0.048, FDR P = 0.20).0.0034527992014LOC1001332862136074727TC
rs2853676246816047015TERTumls:C0242379BeFreeTwo glioma risk variants, TERT rs2853676 and CDKN2BAS1 rs4977756, which are located in regions previously associated with lung cancer, were associated with increased risk of adenocarcinoma (OR = 1.16; 95% CI = 1.10 to 1.22; P = 1.1×10(-8)) and squamous cell carcinoma (OR = 1.13; CI = 1.07 to 1.19; P = 2.5×10(-5)), respectively.0.1554182652014TERT51288432TC
rs289345761022660256996SLC12A9umls:C0242379BeFreeModulation of wild-type p53 activity by mutant p53 R273H depends on the p53 responsive element (p53RE). A comparative study between the p53REs of the MDM2, WAFI/Cip1 and Bax genes in the lung cancer environment. WAFI/Cip1 = WAF1/Cip1.0.0032573021999TP53177673802CT,A
rs2893457610226602581BAXumls:C0242379BeFreeModulation of wild-type p53 activity by mutant p53 R273H depends on the p53 responsive element (p53RE). A comparative study between the p53REs of the MDM2, WAFI/Cip1 and Bax genes in the lung cancer environment. WAFI/Cip1 = WAF1/Cip1.0.0045385671999TP53177673802CT,A
rs28934576102266027157TP53umls:C0242379BeFreeModulation of wild-type p53 activity by mutant p53 R273H depends on the p53 responsive element (p53RE). A comparative study between the p53REs of the MDM2, WAFI/Cip1 and Bax genes in the lung cancer environment. WAFI/Cip1 = WAF1/Cip1.0.161999TP53177673802CT,A
rs28934576102266021026CDKN1Aumls:C0242379BeFreeModulation of wild-type p53 activity by mutant p53 R273H depends on the p53 responsive element (p53RE). A comparative study between the p53REs of the MDM2, WAFI/Cip1 and Bax genes in the lung cancer environment. WAFI/Cip1 = WAF1/Cip1.0.0109012821999TP53177673802CT,A
rs2895680227977251809DPYSL3umls:C0242379BeFreeWe found genome-wide significant (P < 5.0 × 10(-8)) evidence for three additional lung cancer susceptibility loci at 10p14 (rs1663689, close to GATA3, P = 2.84 × 10(-10)), 5q32 (rs2895680 in PPP2R2B-STK32A-DPYSL3, P = 6.60 × 10(-9)) and 20q13.2 (rs4809957 in CYP24A1, P = 1.20 × 10(-8)).0.0002714422012STK32A5147264552CT
rs2895680227977251591CYP24A1umls:C0242379BeFreeWe found genome-wide significant (P < 5.0 × 10(-8)) evidence for three additional lung cancer susceptibility loci at 10p14 (rs1663689, close to GATA3, P = 2.84 × 10(-10)), 5q32 (rs2895680 in PPP2R2B-STK32A-DPYSL3, P = 6.60 × 10(-9)) and 20q13.2 (rs4809957 in CYP24A1, P = 1.20 × 10(-8)).0.0039956832012STK32A5147264552CT
rs289568022797725202374STK32Aumls:C0242379BeFreeWe found genome-wide significant (P < 5.0 × 10(-8)) evidence for three additional lung cancer susceptibility loci at 10p14 (rs1663689, close to GATA3, P = 2.84 × 10(-10)), 5q32 (rs2895680 in PPP2R2B-STK32A-DPYSL3, P = 6.60 × 10(-9)) and 20q13.2 (rs4809957 in CYP24A1, P = 1.20 × 10(-8)).0.0002714422012STK32A5147264552CT
rs2895680227977255521PPP2R2Bumls:C0242379BeFreeWe found genome-wide significant (P < 5.0 × 10(-8)) evidence for three additional lung cancer susceptibility loci at 10p14 (rs1663689, close to GATA3, P = 2.84 × 10(-10)), 5q32 (rs2895680 in PPP2R2B-STK32A-DPYSL3, P = 6.60 × 10(-9)) and 20q13.2 (rs4809957 in CYP24A1, P = 1.20 × 10(-8)).0.0002714422012STK32A5147264552CT
rs2895680227977252625GATA3umls:C0242379BeFreeWe found genome-wide significant (P < 5.0 × 10(-8)) evidence for three additional lung cancer susceptibility loci at 10p14 (rs1663689, close to GATA3, P = 2.84 × 10(-10)), 5q32 (rs2895680 in PPP2R2B-STK32A-DPYSL3, P = 6.60 × 10(-9)) and 20q13.2 (rs4809957 in CYP24A1, P = 1.20 × 10(-8)).0.0026384742012STK32A5147264552CT
rs291016425077922406941MIR149umls:C0242379BeFreeNo clear consensus has been reached on the four single nucleotide polymorphisms (miR-196a2 gene rs11614913, miR-146a gene rs2910164, miR-149 gene rs2292832, and miR-499 gene rs3746444) in microRNA-coding genes and lung cancer risk.0.0008143262014LOC285628;MIR146A5160485411CG
rs291016425077922406938MIR146Aumls:C0242379BeFreeOur study suggested that the miR-196a2 gene rs11614913 polymorphism and the miR-146a gene rs2910164 polymorphism might associate with lung cancer risk.0.0013572092014LOC285628;MIR146A5160485411CG
rs291016425077922574501MIR499Aumls:C0242379BeFreeNo clear consensus has been reached on the four single nucleotide polymorphisms (miR-196a2 gene rs11614913, miR-146a gene rs2910164, miR-149 gene rs2292832, and miR-499 gene rs3746444) in microRNA-coding genes and lung cancer risk.0.0008143262014LOC285628;MIR146A5160485411CG
rs2924471233726584524MTHFRumls:C0242379BeFreeSNPs in MTRR (rs13162612; OR = 0.25; 95% CI: 0.11-0.58; rs10512948; OR = 0.61; 95% CI: 0.41-0.90; rs2924471; OR = 3.31; 95% CI: 1.66-6.59), and MTHFR (rs9651118; OR = 0.63; 95% CI: 0.43-0.95) and three SNP*nutrient interactions (choline*rs10475407; OR = 1.62; 95% CI: 1.11-2.42; choline*rs11134290; OR = 0.51; 95% CI: 0.27-0.92; and riboflavin*rs8767412; OR = 0.40; 95% CI: 0.15-0.95) were associated with lung cancer risk in never smokers.0.056765162013NA58055148TC
rs2924471233726584552MTRRumls:C0242379BeFreeSNPs in MTRR (rs13162612; OR = 0.25; 95% CI: 0.11-0.58; rs10512948; OR = 0.61; 95% CI: 0.41-0.90; rs2924471; OR = 3.31; 95% CI: 1.66-6.59), and MTHFR (rs9651118; OR = 0.63; 95% CI: 0.43-0.95) and three SNP*nutrient interactions (choline*rs10475407; OR = 1.62; 95% CI: 1.11-2.42; choline*rs11134290; OR = 0.51; 95% CI: 0.27-0.92; and riboflavin*rs8767412; OR = 0.40; 95% CI: 0.15-0.95) were associated with lung cancer risk in never smokers.0.0105538952013NA58055148TC
rs3025058163112444321MMP12umls:C0242379BeFreeWe investigated the associations between polymorphisms of MMP-1 (-1607 1G/2G, rs1799750), MMP-3 (-1171 5A/6A, rs3025058), and MMP-12 (-82AG, rs2276109, and 1082A/G, rs652438) and the risk of lung cancer in 2014 Caucasian lung cancer patients and 1323 healthy controls.0.0090011892006NANANANANA
rs3025058163112444314MMP3umls:C0242379BeFreeWe investigated the associations between polymorphisms of MMP-1 (-1607 1G/2G, rs1799750), MMP-3 (-1171 5A/6A, rs3025058), and MMP-12 (-82AG, rs2276109, and 1082A/G, rs652438) and the risk of lung cancer in 2014 Caucasian lung cancer patients and 1323 healthy controls.0.0155594012006NANANANANA
rs30873861978919051455REV1umls:C0242379GAD[When numeric scores were assigned to both the SNP and demographic data, and sequentially combined by a simple algorithm in a risk model, the composite score was found to be linearly related to lung cancer risk with a bimodal distribution.]0.007643982009REV1299439044AG
rs3117582189787877917BAG6umls:C0242379GAD[Common 5p15.33 and 6p21.33 variants influence lung cancer risk.]0.1326494862008BAG6;APOM631652743TG
rs3117582196543037917BAG6umls:C0242379GAD[Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study.]0.1326494862009BAG6;APOM631652743TG
rs3117582258844937917BAG6umls:C0242379BeFreeWe found also that BAG6 rs3117582 SNP was associated with non small cell lung cancer in the Norwegian subjects and the combined Croatian-Norwegian subjects corroborating the earlier finding that BAG6 rs3117582 SNP was associated with lung cancer in Europeans.0.1326494862015BAG6;APOM631652743TG
rs31175821897878755937APOMumls:C0242379GWASCATCommon 5p15.33 and 6p21.33 variants influence lung cancer risk.0.122008BAG6;APOM631652743TG
rs3117582196543037917BAG6umls:C0242379GWASCATDeciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study.0.1326494862009BAG6;APOM631652743TG
rs31175821965430355937APOMumls:C0242379GWASCATDeciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study.0.122009BAG6;APOM631652743TG
rs3117582189787877917BAG6umls:C0242379GWASCATCommon 5p15.33 and 6p21.33 variants influence lung cancer risk.0.1326494862008BAG6;APOM631652743TG
rs3117582189787874439MSH5umls:C0242379GAD[Common 5p15.33 and 6p21.33 variants influence lung cancer risk.]0.0023670322008BAG6;APOM631652743TG
rs3117582249899257917BAG6umls:C0242379BeFreeBAT3 rs1052486 and rs3117582 polymorphisms are associated with lung cancer risk: a meta-analysis.0.1326494862014BAG6;APOM631652743TG
rs3134615236137714610MYCLumls:C0242379BeFreePolymorphisms of miRNA-196a2 rs11614913 and MYCL1 rs3134615 could be potential biomarkers of lung cancer.0.0105538952013MYCL;LOC105378668139896394CA
rs31489245357801209CLPTM1umls:C0242379BeFreeCleft lip and palate transmembrane protein 1 rs31489 polymorphism is associated with lung cancer risk: a meta-analysis.0.0005428842014CLPTM1L51342599CA
rs314892453578081037CLPTM1Lumls:C0242379BeFreeIn conclusion, this meta-analysis suggested that CLPTM1L rs31489 was a potential biomarker for lung cancer risk in Caucasians.0.1428883322014CLPTM1L51342599CA
rs31845042631909910019SH2B3umls:C0242379BeFreeWe identified three pleiotropic loci within the inflammation pathway, including one novel locus in Ch12q24 encoding SH2B3 (rs3184504), which reached GWAS significance with a P value of 1.78 x 10(-8), and it showed an association with lung cancer (P = 2.01 x 10(-6)), colorectal cancer (GECCO P = 6.72x10(-6); CORECT P = 3.32x10(-5)), and breast cancer (P = .009).0.0002714422015SH2B312111446804TC
rs32129642414046010848PPP1R13Lumls:C0242379BeFreeThe haplotype ERCC2 rs3916874(G) and rs238415(C) [OR (95% CI)=1.26 (1.02-1.57), P=0.03] in block 1 and the haplotype PPP1R13L rs4803817(A), CD3EAP rs1046282(T), rs735482(C), ERCC1 rs3212980(A), rs3212964(G) [OR (95% CI)=3.56 (1.55-8.18), P=0.005] in block 3 were associated with lung cancer risk.0.0071770412013ERCC11945417538CT
rs32129802414046010848PPP1R13Lumls:C0242379BeFreeThe haplotype ERCC2 rs3916874(G) and rs238415(C) [OR (95% CI)=1.26 (1.02-1.57), P=0.03] in block 1 and the haplotype PPP1R13L rs4803817(A), CD3EAP rs1046282(T), rs735482(C), ERCC1 rs3212980(A), rs3212964(G) [OR (95% CI)=3.56 (1.55-8.18), P=0.005] in block 3 were associated with lung cancer risk.0.0071770412013ERCC11945413183TG
rs3213245244701377515XRCC1umls:C0242379BeFreeThus, there is a significant association of XRCC1 rs3213245 polymorphism with lung cancer risk.0.0998152572013XRCC1;PINLYP1943575535GA
rs32190732522575025976TIPARPumls:C0242379BeFreePARP-1 rs3219073 polymorphism may contribute to susceptibility to lung cancer.0.0005428842015PARP11226381674GC
rs3219484145791484595MUTYHumls:C0242379BeFreeWe identified three common coding region (V22M, Q324H and S501F) and intronic (157+30A>G, 462+35G>A and 1435-40G>C) variants, but none were over-represented in the patient samples, indicating that MYH variants are unlikely to predispose significantly to the risk of lung cancer.0.0087297472004MUTYH145334484CT
rs3219489145791484595MUTYHumls:C0242379BeFreeWe identified three common coding region (V22M, Q324H and S501F) and intronic (157+30A>G, 462+35G>A and 1435-40G>C) variants, but none were over-represented in the patient samples, indicating that MYH variants are unlikely to predispose significantly to the risk of lung cancer.0.0087297472004MUTYH145331833CG
rs3219489191615914595MUTYHumls:C0242379BeFreeMUTYH Gln324His gene polymorphism and genetic susceptibility for lung cancer in a Japanese population.0.0087297472009MUTYH145331833CG
rs33917957238018854233METumls:C0242379BeFreeLack of association of C-Met-N375S sequence variant with lung cancer susceptibility and prognosis.0.0230402222013MET7116700208AG
rs34330179089957157TP53umls:C0242379BeFreeWhen individuals with variant-containing genotypes were compared with homozygous wild-type carriers, a significantly increased lung cancer risk was identified for polymorphisms in p53 intron 6 [rs1625895; odds ratio (OR), 1.29; 95% confidence interval (95% CI), 1.08-1.55] and in p27 5' untranslated region (UTR; rs34330; OR, 1.27; 95% CI, 1.01-1.60).0.162007CDKN1B;GPR191212717761TC
rs34330179089955715PSMD9umls:C0242379BeFreeWhen individuals with variant-containing genotypes were compared with homozygous wild-type carriers, a significantly increased lung cancer risk was identified for polymorphisms in p53 intron 6 [rs1625895; odds ratio (OR), 1.29; 95% confidence interval (95% CI), 1.08-1.55] and in p27 5' untranslated region (UTR; rs34330; OR, 1.27; 95% CI, 1.01-1.60).0.0024429772007CDKN1B;GPR191212717761TC
rs351855192965382264FGFR4umls:C0242379BeFreeFGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung.0.0108253372009FGFR45177093242GA
rs351855175198992264FGFR4umls:C0242379BeFreeFurther observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis.0.0108253372007FGFR45177093242GA
rs3569413234624601544CYP1A2umls:C0242379BeFreeThese results suggest that the rs3569413 polymorphism of the CYP1A2 gene is associated with an increased risk of lung cancer and the rs762551 polymorphism of the CYP1A2 gene might be a potential biomarker for the risk of cancer among Caucasians.0.0235507682014NANANANANA
rs360721197891903606IL18umls:C0242379GAD[When numeric scores were assigned to both the SNP and demographic data, and sequentially combined by a simple algorithm in a risk model, the composite score was found to be linearly related to lung cancer risk with a bimodal distribution.]0.0052769482009IL1811112155193GC
rs366002172530881037CLPTM1Lumls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.1428883322011MTMR32229941597TC
rs36600217253087015TERTumls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.1554182652011MTMR32229941597TC
rs366002172530855504TNFRSF19umls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.0002714422011MTMR32229941597TC
rs36600217253083976LIFumls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.0002714422011MTMR32229941597TC
rs36600217253088897MTMR3umls:C0242379GWASCATThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.1205428842011MTMR32229941597TC
rs36600217253088626TP63umls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.1253528932011MTMR32229941597TC
rs3660021725308150280HORMAD2umls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.0005428842011MTMR32229941597TC
rs36600217253084285MIPEPumls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.0002714422011MTMR32229941597TC
rs36600217253088897MTMR3umls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.1205428842011MTMR32229941597TC
rs3695760541142970483478ARHGAP24umls:C0242379BeFreeAlthough p73 is infrequently mutated in human cancers, we have previously found two types of p73 mutation with amino acid substitution (P405R and P425L) in primary neuroblastoma and lung cancer.0.004343072001ARHGAP24485994925CT
rs37308592213938026018LRIG1umls:C0242379BeFreeIn addition, rs3730859 in LIG1 was also moderately associated with increased risk for lung cancer among Caucasian smokers.0.0010857672012LIG11948161802GA
rs37309311870964226018LRIG1umls:C0242379BeFreeAmong African Americans, His/His genotype of ERCC5 His1104Asp (rs17655) was associated with increased lung cancer risk (OR = 1.78; 95% CI: 1.09-2.91), and LIG1 haplotype GGGAA (rs20581, rs156641, rs3730931, rs20579 and rs439132) was associated with reduced lung cancer risk (OR = 0.61; 95% CI: 0.42-0.88).0.0010857672008LIG11948143984TC
rs3730931187096422073ERCC5umls:C0242379BeFreeAmong African Americans, His/His genotype of ERCC5 His1104Asp (rs17655) was associated with increased lung cancer risk (OR = 1.78; 95% CI: 1.09-2.91), and LIG1 haplotype GGGAA (rs20581, rs156641, rs3730931, rs20579 and rs439132) was associated with reduced lung cancer risk (OR = 0.61; 95% CI: 0.42-0.88).0.0300330352008LIG11948143984TC
rs3731239252396441029CDKN2Aumls:C0242379BeFreeASSET analyses identified four SNPs significantly associated with multiple cancers: rs3731239 (CDKN2A intronic) with ESCC, GC and BC (P = 3.96 × 10(-) (4)); rs10811474 (3' of IFNW1) with RCC and BrC (P = 0.001); rs12683422 (LINGO2 intronic) with RCC and BC (P = 5.93 × 10(-) (4)) and rs10511729 (3' of ELAVL2) with LC and BrC (P = 8.63 × 10(-) (4)).0.0383169112015CDKN2A921974219AG
rs3731239252396441993ELAVL2umls:C0242379BeFreeASSET analyses identified four SNPs significantly associated with multiple cancers: rs3731239 (CDKN2A intronic) with ESCC, GC and BC (P = 3.96 × 10(-) (4)); rs10811474 (3' of IFNW1) with RCC and BrC (P = 0.001); rs12683422 (LINGO2 intronic) with RCC and BC (P = 5.93 × 10(-) (4)) and rs10511729 (3' of ELAVL2) with LC and BrC (P = 8.63 × 10(-) (4)).0.0013572092015CDKN2A921974219AG
rs3731249169122091029CDKN2Aumls:C0242379BeFreeTherefore, we hypothesized that the genetic variants in these three genes influence the predisposition of lung cancer (i.e., CCND1 G870A, CDKN2A Ala(148)Thr, TP53 Arg(72)Pro, and 16-bp repeat in intron 3) and that the effect of X-ray on lung cancer risk can be modified by the presence of these genetic variations.0.0383169112006CDKN2A921970917CT
rs3731249169122097157TP53umls:C0242379BeFreeTherefore, we hypothesized that the genetic variants in these three genes influence the predisposition of lung cancer (i.e., CCND1 G870A, CDKN2A Ala(148)Thr, TP53 Arg(72)Pro, and 16-bp repeat in intron 3) and that the effect of X-ray on lung cancer risk can be modified by the presence of these genetic variations.0.162006CDKN2A921970917CT
rs37322103424011025171023ASXL1umls:C0242379BeFreeHematologic progression occurred simultaneously with an ASXL1-R693X-negative lung-cancer.0.0002714422013ASXL12032434789CT
rs3734254250436405467PPARDumls:C0242379BeFreeOur findings suggest that lung-cancer patients with the CC variant of PPARD rs3734254 may have a survival advantage over lung-cancer patients with other gene variants.0.0034527992014PPARD635427233CT
rs374644424258110574501MIR499Aumls:C0242379BeFreeIn the subgroup analysis by cancer types, no risk of breast, liver, or lung cancers were found significantly associated with microRNA-499 rs3746444 A/G polymorphism in any of the genetic models.0.0008143262013MYH7B;MIR499A;MIR499B2034990448AG
rs374644425077922574501MIR499Aumls:C0242379BeFreeNo clear consensus has been reached on the four single nucleotide polymorphisms (miR-196a2 gene rs11614913, miR-146a gene rs2910164, miR-149 gene rs2292832, and miR-499 gene rs3746444) in microRNA-coding genes and lung cancer risk.0.0008143262014MYH7B;MIR499A;MIR499B2034990448AG
rs374644425077922406941MIR149umls:C0242379BeFreeNo clear consensus has been reached on the four single nucleotide polymorphisms (miR-196a2 gene rs11614913, miR-146a gene rs2910164, miR-149 gene rs2292832, and miR-499 gene rs3746444) in microRNA-coding genes and lung cancer risk.0.0008143262014MYH7B;MIR499A;MIR499B2034990448AG
rs3747531228782804481MSR1umls:C0242379BeFreeThe relationship of three potentially functional polymorphisms (T-365C, T+25C, and Ala275Pro) in the SR-A gene with lung cancer risk was evaluated in 1287 lung cancer case subjects and 1261 control subjects from the Chinese population.0.0029099162012NANANANANA
rs3755486232320351137CHRNA4umls:C0242379BeFreeSeven SNPs in three nAChR genes were significantly associated with lung cancer at a strict Bonferroni-corrected level, including a novel association on chromosome 2 near the promoter of CHRNA1 (rs3755486: OR = 1.40, 95% CI = 1.18-1.67, P = 1.0 x 10-4).0.0038001862012NA2174767158CT
rs376040996175315257507XPAumls:C0242379BeFreeWe investigated the association of 10 base-excision and nucleotide-excision repair gene polymorphisms (XRCC1 -77 T/C, Arg194Trp, Arg280His and Arg399Gln; APE1 Asp148Glu; OGG1 Ser326Cys; XPA -4 G/A; XPC PAT; XPD Asp312Asn and Lys751Gln) with lung cancer risk in Caucasians.0.0361243082007XPA997687210TC,G
rs376040996175315257508XPCumls:C0242379BeFreeWe investigated the association of 10 base-excision and nucleotide-excision repair gene polymorphisms (XRCC1 -77 T/C, Arg194Trp, Arg280His and Arg399Gln; APE1 Asp148Glu; OGG1 Ser326Cys; XPA -4 G/A; XPC PAT; XPD Asp312Asn and Lys751Gln) with lung cancer risk in Caucasians.0.0443111722007XPA997687210TC,G
rs377591409235589641565CYP2D6umls:C0242379BeFreeCYP2D6 T188C variant is associated with lung cancer risk in the Chinese population.0.026808072013CYP2D6;LOC1027237222242129173GA,T
rs3817198246816044046LSP1umls:C0242379BeFreeOur findings demonstrate a novel pleiotropic association between the breast cancer LSP1 risk region marked by variant rs3817198 and lung cancer risk.0.0002714422014LSP1111887776TC
rs383412923315881841CASP8umls:C0242379BeFreeHowever, we found that homozygote (G/G) of rs2227310 in the CASP-7 gene, del allele, heterozygote (ins/del), and del carrier (ins/del + del/del) of rs3834129 in CASP-8 could be protective factors for lung cancer (OR = 0.17, 95%CI = 0.14-0.21, P = 0.0003; OR = 0.83, 95%CI = 0.72-0.97, P = 0.02; OR = 0.74, 95%CI = 0.64-0.85, P < 0.0001; OR = 0.81, 95%CI = 0.71-0.93, P = 0.002; respectively).0.0142781372014CASP82201232809AGTAAG-
rs383412923315881840CASP7umls:C0242379BeFreeHowever, we found that homozygote (G/G) of rs2227310 in the CASP-7 gene, del allele, heterozygote (ins/del), and del carrier (ins/del + del/del) of rs3834129 in CASP-8 could be protective factors for lung cancer (OR = 0.17, 95%CI = 0.14-0.21, P = 0.0003; OR = 0.83, 95%CI = 0.72-0.97, P = 0.02; OR = 0.74, 95%CI = 0.64-0.85, P < 0.0001; OR = 0.81, 95%CI = 0.71-0.93, P = 0.002; respectively).0.0079154222014CASP82201232809AGTAAG-
rs3841324253296541138CHRNA5umls:C0242379BeFreeHowever, no studies have investigated the association between CHRNA5 rs3841324, which has been proven to have the highest association with CHRNA5 mRNA expression, and the risk of other smoking-associated cancers, except lung cancer.0.0598269662014NANANANANA
rs386493716174179477515XRCC1umls:C0242379BeFreeContrasting impact of DNA repair gene XRCC1 polymorphisms Arg399Gln and Arg194Trp on the risk of lung cancer in the north-Indian population.0.0998152572007NANANANANA
rs386493716253006874968OGG1umls:C0242379BeFreeIn the present study, we investigated the polymorphisms of the following selected members of the base and nucleotide excision repair genes: XPC (Lys939Gln), XPD (Lys751Gln), XRCC1(Arg399Gln), and hOGG1(Ser326Ser), and the risk they present toward the development of lung cancer, with emphasis on the effect of chromium exposure.0.0722050092015NANANANANA
rs386493716175315257515XRCC1umls:C0242379BeFreeIn conclusion, the APE1 Asp148Glu polymorphism is highly predictive for lung cancer, and cumulative cigarette smoking modifies the associations between the XRCC1 Arg399Gln and the XPD Lys751Gln polymorphisms and lung cancer risk.0.0998152572007NANANANANA
rs386493716253006877515XRCC1umls:C0242379BeFreeIn the present study, we investigated the polymorphisms of the following selected members of the base and nucleotide excision repair genes: XPC (Lys939Gln), XPD (Lys751Gln), XRCC1(Arg399Gln), and hOGG1(Ser326Ser), and the risk they present toward the development of lung cancer, with emphasis on the effect of chromium exposure.0.0998152572015NANANANANA
rs38649371617531525328APEX1umls:C0242379BeFreeIn conclusion, the APE1 Asp148Glu polymorphism is highly predictive for lung cancer, and cumulative cigarette smoking modifies the associations between the XRCC1 Arg399Gln and the XPD Lys751Gln polymorphisms and lung cancer risk.0.0489256842007NANANANANA
rs386493716230230284968OGG1umls:C0242379BeFreeFor example, there was a positive association between the OGG1 Ser326Cys variant and gastric and lung cancer, while the XRCC1 Arg399Gln variant was associated with reduced cancer risk.0.0722050092012NANANANANA
rs386493716179524687515XRCC1umls:C0242379BeFreeThese findings suggest that genetic polymorphisms in the DNA repair genes may modulate overall lung cancer susceptibility and that pathological stage and XRCC1 Arg399Gln independently predicted overall survival among Indian lung cancer patients.0.0998152572008NANANANANA
rs386493716175049862068ERCC2umls:C0242379BeFreeProspective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer.0.2138435352007NANANANANA
rs386493716256844777515XRCC1umls:C0242379BeFreeUpdated assessment of the association of the XRCC1 Arg399Gln polymorphism with lung cancer risk in the Chinese population.0.0998152572015NANANANANA
rs386493716241758137515XRCC1umls:C0242379BeFreeThe codon 399 Arg/Gln XRCC1 polymorphism is associated with lung cancer in Indians.0.0998152572014NANANANANA
rs386493716150443287515XRCC1umls:C0242379BeFreeThese results suggest that APE1 Asp148Glu and XRCC1 Arg399Gln polymorphisms might modify the risk of lung cancer attributable to cigarette smoking exposure.0.0998152572004NANANANANA
rs386493716155879887515XRCC1umls:C0242379BeFreeNo associations were found between the polymorphisms OGG1 Ser326Cys, XRCC1 Arg280His, and XRCCI Arg399Gln and risk of lung cancer.0.0998152572004NANANANANA
rs386493716175315252068ERCC2umls:C0242379BeFreeIn conclusion, the APE1 Asp148Glu polymorphism is highly predictive for lung cancer, and cumulative cigarette smoking modifies the associations between the XRCC1 Arg399Gln and the XPD Lys751Gln polymorphisms and lung cancer risk.0.2138435352007NANANANANA
rs386493716230230287515XRCC1umls:C0242379BeFreeFor example, there was a positive association between the OGG1 Ser326Cys variant and gastric and lung cancer, while the XRCC1 Arg399Gln variant was associated with reduced cancer risk.0.0998152572012NANANANANA
rs386493716175049867515XRCC1umls:C0242379BeFreeProspective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer.0.0998152572007NANANANANA
rs386493716238846047515XRCC1umls:C0242379BeFreeAssessment of the association between XRCC1 Arg399Gln polymorphism and lung cancer in Chinese.0.0998152572013NANANANANA
rs386493716169821137515XRCC1umls:C0242379BeFreeThe 399Gln/Gln genotype of the XRCC1 Arg399Gln polymorphism was associated with an increased risk of lung cancer among Asians (OR=1.34, 95% CI=1.16-1.54) but not among Caucasians.0.0998152572006NANANANANA
rs386493716177058147508XPCumls:C0242379BeFreeWe investigated the relationship between polymorphisms in two NER genes, XPC (poly (AT) insertion/deletion: PAT-/+) and XPD (Asp312Asn and Lys751Gln), the BER gene XRCC1 (Arg399Gln), and the DSBR gene XRCC3 (Thr241Met) and the risk of developing lung cancer.0.0443111722007NANANANANA
rs38649371615044328328APEX1umls:C0242379BeFreeThese results suggest that APE1 Asp148Glu and XRCC1 Arg399Gln polymorphisms might modify the risk of lung cancer attributable to cigarette smoking exposure.0.0489256842004NANANANANA
rs386526551243906654255MGMTumls:C0242379BeFreeMGMT Leu84Phe gene polymorphism and lung cancer risk: a meta-analysis.0.0280893352013NANANANANA
rs386545044194422467157TP53umls:C0242379BeFreeFor instance, a greater absolute risk reduction of lung and upper aerodigestive cancers in smokers than in non-smokers carrying the I157T CHEK2 variant has been observed, as has an interaction between TP53 intron 3 16-bp repeats and multiple X-ray exposures on lung cancer risk.0.162009NANANANANA
rs3865450441944224611200CHEK2umls:C0242379BeFreeFor instance, a greater absolute risk reduction of lung and upper aerodigestive cancers in smokers than in non-smokers carrying the I157T CHEK2 variant has been observed, as has an interaction between TP53 intron 3 16-bp repeats and multiple X-ray exposures on lung cancer risk.0.1298155152009NANANANANA
rs386545546158408794968OGG1umls:C0242379BeFreeThe associations between the OGG1 Cys/Cys genotype and adenocarcinoma risk and between XRCC1 Arg194Trp polymorphism and lung cancer risk among heavy smokers remained robust given prior probabilities of 25% (FPRP = 0.238) and 10% (FPRP = 0.276), respectively.0.0722050092005NANANANANA
rs386545546158408797515XRCC1umls:C0242379BeFreeThe associations between the OGG1 Cys/Cys genotype and adenocarcinoma risk and between XRCC1 Arg194Trp polymorphism and lung cancer risk among heavy smokers remained robust given prior probabilities of 25% (FPRP = 0.238) and 10% (FPRP = 0.276), respectively.0.0998152572005NANANANANA
rs386545546245902657515XRCC1umls:C0242379BeFreeNo association between XRCC1 gene Arg194Trp polymorphism and risk of lung cancer: evidence based on an updated cumulative meta-analysis.0.0998152572014NANANANANA
rs386545546209753747515XRCC1umls:C0242379BeFreeHomozygous Trp/Trp variant genotype of XRCC1 Arg194Trp polymorphism could increase lung cancer risk in total population, especially in Asians.0.0998152572010NANANANANA
rs386545546175315254968OGG1umls:C0242379BeFreeBoth the XRCC1 Arg194Trp and Arg280His as well as the OGG1 Ser326Cys heterozygous genotypes were associated with a significantly reduced risk for lung cancer (OR=0.32, p=0.024; OR=0.25, p=0.028; OR=0.51, p=0.033, respectively).0.0722050092007NANANANANA
rs386545546174179477515XRCC1umls:C0242379BeFreeContrasting impact of DNA repair gene XRCC1 polymorphisms Arg399Gln and Arg194Trp on the risk of lung cancer in the north-Indian population.0.0998152572007NANANANANA
rs386545546236533787515XRCC1umls:C0242379BeFreeTherefore, this meta-analysis suggests that XRCC1 Arg194Trp polymorphism is associated with increased risk of lung cancer in Chinese Han population.0.0998152572013NANANANANA
rs386545618172596549NAT1umls:C0242379BeFreeHeterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.0.0116396632007NANANANANA
rs386545618172596542939GSTA2umls:C0242379BeFreeHeterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.0.0050055062007NANANANANA
rs386545618172596544524MTHFRumls:C0242379BeFreeHeterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.0.056765162007NANANANANA
rs386545618172596541548CYP2A6umls:C0242379BeFreeHeterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.0.0333662822007NANANANANA
rs386545618172596542947GSTM3umls:C0242379BeFreeHeterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.0.0158308432007NANANANANA
rs386545618172596545243ABCB1umls:C0242379BeFreeHeterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.0.0410102622007NANANANANA
rs386561660217394807508XPCumls:C0242379BeFreeFurthermore, a significant effect of SNPs in nucleotide excision repair pathway on lung cancer survival was observed among 185 stages III-IV patients treated with platinum-based chemotherapy without surgical operation: XPC rs2228000 (Ala499Val; P = 0.002) and ERCC1 rs11615 (Asn118Asn; P = 0.012).0.0443111722012NANANANANA
rs386561660217394802067ERCC1umls:C0242379BeFreeFurthermore, a significant effect of SNPs in nucleotide excision repair pathway on lung cancer survival was observed among 185 stages III-IV patients treated with platinum-based chemotherapy without surgical operation: XPC rs2228000 (Ala499Val; P = 0.002) and ERCC1 rs11615 (Asn118Asn; P = 0.012).0.0670476142012NANANANANA
rs386584847169122097157TP53umls:C0242379BeFreeTherefore, we hypothesized that the genetic variants in these three genes influence the predisposition of lung cancer (i.e., CCND1 G870A, CDKN2A Ala(148)Thr, TP53 Arg(72)Pro, and 16-bp repeat in intron 3) and that the effect of X-ray on lung cancer risk can be modified by the presence of these genetic variations.0.162006NANANANANA
rs386584847169122091029CDKN2Aumls:C0242379BeFreeTherefore, we hypothesized that the genetic variants in these three genes influence the predisposition of lung cancer (i.e., CCND1 G870A, CDKN2A Ala(148)Thr, TP53 Arg(72)Pro, and 16-bp repeat in intron 3) and that the effect of X-ray on lung cancer risk can be modified by the presence of these genetic variations.0.0383169112006NANANANANA
rs386596107225250416648SOD2umls:C0242379BeFreeAlthough the majority of evidence supports associations between the SOD2 Ala16Val SNP and diseases such as breast, prostate and lung cancers, diabetes and cardiovascular disease, the presence of the SOD2 Ala16Val SNP confers only a small, clinically insignificant reduction (if any) in the risk of these diseases.0.0219221162012NANANANANA
rs386596107182586099NAT1umls:C0242379BeFreeHowever, only four of the previously reported associations with polymorphisms in the GSTP1 (Ala14Val), SOD2 (Val16Ala), EPHX1 (His139Arg) genes and the NAT1 fast acetylator phenotype remained significantly associated with lung cancer.0.0116396632008NANANANANA
rs386596107182586096530SLC6A2umls:C0242379BeFreeHowever, only four of the previously reported associations with polymorphisms in the GSTP1 (Ala14Val), SOD2 (Val16Ala), EPHX1 (His139Arg) genes and the NAT1 fast acetylator phenotype remained significantly associated with lung cancer.0.0021715352008NANANANANA
rs38659610718258609145389SLC38A6umls:C0242379BeFreeHowever, only four of the previously reported associations with polymorphisms in the GSTP1 (Ala14Val), SOD2 (Val16Ala), EPHX1 (His139Arg) genes and the NAT1 fast acetylator phenotype remained significantly associated with lung cancer.0.0019000932008NANANANANA
rs386596107182586092950GSTP1umls:C0242379BeFreeHowever, only four of the previously reported associations with polymorphisms in the GSTP1 (Ala14Val), SOD2 (Val16Ala), EPHX1 (His139Arg) genes and the NAT1 fast acetylator phenotype remained significantly associated with lung cancer.0.0924863262008NANANANANA
rs3865961071825860910991SLC38A3umls:C0242379BeFreeHowever, only four of the previously reported associations with polymorphisms in the GSTP1 (Ala14Val), SOD2 (Val16Ala), EPHX1 (His139Arg) genes and the NAT1 fast acetylator phenotype remained significantly associated with lung cancer.0.0019000932008NANANANANA
rs386596107182586096648SOD2umls:C0242379BeFreeHowever, only four of the previously reported associations with polymorphisms in the GSTP1 (Ala14Val), SOD2 (Val16Ala), EPHX1 (His139Arg) genes and the NAT1 fast acetylator phenotype remained significantly associated with lung cancer.0.0219221162008NANANANANA
rs386596107239904436648SOD2umls:C0242379BeFreeAssociation between SOD2 C47T polymorphism and lung cancer susceptibility: a meta-analysis.0.0219221162013NANANANANA
rs386596107182586092052EPHX1umls:C0242379BeFreeHowever, only four of the previously reported associations with polymorphisms in the GSTP1 (Ala14Val), SOD2 (Val16Ala), EPHX1 (His139Arg) genes and the NAT1 fast acetylator phenotype remained significantly associated with lung cancer.0.0660377912008NANANANANA
rs386596107182586091982EIF4G2umls:C0242379BeFreeHowever, only four of the previously reported associations with polymorphisms in the GSTP1 (Ala14Val), SOD2 (Val16Ala), EPHX1 (His139Arg) genes and the NAT1 fast acetylator phenotype remained significantly associated with lung cancer.0.0019000932008NANANANANA
rs386596107175486726648SOD2umls:C0242379BeFreeWe evaluated potential associations between gene variants that result in reduced neutralization of reactive oxygen species (ROS; MnSOD Ala-16Val, CAT -262 C>T, and GPX1 Pro200Leu) and prostate cancer risk among 724 men with incident prostate cancer who participated in the Carotene and Retinol Efficacy Trial (CARET) cohort, a randomized trial for the prevention of lung cancer among men with a history of smoking and/or asbestos exposure.0.0219221162007NANANANANA
rs386596107175486722876GPX1umls:C0242379BeFreeWe evaluated potential associations between gene variants that result in reduced neutralization of reactive oxygen species (ROS; MnSOD Ala-16Val, CAT -262 C>T, and GPX1 Pro200Leu) and prostate cancer risk among 724 men with incident prostate cancer who participated in the Carotene and Retinol Efficacy Trial (CARET) cohort, a randomized trial for the prevention of lung cancer among men with a history of smoking and/or asbestos exposure.0.0258418552007NANANANANA
rs39168742414046010848PPP1R13Lumls:C0242379BeFreeThe haplotype ERCC2 rs3916874(G) and rs238415(C) [OR (95% CI)=1.26 (1.02-1.57), P=0.03] in block 1 and the haplotype PPP1R13L rs4803817(A), CD3EAP rs1046282(T), rs735482(C), ERCC1 rs3212980(A), rs3212964(G) [OR (95% CI)=3.56 (1.55-8.18), P=0.005] in block 3 were associated with lung cancer risk.0.0071770412013ERCC21945353668CG
rs397507444187895764524MTHFRumls:C0242379BeFreeMeta-analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancer.0.056765162009MTHFR111794407TG
rs397507444222152144524MTHFRumls:C0242379BeFreeOur meta-analysis supports that the common polymorphisms of C677T and A1298C in MTHFR gene are not susceptibility gene for lung cancer from currently available evidence.0.056765162012MTHFR111794407TG
rs4016812463423681037CLPTM1Lumls:C0242379BeFreeDecreased risk of developing lung cancer in subjects carrying the CLPTM1L rs401681 (G>A) polymorphism: evidence from a meta-analysis.0.1428883322014CLPTM1L51321972CT
rs4016812438636181037CLPTM1Lumls:C0242379BeFreeA common sequence variant, rs401681, located in an intronic region of CLPTM1L, has been reported to be associated with lung cancer risk based on genome-wide association study.0.1428883322013CLPTM1L51321972CT
rs4016811897878781037CLPTM1Lumls:C0242379GWASCATCommon 5p15.33 and 6p21.33 variants influence lung cancer risk.0.1428883322008CLPTM1L51321972CT
rs4016812365368181037CLPTM1Lumls:C0242379BeFreeCommon genetic polymorphisms on chromosome 5p15.33, including rs401681 in cleft lip and palate transmembrane 1-like gene (CLPTM1L), have been implicated in susceptibility to lung cancer through genome-wide association studies (GWAS); however, subsequent replication studies yielded controversial results.0.1428883322013CLPTM1L51321972CT
rs4016811897878781037CLPTM1Lumls:C0242379GAD[Common 5p15.33 and 6p21.33 variants influence lung cancer risk.]0.1428883322008CLPTM1L51321972CT
rs4016812490707581037CLPTM1Lumls:C0242379BeFreeAssociation between CLPTM1L polymorphisms (rs402710 and rs401681) and lung cancer susceptibility: evidence from 27 case-control studies.0.1428883322014CLPTM1L51321972CT
rs4027101897879081037CLPTM1Lumls:C0242379GAD[The susceptibility region contains two genes, TERT and CLPTM1L, suggesting that one or both may have a role in lung cancer etiology.]0.1428883322008CLPTM1L51320607CT
rs4027102490707581037CLPTM1Lumls:C0242379BeFreeAssociation between CLPTM1L polymorphisms (rs402710 and rs401681) and lung cancer susceptibility: evidence from 27 case-control studies.0.1428883322014CLPTM1L51320607CT
rs402710189787907015TERTumls:C0242379GAD[The susceptibility region contains two genes, TERT and CLPTM1L, suggesting that one or both may have a role in lung cancer etiology.]0.1554182652008CLPTM1L51320607CT
rs4073197891903576CXCL8umls:C0242379GAD[When numeric scores were assigned to both the SNP and demographic data, and sequentially combined by a simple algorithm in a risk model, the composite score was found to be linearly related to lung cancer risk with a bimodal distribution.]0.0290232122009CXCL8473740307AT
rs4148356217366014363ABCC1umls:C0242379BeFreeABCC1 polymorphism Arg723Gln (2168G> A) is associated with lung cancer susceptibility in a Chinese population.0.0136157012011ABCC11616083418GA
rs421629229456517015TERTumls:C0242379BeFreeSingle-nucleotide polymorphisms rs421629 on 5p15.33 and rs1948, rs660652, rs8040868 and rs2036527 on 15q25.1, previously identified as lung cancer risk or nicotine-addiction modifiers, were associated with tumor DNA methylation levels in the promoters of TERT and CHRNB4 (P<0.001), respectively, in two independent sample sets (n=82; n=150).0.1554182652013CLPTM1L51320021GA
rs4248164221605767124TNFumls:C0242379BeFreeTNF-α 308G/A, IL-6 174G/C, IL-1β 31T/C, IL-1β 511C/T, COX-2 8473T/C polymorphisms were not detected to be related to the risk for LC.0.0423674712012TNF631575571CT
rs4248164221605763569IL6umls:C0242379BeFreeTNF-α 308G/A, IL-6 174G/C, IL-1β 31T/C, IL-1β 511C/T, COX-2 8473T/C polymorphisms were not detected to be related to the risk for LC.0.0403478262012TNF631575571CT
rs4248164221605764513COX2umls:C0242379BeFreeTNF-α 308G/A, IL-6 174G/C, IL-1β 31T/C, IL-1β 511C/T, COX-2 8473T/C polymorphisms were not detected to be related to the risk for LC.0.0067860472012TNF631575571CT
rs4248164221605763553IL1Bumls:C0242379BeFreeTNF-α 308G/A, IL-6 174G/C, IL-1β 31T/C, IL-1β 511C/T, COX-2 8473T/C polymorphisms were not detected to be related to the risk for LC.0.0443111722012TNF631575571CT
rs4248164221605765743PTGS2umls:C0242379BeFreeTNF-α 308G/A, IL-6 174G/C, IL-1β 31T/C, IL-1β 511C/T, COX-2 8473T/C polymorphisms were not detected to be related to the risk for LC.0.0499678442012TNF631575571CT
rs439132187096422073ERCC5umls:C0242379BeFreeAmong African Americans, His/His genotype of ERCC5 His1104Asp (rs17655) was associated with increased lung cancer risk (OR = 1.78; 95% CI: 1.09-2.91), and LIG1 haplotype GGGAA (rs20581, rs156641, rs3730931, rs20579 and rs439132) was associated with reduced lung cancer risk (OR = 0.61; 95% CI: 0.42-0.88).0.0300330352008LIG11948165657TC
rs439132180590211421CRYGDumls:C0242379BeFreeFor lung cancer, when compared to the most common haplotype (rs20581-rs20580-rs20579-rs439132 = T-C-C-A), the adjusted odds ratio (OR) is 1.2 (95% confidence limits (CL) = 0.95, 1.5) for the CACA haplotype, 1.4 (1.0, 1.9) for the CATA haplotype and 1.8 (1.1, 2.8) for the CCCG haplotype, after controlling for age, gender, race/ethnicity, education and tobacco smoking.0.0008143262008LIG11948165657TC
rs4391321870964226018LRIG1umls:C0242379BeFreeAmong African Americans, His/His genotype of ERCC5 His1104Asp (rs17655) was associated with increased lung cancer risk (OR = 1.78; 95% CI: 1.09-2.91), and LIG1 haplotype GGGAA (rs20581, rs156641, rs3730931, rs20579 and rs439132) was associated with reduced lung cancer risk (OR = 0.61; 95% CI: 0.42-0.88).0.0010857672008LIG11948165657TC
rs4488809217253088626TP63umls:C0242379GWASCATThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.1253528932011TP633189638472TC
rs4488809217253084285MIPEPumls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.0002714422011TP633189638472TC
rs448880921725308150280HORMAD2umls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.0005428842011TP633189638472TC
rs44888092172530881037CLPTM1Lumls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.1428883322011TP633189638472TC
rs44888092172530855504TNFRSF19umls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.0002714422011TP633189638472TC
rs4488809217253088897MTMR3umls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.1205428842011TP633189638472TC
rs4488809217253088626TP63umls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.1253528932011TP633189638472TC
rs4488809231436018626TP63umls:C0242379GWASCATGenome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia.0.1253528932012TP633189638472TC
rs4488809217253087015TERTumls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.1554182652011TP633189638472TC
rs4488809217253083976LIFumls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.0002714422011TP633189638472TC
rs464598120661084842CASP9umls:C0242379BeFreeIn individual polymorphism analysis, the CASP7 rs2227310C>G and CASP9 rs4645981C>T were associated with 1.40-fold and 1.28-fold increased risk of lung cancer under recessive and dominant models for the variant allele of each polymorphism, respectively.0.0140066952010CASP9;DNAJC16115524988GA
rs464598120661084840CASP7umls:C0242379BeFreeIn individual polymorphism analysis, the CASP7 rs2227310C>G and CASP9 rs4645981C>T were associated with 1.40-fold and 1.28-fold increased risk of lung cancer under recessive and dominant models for the variant allele of each polymorphism, respectively.0.0079154222010CASP9;DNAJC16115524988GA
rs464598123315881842CASP9umls:C0242379BeFreeMeta-analysis results showed positive associations between heterozygote (A/G) of rs507879 in the CASP-5 gene, the T allele of rs12415607 in the CASP-7 gene, and the T allele and T carrier (C/T+T/T) of rs4645981 in the CASP-9 gene with lung cancer susceptibility [odds ratio (OR) = 1.83, 95% confidence interval (95%CI) = 1.07-3.12, P = 0.03; OR = 1.18, 95%CI = 1.02-1.37, P = 0.03; OR = 1.43, 95%CI = 1.12-1.81, P = 0.004; OR = 1.46, 95%CI = 1.10-1.93, P = 0.009; respectively].0.0140066952014CASP9;DNAJC16115524988GA
rs4646903225255582068ERCC2umls:C0242379BeFreeA pertinent combination of multiple at-risk genotypes of CYP1A1 rs4646903, the GSTM1 deletion polymorphism and ERCC2 rs13181 was at a 5.94-fold (95% CI = 2.77-12.7) increased risk of lung cancer.0.2138435352012CYP1A11574719300AT,G
rs4646903225255582952GSTT1umls:C0242379BeFreeCYP1A1 rs4646903 (OR = 1.72, 95% CI = 1.25-2.38), rs1048943 (OR = 1.40, 95% CI = 1.02-1.92), the GSTM1 deletion polymorphism (OR = 1.38, 95% CI = 1.01-1.89), GSTP1 rs1695 (OR =1.48, 95% CI = 1.04-2.11), ERCC2 rs13181 (OR = 1.89, 95% CI = 1.28-2.78), and Chinese hamster 1 rs25487 (OR = 1.54, 95% CI = 1.12-2.13) were associated with lung cancer risk whereas the GSTT1 deletion polymorphism and XRCC3 rs861539 were not.0.100358142012CYP1A11574719300AT,G
rs4646903225255582944GSTM1umls:C0242379BeFreeA pertinent combination of multiple at-risk genotypes of CYP1A1 rs4646903, the GSTM1 deletion polymorphism and ERCC2 rs13181 was at a 5.94-fold (95% CI = 2.77-12.7) increased risk of lung cancer.0.126416562012CYP1A11574719300AT,G
rs4646903225255581543CYP1A1umls:C0242379BeFreeA pertinent combination of multiple at-risk genotypes of CYP1A1 rs4646903, the GSTM1 deletion polymorphism and ERCC2 rs13181 was at a 5.94-fold (95% CI = 2.77-12.7) increased risk of lung cancer.0.1237021412012CYP1A11574719300AT,G
rs4646903225255582950GSTP1umls:C0242379BeFreeCYP1A1 rs4646903 (OR = 1.72, 95% CI = 1.25-2.38), rs1048943 (OR = 1.40, 95% CI = 1.02-1.92), the GSTM1 deletion polymorphism (OR = 1.38, 95% CI = 1.01-1.89), GSTP1 rs1695 (OR =1.48, 95% CI = 1.04-2.11), ERCC2 rs13181 (OR = 1.89, 95% CI = 1.28-2.78), and Chinese hamster 1 rs25487 (OR = 1.54, 95% CI = 1.12-2.13) were associated with lung cancer risk whereas the GSTT1 deletion polymorphism and XRCC3 rs861539 were not.0.0924863262012CYP1A11574719300AT,G
rs4646903196507941543CYP1A1umls:C0242379BeFreeThe CYP1A1 T6235C polymorphism (rs4646903) gene polymorphism has been linked to the development of coronary heart disease and cigarette smoking-related lung cancer.0.1237021412010CYP1A11574719300AT,G
rs4646903225255587517XRCC3umls:C0242379BeFreeCYP1A1 rs4646903 (OR = 1.72, 95% CI = 1.25-2.38), rs1048943 (OR = 1.40, 95% CI = 1.02-1.92), the GSTM1 deletion polymorphism (OR = 1.38, 95% CI = 1.01-1.89), GSTP1 rs1695 (OR =1.48, 95% CI = 1.04-2.11), ERCC2 rs13181 (OR = 1.89, 95% CI = 1.28-2.78), and Chinese hamster 1 rs25487 (OR = 1.54, 95% CI = 1.12-2.13) were associated with lung cancer risk whereas the GSTT1 deletion polymorphism and XRCC3 rs861539 were not.0.0443871172012CYP1A11574719300AT,G
rs46549821725308150280HORMAD2umls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.0005428842011CLPTM1L51325688AG
rs4654982172530855504TNFRSF19umls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.0002714422011CLPTM1L51325688AG
rs465498217253087015TERTumls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.1554182652011CLPTM1L51325688AG
rs4654982172530881037CLPTM1Lumls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.1428883322011CLPTM1L51325688AG
rs465498217253084285MIPEPumls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.0002714422011CLPTM1L51325688AG
rs465498217253083976LIFumls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.0002714422011CLPTM1L51325688AG
rs465498217253088897MTMR3umls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.1205428842011CLPTM1L51325688AG
rs465498217253088626TP63umls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.1253528932011CLPTM1L51325688AG
rs4680223314611312COMTumls:C0242379BeFreeThe COMT rs4680 A allele was positively associated with lung cancer in never smokers (for G/A or A/A vs. G/G, OR = 1.46, 95% CI: 1.12, 1.90) but not in ever smokers.0.0126494862012COMT;MIR47612219963748GA
rs48038172414046010848PPP1R13Lumls:C0242379BeFreeThe haplotype ERCC2 rs3916874(G) and rs238415(C) [OR (95% CI)=1.26 (1.02-1.57), P=0.03] in block 1 and the haplotype PPP1R13L rs4803817(A), CD3EAP rs1046282(T), rs735482(C), ERCC1 rs3212980(A), rs3212964(G) [OR (95% CI)=3.56 (1.55-8.18), P=0.005] in block 3 were associated with lung cancer risk.0.0071770412013PPP1R13L;CD3EAP1945404702AG
rs4809957227977251809DPYSL3umls:C0242379BeFreeWe found genome-wide significant (P < 5.0 × 10(-8)) evidence for three additional lung cancer susceptibility loci at 10p14 (rs1663689, close to GATA3, P = 2.84 × 10(-10)), 5q32 (rs2895680 in PPP2R2B-STK32A-DPYSL3, P = 6.60 × 10(-9)) and 20q13.2 (rs4809957 in CYP24A1, P = 1.20 × 10(-8)).0.0002714422012CYP24A12054154632AG
rs4809957227977252625GATA3umls:C0242379BeFreeWe found genome-wide significant (P < 5.0 × 10(-8)) evidence for three additional lung cancer susceptibility loci at 10p14 (rs1663689, close to GATA3, P = 2.84 × 10(-10)), 5q32 (rs2895680 in PPP2R2B-STK32A-DPYSL3, P = 6.60 × 10(-9)) and 20q13.2 (rs4809957 in CYP24A1, P = 1.20 × 10(-8)).0.0026384742012CYP24A12054154632AG
rs480995722797725202374STK32Aumls:C0242379BeFreeWe found genome-wide significant (P < 5.0 × 10(-8)) evidence for three additional lung cancer susceptibility loci at 10p14 (rs1663689, close to GATA3, P = 2.84 × 10(-10)), 5q32 (rs2895680 in PPP2R2B-STK32A-DPYSL3, P = 6.60 × 10(-9)) and 20q13.2 (rs4809957 in CYP24A1, P = 1.20 × 10(-8)).0.0002714422012CYP24A12054154632AG
rs4809957227977251591CYP24A1umls:C0242379BeFreeWe found genome-wide significant (P < 5.0 × 10(-8)) evidence for three additional lung cancer susceptibility loci at 10p14 (rs1663689, close to GATA3, P = 2.84 × 10(-10)), 5q32 (rs2895680 in PPP2R2B-STK32A-DPYSL3, P = 6.60 × 10(-9)) and 20q13.2 (rs4809957 in CYP24A1, P = 1.20 × 10(-8)).0.0039956832012CYP24A12054154632AG
rs4809957227977255521PPP2R2Bumls:C0242379BeFreeWe found genome-wide significant (P < 5.0 × 10(-8)) evidence for three additional lung cancer susceptibility loci at 10p14 (rs1663689, close to GATA3, P = 2.84 × 10(-10)), 5q32 (rs2895680 in PPP2R2B-STK32A-DPYSL3, P = 6.60 × 10(-9)) and 20q13.2 (rs4809957 in CYP24A1, P = 1.20 × 10(-8)).0.0002714422012CYP24A12054154632AG
rs488018258609145389SLC38A6umls:C0242379BeFreeHowever, only four of the previously reported associations with polymorphisms in the GSTP1 (Ala14Val), SOD2 (Val16Ala), EPHX1 (His139Arg) genes and the NAT1 fast acetylator phenotype remained significantly associated with lung cancer.0.0019000932008SOD26159692840AG
rs4880182586092052EPHX1umls:C0242379BeFreeHowever, only four of the previously reported associations with polymorphisms in the GSTP1 (Ala14Val), SOD2 (Val16Ala), EPHX1 (His139Arg) genes and the NAT1 fast acetylator phenotype remained significantly associated with lung cancer.0.0660377912008SOD26159692840AG
rs4880182586099NAT1umls:C0242379BeFreeHowever, only four of the previously reported associations with polymorphisms in the GSTP1 (Ala14Val), SOD2 (Val16Ala), EPHX1 (His139Arg) genes and the NAT1 fast acetylator phenotype remained significantly associated with lung cancer.0.0116396632008SOD26159692840AG
rs4880175486722876GPX1umls:C0242379BeFreeWe evaluated potential associations between gene variants that result in reduced neutralization of reactive oxygen species (ROS; MnSOD Ala-16Val, CAT -262 C>T, and GPX1 Pro200Leu) and prostate cancer risk among 724 men with incident prostate cancer who participated in the Carotene and Retinol Efficacy Trial (CARET) cohort, a randomized trial for the prevention of lung cancer among men with a history of smoking and/or asbestos exposure.0.0258418552007SOD26159692840AG
rs4880225250416648SOD2umls:C0242379BeFreeAlthough the majority of evidence supports associations between the SOD2 Ala16Val SNP and diseases such as breast, prostate and lung cancers, diabetes and cardiovascular disease, the presence of the SOD2 Ala16Val SNP confers only a small, clinically insignificant reduction (if any) in the risk of these diseases.0.0219221162012SOD26159692840AG
rs4880182586096530SLC6A2umls:C0242379BeFreeHowever, only four of the previously reported associations with polymorphisms in the GSTP1 (Ala14Val), SOD2 (Val16Ala), EPHX1 (His139Arg) genes and the NAT1 fast acetylator phenotype remained significantly associated with lung cancer.0.0021715352008SOD26159692840AG
rs4880182586091982EIF4G2umls:C0242379BeFreeHowever, only four of the previously reported associations with polymorphisms in the GSTP1 (Ala14Val), SOD2 (Val16Ala), EPHX1 (His139Arg) genes and the NAT1 fast acetylator phenotype remained significantly associated with lung cancer.0.0019000932008SOD26159692840AG
rs4880239904436648SOD2umls:C0242379BeFreeAssociation between SOD2 C47T polymorphism and lung cancer susceptibility: a meta-analysis.0.0219221162013SOD26159692840AG
rs4880221440476648SOD2umls:C0242379BeFreeA review was conducted of 136 patients treated with radiation therapy for lung cancer between 2001 and 2007, and who had prior genotyping of functional single-nucleotide polymorphisms in oxidative stress genes including superoxide dismutase 2 (SOD2; rs4880) and methylene tetrahydrofolate reductase (MTHFR; rs1801131, rs1801133).0.0219221162012SOD26159692840AG
rs4880175486726648SOD2umls:C0242379BeFreeWe evaluated potential associations between gene variants that result in reduced neutralization of reactive oxygen species (ROS; MnSOD Ala-16Val, CAT -262 C>T, and GPX1 Pro200Leu) and prostate cancer risk among 724 men with incident prostate cancer who participated in the Carotene and Retinol Efficacy Trial (CARET) cohort, a randomized trial for the prevention of lung cancer among men with a history of smoking and/or asbestos exposure.0.0219221162007SOD26159692840AG
rs4880182586096648SOD2umls:C0242379BeFreeHowever, only four of the previously reported associations with polymorphisms in the GSTP1 (Ala14Val), SOD2 (Val16Ala), EPHX1 (His139Arg) genes and the NAT1 fast acetylator phenotype remained significantly associated with lung cancer.0.0219221162008SOD26159692840AG
rs48801825860910991SLC38A3umls:C0242379BeFreeHowever, only four of the previously reported associations with polymorphisms in the GSTP1 (Ala14Val), SOD2 (Val16Ala), EPHX1 (His139Arg) genes and the NAT1 fast acetylator phenotype remained significantly associated with lung cancer.0.0019000932008SOD26159692840AG
rs4880182586092950GSTP1umls:C0242379BeFreeHowever, only four of the previously reported associations with polymorphisms in the GSTP1 (Ala14Val), SOD2 (Val16Ala), EPHX1 (His139Arg) genes and the NAT1 fast acetylator phenotype remained significantly associated with lung cancer.0.0924863262008SOD26159692840AG
rs4891247862341421CRYGDumls:C0242379BeFreeWhen Phase 2 software was used to reconstruct the haplotype for GSTP1, the haplotype CACA (rs749174+rs1695 + rs762803+rs4891) exhibited an increased risk of lung cancer among smokers (adjust odds ratio 1.53; 95%CI 1.04-2.25, P=0.033).0.0008143262014GSTP11167586499TC
rs492003720600216102724560LOC102724560umls:C0242379BeFreeAlthough the study size was too small for a definitive conclusion, there was an indication that lung cancer risks might be highest in those with a high %MMA who also carried cystathionine beta-synthase (CBS) rs234709 and rs4920037 variant alleles.0.0005428842010CBS2143061781GA
rs49341978919012SERPINA3umls:C0242379GAD[When numeric scores were assigned to both the SNP and demographic data, and sequentially combined by a simple algorithm in a risk model, the composite score was found to be linearly related to lung cancer risk with a bimodal distribution.]0.0047340642009SERPINA31494614466GA
rs4953354254368042034EPAS1umls:C0242379BeFreeThe aim of this study was to explore a possible association of the EPAS1 gene rs4953354 polymorphism with susceptibility to lung cancer.0.0002714422015EPAS1246348249AG
rs49756161965430381037CLPTM1Lumls:C0242379GAD[Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study.]0.1428883322009NA51315545GA
rs4977756246816047015TERTumls:C0242379BeFreeTwo glioma risk variants, TERT rs2853676 and CDKN2BAS1 rs4977756, which are located in regions previously associated with lung cancer, were associated with increased risk of adenocarcinoma (OR = 1.16; 95% CI = 1.10 to 1.22; P = 1.1×10(-8)) and squamous cell carcinoma (OR = 1.13; CI = 1.07 to 1.19; P = 2.5×10(-5)), respectively.0.1554182652014CDKN2B-AS1922068653GA
rs50787923315881842CASP9umls:C0242379BeFreeMeta-analysis results showed positive associations between heterozygote (A/G) of rs507879 in the CASP-5 gene, the T allele of rs12415607 in the CASP-7 gene, and the T allele and T carrier (C/T+T/T) of rs4645981 in the CASP-9 gene with lung cancer susceptibility [odds ratio (OR) = 1.83, 95% confidence interval (95%CI) = 1.07-3.12, P = 0.03; OR = 1.18, 95%CI = 1.02-1.37, P = 0.03; OR = 1.43, 95%CI = 1.12-1.81, P = 0.004; OR = 1.46, 95%CI = 1.10-1.93, P = 0.009; respectively].0.0140066952014CASP511105007200TG,C,A
rs560191203728527158TP53BP1umls:C0242379BeFreeCigarette smoking, TP53 Arg72Pro, TP53BP1 Asp353Glu and the risk of lung cancer in a Japanese population.0.0084583052010TP53BP11543475576GC,T
rs560191201069007158TP53BP1umls:C0242379BeFreeOnly the association between a non-synonymous variant of TP53BP1 (rs560191) and lung cancer risk was significant (OR = 0.91, P = 0.002).0.0084583052010TP53BP11543475576GC,T
rs5742933217394807515XRCC1umls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0998152572012PMS1;ORMDL12189784590GC
rs574293321739480472ATMumls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0211837362012PMS1;ORMDL12189784590GC
rs5742933217394802068ERCC2umls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.2138435352012PMS1;ORMDL12189784590GC
rs5742933217394805378PMS1umls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0026384742012PMS1;ORMDL12189784590GC
rs5742933217394808930MBD4umls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0102824542012PMS1;ORMDL12189784590GC
rs5742933217394804361MRE11Aumls:C0242379BeFreeSNPs associated with lung cancer prognosis primarily mapped to 14 genes in different repair pathways, and 6 SNPs were remained in the final model after multivariate stepwise Cox regression analysis: ATM rs189037; MRE11A rs11020802; ERCC2 rs1799793; MBD4 rs140693; XRCC1 rs25487, and PMS1 rs5742933.0.0002714422012PMS1;ORMDL12189784590GC
rs57438361978919054106TLR9umls:C0242379GAD[When numeric scores were assigned to both the SNP and demographic data, and sequentially combined by a simple algorithm in a risk model, the composite score was found to be linearly related to lung cancer risk with a bimodal distribution.]0.0063627152009TLR9352226766AG
rs578776218626241138CHRNA5umls:C0242379BeFreeTwo variants in the nicotinic acetylcholine receptor subunit genes CHRNA5 and CHRNA3 on 15q25, rs16969968 and rs578776, were associated with cotinine (P = 0.001 and 0.03, respectively) in current smokers and with lung cancer risk (P < 0.001 and P = 0.001, respectively).0.0598269662011CHRNA31578596058GA
rs578776205876041136CHRNA3umls:C0242379BeFreeA four-SNP haplotype spanning CHRNA5 (rs11637635 C, rs17408276 T, rs16969968 G) and CHRNA3 (rs578776 G) was associated with increased lung cancer risk (P = 0.002).0.1792081372010CHRNA31578596058GA
rs578776205876041138CHRNA5umls:C0242379BeFreeA four-SNP haplotype spanning CHRNA5 (rs11637635 C, rs17408276 T, rs16969968 G) and CHRNA3 (rs578776 G) was associated with increased lung cancer risk (P = 0.002).0.0598269662010CHRNA31578596058GA
rs578776218626241136CHRNA3umls:C0242379BeFreeTwo variants in the nicotinic acetylcholine receptor subunit genes CHRNA5 and CHRNA3 on 15q25, rs16969968 and rs578776, were associated with cotinine (P = 0.001 and 0.03, respectively) in current smokers and with lung cancer risk (P < 0.001 and P = 0.001, respectively).0.1792081372011CHRNA31578596058GA
rs588765262823301138CHRNA5umls:C0242379BeFreeSliding window haplotype analysis within chromosome 15, evaluating 4722250 haplotypes and pair-wise haplotype analysis identified that CHRNA5 rs588765-rs16969968 was the most significant haplotype associated with lung cancer risk (omnibus P = 8.35×10(-15) in discovery and 7.26×10(-14) in replication), and improved the prediction of case status over that provided by the individual SNPs rs16969968 or rs588765 (likelihood ratio test P = 0.006 for rs16969968 and 3.83×10(-14) for rs588765 in discovery, 0.009 for rs16969968 and 4.62×10(-13) for rs588765 in replication, compared with rs588765-rs16969968).0.0598269662015CHRNA51578573083TC
rs6092191176385055SERPINB2umls:C0242379BeFreePlasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.0.0034527992009SERPINE17101128436GA
rs6092191176385054SERPINE1umls:C0242379BeFreePlasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.0.0071770412009SERPINE17101128436GA
rs6092191176385340PLGumls:C0242379BeFreePlasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.0.0010857672009SERPINE17101128436GA
rs6104191176385055SERPINB2umls:C0242379BeFreePlasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.0.0034527992009SERPINB21863903295CG
rs6104191176385054SERPINE1umls:C0242379BeFreePlasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.0.0071770412009SERPINB21863903295CG
rs6104191176385340PLGumls:C0242379BeFreePlasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.0.0010857672009SERPINB21863903295CG
rs61413832593744492747BPIFB1umls:C0242379BeFreeWe identified three low-frequency missense variants in BAT2 (rs9469031, c.1544C>T [p.Pro515Leu]; odds ratio [OR] = 0.55, p = 1.28 × 10(-10)), FKBPL (rs200847762, c.410C>T [p.Pro137Leu]; OR = 0.25, p = 9.79 × 10(-12)), and BPIFB1 (rs6141383, c.850G>A [p.Val284Met]; OR = 1.72, p = 1.79 × 10(-7)); these variants were associated with lung cancer risk. rs9469031 in BAT2 and rs6141383 in BPIFB1 were also associated with the age of onset of lung cancer (p = 0.001 and 0.006, respectively).0.0002714422015BPIFB12033301335GA
rs6141383259374447916PRRC2Aumls:C0242379BeFreeWe identified three low-frequency missense variants in BAT2 (rs9469031, c.1544C>T [p.Pro515Leu]; odds ratio [OR] = 0.55, p = 1.28 × 10(-10)), FKBPL (rs200847762, c.410C>T [p.Pro137Leu]; OR = 0.25, p = 9.79 × 10(-12)), and BPIFB1 (rs6141383, c.850G>A [p.Val284Met]; OR = 1.72, p = 1.79 × 10(-7)); these variants were associated with lung cancer risk. rs9469031 in BAT2 and rs6141383 in BPIFB1 were also associated with the age of onset of lung cancer (p = 0.001 and 0.006, respectively).0.0002714422015BPIFB12033301335GA
rs6183182993122690GHRumls:C0242379BeFreeLung cancer risk associated with Thr495Pro polymorphism of GHR in Chinese population.0.0073725382008GHR542718990CA
rs6413429197891906531SLC6A3umls:C0242379GAD[When numeric scores were assigned to both the SNP and demographic data, and sequentially combined by a simple algorithm in a risk model, the composite score was found to be linearly related to lung cancer risk with a bimodal distribution.]0.0123780442009SLC6A351446912CA
rs6495309252881781136CHRNA3umls:C0242379BeFreeThe association between the rs6495309 polymorphism in CHRNA3 gene and lung cancer risk in Chinese: a meta-analysis.0.1792081372014CHRNA3;CHRNB41578622903CT
rs652438163112444314MMP3umls:C0242379BeFreeWe investigated the associations between polymorphisms of MMP-1 (-1607 1G/2G, rs1799750), MMP-3 (-1171 5A/6A, rs3025058), and MMP-12 (-82AG, rs2276109, and 1082A/G, rs652438) and the risk of lung cancer in 2014 Caucasian lung cancer patients and 1323 healthy controls.0.0155594012006MMP1211102865911TG,C
rs652438163112444321MMP12umls:C0242379BeFreeWe investigated the associations between polymorphisms of MMP-1 (-1607 1G/2G, rs1799750), MMP-3 (-1171 5A/6A, rs3025058), and MMP-12 (-82AG, rs2276109, and 1082A/G, rs652438) and the risk of lung cancer in 2014 Caucasian lung cancer patients and 1323 healthy controls.0.0090011892006MMP1211102865911TG,C
rs660652229456517015TERTumls:C0242379BeFreeSingle-nucleotide polymorphisms rs421629 on 5p15.33 and rs1948, rs660652, rs8040868 and rs2036527 on 15q25.1, previously identified as lung cancer risk or nicotine-addiction modifiers, were associated with tumor DNA methylation levels in the promoters of TERT and CHRNB4 (P<0.001), respectively, in two independent sample sets (n=82; n=150).0.1554182652013CHRNA3;CHRNA51578595490AG
rs662959255972813596IL13umls:C0242379BeFreeCART analyses did not yield a tree structure for overall survival; separate CART tree structures were identified for recurrence, based on three SNPs (IL13:rs1881457, IL1B:rs1143634, and IL12A:rs662959), and for disease-free survival, based on two SNPs (IL12A:rs662959 and IL16:rs7170924), which may suggest that these candidate IL SNPs have a specific impact on lung cancer progression and recurrence.0.0100110122014IL12A-AS13159983443GA
rs662959255972813603IL16umls:C0242379BeFreeCART analyses did not yield a tree structure for overall survival; separate CART tree structures were identified for recurrence, based on three SNPs (IL13:rs1881457, IL1B:rs1143634, and IL12A:rs662959), and for disease-free survival, based on two SNPs (IL12A:rs662959 and IL16:rs7170924), which may suggest that these candidate IL SNPs have a specific impact on lung cancer progression and recurrence.0.0050055062014IL12A-AS13159983443GA
rs662959255972813592IL12Aumls:C0242379BeFreeCART analyses did not yield a tree structure for overall survival; separate CART tree structures were identified for recurrence, based on three SNPs (IL13:rs1881457, IL1B:rs1143634, and IL12A:rs662959), and for disease-free survival, based on two SNPs (IL12A:rs662959 and IL16:rs7170924), which may suggest that these candidate IL SNPs have a specific impact on lung cancer progression and recurrence.0.0079154222014IL12A-AS13159983443GA
rs662959255972813553IL1Bumls:C0242379BeFreeCART analyses did not yield a tree structure for overall survival; separate CART tree structures were identified for recurrence, based on three SNPs (IL13:rs1881457, IL1B:rs1143634, and IL12A:rs662959), and for disease-free survival, based on two SNPs (IL12A:rs662959 and IL16:rs7170924), which may suggest that these candidate IL SNPs have a specific impact on lung cancer progression and recurrence.0.0443111722014IL12A-AS13159983443GA
rs66467722203481472ATMumls:C0242379BeFreeATM rs664677 polymorphism was associated with decreased lung cancer risk as well as increased breast cancer risk.0.0211837362012ATM11108272455CT
rs6721961240400734780NFE2L2umls:C0242379BeFreeWe prepared genomic DNA samples from 387 Japanese patients with primary lung cancer and detected SNP (c.-617C>A; rs6721961) in the ARE-like loci of the human NRF2 gene by the rapid genetic testing method we developed in this study.0.0078718142013NFE2L22177265309TC,G
rs6721961235725604780NFE2L2umls:C0242379BeFreeIn excellent agreement with this finding, we found that minor A/A homozygotes of a single nucleotide polymorphism (SNP) in the human NRF2 upstream promoter region (rs6721961) exhibited significantly diminished NRF2 gene expression and, consequently, an increased risk of lung cancer, especially those who had ever smoked.0.0078718142013NFE2L22177265309TC,G
rs6966187096421081CGAumls:C0242379BeFreeAmong Latinos, ERCC2 haplotype CGA (rs238406, rs11878644, rs6966) was associated with reduced lung cancer risk [odds ratio (OR) of 0.65 and 95% confidence interval (CI): 0.44-0.97], especially among nonsmokers (OR = 0.29; 95% CI: 0.12-0.67).0.0026384742008PPP1R13L1945379704TA
rs699947254688057422VEGFAumls:C0242379BeFreers833061 and rs699947 on promoter gene of vascular endothelial growth factor (VEGF) and associated lung cancer susceptibility and survival: a meta-analysis.0.0429426932015VEGFA643768652AC
rs708680323143601143187VTI1Aumls:C0242379GWASCATGenome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia.0.122012VTI1A10112738717GA
rs7170924255972813603IL16umls:C0242379BeFreeCART analyses did not yield a tree structure for overall survival; separate CART tree structures were identified for recurrence, based on three SNPs (IL13:rs1881457, IL1B:rs1143634, and IL12A:rs662959), and for disease-free survival, based on two SNPs (IL12A:rs662959 and IL16:rs7170924), which may suggest that these candidate IL SNPs have a specific impact on lung cancer progression and recurrence.0.0050055062014IL161581290798GT
rs7170924255972813592IL12Aumls:C0242379BeFreeCART analyses did not yield a tree structure for overall survival; separate CART tree structures were identified for recurrence, based on three SNPs (IL13:rs1881457, IL1B:rs1143634, and IL12A:rs662959), and for disease-free survival, based on two SNPs (IL12A:rs662959 and IL16:rs7170924), which may suggest that these candidate IL SNPs have a specific impact on lung cancer progression and recurrence.0.0079154222014IL161581290798GT
rs7170924255972813596IL13umls:C0242379BeFreeCART analyses did not yield a tree structure for overall survival; separate CART tree structures were identified for recurrence, based on three SNPs (IL13:rs1881457, IL1B:rs1143634, and IL12A:rs662959), and for disease-free survival, based on two SNPs (IL12A:rs662959 and IL16:rs7170924), which may suggest that these candidate IL SNPs have a specific impact on lung cancer progression and recurrence.0.0100110122014IL161581290798GT
rs7170924255972813553IL1Bumls:C0242379BeFreeCART analyses did not yield a tree structure for overall survival; separate CART tree structures were identified for recurrence, based on three SNPs (IL13:rs1881457, IL1B:rs1143634, and IL12A:rs662959), and for disease-free survival, based on two SNPs (IL12A:rs662959 and IL16:rs7170924), which may suggest that these candidate IL SNPs have a specific impact on lung cancer progression and recurrence.0.0443111722014IL161581290798GT
rs7178270205876041143CHRNB4umls:C0242379BeFreeCHRNA5 rs17486278 G had OR = 1.28, 95% CI 1.07-1.54 and P = 0.008, whereas CHRNB4 rs7178270 G had OR = 0.78, 95% CI 0.66-0.94 and P = 0.008 for lung cancer risk.0.018273822010CHRNB41578628735CG,T
rs72147232373728884254CAMKK1umls:C0242379BeFreePolymorphism rs7214723 in CAMKK1 and lung cancer risk in Chinese population.0.0050055062013CAMKK1173872554TC
rs721472323737288805CALM2umls:C0242379BeFreePolymorphism rs7214723 was reported to be associated with lung cancer risk in UK Caucasians and caused the E375G substitution of CAMKK1 which plays important role in the calcium/calmodulin-dependent kinase cascade.0.0010857672013CAMKK1173872554TC
rs7249320191701962208FCER2umls:C0242379GAD[Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China.]0.0023670322009FCER2197698159CA
rs7354822414046010848PPP1R13Lumls:C0242379BeFreeThe haplotype ERCC2 rs3916874(G) and rs238415(C) [OR (95% CI)=1.26 (1.02-1.57), P=0.03] in block 1 and the haplotype PPP1R13L rs4803817(A), CD3EAP rs1046282(T), rs735482(C), ERCC1 rs3212980(A), rs3212964(G) [OR (95% CI)=3.56 (1.55-8.18), P=0.005] in block 3 were associated with lung cancer risk.0.0071770412013ERCC1;CD3EAP1945408744AC
rs7483172596549NAT1umls:C0242379BeFreeHeterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.0.0116396632007GSTM31109737079CT
rs7483172596544524MTHFRumls:C0242379BeFreeHeterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.0.056765162007GSTM31109737079CT
rs7483172596541548CYP2A6umls:C0242379BeFreeHeterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.0.0333662822007GSTM31109737079CT
rs7483172596542947GSTM3umls:C0242379BeFreeHeterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.0.0158308432007GSTM31109737079CT
rs7483172596545243ABCB1umls:C0242379BeFreeHeterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.0.0410102622007GSTM31109737079CT
rs7483172596542939GSTA2umls:C0242379BeFreeHeterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.0.0050055062007GSTM31109737079CT
rs748404196543039333TGM5umls:C0242379GAD[Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study.]0.1223670322009TGM51543267033TC
rs748404196543039333TGM5umls:C0242379GWASCATDeciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study.0.1223670322009TGM51543267033TC
rs749174247862341421CRYGDumls:C0242379BeFreeWhen Phase 2 software was used to reconstruct the haplotype for GSTP1, the haplotype CACA (rs749174+rs1695 + rs762803+rs4891) exhibited an increased risk of lung cancer among smokers (adjust odds ratio 1.53; 95%CI 1.04-2.25, P=0.033).0.0008143262014GSTP11167585782GA
rs7539552172530881037CLPTM1Lumls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.1428883322011LOC1053701131323719720AG
rs753955217253087015TERTumls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.1554182652011LOC1053701131323719720AG
rs753955217253084285MIPEPumls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.0002714422011LOC1053701131323719720AG
rs75395521725308150280HORMAD2umls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.0005428842011LOC1053701131323719720AG
rs753955217253088897MTMR3umls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.1205428842011LOC1053701131323719720AG
rs753955217253088626TP63umls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.1253528932011LOC1053701131323719720AG
rs753955217253083976LIFumls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.0002714422011LOC1053701131323719720AG
rs7539552172530855504TNFRSF19umls:C0242379BeFreeThe combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).0.0002714422011LOC1053701131323719720AG
rs762551242933731544CYP1A2umls:C0242379BeFreeCYP1A2 rs762551 polymorphism contributes to risk of lung cancer: a meta-analysis.0.0235507682013CYP1A21574749576CA
rs762551234624601544CYP1A2umls:C0242379BeFreeThese results suggest that the rs3569413 polymorphism of the CYP1A2 gene is associated with an increased risk of lung cancer and the rs762551 polymorphism of the CYP1A2 gene might be a potential biomarker for the risk of cancer among Caucasians.0.0235507682014CYP1A21574749576CA
rs7626795183856763556IL1RAPumls:C0242379GAD[Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.]0.0023670322008IL1RAP3190632672AG
rs762803247862341421CRYGDumls:C0242379BeFreeWhen Phase 2 software was used to reconstruct the haplotype for GSTP1, the haplotype CACA (rs749174+rs1695 + rs762803+rs4891) exhibited an increased risk of lung cancer among smokers (adjust odds ratio 1.53; 95%CI 1.04-2.25, P=0.033).0.0008143262014GSTP11167584785CA
rs76311019789190356FASLGumls:C0242379GAD[When numeric scores were assigned to both the SNP and demographic data, and sequentially combined by a simple algorithm in a risk model, the composite score was found to be linearly related to lung cancer risk with a bimodal distribution.]0.0200220232009FASLG1172658358CT
rs7631358251442419541CIR1umls:C0242379BeFreeAmong 16 SNPs, three SNPs (colony-stimulating factor 1 receptor [CSF1R] rs10079250A>G, tumor protein p63 [TP63] rs7631358G>A, and corepressor interacting with RBPJ 1 [CIR1] rs13009079T>C) were found to be significantly associated with lung cancer in the same direction as the discovery set.0.0002714422015TP633189630622GA
rs7631358251442418626TP63umls:C0242379BeFreeAmong 16 SNPs, three SNPs (colony-stimulating factor 1 receptor [CSF1R] rs10079250A>G, tumor protein p63 [TP63] rs7631358G>A, and corepressor interacting with RBPJ 1 [CIR1] rs13009079T>C) were found to be significantly associated with lung cancer in the same direction as the discovery set.0.1253528932015TP633189630622GA
rs78378222237426737157TP53umls:C0242379BeFreeAssociation between a rare novel TP53 variant (rs78378222) and melanoma, squamous cell carcinoma of head and neck and lung cancer susceptibility in non-Hispanic Whites.0.162013TP53177668434TG
rs7876893223792636596BCL2umls:C0242379BeFreeAmong the mutations investigated, we previously found that PXN variant A127T in lung cancer cells enhanced cell proliferation and focal adhesion formation and colocalized with the anti-apoptotic protein B Cell Lymphoma 2 (BCL-2), which is known to localize to the mitochondria, among other sites.0.0183061582014PXN12120222977CG,T
rs79699311641026355259CASC1umls:C0242379BeFreeThese findings suggest that the LRMP V141L polymorphism can predict survival in lung ADCA and that the role of LRMP and CASC1 in human lung cancer risk may differ from that in mice.0.0005428842006LRMP1225089661CA,G
rs7969931164102634033LRMPumls:C0242379BeFreeA V141L polymorphism of the human LRMP gene is associated with survival of lung cancer patients.0.0026384742006LRMP1225089661CA,G
rs803419118385738123688HYKKumls:C0242379GWASCATA susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25.0.1337352532008HYKK1578513681TC
rs8034191183857385685PSMA4umls:C0242379GAD[A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25.]0.0147450762008HYKK1578513681TC
rs8034191183856765685PSMA4umls:C0242379GAD[Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.]0.0147450762008HYKK1578513681TC
rs8034191183857381143CHRNB4umls:C0242379GAD[A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25.]0.018273822008HYKK1578513681TC
rs8034191187808721143CHRNB4umls:C0242379GAD[We identified associations between common sequence variants at 15q24-25.1 (that spanned LOC123688 a hypothetical gene, PSMA4, CHRNA3, CHRNA5, and CHRNB4) and lung cancer.]0.018273822008HYKK1578513681TC
rs803419118780872123688HYKKumls:C0242379GWASCATWe identified associations between common sequence variants at 15q24-25.1 (that spanned LOC123688 [a hypothetical gene], PSMA4, CHRNA3, CHRNA5, and CHRNB4) and lung cancer.0.1337352532008HYKK1578513681TC
rs8034191227015901136CHRNA3umls:C0242379BeFreeOur findings demonstrated that CHRNA3 gene rs1051730-A allele and AGPHD1 gene rs8034191-T allele might be risk-conferring factors for the development of lung cancer in Caucasians, but not in East-Asians.0.1792081372012HYKK1578513681TC
rs803419125854352123688HYKKumls:C0242379BeFreeMeta-analysis of the association between the rs8034191 polymorphism in AGPHD1 and lung cancer risk.0.1337352532016HYKK1578513681TC
rs8034191187808721138CHRNA5umls:C0242379GAD[We identified associations between common sequence variants at 15q24-25.1 (that spanned LOC123688 a hypothetical gene, PSMA4, CHRNA3, CHRNA5, and CHRNB4) and lung cancer.]0.0598269662008HYKK1578513681TC
rs803419119654303123688HYKKumls:C0242379GWASCATDeciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study.0.1337352532009HYKK1578513681TC
rs8034191187808725685PSMA4umls:C0242379GAD[We identified associations between common sequence variants at 15q24-25.1 (that spanned LOC123688 a hypothetical gene, PSMA4, CHRNA3, CHRNA5, and CHRNB4) and lung cancer.]0.0147450762008HYKK1578513681TC
rs803419122701590123688HYKKumls:C0242379BeFreeOur findings demonstrated that CHRNA3 gene rs1051730-A allele and AGPHD1 gene rs8034191-T allele might be risk-conferring factors for the development of lung cancer in Caucasians, but not in East-Asians.0.1337352532012HYKK1578513681TC
rs803419118385676123688HYKKumls:C0242379GWASCATGenome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.0.1337352532008HYKK1578513681TC
rs8034191200680851136CHRNA3umls:C0242379BeFreeSimilarly, neither CHRNA3 rs8034191 nor rs1051730 were associated with lung cancer risk.0.1792081372010HYKK1578513681TC
rs8040868229456517015TERTumls:C0242379BeFreeSingle-nucleotide polymorphisms rs421629 on 5p15.33 and rs1948, rs660652, rs8040868 and rs2036527 on 15q25.1, previously identified as lung cancer risk or nicotine-addiction modifiers, were associated with tumor DNA methylation levels in the promoters of TERT and CHRNB4 (P<0.001), respectively, in two independent sample sets (n=82; n=150).0.1554182652013CHRNA31578618839TC
rs8042374189787871136CHRNA3umls:C0242379GWASCATCommon 5p15.33 and 6p21.33 variants influence lung cancer risk.0.1792081372008CHRNA31578615690AG
rs833061254688057422VEGFAumls:C0242379BeFreers833061 and rs699947 on promoter gene of vascular endothelial growth factor (VEGF) and associated lung cancer susceptibility and survival: a meta-analysis.0.0429426932015VEGFA643769749CT
rs861539205005157517XRCC3umls:C0242379BeFreeXRCC3 Thr241Met polymorphism with lung cancer and bladder cancer: a meta-analysis.0.0443871172010KLC1;XRCC314103699416GA
rs861539232894427517XRCC3umls:C0242379BeFreeXRCC3 Thr241Met gene polymorphisms and lung cancer risk: a meta-analysis.0.0443871172013KLC1;XRCC314103699416GA
rs861539250663997517XRCC3umls:C0242379BeFreeMeta analysis of XRCC3 Thr241Met polymorphism and lung cancer susceptibility of populations in East Asia.0.0443871172014KLC1;XRCC314103699416GA
rs861539225255587517XRCC3umls:C0242379BeFreeCYP1A1 rs4646903 (OR = 1.72, 95% CI = 1.25-2.38), rs1048943 (OR = 1.40, 95% CI = 1.02-1.92), the GSTM1 deletion polymorphism (OR = 1.38, 95% CI = 1.01-1.89), GSTP1 rs1695 (OR =1.48, 95% CI = 1.04-2.11), ERCC2 rs13181 (OR = 1.89, 95% CI = 1.28-2.78), and Chinese hamster 1 rs25487 (OR = 1.54, 95% CI = 1.12-2.13) were associated with lung cancer risk whereas the GSTT1 deletion polymorphism and XRCC3 rs861539 were not.0.0443871172012KLC1;XRCC314103699416GA
rs861539225255582952GSTT1umls:C0242379BeFreeCYP1A1 rs4646903 (OR = 1.72, 95% CI = 1.25-2.38), rs1048943 (OR = 1.40, 95% CI = 1.02-1.92), the GSTM1 deletion polymorphism (OR = 1.38, 95% CI = 1.01-1.89), GSTP1 rs1695 (OR =1.48, 95% CI = 1.04-2.11), ERCC2 rs13181 (OR = 1.89, 95% CI = 1.28-2.78), and Chinese hamster 1 rs25487 (OR = 1.54, 95% CI = 1.12-2.13) were associated with lung cancer risk whereas the GSTT1 deletion polymorphism and XRCC3 rs861539 were not.0.100358142012KLC1;XRCC314103699416GA
rs861539255011607517XRCC3umls:C0242379BeFreeXRCC3 T241M polymorphism and lung cancer risk in the Han Chinese population: a meta-analysis.0.0443871172015KLC1;XRCC314103699416GA
rs861539190319377517XRCC3umls:C0242379BeFreeOn the other hand, they suggested an increased risk in individuals with the XRCC3 Thr241Met polymorphism thus warranting further study to definitively evaluate the role of DNA repair mechanisms in colorectal and lung cancer susceptibility.0.0443871172008KLC1;XRCC314103699416GA
rs861539239904587517XRCC3umls:C0242379BeFreePrevious published data on the association between X-ray repair cross-complementing group 3 (XRCC3) Thr241Met polymorphism and clinical outcome of platinum-based chemotherapy in patients with lung cancer reported conflicting results.0.0443871172013KLC1;XRCC314103699416GA
rs861539235627217517XRCC3umls:C0242379BeFreeIn summary, this meta-analysis suggests the participation of XRCC3 T241M in the susceptibility for bladder cancer and breast cancer, especially in Caucasians, and XRCC3 T241M polymorphism is associated with decreased lung cancer risk.0.0443871172013KLC1;XRCC314103699416GA
rs861539257945977517XRCC3umls:C0242379BeFreeDNA repair gene XRCC3 Thr241Met polymorphisms and lung cancer risk: a meta-analysis.0.0443871172014KLC1;XRCC314103699416GA
rs861539239828807517XRCC3umls:C0242379BeFreeComprehensive assessment of the association between DNA repair gene XRCC3 rs861539 C/T polymorphism and lung cancer risk.0.0443871172013KLC1;XRCC314103699416GA
rs861539189907487157TP53umls:C0242379BeFreeFour of the variants were found to be weakly associated with lung cancer risk with borderline significance: these were XRCC3 T241M [heterozygote odds ratio (OR), 0.89; 95% confidence interval (95% CI), 0.79-0.99 and homozygote OR, 0.84; 95% CI, 0.71-1.00] based on 3,467 cases and 5,021 controls from 8 studies, XPD K751Q (heterozygote OR, 0.99; 95% CI, 0.89-1.10 and homozygote OR, 1.19; 95% CI, 1.02-1.39) based on 6,463 cases and 6,603 controls from 9 studies, and TP53 R72P (heterozygote OR, 1.14; 95% CI, 1.00-1.29 and homozygote OR, 1.20; 95% CI, 1.02-1.42) based on 3,610 cases and 5,293 controls from 6 studies.0.162008KLC1;XRCC314103699416GA
rs861539235261287517XRCC3umls:C0242379BeFreeLack of association between XRCC3 rs861539 (C > T) polymorphism and lung cancer risks: an update meta-analysis.0.0443871172013KLC1;XRCC314103699416GA
rs861539225255582950GSTP1umls:C0242379BeFreeCYP1A1 rs4646903 (OR = 1.72, 95% CI = 1.25-2.38), rs1048943 (OR = 1.40, 95% CI = 1.02-1.92), the GSTM1 deletion polymorphism (OR = 1.38, 95% CI = 1.01-1.89), GSTP1 rs1695 (OR =1.48, 95% CI = 1.04-2.11), ERCC2 rs13181 (OR = 1.89, 95% CI = 1.28-2.78), and Chinese hamster 1 rs25487 (OR = 1.54, 95% CI = 1.12-2.13) were associated with lung cancer risk whereas the GSTT1 deletion polymorphism and XRCC3 rs861539 were not.0.0924863262012KLC1;XRCC314103699416GA
rs861539233000097517XRCC3umls:C0242379BeFreeNo significant association between the XRCC3 Thr241Met polymorphism and lung cancer risk: a meta-analysis.0.0443871172013KLC1;XRCC314103699416GA
rs861539189907487517XRCC3umls:C0242379BeFreeFour of the variants were found to be weakly associated with lung cancer risk with borderline significance: these were XRCC3 T241M [heterozygote odds ratio (OR), 0.89; 95% confidence interval (95% CI), 0.79-0.99 and homozygote OR, 0.84; 95% CI, 0.71-1.00] based on 3,467 cases and 5,021 controls from 8 studies, XPD K751Q (heterozygote OR, 0.99; 95% CI, 0.89-1.10 and homozygote OR, 1.19; 95% CI, 1.02-1.39) based on 6,463 cases and 6,603 controls from 9 studies, and TP53 R72P (heterozygote OR, 1.14; 95% CI, 1.00-1.29 and homozygote OR, 1.20; 95% CI, 1.02-1.42) based on 3,610 cases and 5,293 controls from 6 studies.0.0443871172008KLC1;XRCC314103699416GA
rs861539189907482068ERCC2umls:C0242379BeFreeFour of the variants were found to be weakly associated with lung cancer risk with borderline significance: these were XRCC3 T241M [heterozygote odds ratio (OR), 0.89; 95% confidence interval (95% CI), 0.79-0.99 and homozygote OR, 0.84; 95% CI, 0.71-1.00] based on 3,467 cases and 5,021 controls from 8 studies, XPD K751Q (heterozygote OR, 0.99; 95% CI, 0.89-1.10 and homozygote OR, 1.19; 95% CI, 1.02-1.39) based on 6,463 cases and 6,603 controls from 9 studies, and TP53 R72P (heterozygote OR, 1.14; 95% CI, 1.00-1.29 and homozygote OR, 1.20; 95% CI, 1.02-1.42) based on 3,610 cases and 5,293 controls from 6 studies.0.2138435352008KLC1;XRCC314103699416GA
rs861539211982607517XRCC3umls:C0242379BeFreeWe here analyzed associations of XPD Lys751Gln, APEX1 Asp148Glu, XRCC1 Arg399Gln, and XRCC3 Thr241Met gene polymorphisms in DNA repair pathways in relation to the risk of lung cancer using PCR-RFLP.0.0443871172010KLC1;XRCC314103699416GA
rs861539177058147508XPCumls:C0242379BeFreeWe investigated the relationship between polymorphisms in two NER genes, XPC (poly (AT) insertion/deletion: PAT-/+) and XPD (Asp312Asn and Lys751Gln), the BER gene XRCC1 (Arg399Gln), and the DSBR gene XRCC3 (Thr241Met) and the risk of developing lung cancer.0.0443111722007KLC1;XRCC314103699416GA
rs868188166916269826ARHGEF11umls:C0242379BeFreeFor the current report, the authors studied the risk of lung cancer associated with a nonsynonymous SNP (rs868188; Ser1416Gly) in PDZ-RhoGEF in a large lung cancer case-control study of 2260 Caucasians and 369 Mexican Americans.0.0026384742006ARHGEF11;LRRC71;MIR7651156937323TC
rs8767412233726584552MTRRumls:C0242379BeFreeSNPs in MTRR (rs13162612; OR = 0.25; 95% CI: 0.11-0.58; rs10512948; OR = 0.61; 95% CI: 0.41-0.90; rs2924471; OR = 3.31; 95% CI: 1.66-6.59), and MTHFR (rs9651118; OR = 0.63; 95% CI: 0.43-0.95) and three SNP*nutrient interactions (choline*rs10475407; OR = 1.62; 95% CI: 1.11-2.42; choline*rs11134290; OR = 0.51; 95% CI: 0.27-0.92; and riboflavin*rs8767412; OR = 0.40; 95% CI: 0.15-0.95) were associated with lung cancer risk in never smokers.0.0105538952013NANANANANA
rs8767412233726584524MTHFRumls:C0242379BeFreeSNPs in MTRR (rs13162612; OR = 0.25; 95% CI: 0.11-0.58; rs10512948; OR = 0.61; 95% CI: 0.41-0.90; rs2924471; OR = 3.31; 95% CI: 1.66-6.59), and MTHFR (rs9651118; OR = 0.63; 95% CI: 0.43-0.95) and three SNP*nutrient interactions (choline*rs10475407; OR = 1.62; 95% CI: 1.11-2.42; choline*rs11134290; OR = 0.51; 95% CI: 0.27-0.92; and riboflavin*rs8767412; OR = 0.40; 95% CI: 0.15-0.95) were associated with lung cancer risk in never smokers.0.056765162013NANANANANA
rs9282861222060162052EPHX1umls:C0242379BeFreeMDR analysis identified two distinct predictor models for the risk of lung cancer in smokers (tobacco chewing, EPHX1 Tyr113His, and SULT1A1 Arg213His) and non-smokers (CYP1A1*2A, GSTP1 Ile105Val and SULT1A1 Arg213His) with testing balance accuracy (TBA) of 0.6436 and 0.6677 respectively.0.0660377912011SULT1A1;NPIPB81628606193CT
rs9282861222060166817SULT1A1umls:C0242379BeFreeMDR analysis identified two distinct predictor models for the risk of lung cancer in smokers (tobacco chewing, EPHX1 Tyr113His, and SULT1A1 Arg213His) and non-smokers (CYP1A1*2A, GSTP1 Ile105Val and SULT1A1 Arg213His) with testing balance accuracy (TBA) of 0.6436 and 0.6677 respectively.0.0134638112011SULT1A1;NPIPB81628606193CT
rs9282861193505376817SULT1A1umls:C0242379BeFreeAn investigation of the relationship between SULT1A1 Arg(213)His polymorphism and lung cancer susceptibility in a Turkish population.0.0134638112009SULT1A1;NPIPB81628606193CT
rs9282861193505376876TAGLNumls:C0242379BeFreeStatistical analyses of histological types of lung cancer in comparison with the control individuals indicated a significant difference between SULT1A1 Arg(213)His polymorphism and SCC (p = 0.027) and other types of cancer (p = 0.037), except SMCC (p = 0.854).0.0008143262009SULT1A1;NPIPB81628606193CT
rs9282861225248286817SULT1A1umls:C0242379BeFreeSULT1A1 Arg213His polymorphism and lung cancer risk: a meta-analysis.0.0134638112012SULT1A1;NPIPB81628606193CT
rs9282861146880216817SULT1A1umls:C0242379BeFreeA functional polymorphism in the SULT1A1 gene (G638A) is associated with risk of lung cancer in relation to tobacco smoking.0.0134638112004SULT1A1;NPIPB81628606193CT
rs934421965784595CCND1umls:C0242379BeFreeThese findings support the conclusion that cell cycle regulation may play a role in lung cancer development and that CCND1 rs9344 polymorphism together with smoking habit maybe a useful biomarker for lung cancer prediction.0.0240500442011CCND11169648142GA
rs9469031259374447916PRRC2Aumls:C0242379BeFreeWe identified three low-frequency missense variants in BAT2 (rs9469031, c.1544C>T [p.Pro515Leu]; odds ratio [OR] = 0.55, p = 1.28 × 10(-10)), FKBPL (rs200847762, c.410C>T [p.Pro137Leu]; OR = 0.25, p = 9.79 × 10(-12)), and BPIFB1 (rs6141383, c.850G>A [p.Val284Met]; OR = 1.72, p = 1.79 × 10(-7)); these variants were associated with lung cancer risk. rs9469031 in BAT2 and rs6141383 in BPIFB1 were also associated with the age of onset of lung cancer (p = 0.001 and 0.006, respectively).0.0002714422015PRRC2A631628018CT
rs94690312593744492747BPIFB1umls:C0242379BeFreeWe identified three low-frequency missense variants in BAT2 (rs9469031, c.1544C>T [p.Pro515Leu]; odds ratio [OR] = 0.55, p = 1.28 × 10(-10)), FKBPL (rs200847762, c.410C>T [p.Pro137Leu]; OR = 0.25, p = 9.79 × 10(-12)), and BPIFB1 (rs6141383, c.850G>A [p.Val284Met]; OR = 1.72, p = 1.79 × 10(-7)); these variants were associated with lung cancer risk. rs9469031 in BAT2 and rs6141383 in BPIFB1 were also associated with the age of onset of lung cancer (p = 0.001 and 0.006, respectively).0.0002714422015PRRC2A631628018CT
rs9651118233726584524MTHFRumls:C0242379BeFreeSNPs in MTRR (rs13162612; OR = 0.25; 95% CI: 0.11-0.58; rs10512948; OR = 0.61; 95% CI: 0.41-0.90; rs2924471; OR = 3.31; 95% CI: 1.66-6.59), and MTHFR (rs9651118; OR = 0.63; 95% CI: 0.43-0.95) and three SNP*nutrient interactions (choline*rs10475407; OR = 1.62; 95% CI: 1.11-2.42; choline*rs11134290; OR = 0.51; 95% CI: 0.27-0.92; and riboflavin*rs8767412; OR = 0.40; 95% CI: 0.15-0.95) were associated with lung cancer risk in never smokers.0.056765162013MTHFR111802157TC
rs9651118233726584552MTRRumls:C0242379BeFreeSNPs in MTRR (rs13162612; OR = 0.25; 95% CI: 0.11-0.58; rs10512948; OR = 0.61; 95% CI: 0.41-0.90; rs2924471; OR = 3.31; 95% CI: 1.66-6.59), and MTHFR (rs9651118; OR = 0.63; 95% CI: 0.43-0.95) and three SNP*nutrient interactions (choline*rs10475407; OR = 1.62; 95% CI: 1.11-2.42; choline*rs11134290; OR = 0.51; 95% CI: 0.27-0.92; and riboflavin*rs8767412; OR = 0.40; 95% CI: 0.15-0.95) were associated with lung cancer risk in never smokers.0.0105538952013MTHFR111802157TC
rs9675912233588810849CD3EAPumls:C0242379BeFreeA specific diplotype defined by PPP1R13L rs1970764, CD3EAP rs967591 and ERCC1 rs11615 and lung cancer risk in a Chinese population.0.0039956832012PPP1R13L;CD3EAP1945406676GA
rs9675911828936710848PPP1R13Lumls:C0242379BeFreeThe haplotype at chromosome 19q13.2-3 encompassing the three SNPs ASE-1 G-21A, RAI IVS1 A4364G and ERCC1 Asn118Asn have been associated with risk of breast cancer and lung cancer.0.0071770412008PPP1R13L;CD3EAP1945406676GA
rs967591223358882067ERCC1umls:C0242379BeFreeA specific diplotype defined by PPP1R13L rs1970764, CD3EAP rs967591 and ERCC1 rs11615 and lung cancer risk in a Chinese population.0.0670476142012PPP1R13L;CD3EAP1945406676GA
rs9675911828936710849CD3EAPumls:C0242379BeFreeThe haplotype at chromosome 19q13.2-3 encompassing the three SNPs ASE-1 G-21A, RAI IVS1 A4364G and ERCC1 Asn118Asn have been associated with risk of breast cancer and lung cancer.0.0039956832008PPP1R13L;CD3EAP1945406676GA
rs9675912233588810848PPP1R13Lumls:C0242379BeFreeA specific diplotype defined by PPP1R13L rs1970764, CD3EAP rs967591 and ERCC1 rs11615 and lung cancer risk in a Chinese population.0.0071770412012PPP1R13L;CD3EAP1945406676GA
rs967591182893672067ERCC1umls:C0242379BeFreeThe haplotype at chromosome 19q13.2-3 encompassing the three SNPs ASE-1 G-21A, RAI IVS1 A4364G and ERCC1 Asn118Asn have been associated with risk of breast cancer and lung cancer.0.0670476142008PPP1R13L;CD3EAP1945406676GA
rs99123002522779747ACLYumls:C0242379BeFreeAdditionally, SNP rs9912300 in ACLY gene was significantly associated with overall survival in lung cancer patients (HR, 1.41; 95%CI, 1.02-1.94, p=0.04) under the dominant model.0.0013572092015ACLY1741869011GT
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:3556)
CHR POS SNPID REF ALT ORI_SNPID PMID P_VALUE P_VALUE_TEXT OR/BETA CI95_TEXT GWAS_INITIAL_SAMPLE_SIZE SUB_POPULATION SUPER_POPULATION GWAS_TRAIT HPO_ID HPO_TERM DO_ID DO_TERM MESH_ID MESH_TERM EFO_ID EFO_TERM DOLITE_TERM RISK_ALLELE PUBLICATION_TYPE AA GENE_SYMBOL TYPE REFGENE
12865778rs7548727TCrs7548727230064234.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
14224558rs4654497TCrs4654497230064239.22E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
15913621rs548726TCrs548726230064235.00E-07NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
17485306rs11120921CTrs11120921230064234.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
18046672rs12727642CArs12727642230064235.94E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
18129507rs12748993AGrs12748993230064239.00E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
18133352rs7539255TCrs7539255230064236.76E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
112796044rs3010903GTrs3010903230064234.39E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
117305903rs9435730GArs9435730230064233.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
117310019rs3754511GArs3754511230064231.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
117323449rs9435736TCrs9435736230064237.78E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
117660499rs874881GCrs874881230064238.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
118447490rs16861578CArs16861578230064232.99E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
119135214rs7417542GArs7417542230064238.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
127883227rs17162040TCrs17162040230064233.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
134023749rs915108TCrs915108189787875.88E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
135315737rs6703979CTrs6703979189787903.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
137197720rs6425998TCrs6425998230064236.29E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
137198352rs7549591TCrs7549591230064235.81E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
137212617rs502808GArs502808230064235.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
137220721rs1472823GArs1472823230064236.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
137233430rs12083196TCrs12083196230064234.76E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
139060495rs12026014GArs12026014230064235.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
140362066rs3134615CArs3134615230064235.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
141104475rs3767955GArs3767955230064233.60E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
141464437rs12408576AGrs12408576230064239.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
141485589rs6678816GTrs6678816230064234.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
141487337rs17357954GTrs17357954230064235.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
141562243rs2024860CTrs2024860230064236.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
141563329rs721651ACrs721651230064237.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
141607331rs213753AGrs213753230064235.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
141638398rs12127030ACrs12127030230064238.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
141666929rs6672914CTrs6672914230064236.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
141716039rs3845571ACrs3845571230064235.39E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
142879737rs9803864TGrs9803864230064238.36E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
143785768rs1098182GCrs1098182230064234.51E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
149059615rs319960CTrs319960230064231.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
150105201rs2051086TA,Crs2051086230064239.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
153713336rs10788950AGrs10788950230064235.50E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
154585415rs12063422TCrs12063422230064231.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
155803411rs207160CTrs207160230064238.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
156898998rs4363444CTrs4363444230064232.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
156903392rs7550882CTrs7550882230064238.33E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
156905072rs2780293AGrs2780293230064239.71E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
156905211rs6588628AGrs6588628230064234.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
156907720rs4319365GArs4319365230064235.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
156909550rs6694114GArs6694114230064239.88E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
157954416rs2691462CTrs2691462230064233.42E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
158431135rs1343635TCrs1343635230064237.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
161607034rs2008968CTrs2008968230064231.01E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
162387598rs2482863TCrs2482863230064239.34E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
162516683rs2498982GCrs2498982230064238.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
163389782rs13376351GArs13376351230064238.00E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
163456797rs17124192AGrs17124192230064235.76E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
163459814rs17124200GArs17124200230064231.28E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
169993512rs4589058AGrs4589058230064233.33E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
170014986rs947420CTrs947420230064232.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
171520017rs12402425GArs12402425230064237.88E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
173911420rs4350155CGrs4350155230064235.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
178025551rs3509CTrs3509230064237.21E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
179036992rs12737480CTrs12737480189787904.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
179041520rs6424779CTrs6424779189787908.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
179543571rs1332829CArs1332829230064238.71E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
180116138rs11162772AGrs11162772230064236.89E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
183036341rs11579295AGrs11579295230064238.18E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
183039338rs9729834GArs9729834230064234.73E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
183052706rs17108556GArs17108556230064231.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
183054799rs10874322CTrs10874322230064232.00E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (docetaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
183055625rs1281400CGrs1281400230064237.14E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
183058155rs2011057CTrs2011057230064235.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
183221252rs17109039GTrs17109039230064232.53E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
183225779rs11807023CTrs11807023230064233.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
183701728rs12403322AGrs12403322230064238.36E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
184067452rs4363435GArs4363435230064235.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
192153974rs11165262TCrs11165262230064232.39E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
192156208rs12133463CTrs12133463230064237.99E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
192175008rs2046736CTrs2046736230064232.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
192177062rs17512269CTrs17512269230064233.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
195379758rs12067920AGrs12067920230064233.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
197701403rs17116594CTrs17116594230064236.96E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1101834723rs11802191CArs11802191230064237.86E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1104547617rs4141899TCrs4141899230064232.88E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1104562381rs12026645AGrs12026645230064239.09E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1104572622rs12031508ATrs12031508230064238.75E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1105081913rs12022925TGrs12022925230064238.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1105088785rs12026360GArs12026360230064235.19E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1105089396rs2121956AGrs2121956230064231.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1105090738rs316942AGrs316942230064232.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1105091696rs1448378TCrs1448378230064232.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1105095501rs11578246TGrs11578246230064235.16E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1105102314rs2084447AGrs2084447230064233.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1105106498rs7553985TCrs7553985230064232.77E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1105115188rs11184211AGrs11184211230064233.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1105118613rs1448394GArs1448394230064234.30E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1105119392rs11184213CTrs11184213230064238.32E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1105449139rs1376368CTrs1376368230064234.25E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1105508155rs991024TCrs991024230064239.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1105509351rs9729540TCrs9729540230064239.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1106653622rs1889463TCrs1889463230064237.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1109471634rs839854TGrs839854230064231.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1109486196rs338466AGrs338466230064234.62E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1109494147rs839547AGrs839547230064231.42E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1109611326rs28634276TGrs28634276230064237.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1110684287rs10494113TCrs10494113230064234.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1110686356rs1123250AGrs1123250230064239.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1110690577rs975512GArs975512230064236.16E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1111062049rs17025957CTrs17025957230064233.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1119319805rs4659120AGrs4659120230064231.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1119899035rs838528GTrs838528230064239.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1154423485rs4845626GTrs4845626230064234.96E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1154430092rs11265618CTrs11265618230064238.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1155095158rs11264329AGrs11264329196543031.22E-06NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1156063880rs10737170CArs10737170230064232.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1159680868rs2808630CTrs2808630183856767.00E-06 1.22[1.10-1.35] 1,154 cases; 1,137 controlsNOPOP(2291)ALL(2291)NOPOP(2291)ALL(2291)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs2808630-GResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
1160415924rs12757461GArs12757461230064234.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1160420036rs11585691CTrs11585691230064235.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1160428188rs1149392AGrs1149392230064237.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1160922195rs2252389AGrs2252389230064234.87E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1161956109rs12217099CTrs12217099230064238.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1163364512rs6704467AGrs6704467230064238.03E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1165462091rs184041GCrs184041230064235.29E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1165573850rs1337441AGrs1337441230064233.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1167506663rs932398TCrs932398230064239.81E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1167510837rs2860662TCrs2860662230064236.00E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1167510996rs2143300GArs2143300230064236.00E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1167523387rs1737487TCrs1737487230064236.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1170715531rs2421494GArs2421494230064238.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1170719187rs991230GArs991230230064237.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1170797204rs6677161CTrs6677161230064236.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1171151638rs12752688CTrs12752688230064233.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1173389640rs4294450CTrs4294450230064231.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1173398436rs3934576TCrs3934576230064231.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1173398533rs3934575TCrs3934575230064231.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1173438399rs6660804CArs6660804230064237.89E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1173456445rs912767AGrs912767230064236.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1173465265rs7521536TCrs7521536230064233.46E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1173470105rs12065426AGrs12065426230064233.61E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1174988016rs10912870CTrs10912870230064237.25E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1176520317rs6671694CTrs6671694230064239.65E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1178719306rs4651005CTrs4651005230064238.94E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1179084080rs2274230TGrs2274230230064234.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1179084408rs9724754CArs9724754230064234.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1179100710rs17277358CTrs17277358230064234.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1184391279rs11799574CArs11799574230064235.16E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1184394956rs12145326CTrs12145326230064235.16E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1184560541rs17255321CArs17255321230064234.19E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1186844926rs2223307CTrs2223307230064237.33E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1187522674rs2891285TCrs2891285230064238.96E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1191622277rs6698540ATrs6698540230064232.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1191627004rs1338035CTrs1338035230064239.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1195267072rs6428282CArs6428282230064237.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1197361571rs2759662GArs2759662230064238.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1197363948rs10922215GArs10922215230064236.78E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1197372250rs11802794CArs11802794230064236.78E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1197372437rs11799515GTrs11799515230064238.60E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1197555860rs11583319AGrs11583319230064238.40E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1197615058rs6688289CTrs6688289230064232.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1197702401rs2488401CTrs2488401230064231.88E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1197743506rs1539414GArs1539414230064232.01E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1197785420rs12121863AGrs12121863230064237.42E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1201041198rs9427712GArs9427712230064233.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1201041364rs9427713GArs9427713230064232.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1201256533rs7517345GArs7517345230064236.79E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1201257373rs16848229AGrs16848229230064239.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1201258519rs832174ATrs832174230064238.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1202151566rs10920357AGrs10920357230064232.75E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1203492121rs6688116AGrs6688116230064231.14E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1204810161rs750087GArs750087230064239.36E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1205070573rs11240358GArs11240358230064238.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1209081485rs12566014TCrs12566014230064239.98E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1209600258rs17014465ACrs17014465230064238.89E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1209871977rs11808911CTrs11808911230064233.29E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1210819646rs12096661ACrs12096661230064235.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1210830320rs4472816TCrs4472816230064235.89E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1211081403rs6656271AGrs6656271230064233.61E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1211222705rs6662529CTrs6662529230064237.75E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1211272818rs17267442CTrs17267442230064237.16E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1212913168rs2271148TCrs2271148230064237.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1213932821rs12041173TCrs12041173230064232.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1214293994rs1795033TGrs1795033230064233.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1218008788rs6674883GArs6674883230064235.62E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1218761681rs17048238CTrs17048238230064239.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1222732656rs4481859TGrs4481859230064239.43E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1222733971rs10495194CTrs10495194230064238.20E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1222759007rs3008647TCrs3008647230064231.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1222762709rs17464857TGrs17464857230064239.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1222762773rs2936041TArs2936041230064231.03E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1222762958rs17511318AGrs17511318230064239.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1222764791rs3008653GCrs3008653230064231.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1222766609rs3008654AGrs3008654230064233.93E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1222770703rs1909194AGrs1909194230064239.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1222772139rs3002130CTrs3002130230064233.93E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1222779948rs3008598TCrs3008598230064239.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1226012686rs3753658GTrs3753658230064234.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1226287622rs11577282TGrs11577282230064233.91E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1227584651rs3000777GArs3000777230064235.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1230983656rs1202558CTrs1202558230064234.32E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1231000791rs1202580AGrs1202580230064237.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1231001233rs1202582TCrs1202582230064236.07E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1231002150rs1202584AGrs1202584230064239.53E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1232394263rs4649384TGrs4649384230064232.87E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1233052341rs2224402AGrs2224402230064238.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1233477868rs6665230ACrs6665230230064235.03E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1233479064rs7526011TCrs7526011230064237.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1233479355rs1533777TCrs1533777230064232.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1234581891rs3768286CTrs3768286230064234.05E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1234584926rs1334814ACrs1334814230064237.60E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1234666319rs271742TCrs271742230064234.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1237478709rs7514372AGrs7514372230064239.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1237613274rs2100969AGrs2100969230064235.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1237613571rs2086209CTrs2086209230064235.85E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1237617399rs4258212ACrs4258212230064235.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1237617757rs3765097CTrs3765097230064234.99E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1237620049rs2045955TCrs2045955230064231.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1237620954rs11588591GArs11588591230064231.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1237621239rs1478912TCrs1478912230064236.00E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (docetaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1237635103rs4436381ACrs4436381230064235.76E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1237635303rs4329502CArs4329502230064238.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1237635321rs4397648TCrs4397648230064238.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1237635416rs4625270TCrs4625270230064238.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1237635564rs4329503CTrs4329503230064238.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1237937874rs2249287CTrs2249287230064231.46E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1240055473rs10495448GArs10495448230064231.30E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1240786782rs6689991CTrs6689991230064239.32E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1241255581rs2492990TGrs2492990230064237.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1241257765rs2492988GArs2492988230064238.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1241885307rs7519667CTrs7519667230064232.71E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1244044810rs7553354ACrs7553354230064237.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1245626039rs1173657AGrs1173657230064232.40E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1245626278rs1093932TCrs1093932230064239.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1245626920rs1173658CTrs1173658230064232.40E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1245915582rs2185368AGrs2185368230064232.71E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1245932792rs2247524GArs2247524230064233.01E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1247000748rs2996550AGrs2996550230064231.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1247001166rs6685066AGrs6685066230064237.52E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1247006160rs5021094GTrs5021094230064237.27E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1247010734rs6688227CTrs6688227230064236.85E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1247018184rs7530860AGrs7530860230064234.35E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1247023866rs1630829CTrs1630829230064236.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1247139343rs6673828GArs6673828230064231.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1247202032rs10924897GTrs10924897230064234.68E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1247203606rs7547915TCrs7547915230064234.68E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1247204494rs12141355GCrs12141355230064234.68E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1247205056rs7549105AGrs7549105230064234.42E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1247214878rs4925540ACrs4925540230064232.00E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (docetaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1247215054rs1573897TCrs1573897230064232.00E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1247225034rs4634944TCrs4634944230064234.68E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1247226344rs10924899GArs10924899230064234.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1247226986rs7542852TGrs7542852230064234.34E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1247240863rs4925622TCrs4925622230064236.69E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1247251453rs12135374AGrs12135374230064233.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
21287872rs13411595TCrs13411595230064236.40E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
21287922rs11211641TA,Grs11211641230064239.33E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
21288297rs6738955CTrs6738955230064231.76E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
21291096rs7421044GArs7421044230064239.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
22605757rs7556672GTrs7556672230064236.09E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
22609713rs752787TArs752787230064238.02E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
22699840rs6714525TArs6714525230064237.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
23243238rs2694103GArs2694103230064231.62E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
25942145rs2722583CArs2722583230064232.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
26661877rs12465667TCrs12465667230064231.05E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
210521126rs6721270AGrs6721270230064237.37E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
210524780rs10198351CTrs10198351230064236.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
211226507rs4668712GArs4668712230064234.50E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
213367633rs10203818GArs10203818230064234.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
213368225rs13403000CTrs13403000230064232.22E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
213384186rs9678154AGrs9678154230064235.40E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
225165825rs17046742GArs17046742230064233.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
225596322rs562908097TGTrs7586928230064232.52E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
225596322rs7586928TCrs7586928230064232.52E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
226635328rs10179397ACrs10179397230064235.78E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
228690849rs11127158ACrs11127158230064238.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
228714750rs10203313CTrs10203313230064233.87E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
228716955rs11127160CArs11127160230064235.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
228726440rs12621347GCrs12621347230064234.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
228728254rs4398231AGrs4398231230064234.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
228731702rs12478824TCrs12478824230064234.50E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
228733361rs6748157AGrs6748157230064239.79E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
228735998rs13023754TCrs13023754230064234.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
230540833rs13014895TCrs13014895230064234.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
232510072rs390480GTrs390480230064235.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
233861293rs10200581CArs10200581230064237.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
234326938rs17014711GArs17014711230064236.07E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
236617528rs3770939GArs3770939230064237.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
243347127rs10199639CGrs10199639230064239.22E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
244112422rs2955279CTrs2955279230064237.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
244176225rs4390811GCrs4390811230064234.73E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
244185345rs10206724GArs10206724230064233.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
244187204rs6723119AGrs6723119230064235.94E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
244187829rs10190161ACrs10190161230064236.43E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
244189607rs10865195CTrs10865195230064238.77E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
244231918rs6730684CGrs6730684230064238.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
244231969rs6759184AGrs6759184230064234.43E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
245129440rs7561677CTrs7561677230064231.03E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
245465435rs11125013AGrs11125013230064237.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
247257977rs4952863TCrs4952863230064235.94E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
247262695rs11695952AGrs11695952230064236.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
247280156rs17541472GArs17541472230064233.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
247283557rs2436772GArs2436772230064234.26E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
247286759rs13393256ACrs13393256230064234.89E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
247819972rs4245815GArs4245815189787877.07E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
248824698rs13018198TCrs13018198230064232.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
248832414rs11693317TGrs11693317230064239.78E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
248832433rs7604334AGrs7604334230064237.39E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
248847174rs13028463GArs13028463230064235.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
251427174rs3732051CTrs3732051230064237.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
251680339rs13022923GArs13022923230064233.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
252332457rs13390640AGrs13390640230064239.50E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
252690413rs10193067ACrs10193067230064233.61E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
254041983rs2542571GTrs2542571230064233.36E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256088667rs11694213TArs11694213230064238.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256619366rs7563921TArs7563921230064231.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256628301rs4671281ATrs4671281230064233.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256629071rs17038123CArs17038123230064235.80E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256629093rs17038122AGrs17038122230064233.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256638627rs11694963TCrs11694963230064236.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256638856rs7582028CTrs7582028230064237.43E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256643955rs7600814CTrs7600814230064235.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256666949rs10202807TCrs10202807230064231.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256667121rs1117260TCrs1117260230064236.63E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256669447rs2869826AGrs2869826230064237.23E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256673449rs956157TCrs956157230064234.40E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256676363rs986787GArs986787230064236.18E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256679612rs11885335GArs11885335230064232.05E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256680920rs17047946GTrs17047946230064231.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256682547rs13397156CArs13397156230064232.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256687629rs4614971GArs4614971230064235.23E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256688264rs1465360AGrs1465360230064233.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256688330rs1465359AGrs1465359230064231.09E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256689048rs13382678GArs13382678230064231.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256695597rs10193613ACrs10193613230064235.21E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256696778rs1017272CTrs1017272230064234.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256700945rs1030334CG,Trs1030334230064236.66E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256701022rs1030333CArs1030333230064234.59E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256701657rs17047986TCrs17047986230064236.00E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256702495rs10490404CTrs10490404230064231.60E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256702871rs2033015TArs2033015230064232.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256708945rs879807GArs879807230064232.64E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256716928rs2113866ACrs2113866230064239.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256734035rs890100CArs890100230064236.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256734070rs890099GArs890099230064232.32E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256739650rs982116AGrs982116230064239.01E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256741751rs7605943TArs7605943230064232.28E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256746396rs2162025ATrs2162025230064232.62E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256746524rs10490407CTrs10490407230064239.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256750209rs17268931CTrs17268931230064232.53E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256752025rs987576AGrs987576230064236.25E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256754479rs1477521TCrs1477521230064233.81E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256756857rs6718973TCrs6718973230064232.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256759264rs7580218TGrs7580218230064232.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256759547rs7580549TCrs7580549230064231.46E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256759863rs1304899CGrs1304899230064231.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256760592rs2870064AGrs2870064230064235.37E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256761626rs4671282AGrs4671282230064236.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256761998rs4672130AGrs4672130230064232.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256764646rs996846AGrs996846230064231.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256765050rs1160085GArs1160085230064238.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256765635rs1156972ACrs1156972230064232.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256766538rs17048108CArs17048108230064239.64E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256770848rs1156672CTrs1156672230064232.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256771307rs17039629CArs17039629230064236.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256771330rs17190394TCrs17190394230064233.16E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256772337rs10490411TCrs10490411230064231.40E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256778009rs10208385CTrs10208385230064234.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256778360rs10210929CTrs10210929230064235.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256778687rs6721009ATrs6721009230064236.52E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256787100rs2194794CTrs2194794230064235.38E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256788428rs6719808AGrs6719808230064239.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256792506rs17048168TCrs17048168230064232.62E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256798398rs17048179GArs17048179230064233.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256798910rs4672140GArs4672140230064232.09E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256814463rs11125642GTrs11125642230064232.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256836621rs2112027TCrs2112027230064238.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256843605rs737030GArs737030230064233.03E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256849161rs6545584GArs6545584230064234.37E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256854346rs6722231ACrs6722231230064235.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256896324rs6757997CTrs6757997230064237.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256899555rs6728372TCrs6728372230064238.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
256924658rs2042119AGrs2042119230064235.61E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
259042739rs12386185CGrs12386185230064239.01E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
259047973rs10182324CTrs10182324230064239.46E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
259082438rs10198586GArs10198586230064234.14E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
260588713rs243016ATrs243016230064239.64E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
260590257rs243052GArs243052230064235.10E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
260592027rs243050GArs243050230064232.72E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
260595793rs243044GTrs243044230064232.57E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
260597565rs243039GArs243039230064232.98E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
260599100rs243037CGrs243037230064231.04E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
263126755rs11901070TCrs11901070183857383.60E-05NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
269036054rs6743599AGrs6743599230064235.43E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
269198388rs4254535TCrs4254535189787877.05E-06NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
269198388rs4254535TCrs4254535196543035.00E-06NA1.12NA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
269800579rs13431612TCrs13431612230064234.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
275363186rs741418GArs741418230064232.07E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
276146755rs6720541GArs6720541230064239.38E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
279699411rs1864549CArs1864549230064236.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
279708518rs17040658AGrs17040658230064239.50E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
279715879rs11900604TGrs11900604230064233.22E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
280230424rs6741085TGrs6741085230064234.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
281420899rs1968758GTrs1968758230064232.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
281421951rs13430688AGrs13430688230064231.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
281425437rs4852611CArs4852611230064238.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
281426483rs921963CArs921963230064232.65E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
281427187rs2010447CTrs2010447230064233.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
281440526rs6710284TCrs6710284230064234.09E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
281442038rs1379387GArs1379387230064237.03E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
281461019rs7557024AGrs7557024230064238.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
283278233rs17040798ACrs17040798230064234.48E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
283301097rs2043074TCrs2043074230064232.93E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
283315550rs724302CTrs724302230064239.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
283332983rs17023156TCrs17023156230064238.98E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
283335815rs963064AGrs963064230064239.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
283336271rs1430275AGrs1430275230064232.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
283336680rs1946554ATrs1946554230064236.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
283340623rs17023205CTrs17023205230064232.86E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
283342154rs10496293AGrs10496293230064234.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
283352379rs17023229TGrs17023229230064233.08E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
283357496rs17023252AGrs17023252230064236.70E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
283416683rs1430282CArs1430282230064238.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
285379914rs2568225TCrs2568225230064238.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
286613175rs6547678GArs6547678230064233.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
295812372rs3112996GArs3112996230064238.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
295816365rs3105104GArs3105104230064239.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
295838674rs3112229AGrs3112229230064238.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
295848018rs3105105TCrs3105105230064239.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
295848354rs1875402GArs1875402230064236.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
295856611rs2320624AGrs2320624230064239.32E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
295914095rs6748967GArs6748967230064239.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
295926154rs1966272CArs1966272230064239.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2100746573rs11692215CTrs11692215230064237.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2100811970rs7566527CTrs7566527230064238.79E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2100818479rs4851266CTrs4851266230064238.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2100839430rs2871344AGrs2871344230064238.65E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2105141788rs1866555CTrs1866555230064237.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2105144490rs6738747GArs6738747230064236.37E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2105148418rs17624303CTrs17624303230064239.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2105154379rs13429262GArs13429262230064239.76E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2105158182rs7608295ATrs7608295230064238.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2105158638rs17624523AGrs17624523230064238.00E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (docetaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2105160828rs17670403CTrs17670403230064232.52E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2105163835rs1530129CTrs1530129230064232.87E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2105165756rs2083350CArs2083350230064238.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2105167888rs714753GArs714753230064233.52E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2105170353rs6733728TCrs6733728230064233.31E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2105173128rs1561513CArs1561513230064235.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2105176835rs7586619TArs7586619230064236.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2106586012rs7609295AGrs7609295230064231.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2108891096rs2100405CTrs2100405230064238.28E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2111609385rs12151613CTrs12151613230064237.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2111609943rs10197140TCrs10197140230064235.03E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2111613145rs17465162TCrs17465162230064236.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2111627300rs880506GArs880506230064232.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2111630489rs1872062GTrs1872062230064234.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2111638063rs6542190TGrs6542190230064238.96E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2111641138rs9308691TCrs9308691230064232.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2111644475rs10188079CTrs10188079230064232.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2121632454rs277552GArs277552230064239.46E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2124429542rs2670610GArs2670610230064232.87E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2124433560rs2256248GArs2256248230064238.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2124729011rs1400064AC,G,Trs1400064230064236.87E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2124754515rs4848905CTrs4848905230064236.81E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2124754742rs13431665AGrs13431665230064235.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2129594921rs10496673CArs10496673230064238.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2130326385rs739659GArs739659230064236.15E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2130336129rs2188910GTrs2188910230064239.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2130336225rs2188909CGrs2188909230064238.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2134794256rs11899367CTrs11899367230064235.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2137868769rs1368061GArs1368061230064237.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2137868836rs1432219ACrs1432219230064238.77E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2137870582rs974528TCrs974528230064234.61E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2141355107rs492190AGrs492190230064234.79E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2141362058rs491391ACrs491391230064232.96E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2141377607rs487419TCrs487419230064233.89E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2141604351rs12467730AGrs12467730230064231.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2141605983rs11901880GArs11901880230064231.07E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2141640478rs12691579TGrs12691579230064231.86E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2141652239rs2016582CTrs2016582230064239.49E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2141662215rs10170474ACrs10170474230064233.27E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2141664879rs1469481GArs1469481230064232.80E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2141668678rs10496859ACrs10496859230064234.26E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2141878501rs12691592CArs12691592230064233.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2144128555rs11676611GCrs11676611230064236.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2146511295rs2704788GTrs2704788230064233.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2147530335rs7568410GTrs7568410230064234.73E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2147531594rs5000314TArs5000314230064236.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2147541992rs6430138CTrs6430138230064238.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2148106509rs1996848GCrs1996848230064234.79E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2148148960rs16827299AGrs16827299230064232.22E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2148150029rs16827303GTrs16827303230064232.22E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2148165153rs1371040AGrs1371040230064236.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2148165723rs6708612CTrs6708612230064233.92E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2148166428rs1438887ACrs1438887230064231.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2148175799rs728621TCrs728621230064237.48E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2151902601rs13034178ATrs13034178230064239.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2151931439rs13026867TCrs13026867230064235.81E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2152253918rs10197940TCrs10197940231436015.00E-06NA1.12[1.06-1.18]5,510 East Asian ancestry cases; 4,544 East Asian ancestry controlsEast Asian(10054)ALL(10054)ASN(10054)ALL(10054)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs10197940-TResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, N.I.H., Intramural
2152981827rs17398246GArs17398246230064232.25E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2153153555rs17326775AGrs17326775230064235.79E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2155844952rs13011654CTrs13011654230064234.38E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2155941970rs12986694GArs12986694230064234.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2155946659rs17644050GCrs17644050230064234.38E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2155996947rs13004840CTrs13004840230064238.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2156023943rs13014709TCrs13014709230064238.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2156066815rs7576616TCrs7576616230064238.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2156069998rs949781TCrs949781230064239.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2156083344rs10497148AGrs10497148230064235.77E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2157935103rs13403315CTrs13403315230064238.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2158117300rs16841426CTrs16841426230064236.16E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2158117405rs16841428TCrs16841428230064236.16E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2158123570rs16841450GArs16841450230064238.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2158137003rs1156560CTrs1156560230064239.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2159071260rs4664932CTrs4664932230064236.02E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2159586588rs2528630GCrs2528630230064233.13E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2160025639rs3796105ACrs3796105230064237.14E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2169071348rs4438452CTrs4438452194146799.97E-06Lung cancer (non-small cell lung cancer), survival in early stageNANA100 samplesNOPOP(100)ALL(100)NOPOP(100)ALL(100)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAMulticenter StudyResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
2169084859rs10176669TCrs10176669194146791.74E-06Lung cancer (non-small cell lung cancer), survival in early stageNANA100 samplesNOPOP(100)ALL(100)NOPOP(100)ALL(100)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAMulticenter StudyResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
2169692369rs481067GTrs481067230064234.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2170129528rs830994GArs830994230064237.64E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2173300053rs7608097TCrs7608097230064235.98E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2173592663rs1349497GCrs1349497230064233.98E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2173955062rs3769203AGrs3769203230064239.02E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2174002064rs3754744TCrs3754744230064233.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2174002092rs3754743GTrs3754743230064234.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2174053219rs3754741AGrs3754741230064233.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2174055731rs2289399AGrs2289399230064233.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2174184206rs7595292AGrs7595292230064231.99E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2177692572rs840706AGrs840706230064236.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2177710534rs1866131TCrs1866131230064237.98E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2177713373rs6723196AGrs6723196230064234.78E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2177716131rs1513870AGrs1513870230064236.88E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2178487729rs2293471TGrs2293471230064238.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2178576681rs13428806GArs13428806230064239.81E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2180511629rs6743733TCrs6743733230064238.62E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2183981448rs16823994TCrs16823994230064238.14E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2185225038rs7602691AGrs7602691230064235.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2186338274rs2081326AGrs2081326230064232.50E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2188573244rs13388743CTrs13388743230064238.88E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2192461297rs7596196CArs7596196230064235.32E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2192640624rs7593737GArs7593737230064234.39E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2192797035rs11896499ACrs11896499230064236.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2198075674rs2697306GArs2697306230064239.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2198081078rs2697299AGrs2697299230064234.39E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2198094771rs17390362CTrs17390362230064234.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2198132451rs4850776GArs4850776230064235.00E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2198132524rs4850777GArs4850777230064239.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2198134188rs4850779GArs4850779230064235.49E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2207053416rs16838023GTrs16838023230064233.66E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2208646851rs7582078CArs7582078230064234.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2209578600rs13383928TGrs13383928226377432.00E-06NANANA1,154 European ancestry cases; 1,137 European ancestry controlsEuropean(2291)ALL(2291)EUR(2291)ALL(2291)Lung cancer-asbestos exposure interactionHPOID:0010616Lung fibromaDOID:1324lung cancerD001195AsbestosisNANALung cancerrs13383928-CResearch Support, N.I.H., ExtramuralTNA
2210465558rs6733319GArs6733319230064238.31E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2210498057rs906831GArs906831230064239.50E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2213186351rs7559911CArs7559911230064232.02E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2213187034rs10164675GTrs10164675230064238.71E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2213188013rs12993440AGrs12993440230064232.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2213194405rs6719811GArs6719811230064238.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2213230879rs1394799AGrs1394799230064237.42E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2214932580rs2058991AGrs2058991230064231.37E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2215325694rs7563874TCrs7563874230064236.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2217456567rs940794TGrs940794230064236.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2220512823rs659266CTrs659266230064232.03E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2220521602rs628917GTrs628917230064232.30E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2220526923rs661039AGrs661039230064232.28E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2223817023rs4330101AGrs4330101230064238.79E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2223823132rs2028383TCrs2028383230064236.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2223823654rs1465882GCrs1465882230064239.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2225305832rs1642922CTrs1642922230064235.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2225308978rs1523921TCrs1523921230064232.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2225845136rs9967872CGrs9967872230064237.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2225845489rs4674958CArs4674958230064237.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2225847668rs7566475CArs7566475230064237.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2225853618rs281526CTrs281526230064231.42E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2227977893rs6743614CArs6743614230064238.02E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2231114593rs2114590CGrs2114590230064231.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2231115603rs9989792TCrs9989792230064234.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2231546750rs16827514TCrs16827514230064235.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2233149600rs13020779AGrs13020779189787908.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
2236514769rs11676226AGrs11676226230064237.63E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2236516480rs7564374GArs7564374230064237.16E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2238498996rs6760287AGrs6760287230064231.51E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2238499727rs6755617GArs6755617230064231.37E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2238984129rs2262425AGrs2262425230064237.76E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2241066280rs4292120CTrs4292120230064238.65E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2241070240rs1866646AGrs1866646230064237.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2242490658rs13408032CTrs13408032230064238.62E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
31495993rs12489351TGrs12489351230064232.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
31496493rs17039498AGrs17039498230064231.79E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
31496821rs17786098TCrs17786098230064237.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
31565113rs9829889TCrs9829889189787878.63E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
32223722rs7613165TCrs7613165230064232.02E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
32227373rs17009194GArs17009194230064238.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
32230964rs13324989GArs13324989230064233.25E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
32770509rs17019466GArs17019466230064234.00E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
32901065rs7636197GArs7636197230064233.43E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
33078840rs9820464CTrs9820464230064237.99E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
33376689rs1499088TCrs1499088230064233.49E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
35525968rs2686534GArs2686534230064232.53E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
35881625rs4684510TCrs4684510230064238.15E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
36179757rs17215895AGrs17215895230064237.49E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
37189058rs17234983ACrs17234983230064238.62E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
37195141rs17234990TCrs17234990230064234.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
37883963rs9883082CArs9883082230064231.75E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
37886455rs2324413TCrs2324413230064235.93E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
37886502rs2160954AGrs2160954230064233.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
37888645rs2875342TCrs2875342230064238.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
37891227rs399150TGrs399150230064237.19E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
37897016rs326416AGrs326416230064238.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
37905067rs1386987GTrs1386987230064239.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
37905601rs9829153GArs9829153230064233.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
37962284rs1825924CTrs1825924230064232.28E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
37982827rs4591494TCrs4591494230064231.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
39373721rs3930151TCrs3930151230064235.25E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
39374170rs10510398TCrs10510398230064238.35E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
310443000rs759692CTrs759692230064231.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
310463507rs11707511GArs11707511230064239.47E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
311727998rs9854973CTrs9854973230064233.77E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
311730846rs1039200CArs1039200230064238.76E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
311736267rs9835698AGrs9835698230064235.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
314473278rs6801669GArs6801669230064234.02E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
314478231rs4402920CGrs4402920230064232.60E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
314480778rs6790433TCrs6790433230064231.00E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (docetaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
315075360rs612051AGrs612051230064232.25E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
315162577rs7625117TCrs7625117230064233.60E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
315317938rs851848TCrs851848230064233.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
316293425rs842246TCrs842246230064236.53E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
316365223rs483682GArs483682230064232.71E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
316397878rs7634895TCrs7634895230064238.88E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
316398797rs17200269GCrs17200269230064233.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
317049965rs9876768TCrs9876768230064239.41E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
319854531rs7431008CArs7431008230064239.05E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
320362439rs6809146TCrs6809146230064231.71E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
322594055rs13071252CTrs13071252230064237.14E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
323312158rs9846398AGrs9846398183857384.10E-05NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
324646108rs10490835GArs10490835230064239.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
325065129rs873429GArs873429230064238.79E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
325418008rs1864911GArs1864911230064231.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
325418646rs4681053TCrs4681053230064234.02E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
325422696rs7628541GArs7628541230064231.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
325422776rs7618590AGrs7618590230064231.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
325423766rs9839276AGrs9839276230064234.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
325424428rs1159899GArs1159899230064237.28E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
325424561rs2306624TCrs2306624230064231.63E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
326688971rs4496439TCrs4496439230064239.37E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
326802920rs9872064AGrs9872064230064237.52E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
327975263rs10510599TCrs10510599230064231.40E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
329575463rs1530057GTrs1530057196543033.00E-06NA1.26NA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
330443869rs7653262GArs7653262230064234.31E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
330467155rs1117751GArs1117751230064234.96E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
333240314rs4384906TGrs4384906230064234.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
337611860rs2844363CTrs2844363196543035.90E-06NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
338659275rs7637849GArs7637849230064233.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
339266121rs1344220CTrs1344220230064231.50E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
343401268rs17075600GArs17075600230064235.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
343417349rs1848069TCrs1848069230064231.48E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
343417495rs17075630TCrs17075630230064232.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
343445129rs1105263GArs1105263230064236.77E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
346700713rs6442013CTrs6442013230064234.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
348384388rs6779517CTrs6779517230064234.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
348395372rs7610524AGrs7610524230064239.87E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
351824167rs6796373GCrs6796373230064232.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
353865433rs4687747GTrs4687747230064238.77E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
354122673rs13322861GArs13322861230064232.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
354123011rs4472075GTrs4472075230064232.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
354128575rs17801638TCrs17801638230064237.95E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
355462573rs17327860GArs17327860230064234.89E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
355481075rs3913369GTrs3913369230064234.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
359772460rs780354ACrs780354230064233.49E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
362525450rs855586CArs855586230064239.93E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
362686403rs13090570GTrs13090570230064233.47E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
362688923rs1344072AGrs1344072230064232.70E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
373987905rs11718192AGrs11718192230064235.60E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
376725903rs10511052GArs10511052230064237.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
376739295rs3849508ACrs3849508230064231.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
376741635rs7630682TArs7630682230064232.27E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
384356646rs1384300TCrs1384300230064235.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
384357635rs4856502GArs4856502230064237.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
384394801rs11929542CTrs11929542230064236.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
384425895rs1384307CTrs1384307230064235.61E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
384616264rs1471804TCrs1471804230064234.88E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
388381469rs9874952ACrs9874952230064238.13E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
388442421rs9816432GArs9816432230064236.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
396112179rs2875764CTrs2875764230064233.75E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
396121386rs6797214GArs6797214230064233.75E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
397443050rs4257593CTrs4257593230064232.61E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3102360190rs1296064CTrs1296064230064237.48E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3102863976rs11918929TArs11918929230064234.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3111556141rs3925081CTrs3925081230064236.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3111567238rs1282970ACrs1282970230064236.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3111847985rs1492483AGrs1492483230064234.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3111851817rs950528CTrs950528230064237.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3112916203rs1846594GArs1846594217253088.58E-37NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyT
3113637424rs6794522GArs6794522230064236.84E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3115624440rs4831119CTrs4831119230064232.98E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3115624856rs9853758GCrs9853758230064233.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3115627355rs9827155AGrs9827155230064234.14E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3116558335rs6438347AGrs6438347196543039.52E-06NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
3117831093rs4688077AGrs4688077230064234.31E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3117877410rs2101367GArs2101367230064239.88E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3118380279rs16828751CGrs16828751230064239.03E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3118600075rs962115ACrs962115230064234.15E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3118618860rs6438476ACrs6438476230064239.99E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3118700783rs35874TCrs35874230064238.65E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3118803278rs1369574TCrs1369574230064234.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3118899855rs7613994CArs7613994230064231.75E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3119218714rs6438535TCrs6438535230064236.99E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3119244421rs7628626ACrs7628626230064236.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3119359045rs571352CTrs571352230064235.53E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3119390844rs4327424TCrs4327424230064239.25E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3122601270rs9859701AGrs9859701230064231.15E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3122610629rs7640146AGrs7640146230064237.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3124730132rs4679232TCrs4679232189787877.22E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
3126222207rs3108333GCrs3108333230064235.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3126934437rs7616053AGrs7616053230064233.52E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3127481318rs664954TCrs664954230064238.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3129766327rs7355998GArs7355998230064234.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3131519641rs1543099TCrs1543099230064235.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3131541029rs9839168CArs9839168230064237.13E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3131578501rs4574338GCrs4574338230064234.19E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3131578561rs1513378CTrs1513378230064235.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3131585137rs1005996CTrs1005996230064234.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3131586635rs1513376GArs1513376230064238.00E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3131587773rs1463518CTrs1463518230064239.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3131592696rs4107954CArs4107954230064233.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3131593461rs11921795TCrs11921795230064235.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3131595809rs4345110GArs4345110230064236.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3131607539rs2199351GArs2199351230064239.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3131621088rs1381074GArs1381074230064233.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3131621309rs1381073AGrs1381073230064233.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3133419805rs6802154CTrs6802154230064232.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3134431409rs4955479GTrs4955479196543037.75E-06NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
3137524754rs2024370TCrs2024370230064232.64E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3137533273rs11708430AGrs11708430230064236.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3139782336rs2350491CTrs2350491230064231.22E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3140869794rs9841889CTrs9841889230064236.76E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3141812759rs9877817GArs9877817196543038.09E-06NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
3141818850rs11705932CTrs11705932196543036.38E-06NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
3143160538rs11923950GTrs11923950230064237.61E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3149099575rs10935749GArs10935749230064235.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3150114504rs12639090CTrs12639090230064234.28E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3150181413rs4681620AGrs4681620230064234.86E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3150614600rs13322091TCrs13322091230064235.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3150738755rs9837084ACrs9837084230064235.93E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3151396728rs2049168CTrs2049168230064234.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3151438247rs16846748TGrs16846748230064237.96E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3154491978rs11927211AGrs11927211230064238.42E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3154493381rs10935990GTrs10935990230064238.42E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3163653210rs1150433CA,G,Trs1150433230064232.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3163658583rs1176943GArs1176943230064236.31E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3163711497rs9828272CTrs9828272230064235.73E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3165785410rs7613317TCrs7613317230064239.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3168622049rs1877268GArs1877268230064238.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3169613751rs6796010TA,Grs6796010230064234.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3170422887rs534024ACrs534024230064235.98E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3173339777rs9868927AGrs9868927230064239.49E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3174733081rs9868994CTrs9868994230064235.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3176820705rs1201292AGrs1201292183857383.80E-05NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
3176830302rs1201296GArs1201296183857382.40E-05NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
3176837749rs1950081GArs1950081183857382.90E-05NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
3181484270rs9840545ACrs9840545183857384.70E-05NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
3182440135rs2700868CTrs2700868230064236.56E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3182454115rs16833439GTrs16833439230064234.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3182456918rs2700842AGrs2700842230064236.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3183829733rs9290781CArs9290781194146795.76E-06Lung cancer (non-small cell lung cancer), survival in early stageNANA100 samplesNOPOP(100)ALL(100)NOPOP(100)ALL(100)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAMulticenter StudyResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
3183830393rs11718245GArs11718245194146791.14E-04Lung cancer (non-small cell lung cancer), survival in early stageNANA100 samplesNOPOP(100)ALL(100)NOPOP(100)ALL(100)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAMulticenter StudyResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
3186634074rs9876387GArs9876387230064232.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3186644343rs7356053GCrs7356053230064236.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3187735687rs9816541TCrs9816541230064233.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3188873939rs12494229GArs12494229230064235.77E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3189356261rs4488809TCrs4488809217253087.00E-26NA1.26[1.21-1.32]2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs4488809-CResearch Support, Non-U.S. Gov'tComparative StudyT
3189356261rs4488809TCrs4488809231436014.00E-09NA1.19[1.12-1.26]5,510 East Asian ancestry cases; 4,544 East Asian ancestry controlsEast Asian(10054)ALL(10054)ASN(10054)ALL(10054)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs4488809-CResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, N.I.H., Intramural
3189356941rs7636839AGrs7636839217253082.60E-06NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyG
3189357602rs13314271TCrs13314271248803421.82E-05(All lung cancer)1.06[1.03-1.09]3,442 European ancestry adenocarcinoma cases; 3,275 European ancestry squamous cell carcinoma cases; 4,631 cases; up to 15,861 controlsNOPOP(20492)European(6717)ALL(27209)NOPOP(20492)EUR(6717)ALL(27209)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs13314271-TResearch Support, N.I.H., Extramural
3189357602rs13314271TCrs13314271248803427.00E-10(Adenocarcinoma)1.13[1.09-1.18] 3,442 European ancestry adenocarcinoma cases; 3,275 European ancestry squamous cell carcinoma cases; 4,631 cases; up to 15,861 controlsNOPOP(20492)European(6717)ALL(27209)NOPOP(20492)EUR(6717)ALL(27209)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs13314271-TResearch Support, N.I.H., Extramural
3190297036rs1559017CGrs1559017230064235.87E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3190297083rs1559018AGrs1559018230064237.35E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3190350461rs7626795AGrs7626795183856768.00E-06 1.16[1.05-1.28] 1,154 cases; 1,137 controlsNOPOP(2291)ALL(2291)NOPOP(2291)ALL(2291)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs7626795-GResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
3191216111rs7632529TCrs7632529230064237.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3196394518rs6805151TCrs6805151230064239.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
3197079826rs6583204GTrs6583204230064237.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
41684409rs6852065CTrs6852065230064231.46E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
42320937rs17132455CTrs17132455230064235.15E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
44767695rs6830371CTrs6830371230064235.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
48122628rs10001300CTrs10001300230064238.60E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
410550193rs2159245GArs2159245230064232.93E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
414911059rs7680772AGrs7680772230064231.46E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
415227300rs11733875AGrs11733875230064234.60E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
420660406rs10024417CTrs10024417230064236.21E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
420698104rs10032537CTrs10032537230064235.12E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
420730780rs16869915ACrs16869915230064233.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
420882971rs10516367CArs10516367183857385.80E-06NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
423810647rs3774921CTrs3774921230064237.59E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
423812757rs4697045GArs4697045230064238.59E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
424207765rs1995917GArs1995917189787875.16E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
424477340rs3857107GArs3857107189787905.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
425659608rs12501856TCrs12501856230064234.00E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
428928041rs1402499CTrs1402499230064237.30E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
429112064rs10014019CTrs10014019230064231.60E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
430774083rs10517215CArs10517215194146792.45E-05Lung cancer (non-small cell lung cancer), survival in early stageNANA100 samplesNOPOP(100)ALL(100)NOPOP(100)ALL(100)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAMulticenter StudyResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
430789609rs1374653GArs1374653194146796.71E-05Lung cancer (non-small cell lung cancer), survival in early stageNANA100 samplesNOPOP(100)ALL(100)NOPOP(100)ALL(100)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAMulticenter StudyResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
431669915rs980038TGrs980038230064238.77E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
431779135rs887918AGrs887918230064238.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
438932165rs7666822CArs7666822230064238.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
438933859rs17429619GArs17429619230064234.62E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
440508004rs278953CArs278953230064231.39E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
454618574rs2590767CTrs2590767230064231.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
454631772rs4457010CTrs4457010230064231.37E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
454638699rs2412493AGrs2412493230064231.14E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
456635884rs10517360AGrs10517360230064234.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
456779258rs11938985GArs11938985230064239.32E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
458531386rs11133515ACrs11133515230064235.89E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
461225009rs4860053GArs4860053230064235.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
461226507rs6833291CTrs6833291230064233.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
461226648rs6815467TCrs6815467230064235.81E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
461228799rs10017324ACrs10017324230064232.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
463243647rs7671984GCrs7671984230064235.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
463250043rs11131367CTrs11131367230064236.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
464229294rs10009946TCrs10009946230064238.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
464699179rs1344164TCrs1344164230064234.75E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
466777683rs7679437CTrs7679437230064231.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
466784345rs6817536TCrs6817536230064234.30E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
466839259rs4558912GArs4558912230064239.75E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
470547253rs13144303GTrs13144303230064238.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
470567104rs1587765AGrs1587765230064236.28E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
471514505rs16845288CTrs16845288230064238.36E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
475230930rs6836436TGrs6836436230064237.71E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
478306419rs9307270AGrs9307270194146791.51E-04Lung cancer (non-small cell lung cancer), survival in early stageNANA100 samplesNOPOP(100)ALL(100)NOPOP(100)ALL(100)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAMulticenter StudyResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
478521525rs171388CTrs171388189787873.44E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
480544474rs13120966TCrs13120966230064239.28E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
482936650rs7695454GCrs7695454230064235.42E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
484161522rs4590012CTrs4590012230064237.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
484374480rs1494961CTrs1494961189787906.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
484784665rs1505792TCrs1505792230064237.15E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
486818384rs6840989TCrs6840989230064234.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
490500833rs4414921CTrs4414921230064233.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
494003724rs7686545AGrs7686545230064239.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
494064059rs11097358GArs11097358230064239.13E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
494623649rs1371357TCrs1371357230064236.30E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
495857301rs7657460AGrs7657460230064233.01E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
496736478rs12510298AGrs12510298230064234.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4100391317rs10032685CTrs10032685230064233.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4100784980rs3737484CTrs3737484230064237.31E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4100790328rs6532834GArs6532834230064238.62E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4100792483rs6829912CTrs6829912230064239.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4100847105rs17029662GArs17029662230064234.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4103360161rs4699029CTrs4699029230064237.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4110085820rs2189702GCrs2189702230064231.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4110097567rs2526434TGrs2526434230064232.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4110135175rs2345417TCrs2345417230064232.38E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4110155038rs17304953AGrs17304953230064231.29E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4114014365rs17045555AGrs17045555230064238.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4114805925rs9994002TCrs9994002230064238.64E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4115255278rs10516601GArs10516601230064237.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4118244984rs9998109AGrs9998109230064235.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4118246863rs4074599GArs4074599230064231.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4118483198rs11562934CArs11562934230064234.46E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4118492252rs11562866CTrs11562866230064234.46E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4118500850rs11732304GArs11732304230064238.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4120235686rs17050312CTrs17050312230064237.94E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4122151897rs2278865TCrs2278865230064233.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4122735142rs1803183AGrs1803183230064235.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4125666719rs6841569CTrs6841569230064233.98E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4125675055rs2036203GArs2036203230064231.44E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4125682930rs313997GTrs313997230064233.78E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4125720431rs11931944GArs11931944230064237.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4126504601rs6534494CTrs6534494230064238.42E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4127611336rs313069TCrs313069230064236.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4127620851rs313063GTrs313063230064239.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4127624935rs313048TCrs313048230064239.37E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4127626494rs313047TCrs313047230064236.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4128668806rs13147065AGrs13147065230064234.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4128735475rs13122568AGrs13122568230064237.36E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4131293662rs967076TCrs967076230064238.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4131307585rs2310956GArs2310956230064235.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4131396692rs1459302AGrs1459302230064238.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4136013237rs4129152CTrs4129152230064239.89E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4137834967rs994912GTrs994912230064232.33E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4137851689rs12500811GArs12500811230064231.29E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4137885582rs1589127TCrs1589127230064238.61E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4137886834rs7695609GArs7695609230064236.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4137899609rs17049202CTrs17049202230064238.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4139590199rs7692637GTrs7692637230064234.65E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4139600081rs10033127CTrs10033127230064238.15E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4140457430rs1037149GTrs1037149230064239.25E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4141249662rs10519535CTrs10519535230064233.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4141815089rs10034843ACrs10034843230064236.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4143247240rs6844681CArs6844681230064239.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4143848478rs13148238GArs13148238230064233.03E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4144030000rs7696032AGrs7696032230064235.38E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4147788709rs10013280CTrs10013280230064235.75E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4151130051rs9307870GTrs9307870230064233.98E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4151144170rs7679888TGrs7679888230064238.01E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4151515966rs7657997ACrs7657997230064232.38E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4151519232rs4435730TCrs4435730230064235.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4151602118rs4318628GArs4318628230064237.35E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4151617093rs10000193AGrs10000193230064232.49E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4151619029rs4235251CTrs4235251230064234.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4151625361rs4455394GArs4455394230064232.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4151641186rs10520078AGrs10520078230064239.73E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4151656589rs1993109CTrs1993109230064231.52E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4151664792rs10028040GTrs10028040230064239.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4151668526rs1451635AGrs1451635230064233.76E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4151693149rs7665654AGrs7665654230064232.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4151790540rs2407549CArs2407549230064239.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4151801938rs1148652TCrs1148652230064237.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4151809625rs7693278GArs7693278230064236.38E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4151815783rs1201214TCrs1201214230064235.60E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4151824966rs1148645TGrs1148645230064237.53E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4151850524rs2407548TGrs2407548230064238.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4151859674rs1201198TCrs1201198230064232.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4151880765rs9992474AGrs9992474230064239.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4151888609rs11099780AGrs11099780230064238.03E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4153800029rs4254753TGrs4254753230064232.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4156587887rs3806782TCrs3806782230064239.48E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4161206712rs13145112GArs13145112230064239.65E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4161785781rs6854952AGrs6854952230064234.79E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4163936185rs11725452CGrs11725452230064237.65E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4164418994rs6816145GArs6816145230064237.71E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4164446514rs17576350GArs17576350230064234.09E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4164459307rs3797023TCrs3797023230064231.25E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4164463778rs17473108AGrs17473108230064239.49E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4164634372rs1565840CArs1565840230064239.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4164809025rs10023694GTrs10023694230064236.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4164829751rs3890761TCrs3890761230064236.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4167296709rs2199226GArs2199226230064232.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4169360558rs2451039AGrs2451039230064234.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4169409958rs2710833TCrs2710833230064232.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4169948058rs10518033CGrs10518033230064236.73E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4170464440rs11931954TCrs11931954230064238.21E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4170559440rs17659581TCrs17659581230064232.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4171311501rs13109743TArs13109743230064231.15E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4171388510rs2135900AGrs2135900230064238.33E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4171391594rs2202722TCrs2202722230064238.33E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4171402225rs1581676AGrs1581676230064232.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4171403782rs2612420AGrs2612420230064234.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4171409039rs1507680CTrs1507680230064239.34E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4171413205rs2135899TCrs2135899230064231.37E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4171413827rs1022004CTrs1022004230064231.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4171418232rs13120637CArs13120637230064238.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4171418411rs2020059ACrs2020059230064233.19E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4175476462rs6837393GArs6837393230064237.73E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4176677770rs722825CTrs722825230064235.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4176680675rs17658458CArs17658458230064234.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4179549653rs10434287GArs10434287230064237.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4180261198rs10520423GArs10520423230064233.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4180281632rs7657084GArs7657084230064233.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4180285435rs10520425CGrs10520425230064235.50E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4180292661rs4861770GArs4861770230064234.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4180292791rs4861771ATrs4861771230064234.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4180293616rs4861773GArs4861773230064236.88E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4180301379rs12505720ACrs12505720230064234.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4181361180rs13127074AGrs13127074230064237.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4181925065rs6843038CTrs6843038230064234.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4182195136rs17070928TCrs17070928230064232.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4182753524rs17072378TCrs17072378230064234.52E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4183404294rs961532GArs961532230064232.40E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4183404353rs961533CTrs961533230064231.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4183404568rs961534TArs961534230064232.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4187380057rs2100281TCrs2100281230064234.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4187382542rs6846710AGrs6846710230064233.31E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
4188477282rs12651293TCrs12651293230064236.99E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
51286516rs2736100CArs2736100189787904.00E-06NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
51286516rs2736100CArs2736100217253081.00E-27NA1.27[1.22-1.33]2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs2736100-CResearch Support, Non-U.S. Gov'tComparative StudyT
51286516rs2736100CArs2736100228996535.00E-08NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
51286516rs2736100CArs2736100231436014.00E-27NA1.38[1.30-1.47]5,510 East Asian ancestry cases; 4,544 East Asian ancestry controlsEast Asian(10054)ALL(10054)ASN(10054)ALL(10054)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs2736100-GResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, N.I.H., Intramural
51308552rs4635969GArs4635969196543032.17E-07NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
51308552rs4635969GArs4635969228996534.90E-07NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
51315343rs4975615GArs4975615217253081.50E-05NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyA
51315660rs4975616GArs4975616189787878.90E-06NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
51315660rs4975616GArs4975616189787902.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
51315660rs4975616GArs4975616196543033.00E-09NA1.15[1.10-1.20] 1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
51315660rs4975616GArs4975616217253081.30E-05NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyG
51315660rs4975616GArs4975616228996533.20E-05NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
51319680rs451360CArs451360217253086.60E-05NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyG
51319680rs451360CArs451360231436012.68E-04NANANA5,510 East Asian ancestry cases; 4,544 East Asian ancestry controlsEast Asian(10054)ALL(10054)ASN(10054)ALL(10054)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, N.I.H., Intramural
51320722rs402710CTrs402710189787904.00E-06NA1.18[1.12-1.24] 2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs402710-CResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
51322087rs401681CTrs401681189787878.00E-09 1.15[1.09-1.19] 1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs401681-GResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
51322087rs401681CTrs401681189787902.00E-06NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
51322087rs401681CTrs401681228996531.70E-07NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
51322087rs401681CTrs401681231436017.24E-04NANANA5,510 East Asian ancestry cases; 4,544 East Asian ancestry controlsEast Asian(10054)ALL(10054)ASN(10054)ALL(10054)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, N.I.H., Intramural
51325767rs466502AGrs466502217253082.50E-06NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyT
51325803rs465498AGrs465498217253083.20E-06NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyC
51330253rs452932TCrs452932217253082.20E-06NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyG
51330840rs452384TCrs452384217253085.70E-06NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyG
51336221rs467095TCrs467095217253086.30E-06NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyG
51337906rs31484ATrs31484217253083.80E-05NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyT
51342714rs31489CArs31489189787872.48E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
51342714rs31489CArs31489189787908.00E-07NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
51342714rs31489CArs31489196543035.62E-08NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
51342714rs31489CArs31489217253085.30E-05NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyC
51342714rs31489CArs31489228996531.10E-06NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
51346303rs27070GCrs27070217253086.00E-05NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyA
55796906rs39964GArs39964230064231.79E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
58410155rs13361808GArs13361808230064232.28E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
58411410rs16880521GCrs16880521230064232.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
59948723rs1366625GArs1366625183857381.60E-05NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
510109791rs884355CArs884355230064231.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
510111180rs11744434AGrs11744434230064233.64E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
510111690rs10052112CTrs10052112230064236.78E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
510113778rs1876152GArs1876152230064233.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
510115751rs10060606CTrs10060606230064233.81E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
510116479rs4484395AGrs4484395230064237.96E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
510117760rs10073259GTrs10073259230064231.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
510125556rs2662415TCrs2662415230064231.62E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
510127437rs2658109AGrs2658109230064235.36E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
510133704rs2662411GArs2662411230064236.36E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
510141550rs3111083GArs3111083230064235.61E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
510275870rs3843011GCrs3843011230064235.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
510283490rs6892818TCrs6892818230064237.71E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
510284270rs6876709CGrs6876709230064231.28E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
511720017rs6861373CTrs6861373230064233.00E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
511735134rs7716895GTrs7716895230064231.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
514052904rs7712871CTrs7712871230064239.46E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
516787384rs17541774GArs17541774230064235.16E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
517231485rs298525TCrs298525230064231.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
517374898rs159606AGrs159606230064235.88E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
518692338rs16886725ACrs16886725230064231.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
518713832rs9292313ATrs9292313230064233.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
518733182rs16886683TGrs16886683230064239.64E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
520820895rs12519026AGrs12519026230064235.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
523216237rs10072467CTrs10072467183857382.60E-05NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
524868417rs962088CA,Trs962088230064235.49E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
526310818rs10061965TCrs10061965230064233.99E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
526321661rs2036010CArs2036010230064233.83E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
526626794rs6452348ATrs6452348230064234.77E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
526951682rs7725061CTrs7725061230064239.42E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
526992816rs6874394ATrs6874394230064239.87E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
529596752rs10074734TCrs10074734230064233.60E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
529604899rs4331915AGrs4331915230064232.14E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
529606615rs4288125GArs4288125230064237.15E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
531053384rs36003087ACrs36003087230064236.65E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
531058626rs13162806GArs13162806230064234.80E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
531944975rs4867405GArs4867405230064232.00E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
531957885rs7724279AGrs7724279230064233.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
531967192rs7726919TGrs7726919230064239.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
532887610rs1472261GArs1472261230064235.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
533082366rs16890712TGrs16890712230064238.79E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
533104956rs7712171ACrs7712171230064235.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
533153247rs9292484TArs9292484230064236.43E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
535827665rs903389CGrs903389230064238.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
541587285rs650073GA,Trs650073230064239.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
541648335rs675785CTrs675785230064235.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
541666637rs623078AGrs623078230064235.71E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
541683141rs316746TGrs316746230064231.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
541688787rs685396TCrs685396230064237.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
541701237rs600645GTrs600645230064237.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
541701618rs588469AGrs588469230064237.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
541711886rs316768AGrs316768230064231.15E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
541786266rs1027348CTrs1027348230064233.15E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
541828669rs9292826GArs9292826230064233.15E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
541838232rs9292828TCrs9292828230064238.63E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
541853514rs7723992TGrs7723992230064233.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
541955746rs10052226GArs10052226230064239.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
541961622rs10053522CTrs10053522230064239.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
542231896rs4245983TCrs4245983230064231.76E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
542288593rs11748684CTrs11748684230064233.00E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (docetaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
542304953rs6887313AGrs6887313230064236.58E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
542312716rs10051562TCrs10051562230064232.09E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
542315700rs10064948AGrs10064948230064238.50E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
542321011rs10472369AGrs10472369230064238.50E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
542953802rs3849698CTrs3849698230064236.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
550905979rs7719291CGrs7719291230064239.93E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
553694171rs6882064TCrs6882064230064231.71E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
555827264rs10461608TCrs10461608230064236.73E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
557474848rs1981838TCrs1981838230064231.42E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
557905474rs167132GTrs167132230064239.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
558396111rs2910642AGrs2910642230064235.86E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
559039858rs981230CTrs981230230064236.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
559648716rs7737905GTrs7737905230064239.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
559821598rs10065640AGrs10065640230064235.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
559829465rs10056275CTrs10056275230064235.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
560854916rs17340123CTrs17340123230064238.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
561165960rs1995274GArs1995274230064239.81E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
565139475rs6449794TCrs6449794230064238.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
566265041rs16896069AGrs16896069230064238.37E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
566275052rs1946260TCrs1946260230064237.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
566654519rs11950678AGrs11950678183857383.20E-05NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
574242852rs3934476AGrs3934476230064238.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
574287742rs7707671TCrs7707671230064236.15E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
574292483rs6860492ACrs6860492230064237.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
574292694rs10067703TGrs10067703230064236.62E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
575427935rs10070440GArs10070440230064239.03E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
575769258rs10038589TCrs10038589230064239.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
575769568rs6859984CTrs6859984230064234.89E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
575785264rs13154264AGrs13154264230064231.35E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
576893947rs10474519CTrs10474519230064233.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
579398709rs6865426CTrs6865426230064239.04E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
580488122rs17227696GArs17227696230064236.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
581226548rs589080ACrs589080230064234.40E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
581232844rs4410626TCrs4410626230064232.09E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
581234197rs4703858AGrs4703858230064234.76E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
582311564rs440499CTrs440499230064239.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
588871745rs12658195CTrs12658195230064233.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
589265958rs13362216TCrs13362216230064238.95E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
589375165rs256515GTrs256515230064236.75E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
589378726rs157566CTrs157566230064233.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
589382503rs157563AGrs157563230064238.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
589578774rs2916612CTrs2916612230064239.28E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
594533213rs10044143CTrs10044143230064232.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
594621783rs33811CTrs33811230064231.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
594640373rs255957GArs255957230064238.01E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
596483480rs6863597TCrs6863597230064231.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
598532010rs2166724CTrs2166724230064239.28E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
598537121rs2121665TCrs2121665230064236.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
598569709rs1574968GArs1574968230064234.75E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
598931151rs681634CArs681634230064236.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
598941127rs10900675AGrs10900675230064234.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
598954234rs6892152TCrs6892152230064237.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
599082357rs2118735GArs2118735230064237.19E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
599124408rs749527CTrs749527230064232.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
599127127rs1161252TGrs1161252230064231.78E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
599129327rs1161257GArs1161257230064232.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
599134657rs11950209CTrs11950209230064231.07E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
599136563rs7449116TCrs7449116230064231.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
599140203rs6594760AGrs6594760230064232.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
599141638rs10067053ACrs10067053230064237.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
599143862rs2369765TGrs2369765230064232.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
599145743rs1901968CTrs1901968230064234.25E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
599146521rs2123812AGrs2123812230064232.39E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
599147433rs7705032CGrs7705032230064232.37E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
599147531rs7705200CGrs7705200230064232.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
599149553rs4451090TCrs4451090230064233.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
599150166rs6879586GArs6879586230064232.21E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
599150534rs11955182CTrs11955182230064232.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
599151377rs1078772AGrs1078772230064232.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
599152672rs6877816TGrs6877816230064231.28E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
599153139rs6878343AGrs6878343230064232.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
599156362rs2369754CArs2369754230064234.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
599159595rs2168006TCrs2168006230064239.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
599161947rs11740912ACrs11740912230064233.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5101291960rs6870397TCrs6870397230064237.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5101319870rs4272111TCrs4272111230064237.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5101320175rs6877249GArs6877249230064239.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5104582841rs2436365CTrs2436365230064233.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5111033422rs17133649CGrs17133649230064238.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5111036995rs17133655GArs17133655230064232.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5111081708rs3797730GArs3797730230064234.67E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5111081708rs574298668GGTAGAGrs3797730230064234.67E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5111914106rs13188321CTrs13188321230064231.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5114023787rs10491499AGrs10491499230064239.21E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5114508588rs7737426TArs7737426230064235.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5117390364rs10071435GArs10071435230064232.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5118089798rs1510973AGrs1510973230064239.05E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5122473962rs7705950AGrs7705950230064237.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5122492523rs189189GArs189189230064233.21E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5122510129rs335200GTrs335200230064233.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5122512699rs163041CTrs163041230064233.21E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5122513814rs179805CTrs179805230064237.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5122520209rs335194CTrs335194230064233.21E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5122598142rs35824CTrs35824230064237.21E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5123741828rs467401TCrs467401230064235.85E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5123754638rs154463GTrs154463230064236.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5128595494rs7705332AGrs7705332230064239.32E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5128627794rs252668ACrs252668230064238.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5135150207rs4386730AGrs4386730230064239.01E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5135645015rs1353885CTrs1353885230064236.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5138733811rs4835726CTrs4835726230064239.30E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5138762305rs11242465TGrs11242465230064237.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5142047191rs11742776AGrs11742776230064239.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5142048715rs10477189TCrs10477189230064235.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5142055537rs7708257TGrs7708257230064235.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5142055973rs7722035GCrs7722035230064237.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5142058904rs1867663TCrs1867663230064236.87E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5142059400rs9324892TCrs9324892230064232.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5142063729rs11167785TCrs11167785230064233.71E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5143678790rs6878187TGrs6878187230064232.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5143688636rs1422715AGrs1422715230064233.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5143747325rs10040935TGrs10040935230064236.15E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5143766246rs10055809CTrs10055809230064237.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5145532859rs17500483TCrs17500483230064234.81E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5149548823rs887343GArs887343230064238.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5149568093rs3776084GArs3776084230064238.13E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5155528085rs3097865TCrs3097865230064234.65E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5155528225rs1368320CTrs1368320230064234.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5155540311rs1368319GArs1368319230064237.01E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5158059517rs386503TCrs386503230064236.03E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5158666731rs254850CTrs254850230064233.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5158883027rs6869688AGrs6869688230064237.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5158904313rs12657996GArs12657996230064239.00E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5159005439rs34618866GArs34618866230064239.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5159013045rs11958511TGrs11958511230064236.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5159015248rs17056819GArs17056819230064234.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5159031373rs4640778GArs4640778230064233.88E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5159056499rs11949241CArs11949241230064237.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5159478541rs3733870GArs3733870230064231.89E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5160187121rs11135114GArs11135114230064237.77E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5160188914rs4371793CArs4371793230064239.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5160190132rs12656418CTrs12656418230064233.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5160201741rs17058247CTrs17058247230064238.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5160208277rs4921336AGrs4921336230064239.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5160770795rs2962403CTrs2962403230064239.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5162627644rs1366150TCrs1366150230064236.49E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5166345088rs13169373CTrs13169373230064238.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5167444365rs17069617AGrs17069617230064237.08E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5167620250rs903850GArs903850230064234.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5167669233rs6887837CTrs6887837230064231.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5167674472rs17070023GArs17070023230064236.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5168211254rs2163761CTrs2163761230064236.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5169255406rs39823CTrs39823230064231.42E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5169535522rs10063424TCrs10063424230064234.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5169536150rs6555888AGrs6555888230064234.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5169538188rs4867917AGrs4867917230064238.21E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5169540204rs1477320AGrs1477320230064233.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5169551236rs11134612GArs11134612230064232.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5169563583rs6861611GArs6861611230064232.60E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5171150423rs10516088CTrs10516088230064235.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5171362662rs10040841CTrs10040841230064237.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5171373215rs10475994CTrs10475994230064237.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5171579380rs10223190TCrs10223190230064233.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5171733971rs4560562CTrs4560562230064239.73E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5172702998rs11134782CTrs11134782230064239.53E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5172764398rs895312GTrs895312230064238.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5173292977rs165533CArs165533230064236.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5173297899rs359439TCrs359439230064234.96E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5173298462rs359440GTrs359440230064236.79E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
5174309210rs12520919CTrs12520919230064237.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
62412228rs4959663CTrs4959663230064238.96E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
62413911rs9503185CTrs9503185230064233.96E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
62414213rs9501836CGrs9501836230064237.05E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
62414740rs6911665TCrs6911665230064235.31E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
62452024rs9391949AGrs9391949230064233.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
66628721rs3804477CTrs3804477230064238.76E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
611143569rs10484447GArs10484447230064231.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
611182079rs9295808GArs9295808230064233.50E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
611269466rs10947075ACrs10947075230064236.22E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
611270935rs4713334CTrs4713334230064233.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
611271992rs16871186TCrs16871186230064238.73E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
612859556rs6458503TCrs6458503230064236.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
612875054rs1332841GTrs1332841230064237.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
614904327rs1408254ACrs1408254230064239.28E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
615376994rs2299059AGrs2299059230064232.22E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
615763793rs420350ACrs420350230064233.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
615769538rs220896GArs220896230064238.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
615786602rs74111GTrs74111230064237.36E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
615788380rs2007855TCrs2007855230064231.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
619988653rs9348404ACrs9348404230064236.38E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
619991043rs965036GTrs965036230064233.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
619991446rs9295456TCrs9295456230064236.38E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
619995731rs9358292GArs9358292230064237.14E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
623243562rs4236026TGrs4236026230064235.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
625925987rs3734523GArs3734523189787876.54E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
626233387rs10946808AGrs10946808189787872.58E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
627491299rs6904596GArs6904596189787871.54E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
627491299rs6904596GArs6904596228996534.70E-08NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
627534528rs10484399AGrs10484399228996533.10E-08NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
627689502rs9295740GArs9295740189787873.63E-07NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
627689502rs9295740GArs9295740196543033.41E-06NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
627810626rs175597TCrs175597189787879.41E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
628257377rs13211507TCrs13211507189787879.60E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
628257377rs13211507TCrs13211507189787905.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
628257377rs13211507TCrs13211507228996538.20E-07NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
628630691rs13194504GArs13194504183857389.60E-06NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
628630691rs13194504GArs13194504189787875.84E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
628630691rs13194504GArs13194504189787905.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
628630691rs13194504GArs13194504228996533.60E-06NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
628712663rs1233579AGrs1233579183857383.60E-05NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
628712663rs1233579AGrs1233579189787874.22E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
628712663rs1233579AGrs1233579196543032.05E-06NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
628712663rs1233579AGrs1233579228996532.70E-08NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
628776117rs4324798GArs4324798183857385.60E-06NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
628776117rs4324798GArs4324798189787878.40E-06NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
628776117rs4324798GArs4324798189787904.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
628776117rs4324798GArs4324798196543032.98E-07NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
628776117rs4324798GArs4324798228996531.60E-07NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
628810817rs422331CTrs422331183857383.70E-05NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
628810817rs422331CTrs422331189787871.63E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
628837437rs3131093CTrs3131093183857381.60E-05NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
628837437rs3131093CTrs3131093189787871.56E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
628837437rs3131093CTrs3131093196543034.20E-07NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
628837437rs3131093CTrs3131093228996533.10E-09NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
628954293rs3129791GArs3129791183857381.20E-05NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
628954293rs3129791GArs3129791189787871.61E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
628954293rs3129791GArs3129791189787904.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
628954293rs3129791GArs3129791196543034.59E-07NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
628954293rs3129791GArs3129791228996537.10E-08NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
628980707rs3130893AGrs3130893183857381.70E-05NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
628980707rs3130893AGrs3130893189787871.12E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
628980707rs3130893AGrs3130893189787904.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
628980707rs3130893AGrs3130893196543032.68E-07NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
628980707rs3130893AGrs3130893228996535.80E-08NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
629031142rs3117143CArs3117143183857381.70E-05NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
629031142rs3117143CArs3117143189787903.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
629031142rs3117143CArs3117143196543033.50E-08NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
629031142rs3117143CArs3117143228996536.90E-05NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
629306456rs3130805GArs3130805189787903.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
629337500rs6934993AGrs6934993189787876.61E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
629342775rs3749971GArs3749971183857381.90E-05NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
629342775rs3749971GArs3749971189787873.62E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
629342775rs3749971GArs3749971189787905.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
629342775rs3749971GArs3749971196543034.02E-06NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
629342775rs3749971GArs3749971228996531.40E-07NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
629442701rs2746150CTrs2746150183857381.60E-05NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
629442701rs2746150CTrs2746150189787871.45E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
629442701rs2746150CTrs2746150189787901.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
629442701rs2746150CTrs2746150196543031.21E-06NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
629442701rs2746150CTrs2746150228996533.60E-09NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
629537224rs1235162AGrs1235162189787875.13E-06NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
629537224rs1235162AGrs1235162189787902.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
629537224rs1235162AGrs1235162196543038.74E-07NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
629537224rs1235162AGrs1235162228996532.30E-13NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
629615822rs3129073AGrs3129073228996531.90E-08NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
629645038rs2535238CArs2535238228996532.70E-09NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
629656417rs2747457TGrs2747457228996535.50E-09NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
629818568rs2734986TCrs2734986189787872.53E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
629818568rs2734986TCrs2734986189787905.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
629818568rs2734986TCrs2734986196543032.59E-07NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
629818568rs2734986TCrs2734986228996532.20E-10NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
629821982rs2517861CTrs2517861228996531.80E-06NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
629823883rs2508049AGrs2508049228996532.50E-08NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
629899677rs2524005GArs2524005189787877.66E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
629899677rs2524005GArs2524005189787905.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
629899677rs2524005GArs2524005228996531.30E-06NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
629916855rs1655902GArs1655902217253084.59E-08NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyA
629937833rs2256543TCrs2256543189787874.44E-06NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
629937833rs2256543TCrs2256543189787909.00E-06NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
629937833rs2256543TCrs2256543196543038.73E-08NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
629937833rs2256543TCrs2256543228996532.70E-04NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
629945949rs3132685GA,C,Trs3132685189787901.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
629945949rs3132685GA,C,Trs3132685196543031.38E-07NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
629945949rs3132685GA,C,Trs3132685228996531.60E-11NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
630011934rs259940AGrs259940189787877.06E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
630011934rs259940AGrs259940189787907.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
630011934rs259940AGrs259940228996532.20E-07NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
630025503rs259919GArs259919228996536.20E-10NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
630032522rs8321ACrs8321189787875.91E-06NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
630032522rs8321ACrs8321189787902.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
630032522rs8321ACrs8321196543031.44E-07NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
630032522rs8321ACrs8321228996533.90E-14NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
630038352rs1245371AGrs1245371228996536.00E-08NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
630038647rs9261290TCrs9261290189787871.84E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
630038647rs9261290TCrs9261290189787903.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
630038647rs9261290TCrs9261290196543034.76E-07NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
630038647rs9261290TCrs9261290228996532.40E-12NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
630045199rs1150735GArs1150735228996533.80E-08NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
630078275rs2523989CTrs2523989228996538.60E-07NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
630079993rs2523987ACrs2523987228996535.40E-07NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
630080274rs2517598GArs2517598228996531.50E-08NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
630120563rs2257914CArs2257914217253082.94E-07NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyG
630207495rs2844773CArs2844773228996531.50E-09NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
630231224rs3094073GArs3094073228996533.90E-09NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
630279130rs3130380GArs3130380189787871.27E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
630279130rs3130380GArs3130380196543039.42E-07NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
630279130rs3130380GArs3130380228996531.20E-13NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
630327839rs3130350GTrs3130350189787904.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
630327839rs3130350GTrs3130350196543038.70E-08NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
630327839rs3130350GTrs3130350228996532.70E-14NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
630333505rs3094054GTrs3094054196543031.13E-07NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
630333505rs3094054GTrs3094054228996537.70E-14NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
630451904rs3094694TCrs3094694228996539.20E-08NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
630544401rs3132610AGrs3132610189787872.21E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
630544401rs3132610AGrs3132610189787905.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
630544401rs3132610AGrs3132610196543034.92E-07NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
630544401rs3132610AGrs3132610228996531.20E-13NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
630652781rs9262143CTrs9262143189787871.45E-06NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
630652781rs9262143CTrs9262143189787906.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
630652781rs9262143CTrs9262143196543033.55E-08NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
630652781rs9262143CTrs9262143228996531.00E-12NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
630697447rs3094127AGrs3094127228996538.00E-09NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
630724430rs2394401TCrs2394401230064237.99E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
630742134rs4248148GArs4248148230064237.33E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
630749233rs9468829TGrs9468829230064234.09E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
630782002rs886424CTrs886424196543035.41E-06NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
630782002rs886424CTrs886424228996536.60E-11NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
630824532rs2844659CTrs2844659228996534.40E-07NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
630893941rs4678GArs4678228996534.50E-05NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
630920124rs3132580GArs3132580228996531.40E-10NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
631058340rs3130544CArs3130544228996532.10E-12NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
631081205rs2233956TCrs2233956228996532.40E-08NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
631101674rs3130564CTrs3130564196543038.15E-06NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
631101674rs3130564CTrs3130564228996533.00E-08NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
631129310rs7750641CTrs7750641189787872.59E-06NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
631129310rs7750641CTrs7750641189787907.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
631129310rs7750641CTrs7750641196543036.77E-08NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
631129310rs7750641CTrs7750641228996532.40E-11NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
631162520rs7762933TCrs7762933217253084.88E-07NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyC
631209510rs3130712CTrs3130712230064239.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
631272553rs9264904GArs9264904230064238.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
631331829rs2523554CTrs2523554189787902.00E-06NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tNA
631335454rs2844573ACrs2844573228996533.80E-08NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
631347930rs2596573CTrs2596573217253085.56E-09NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyNA
631348022rs2596571GCrs2596571217253084.70E-09NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyG
631448976rs3099844CArs3099844189787871.98E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
631448976rs3099844CArs3099844196543038.88E-07NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
631448976rs3099844CArs3099844228996531.80E-10NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
631518354rs2523500GArs2523500230064238.31E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
631529883rs2516390CTrs2516390230064235.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
631531215rs928815TGrs928815230064233.07E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
631533378rs2857602GArs2857602230064231.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
631536224rs2844484AGrs2844484230064232.88E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
631539768rs2071590AGrs2071590230064235.76E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
631540141rs2239704ACrs2239704230064231.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
631555392rs2256974CArs2256974230064236.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
631620520rs3117582TGrs3117582189787875.00E-10NA1.24[1.16-1.33]1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs3117582-CResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
631620520rs3117582TGrs3117582189787905.00E-06NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
631620520rs3117582TGrs3117582196543034.00E-10NA1.24[1.16-1.33]1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
631620520rs3117582TGrs3117582228996532.30E-14NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
631721033rs3131379GArs3131379189787871.91E-07NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
631721033rs3131379GArs3131379189787906.00E-06NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
631721033rs3131379GArs3131379196543031.02E-08NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
631721033rs3131379GArs3131379228996536.80E-12NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
631870326rs558702GArs558702189787876.96E-07NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
631870326rs558702GArs558702189787901.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
631870326rs558702GArs558702196543036.89E-06NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
631870326rs558702GArs558702228996539.90E-13NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
631918860rs1270942AGrs1270942189787872.16E-06NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
631918860rs1270942AGrs1270942189787902.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
631918860rs1270942AGrs1270942196543038.66E-06NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
631918860rs1270942AGrs1270942228996531.40E-13NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
631940897rs389884AGrs389884189787872.84E-06NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
631940897rs389884AGrs389884189787901.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
631940897rs389884AGrs389884196543039.30E-06NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
631940897rs389884AGrs389884228996531.30E-13NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
632064726rs1150752TCrs1150752196543031.93E-06NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
632134510rs3096697GArs3096697196543035.59E-06NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
632168771rs3134942GTrs3134942196543035.73E-06NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
632168771rs3134942GTrs3134942228996533.00E-07NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
632261252rs7775397TGrs7775397189787877.73E-06NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
632261252rs7775397TGrs7775397189787906.00E-06NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
632261252rs7775397TGrs7775397196543039.94E-08NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
632261252rs7775397TGrs7775397228996533.10E-09NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
632433167rs2395185GTrs2395185231436011.00E-08NA1.17[1.11-1.23]5,510 East Asian ancestry cases; 4,544 East Asian ancestry controlsEast Asian(10054)ALL(10054)ASN(10054)ALL(10054)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs2395185-TResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, N.I.H., Intramural
632560859rs28366298ACrs28366298231436011.00E-08NANANA5,510 East Asian ancestry cases; 4,544 East Asian ancestry controlsEast Asian(10054)ALL(10054)ASN(10054)ALL(10054)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, N.I.H., Intramural
632590925rs3129763GArs3129763228996531.50E-08NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
632605884rs2187668CTrs2187668189787872.32E-06NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
632605884rs2187668CTrs2187668196543031.92E-07NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
632605884rs2187668CTrs2187668228996532.70E-13NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
632666526rs1794282CTrs1794282189787877.15E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
632666526rs1794282CTrs1794282189787906.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
632666526rs1794282CTrs1794282228996537.10E-13NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
632755290rs7762279TCrs7762279228996531.00E-08NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
633024654rs3135402ACrs3135402230064237.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
636140636rs9470224TCrs9470224189787879.25E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
636269603rs10947600GArs10947600230064239.76E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
636665639rs9394373TCrs9394373230064233.53E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
636673510rs9380590AGrs9380590230064234.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
636855382rs9357230GCrs9357230230064234.32E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
637499842rs12527264GArs12527264230064236.67E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
639291807rs1328384CArs1328384230064234.38E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
640949933rs9381017TCrs9381017230064232.79E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
644498472rs9369494CTrs9369494230064233.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
644501873rs932680GTrs932680230064233.36E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
652478364rs2063643AGrs2063643230064236.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
655688361rs9475417AGrs9475417230064234.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
662550428rs4513770CTrs4513770230064238.40E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
662559728rs6925549GTrs6925549230064237.15E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
662589167rs1931814AGrs1931814230064233.83E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
662589325rs10498817GArs10498817230064239.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
662630863rs1931805TCrs1931805230064234.50E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
662633416rs9453572TCrs9453572230064232.02E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
662682069rs1516709TCrs1516709230064239.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
666119463rs2753977CTrs2753977230064238.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
666154647rs2036475TGrs2036475230064231.78E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
667335614rs12194460AGrs12194460230064239.17E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
667350044rs12208629GArs12208629230064237.39E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
667368150rs17527707TCrs17527707230064234.91E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
667372927rs1037576CArs1037576230064235.65E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
667391027rs7740653ATrs7740653230064236.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
667391355rs9294716AGrs9294716230064235.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
667391578rs994377AGrs994377230064237.40E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
667402281rs4639316GArs4639316230064232.78E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
667453417rs6935468CTrs6935468230064232.22E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
667488602rs12201073CTrs12201073230064233.52E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
667488728rs12201163CTrs12201163230064238.54E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
667507305rs12203012GTrs12203012230064237.52E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
667519114rs12209528AGrs12209528230064237.05E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
667520962rs4298331TArs4298331230064237.05E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
667541579rs11753204TCrs11753204230064237.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
671104467rs12529984GTrs12529984230064231.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
672582426rs13206808GCrs13206808230064235.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
674770939rs13200840CTrs13200840230064233.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
678549277rs9343676CTrs9343676217253081.46E-08NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyC
679212957rs4632856GArs4632856230064238.14E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
680081376rs2038297CTrs2038297230064239.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
680082927rs725750CTrs725750230064239.42E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
685127929rs16874544AGrs16874544230064236.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
685953860rs4706229AGrs4706229230064234.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
685957696rs1575188AG,Trs1575188230064233.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
685982579rs1885016AGrs1885016230064232.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
687753317rs9359725ACrs9359725230064233.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
688671201rs16879998CTrs16879998230064237.25E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
690880393rs10944479GArs10944479230064232.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
695016416rs431852TArs431852230064234.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
695341309rs4282379TCrs4282379230064238.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
698928272rs210406TCrs210406230064238.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6105462004rs314272GArs314272230064238.79E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6105991031rs4946672GArs4946672230064235.43E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6107991893rs846987CGrs846987230064237.29E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6107992045rs2915CArs2915230064232.25E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6107992074rs2914CArs2914230064231.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6107995121rs7754879AGrs7754879230064237.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6108448611rs17069280CTrs17069280230064238.78E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6110750986rs9481069GArs9481069230064235.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6116834007rs2250263TCrs2250263230064231.98E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6116859793rs2064878TCrs2064878230064237.28E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6116861883rs9372465GCrs9372465230064235.25E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6116871496rs6568947CTrs6568947230064232.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6116954186rs784136TCrs784136230064237.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6117786180rs9387478CArs9387478231436014.00E-10NA1.18[1.11-1.23]5,510 East Asian ancestry cases; 4,544 East Asian ancestry controlsEast Asian(10054)ALL(10054)ASN(10054)ALL(10054)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs9387478-CResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, N.I.H., Intramural
6123027861rs9482269ATrs9482269230064239.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6123031388rs9490529GArs9490529230064236.40E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6123853556rs6939403TCrs6939403230064236.87E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6124023675rs17703235CTrs17703235230064232.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6124910739rs635837AGrs635837230064236.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6124921140rs1031881TGrs1031881230064234.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6125268385rs4896606AGrs4896606230064233.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6125287561rs17720559GArs17720559230064232.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6130913854rs7745661AGrs7745661230064239.93E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6131481670rs1569196CTrs1569196230064238.75E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6132133116rs6569759AGrs6569759230064237.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6132417564rs7745875GArs7745875230064239.53E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6132617072rs6902875AGrs6902875230064238.39E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6132885423rs9321351CArs9321351230064236.05E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6134399058rs6905952CTrs6905952230064237.07E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6134615030rs12202855AGrs12202855230064235.63E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6134623840rs9493891GArs9493891230064239.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6135415004rs7745098CTrs7745098230064235.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6135419305rs9402684TCrs9402684230064235.73E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6137867448rs203691AGrs203691230064239.29E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6138005300rs606539CTrs606539230064238.22E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6138007530rs636393GTrs636393230064236.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6138011665rs602414GTrs602414230064239.71E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6138013665rs508214AGrs508214230064237.01E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6138016125rs667520AGrs667520230064238.70E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6138018439rs6917441AGrs6917441189787909.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
6138022540rs647108TGrs647108230064238.62E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6138244943rs1545092CTrs1545092189787876.90E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
6138244943rs1545092CTrs1545092189787905.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
6139622545rs3861395TCrs3861395230064234.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6143943314rs9390123TCrs9390123231081457.00E-06NANANA914 European ancestry non-small cell lung cancer cases; 860 European ancestry controlsEuropean(1774)ALL(1774)EUR(1774)ALL(1774)Lung Cancer (DNA repair capacity)HPOID:0003254HPOID:0100526Abnormality of DNA repairNeoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsNANALung cancerrs9390123-AResearch Support, N.I.H., Extramural
6144428387rs4895631GArs4895631230064237.29E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6144530533rs4286803TCrs4286803189787905.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
6144596093rs2473129GArs2473129230064235.86E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6146855097rs11155474ACrs11155474230064238.09E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6146855856rs9386156TCrs9386156230064232.50E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6146861189rs9377003CArs9377003230064235.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6146872685rs11155475AGrs11155475230064233.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6148403405rs1007475TGrs1007475183857384.00E-05NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
6149283811rs17729143GArs17729143230064239.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6149293508rs12197795GTrs12197795230064237.53E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6149307684rs7741054AGrs7741054230064237.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6149366064rs2153252GTrs2153252230064233.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6149369985rs6914925ACrs6914925230064234.75E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6149374605rs1934221CArs1934221230064237.99E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6150370552rs17054300GArs17054300230064231.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6150557220rs6936990TCrs6936990230064238.64E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6152340288rs2207232TCrs2207232230064238.86E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6153503386rs9478395CTrs9478395230064236.99E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6155317769rs9479998AGrs9479998230064237.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6156463321rs6914206TCrs6914206230064235.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6156468407rs6928850CGrs6928850230064236.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6159549389rs7765276GArs7765276230064235.25E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6162368885rs9458424TCrs9458424230064231.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6162371705rs6902304GTrs6902304230064234.67E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6163477104rs571644AGrs571644230064234.89E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6163483731rs491862AGrs491862230064239.74E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6163487685rs568041GArs568041230064231.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6163487872rs569879CArs569879230064232.31E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6163488937rs511715AGrs511715230064232.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6167201033rs1927432GArs1927432230064233.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6167223099rs845670TGrs845670230064237.79E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6168305276rs7770588AGrs7770588230064231.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6168337882rs7772997GCrs7772997230064233.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
6169696264rs7452888AGrs7452888189787904.00E-06NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
6169706687rs9505900CTrs9505900189787902.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
71569418rs3814477CTrs3814477230064237.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
76036245rs10235277CTrs10235277230064238.71E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
76055706rs7803611TCrs7803611230064239.92E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
76062528rs3801032TGrs3801032230064233.25E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
76090600rs475323AGrs475323230064237.87E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
78370732rs17147491CTrs17147491230064234.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
78510964rs12667662ACrs12667662230064234.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
78739365rs11536481TCrs11536481230064233.33E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
79891469rs1514882CGrs1514882230064234.29E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
711887677rs6958721CTrs6958721230064235.98E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712219148rs7786495TCrs7786495230064236.63E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712250402rs3807865GArs3807865230064234.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712251790rs1019307GCrs1019307230064238.05E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712252540rs6460895CGrs6460895230064232.90E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712253088rs6460900AGrs6460900230064233.13E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712258755rs3823612GCrs3823612230064231.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712264151rs3800845GCrs3800845230064239.62E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712265988rs6966915CTrs6966915230064234.29E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712267495rs4721059GCrs4721059230064234.94E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712275508rs1468804TCrs1468804230064231.42E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712275818rs1060700AGrs1060700230064233.38E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712283787rs1990622AGrs1990622230064235.73E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712298311rs10234185CArs10234185230064239.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712304555rs2098366GArs2098366230064231.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712310445rs6460910CTrs6460910230064232.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712326930rs2192839CTrs2192839230064237.65E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712337549rs10232196CGrs10232196230064232.88E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712339495rs6947878AGrs6947878230064231.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712360805rs2356167TCrs2356167230064235.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712373082rs6460929CTrs6460929230064236.60E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712376811rs2192828ACrs2192828230064236.00E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712382637rs1440030CTrs1440030230064236.33E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712385521rs2110803CTrs2110803230064238.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712390186rs10280443CTrs10280443230064233.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712391319rs6967385GTrs6967385230064236.00E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712400587rs2053382AGrs2053382230064232.00E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712400710rs2053381CArs2053381230064232.71E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712405098rs2033871CArs2033871230064231.73E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712420989rs6460942TCrs6460942230064233.43E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712498138rs12669338TGrs12669338230064239.42E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712498835rs12699376CGrs12699376230064238.38E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
712508894rs10488158CTrs10488158230064235.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
713008198rs10267804TGrs10267804230064235.61E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
714350817rs2215035CGrs2215035230064239.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
714856355rs10260109CTrs10260109230064239.61E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
715603853rs17389549GArs17389549230064235.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
715881632rs1942637CTrs1942637230064239.16E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
716060201rs11761043CTrs11761043230064235.14E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
718485913rs11977093TCrs11977093230064235.28E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
718941624rs17350515GArs17350515230064231.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
721027606rs10245794TCrs10245794230064234.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
721062826rs2192055AGrs2192055230064237.40E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
721680849rs10274168CTrs10274168230064236.87E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
722594509rs17146997AGrs17146997230064236.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
724096501rs1003634CGrs1003634230064238.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
724923761rs17150421CTrs17150421230064232.03E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
724936098rs136CTrs136230064237.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
727916218rs720659ACrs720659230064231.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
727917094rs7789880CTrs7789880230064237.93E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
728576766rs216723CTrs216723230064235.28E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
728945827rs2391704CTrs2391704230064235.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
729034840rs1012090CTrs1012090230064239.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
729497630rs3909209ACrs3909209230064232.76E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
729498356rs3793260AGrs3793260230064239.65E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
734429228rs12537903ACrs12537903230064232.87E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
734530855rs16878934TGrs16878934230064236.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
736219846rs16880939CTrs16880939230064232.91E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
738636528rs12536957CGrs12536957230064239.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
743645433rs7802995AGrs7802995230064234.79E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
745143892rs6973982AGrs6973982230064238.99E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
747513110rs6963440ATrs6963440230064238.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
748244414rs6583476AGrs6583476230064231.78E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
748262153rs4917139AGrs4917139230064231.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
748963750rs28657937TCrs28657937230064236.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
748964255rs6968293ACrs6968293230064234.78E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
748972943rs13247910CTrs13247910230064234.60E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
748973352rs4917187GArs4917187230064234.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
748973560rs2215362AGrs2215362230064233.38E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
748994025rs993870TCrs993870230064239.36E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
748997648rs7357214AGrs7357214230064239.48E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
748997892rs2191299TCrs2191299230064239.48E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
748999902rs1473148GArs1473148230064239.46E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
749213642rs4606010TCrs4606010230064237.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
755664717rs4948041AGrs4948041230064234.28E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
768667866rs10265857TCrs10265857230064237.65E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
770316564rs13243605CTrs13243605230064231.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
770329434rs2866834GArs2866834230064231.43E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
770370469rs7808758TCrs7808758230064236.15E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
771055111rs9638627GArs9638627230064235.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
771080398rs10807735AGrs10807735230064238.07E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
771088735rs3857700GArs3857700230064234.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
771093257rs12699060AGrs12699060230064238.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
771654175rs17673882ACrs17673882230064231.33E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
777055836rs740158TCrs740158189787907.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
777351705rs7783032GTrs7783032230064238.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
777679478rs3807769GArs3807769230064239.22E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
778403070rs10244070AGrs10244070230064236.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
778403188rs12705771CTrs12705771230064237.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
778428741rs37872GArs37872230064235.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
778430226rs39731GArs39731230064233.73E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
779707387rs17804238GCrs17804238230064239.00E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
780392371rs10085651TCrs10085651230064237.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
781715040rs6977982GCrs6977982230064231.28E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
781723112rs10265730AGrs10265730230064231.55E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
781724717rs10225295GArs10225295230064232.05E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
781725129rs258658GArs258658230064231.40E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
781727702rs258665GArs258665230064232.30E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
781727778rs10808296TCrs10808296230064235.76E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
781728516rs258668TCrs258668230064231.77E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
781731446rs258671CTrs258671230064231.00E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (docetaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
781732714rs1963788AGrs1963788230064235.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
781733751rs258679ACrs258679230064231.73E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
781734211rs258681AGrs258681230064233.40E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
781734933rs258683GTrs258683230064231.52E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
781735015rs258684AGrs258684230064232.15E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
781736267rs4732421GCrs4732421230064235.88E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
781737327rs6960102TCrs6960102230064232.63E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
781744432rs2887115GArs2887115230064238.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
781751207rs258688GArs258688230064232.16E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
781755456rs2097915CGrs2097915230064233.80E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
781756313rs929381CArs929381230064234.36E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
781759508rs3801748AGrs3801748230064233.99E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
781764719rs10234372TCrs10234372230064233.94E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
781782514rs6942458AGrs6942458230064234.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
781827009rs4732434AGrs4732434230064236.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
781843391rs9692165AGrs9692165230064236.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
788890591rs35422524CTCrs7783629230064235.47E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
788890591rs529217692CTTCrs7783629230064235.47E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
788890591rs7783629CTrs7783629230064235.47E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7101741571rs201460AGrs201460230064234.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7102041679rs7385225AGrs7385225230064234.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7102825732rs7455141TCrs7455141230064236.78E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7102828337rs4266582GArs4266582230064235.64E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7102828569rs4727563AGrs4727563230064234.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7102828670rs4729887CTrs4729887230064236.53E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7102831775rs4593456ACrs4593456230064238.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7102850726rs17136078TArs17136078230064236.53E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7103591822rs10230291TCrs10230291230064237.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7103621267rs11772975AGrs11772975230064239.88E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7106593595rs6959577TCrs6959577230064234.21E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7107495145rs2395932CTrs2395932230064238.33E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7107495217rs6949033TCrs6949033230064234.53E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7107499761rs6964905GArs6964905230064232.42E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7107509273rs4348408GArs4348408230064237.50E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7107573254rs881176TGrs881176230064238.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7107580839rs2158836AGrs2158836230064236.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7107581346rs10953555TCrs10953555230064236.86E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7107696289rs17154865CTrs17154865230064236.86E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7108490660rs10252772AGrs10252772230064236.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7108497232rs6959243AGrs6959243230064231.96E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7108497479rs9690914TCrs9690914230064237.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7108503008rs1525183ACrs1525183230064239.81E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7108505208rs1525181TCrs1525181230064239.81E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7110036601rs10487324GArs10487324230064233.62E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7118216736rs1510498GTrs1510498230064237.71E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7118222312rs1355313GArs1355313230064232.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7121123423rs4731018AGrs4731018230064237.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7122819879rs2402635GArs2402635230064234.73E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7122825956rs10253693CTrs10253693230064233.29E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7122828502rs10265711GTrs10265711230064235.88E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7122835742rs2204294CArs2204294230064231.32E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7122838862rs1880180TCrs1880180230064231.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7122841575rs3824026GArs3824026230064239.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7122846211rs7810239CArs7810239230064233.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7122858776rs7776703AGrs7776703230064231.43E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7122864924rs4731086CArs4731086230064231.93E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7122872334rs2402637CGrs2402637230064238.77E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7122878459rs7807163TGrs7807163230064232.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7123504320rs17703063GArs17703063230064236.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7123514896rs6949082GTrs6949082230064237.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7123584796rs10269135AGrs10269135230064237.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7123610077rs12706565AGrs12706565230064238.62E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7123854695rs1990393GArs1990393230064233.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7132097016rs1000058CArs1000058230064237.33E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7132480895rs2241439TGrs2241439230064237.75E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7132495299rs10435414TCrs10435414230064234.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7132523462rs3807325AGrs3807325230064234.64E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7132533663rs12667678TCrs12667678230064233.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7132586161rs7790698CTrs7790698230064238.59E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7132599986rs4731919GArs4731919230064234.00E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7132603303rs2058943CTrs2058943230064235.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7132607171rs7790787TCrs7790787230064235.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7132611681rs2042066CTrs2042066230064239.37E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7134508087rs1452912GArs1452912230064232.73E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7135896478rs11768716TGrs11768716230064239.76E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7135897003rs10278072AGrs10278072230064235.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7136024177rs4520107CTrs4520107230064235.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7136026926rs7788841GArs7788841230064236.43E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7139694500rs3801148CTrs3801148230064232.09E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7141672604rs10246939TCrs10246939230064234.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7141672705rs1726866GArs1726866230064238.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7141689666rs12703414CA,G,Trs12703414230064239.67E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7141707530rs1298582ATrs1298582230064236.14E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7141972755rs2960765CTrs2960765230064233.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7144710520rs7788803CArs7788803230064232.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7147035067rs826802GTrs826802189787877.22E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
7149319439rs354064TCrs354064230064233.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7150092031rs1880316GTrs1880316230064236.75E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7150997313rs1860116AGrs1860116230064237.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7152290536rs7792702AGrs7792702230064237.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7153176705rs4629773AGrs4629773230064236.16E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7155672944rs1106697GArs1106697230064237.00E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7156092540rs4645464TCrs4645464230064231.39E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7156542221rs6954725AGrs6954725230064237.78E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
7156548645rs10488060TCrs10488060230064239.88E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
81731855rs10089616CTrs10089616230064237.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
83272541rs17066062GCrs17066062230064234.09E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
83952388rs13340565GArs13340565230064232.65E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
83952623rs13340606ACrs13340606230064238.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
83952966rs13340578CA,G,Trs13340578230064232.37E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
83955025rs918917ACrs918917230064232.22E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
83957182rs17068975GCrs17068975230064232.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
83969602rs17404627AGrs17404627230064231.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
83978488rs1991139CArs1991139230064234.98E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
83980978rs766045TCrs766045230064231.03E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
83984909rs2680611AGrs2680611230064231.65E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
84040458rs1625309GArs1625309230064233.75E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
84049374rs779130AGrs779130230064232.77E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
84067803rs1519167TGrs1519167230064236.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
84070495rs3849840CA,Trs3849840230064231.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
84071438rs890000CGrs890000230064238.46E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
84266162rs13264886AGrs13264886230064236.64E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
84684203rs1992205ACrs1992205230064232.19E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
85824341rs2816428TGrs2816428230064235.30E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
86737196rs2741136AGrs2741136230064231.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
86737582rs5743401AGrs5743401230064231.52E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
86740074rs2977826CTrs2977826230064233.07E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
88881820rs1016512CTrs1016512230064232.86E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
89184628rs10106829AGrs10106829230064235.39E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
89187595rs7004769AGrs7004769230064234.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
89224907rs11784552CTrs11784552230064237.39E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
813535612rs17237821GTrs17237821230064231.60E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
813536022rs11785907ATrs11785907230064237.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
813553686rs12375315ATrs12375315230064235.13E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
814808713rs4607611TGrs4607611230064235.64E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
816907317rs2014301TArs2014301230064239.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
816939284rs12056715GArs12056715230064236.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
816953674rs17624958TCrs17624958230064236.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
818950578rs12677573TCrs12677573230064238.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
819379421rs10107533CArs10107533230064232.35E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
819400018rs4921659CTrs4921659230064233.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
819408508rs4922060TArs4922060230064235.19E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
820685467rs10103263TGrs10103263230064234.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
823593988rs6998928CTrs6998928230064235.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
823607733rs10866835TCrs10866835230064233.75E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
823612138rs11985119CTrs11985119230064238.02E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
823612956rs17089603AGrs17089603230064234.64E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
823689919rs310318GTrs310318230064231.38E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
825836119rs901173AGrs901173230064234.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
828459468rs2028486GArs2028486230064233.63E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
828694549rs907133CTrs907133230064238.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
828981063rs3750263TGrs3750263230064239.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
829231378rs746959CTrs746959230064231.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
829239838rs17060069TCrs17060069230064233.16E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
832120188rs900102AGrs900102230064238.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
834899821rs9297228CTrs9297228230064238.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
840676437rs16889986GArs16889986230064238.87E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
841180008rs1447210AGrs1447210189787872.29E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
841181421rs7814391GArs7814391189787873.66E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
841478361rs890220GArs890220230064238.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
841525914rs750625CTrs750625230064239.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
849880975rs11774804TCrs11774804230064239.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
849941703rs6982145GArs6982145230064238.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
851991602rs6993652TCrs6993652230064237.31E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
859171944rs4237026CArs4237026230064237.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
859174576rs9643503GArs9643503230064237.48E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
860375664rs2222249TGrs2222249230064234.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
860413073rs10103231CTrs10103231230064233.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
861100494rs2242154CTrs2242154217253088.34E-05NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyT
861831999rs7008176GArs7008176230064235.91E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
862484860rs16927566ATrs16927566230064234.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
862728573rs1390027CTrs1390027230064236.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
863463719rs2928389TGrs2928389230064237.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
863798898rs2124296GArs2124296230064236.73E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
863955160rs10464904TCrs10464904230064234.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
864006201rs4737627TCrs4737627230064238.19E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
864390729rs1431586TCrs1431586230064236.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
867432106rs2555561CTrs2555561230064239.49E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
868527890rs900114GTrs900114230064239.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
869057145rs13251311TGrs13251311230064231.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
869057972rs7839608CArs7839608230064236.22E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
869100070rs1155491GArs1155491230064234.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
870554689rs7814130AGrs7814130230064232.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
872136861rs13260349CTrs13260349230064239.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
872753740rs3779757CArs3779757230064237.30E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
872755040rs7812453ACrs7812453230064233.35E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
872781495rs1481847GArs1481847189787872.38E-06NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
872828300rs1481855TCrs1481855189787871.51E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
872830625rs1020312TCrs1020312189787877.48E-06NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
880612714rs2920942CTrs2920942230064236.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
880617721rs1813496GCrs1813496230064239.28E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
881407333rs4587368AGrs4587368230064232.07E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
881435942rs16907781AGrs16907781230064232.07E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
881973259rs4574807TGrs4574807230064239.52E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
882455143rs6985243GTrs6985243183857382.90E-06NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
883629042rs4270965AGrs4270965230064234.71E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
884044940rs4469455CTrs4469455230064234.13E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
884050892rs4481591TCrs4481591230064235.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
884059022rs11998040GTrs11998040230064237.09E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
884072321rs1464467GArs1464467230064234.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
884075113rs2140016AGrs2140016230064233.43E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
884077832rs10087985CTrs10087985230064235.02E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
884084432rs1521825GArs1521825230064239.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
884085561rs1521826CTrs1521826230064231.33E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
884089379rs12676236TCrs12676236230064234.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
889311785rs7834743AGrs7834743230064233.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
890020164rs7014732TCrs7014732230064235.29E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
892619874rs1014764TCrs1014764230064233.31E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
892622980rs16914398CArs16914398230064237.50E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
895047195rs2978141AGrs2978141230064233.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
895050753rs2978138AGrs2978138230064234.53E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
896453705rs17746436CTrs17746436230064238.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
8105408828rs2246650TCrs2246650230064237.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
8105409476rs1317472GArs1317472230064236.96E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
8105558914rs7819498GTrs7819498230064237.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
8109044587rs2443780GTrs2443780230064233.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
8112164318rs890564TCrs890564230064232.88E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
8112173085rs960209CTrs960209230064237.32E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
8112184059rs2195066CTrs2195066230064239.03E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
8117951521rs6998067GTrs6998067230064233.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
8118322087rs1499424TGrs1499424230064238.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
8123547148rs7818523CArs7818523230064232.30E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
8124604759rs9650084GArs9650084189787876.90E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
8124835357rs964059ACrs964059230064232.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
8126338887rs10956241AGrs10956241230064238.53E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
8126368375rs7822592GArs7822592230064239.64E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
8128548678rs13258742AGrs13258742230064232.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
8133922914rs3847173AGrs3847173230064232.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
8133935499rs7011493TCrs7011493230064231.03E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
8134323337rs4736648TCrs4736648230064234.31E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
8141480330rs6993904AGrs6993904230064234.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
8142222445rs3739238TCrs3739238230064238.94E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
8142227854rs9324542TArs9324542230064237.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
8142232878rs4961258GArs4961258230064236.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
8142233396rs10875467CArs10875467230064239.60E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
91218605rs10960472GTrs10960472230064234.52E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
91448017rs10121536TCrs10121536230064234.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
91449360rs10491860CGrs10491860230064236.53E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
91453731rs1332004GArs1332004230064234.50E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
91456797rs1412259CTrs1412259230064234.00E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (docetaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
91459663rs10114417TCrs10114417230064235.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
92064507rs7035608CTrs7035608230064238.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
92663788rs2063570GTrs2063570230064235.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
92707420rs1823903AGrs1823903230064235.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
94079470rs4741887GArs4741887230064237.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
94331760rs13286735CArs13286735230064235.28E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
96654050rs11999442GArs11999442230064233.15E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
97625060rs3912454CArs3912454230064238.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
99357065rs1889107GArs1889107230064234.39E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
99750139rs1359176CTrs1359176230064235.48E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
911039910rs7028285AGrs7028285230064236.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
912421929rs12683218AGrs12683218196543039.37E-06NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
914772384rs7852390ACrs7852390230064231.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
914889834rs16892TCrs16892230064239.36E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
914891600rs17222108TCrs17222108230064237.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
915218947rs7870690CArs7870690230064237.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
915349934rs473315AGrs473315230064237.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
915731398rs11792770CTrs11792770230064235.29E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
916309559rs7032123AGrs7032123230064238.94E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
919881986rs12377344CTrs12377344230064234.83E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
920028452rs4073871ACrs4073871230064237.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
921151553rs10964862CArs10964862230064239.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
921368609rs643070TCrs643070230064232.01E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
921391698rs1224391TCrs1224391230064233.03E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
921419723rs2104880CTrs2104880230064236.39E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
922207255rs6475619ATrs6475619230064239.89E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
922690660rs11792221TCrs11792221230064239.01E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
922697535rs524361CTrs524361230064238.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
922741961rs528204ATrs528204230064239.46E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
922749869rs644917GArs644917230064236.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
922965874rs7857311TArs7857311230064235.36E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
923546461rs7028484GTrs7028484230064239.43E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
925719190rs13286794GArs13286794230064239.25E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
927284363rs1126107CTrs1126107230064239.64E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
927725305rs10732349GArs10732349230064238.81E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
927974789rs10968243TCrs10968243230064236.46E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
927992871rs7034075TArs7034075230064233.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
929498319rs16914891CTrs16914891230064234.86E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
929739205rs928636AGrs928636230064238.73E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
932344825rs10511903CTrs10511903230064233.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
932367887rs7857056AGrs7857056230064233.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
934974974rs7045765TCrs7045765230064234.01E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
934978431rs3739873GArs3739873230064234.89E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
971745307rs10869918CTrs10869918230064234.05E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
972345603rs10511968GCrs10511968230064235.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
974156121rs10512001GArs10512001230064239.63E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
978250260rs10869613ACrs10869613230064233.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
978351260rs11144603ACrs11144603189787877.72E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
978455655rs11144641AGrs11144641189787878.64E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
979116755rs3739517TCrs3739517230064233.53E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
979282170rs17062868GArs17062868230064231.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
979702675rs10781417TCrs10781417230064234.30E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
979709824rs11145281AGrs11145281230064238.76E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
980292007rs10869954AGrs10869954230064233.88E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
981882407rs4486277AGrs4486277189787907.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
983052940rs17083352CArs17083352230064234.32E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
983070557rs17083391CGrs17083391230064232.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
991049113rs7045192AGrs7045192230064237.81E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
991112102rs7871303AGrs7871303230064238.46E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
995996573rs2398820GArs2398820230064236.31E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
997356243rs35600708CTrs35600708230064238.73E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
998516889rs10981787CTrs10981787230064238.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
998519783rs10981895CTrs10981895230064237.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
999260928rs13302712AGrs13302712230064236.02E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9101598609rs1407503GArs1407503189787904.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
9102128509rs10819657CTrs10819657230064238.36E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9102129789rs2281728TArs2281728230064235.86E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9105045726rs10820123ACrs10820123230064232.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9105275743rs12002921ACrs12002921230064238.09E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9105405415rs10820216GArs10820216230064235.46E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9105406083rs10820217TCrs10820217230064236.62E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9105414477rs13283389AGrs13283389230064235.40E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9107239149rs10120811ATrs10120811230064238.72E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9107547230rs11789818CTrs11789818230064238.38E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9110084261rs1805330CTrs1805330230064231.65E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9110779419rs10816609CArs10816609230064235.52E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9111511616rs4636276AGrs4636276230064239.87E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9111511670rs2039810GArs2039810230064238.62E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9113060439rs7869617ACrs7869617230064233.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9113068793rs7855326GCrs7855326230064233.09E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9116898696rs12338900GCrs12338900230064235.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9116902782rs7868176AGrs7868176230064235.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9118030920rs2225749AGrs2225749230064236.50E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9119519588rs1372330GArs1372330230064237.46E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9123341189rs7857382TGrs7857382230064236.94E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9129353178rs4083650ATrs4083650230064239.49E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9129465233rs867560CGrs867560230064234.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9130670532rs3818509CTrs3818509230064235.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9130755693rs4837218GArs4837218230064236.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9132448019rs10125991AGrs10125991230064236.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9132449529rs1867099CGrs1867099230064233.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9133917807rs4740396TCrs4740396230064233.86E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9135998623rs7036096GArs7036096230064235.43E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9136195374rs10751505AGrs10751505230064235.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9136235100rs28374096GCrs28374096230064234.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9136277482rs2285487TCrs2285487189787904.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
9137373598rs7033608TCrs7033608230064236.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9137592961rs4341231TCrs4341231230064236.02E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9137730956rs9410002GArs9410002230064237.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
9139634495rs9886752GArs9886752230064232.79E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
102085671rs870041CTrs870041230064232.99E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
102086923rs10794839AGrs10794839230064237.64E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
102087959rs10903646AGrs10903646230064234.69E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
102089841rs10794843CArs10794843230064234.06E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
102089982rs10903651AGrs10903651230064233.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
102831743rs10736960AGrs10736960230064233.87E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
106926362rs17142139GArs17142139230064231.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
107768221rs7912641GTrs7912641230064239.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
107796891rs11255338AGrs11255338230064238.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1010886244rs10752209TCrs10752209230064238.00E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1011656600rs11592006TCrs11592006230064237.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1012538491rs7078980GArs7078980194146791.40E-04Lung cancer (non-small cell lung cancer), survival in early stageNANA100 samplesNOPOP(100)ALL(100)NOPOP(100)ALL(100)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAMulticenter StudyResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1012836482rs17152268ACrs17152268230064239.99E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1016810847rs2004489GArs2004489230064234.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1016838866rs7068881AGrs7068881230064239.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1018703895rs997264CArs997264230064232.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1018711288rs10828679GArs10828679230064233.22E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1018714705rs1575836GTrs1575836230064236.02E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1018716145rs10741058TCrs10741058230064232.82E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1018716346rs10764483AGrs10764483230064231.71E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1018719441rs7077248TCrs7077248230064235.49E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1018721204rs10741061AGrs10741061230064237.62E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1018725659rs1926026GArs1926026230064238.96E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1018744719rs7923938TCrs7923938230064232.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1020284083rs11597892CTrs11597892230064235.39E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1020290021rs1326246GArs1326246230064239.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1020291113rs768654GArs768654230064234.15E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1020309308rs7077535CTrs7077535230064238.14E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1020763305rs11012068TArs11012068230064233.43E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1020768098rs11012077GArs11012077230064234.50E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1022928514rs943196GArs943196230064233.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1022928868rs2559534TGrs2559534230064236.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1022932148rs1778335TCrs1778335230064236.04E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1022937071rs1614387ACrs1614387230064231.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1022941037rs1171492ACrs1171492230064231.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1027906212rs1908274CTrs1908274230064234.19E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1027906348rs1908275TCrs1908275230064235.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1027908124rs980135CGrs980135230064233.25E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1027911671rs11015914CArs11015914230064235.01E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1027912301rs1494207CTrs1494207230064234.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1029768353rs7096194CGrs7096194230064238.94E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1030124617rs1929239GArs1929239230064239.62E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1030407984rs10826765TCrs10826765230064232.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1030848725rs10763801CArs10763801230064236.87E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1030849466rs11008110TArs11008110230064235.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1032067712rs7090529CGrs7090529230064234.75E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1032487505rs7900894TCrs7900894230064239.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1044014299rs2393949TCrs2393949230064239.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1047685591rs3013794CTrs3013794230064237.31E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1049698113rs1077960TGrs1077960230064237.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1050469281rs11812365TCrs11812365230064231.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1052792194rs10822139AGrs10822139230064232.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1053199410rs293244ACrs293244230064238.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1053218458rs1348542TGrs1348542230064239.71E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1053218926rs10508940CTrs10508940230064236.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1054676411rs1343065GArs1343065230064234.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1060610919rs7910260CTrs7910260183857382.90E-05NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1061573386rs4948367CArs4948367230064237.98E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1061612159rs17791484CTrs17791484230064233.35E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1063307475rs2787702TCrs2787702230064239.00E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1063308069rs2650717CGrs2650717230064232.46E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1063308159rs2254096GArs2254096230064233.03E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1063308714rs2787703TCrs2787703230064232.46E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1063314472rs1869927CTrs1869927230064232.32E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1063318019rs2257189GCrs2257189230064232.91E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1063318204rs2787713ATrs2787713230064237.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1063319932rs1378884GCrs1378884230064232.05E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1063323353rs2787716CTrs2787716230064236.15E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1063324847rs2606094TCrs2606094230064233.53E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1063331594rs2814033GTrs2814033230064231.77E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1063332127rs2650741AGrs2650741230064231.76E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1063336683rs2814032GArs2814032230064233.43E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1063337793rs2814030GArs2814030230064239.87E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1063339655rs2650731CArs2650731230064234.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1063342112rs2814027AGrs2814027230064234.32E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1063342487rs753246GArs753246230064234.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1063342861rs2606104CTrs2606104230064234.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1063348465rs2787720TCrs2787720230064231.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1063348767rs1350172GTrs1350172230064234.00E-07NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1063351803rs2606117CArs2606117230064234.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1066206804rs7920723GArs7920723230064239.94E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1066222693rs7913086CTrs7913086230064239.94E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1067493413rs9633568CArs9633568230064233.05E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1067689189rs1786923GArs1786923230064234.98E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1067701548rs1670136ACrs1670136230064235.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1071263264rs1227969CTrs1227969230064236.00E-07NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1071264325rs1652804GA,C,Trs1652804230064236.11E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1071267849rs1236904ACrs1236904230064235.07E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1071272018rs972570CTrs972570230064233.79E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1071272134rs10509313AGrs10509313230064234.31E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1071274737rs891562GTrs891562230064237.96E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1072062862rs10762361CTrs10762361230064234.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1077504287rs7097617AGrs7097617230064233.30E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1077564560rs7915846TCrs7915846230064238.07E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1077614004rs1885822TCrs1885822230064235.16E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1077617557rs12778915GArs12778915230064239.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1078297974rs16933641TCrs16933641230064235.75E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1079789657rs12267420CArs12267420230064239.15E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1079798919rs16935567GArs16935567230064236.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1086056141rs12414938GTrs12414938230064231.28E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1086058209rs11200975GArs11200975230064239.56E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1086059232rs11200981GArs11200981230064234.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1086972838rs7075770ACrs7075770230064239.48E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1088061803rs2814320AGrs2814320189787907.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1090686043rs7085698AGrs7085698230064235.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1090727334rs1926203CArs1926203189787879.91E-06NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1090727334rs1926203CArs1926203196543031.00E-06NA1.12NA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1092434907rs2710767CArs2710767230064231.81E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1099257815rs7915501TGrs7915501231081454.63E-05NANANA914 European ancestry non-small cell lung cancer cases; 860 European ancestry controlsEuropean(1774)ALL(1774)EUR(1774)ALL(1774)Lung Cancer (DNA repair capacity)HPOID:0003254HPOID:0100526Abnormality of DNA repairNeoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsNANALung cancerNAResearch Support, N.I.H., Extramural
10101235813rs7912109GCrs7912109230064233.77E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10101247551rs12355928CTrs12355928230064234.76E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10101260443rs11190120CArs11190120230064234.32E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10101263128rs10509737TGrs10509737230064237.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10101264162rs4595481AGrs4595481230064231.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10102912649rs701840CArs701840230064232.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10102919101rs792720CGrs792720230064232.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10102928131rs1743829TCrs1743829230064233.61E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10107941877rs2150602TCrs2150602230064231.29E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10107942299rs7918637TCrs7918637230064235.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10109794993rs7082958GArs7082958230064235.71E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10110111704rs10884620CTrs10884620230064239.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10110172512rs1754614TCrs1754614230064234.31E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10110172699rs1762059GArs1762059230064234.31E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10110270804rs10748985TCrs10748985230064234.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10112612802rs4917589AGrs4917589230064238.98E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10114498476rs7086803GArs7086803231436014.00E-18NA1.28NA5,510 East Asian ancestry cases; 4,544 East Asian ancestry controlsEast Asian(10054)ALL(10054)ASN(10054)ALL(10054)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs7086803-AResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, N.I.H., Intramural
10116188485rs11196739CTrs11196739230064231.38E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10116189930rs11812741GArs11812741230064237.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10116190274rs11196740GArs11196740230064231.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10116192120rs11551242TCrs11551242230064231.39E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10117928218rs2270181CTrs2270181230064239.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10117935065rs2420244CArs2420244230064235.65E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10120595466rs10886319TGrs10886319230064239.79E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10120615752rs1409314AGrs1409314230064236.46E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10121065385rs915391AGrs915391230064235.86E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10121429633rs2234962TCrs2234962230064237.50E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10123317185rs11814493TCrs11814493230064233.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10123606502rs6585765GArs6585765230064234.71E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10126261541rs4962651AGrs4962651230064239.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10126262395rs4962653AGrs4962653230064239.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10126837944rs6597883TCrs6597883230064237.16E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10130900206rs2039371CTrs2039371230064234.78E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10130900389rs2039372TCrs2039372230064233.86E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10130902337rs12778834CArs12778834230064233.75E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10130903024rs11597093GArs11597093230064234.63E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10130905792rs12774599GTrs12774599230064236.42E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10131711365rs11597635GArs11597635230064233.73E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10131800501rs11017044CTrs11017044230064236.32E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10131802533rs7910342CTrs7910342230064233.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10131810153rs4751158ATrs4751158230064238.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10132879852rs7098146TCrs7098146230064237.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10133146930rs7898539CTrs7898539230064235.93E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10134026212rs11146253GArs11146253230064235.36E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
10134873188rs4294501ACrs4294501230064232.48E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
111068900rs7942850TCrs7942850230064237.16E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
111087972rs10902088CTrs10902088230064239.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
111884342rs2137320GArs2137320230064234.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
112739110rs231888CTrs231888230064237.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
114466833rs331538TArs331538230064239.86E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
115729580rs2291845TCrs2291845230064235.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
115731455rs7113258TArs7113258230064231.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
115733594rs4910841AGrs4910841230064235.52E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
116569896rs11606889GArs11606889230064239.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
117594803rs7120154CTrs7120154230064235.88E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
118265652rs12277079AGrs12277079230064237.73E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1110424939rs10840403TCrs10840403230064237.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1110425417rs10743140AGrs10743140230064234.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1111386340rs12787100AGrs12787100230064239.19E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1111386594rs1843784TArs1843784230064233.63E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1111387713rs12794600ACrs12794600230064233.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1111387855rs17436486AGrs17436486230064233.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1111395489rs10047474CTrs10047474230064234.81E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1111397472rs12294127AGrs12294127230064236.83E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1111398698rs10444245GArs10444245230064237.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1112072503rs923175GCrs923175230064237.00E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (docetaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1112911236rs10831916CTrs10831916230064231.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1113990544rs1528657TGrs1528657230064233.83E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1115252444rs1792543AGrs1792543230064236.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1115258289rs11023482GArs11023482230064233.49E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1115824138rs326686GArs326686230064231.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1116534415rs12802656ACrs12802656230064236.39E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1117823296rs11024408TCrs11024408230064234.75E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1118267997rs7113375ATrs7113375230064232.88E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1118276336rs11024586AGrs11024586230064238.73E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1119955194rs16937251GCrs16937251230064239.05E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1120431016rs7482968CA,G,Trs7482968230064231.63E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1120461625rs7933513TCrs7933513230064235.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1120523657rs7934715AGrs7934715230064239.43E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1120730761rs1715282CArs1715282230064234.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1124399097rs12577327CTrs12577327230064239.39E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1125157509rs11028449GCrs11028449230064232.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1125538293rs11028743CTrs11028743230064239.29E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1126648071rs1353142AGrs1353142230064235.60E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1126651147rs12269966TGrs12269966230064231.64E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1126652962rs7127915TArs7127915230064233.37E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1129589341rs1231682AGrs1231682230064236.73E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1129632786rs326782TCrs326782230064235.18E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1129642280rs326789TCrs326789230064234.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1129650626rs326790TCrs326790230064231.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1129659444rs2447045AGrs2447045230064231.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1130761964rs584591ACrs584591230064238.75E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1135244887rs10836343TCrs10836343230064238.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1135245907rs10128586TCrs10128586230064233.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1138700909rs10742437CGrs10742437230064236.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1138702667rs325183TCrs325183230064238.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1138726426rs374082TCrs374082230064232.93E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1138738683rs1504232GArs1504232230064237.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1139611165rs10501215GTrs10501215230064237.07E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1139620131rs7932035AGrs7932035230064233.94E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1139632506rs12416853TCrs12416853230064231.87E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1139633353rs1477869GArs1477869230064239.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1139643150rs10837192CArs10837192230064231.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1139652635rs10837198ACrs10837198230064231.73E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1144014312rs16937777GArs16937777230064231.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1144015866rs4595529ACrs4595529230064232.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1144016981rs739568GArs739568230064231.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1156925021rs3017569GTrs3017569230064236.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1156931832rs2860508GArs2860508230064234.88E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1158111513rs1938648TCrs1938648189787878.66E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1158255763rs2510866AGrs2510866230064238.53E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1158264181rs2515368GArs2515368230064239.59E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1158265949rs11229497TArs11229497230064239.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1158274370rs2515366TCrs2515366230064232.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1158278349rs7115326CTrs7115326230064232.09E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1158287319rs7952094CTrs7952094230064232.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1158309914rs7109553CTrs7109553230064232.64E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1158316567rs2515359TCrs2515359230064234.48E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1158326795rs10896791GCrs10896791230064233.38E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1158327398rs2515346CArs2515346230064238.33E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1158331924rs1944054CGrs1944054230064233.01E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1158336544rs2509920GCrs2509920230064238.80E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1158381686rs1938596AGrs1938596230064237.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1158392951rs2515362TCrs2515362230064237.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1158404733rs2154631ACrs2154631230064234.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1158405458rs2509928TCrs2509928230064234.96E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1158800374rs1943141GArs1943141230064235.45E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1158976711rs3847AGrs3847230064231.03E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1158980549rs6591509AGrs6591509230064231.43E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1158981586rs2000875GArs2000875230064231.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1158984717rs1938593GArs1938593230064231.25E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1158989046rs17153461GArs17153461230064231.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1158996396rs4939263GArs4939263230064231.93E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1159014108rs6591515AGrs6591515230064231.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1159014658rs7938115GArs7938115230064231.62E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1159014749rs7931234TGrs7931234230064234.72E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1159025022rs12280107CTrs12280107230064235.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1159027039rs11229896TArs11229896230064237.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1159029485rs11229898TCrs11229898230064237.15E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1161549458rs174534AGrs174534217253087.68E-07NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyA
1161564299rs4246215GTrs4246215217253089.35E-07NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyG
1161571348rs174548CGrs174548217253081.66E-07NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyG
1161571382rs174549GArs174549217253085.77E-07NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyA
1161597212rs174570CTrs174570189787872.47E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1161597212rs174570CTrs174570217253088.14E-07NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyC
1161604814rs174577CArs174577217253082.10E-07NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyA
1161609750rs174583CTrs174583217253082.20E-07NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyT
1168804806rs10896396GTrs10896396230064232.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1172289291rs1135029TCrs1135029230064235.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1174399425rs1893361GArs1893361189787905.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
1175865197rs10793139TCrs10793139230064237.05E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1178929703rs4945334TGrs4945334230064235.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1179697979rs486935TCrs486935230064239.35E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1180413739rs7949324AGrs7949324230064234.64E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1182411635rs1497104TCrs1497104230064235.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1182414527rs11233281CGrs11233281230064235.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1182434877rs1811661CTrs1811661230064238.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1182437492rs1497111TCrs1497111230064235.37E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1182449606rs9666486TCrs9666486230064239.03E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1187238011rs1815083CTrs1815083230064232.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1187238155rs7119134AGrs7119134230064234.77E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1187249507rs4944716TCrs4944716230064231.19E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1187275855rs11235204TGrs11235204230064237.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1187277924rs4512880GArs4512880230064235.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1187284641rs5010075TCrs5010075230064239.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1187286604rs7121003ACrs7121003230064236.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1187294548rs6592387AGrs6592387230064237.21E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1187295319rs7929162GArs7929162230064237.21E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1189444754rs7111680GArs7111680230064235.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1189502376rs2130017CArs2130017230064238.00E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (docetaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1191815940rs7924406GCrs7924406230064231.31E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1192306628rs1623581ACrs1623581230064233.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1194260957rs7936320TCrs7936320230064233.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1199377407rs2726417TCrs2726417230064239.86E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1199399190rs11220314AGrs11220314230064235.75E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11103904556rs7128670AC,G,Trs7128670230064235.07E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11105758104rs2508467GArs2508467230064236.62E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11106559413rs10502074CGrs10502074230064237.56E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11108657507rs7109110GCrs7109110230064235.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11108703297rs7342253CTrs7342253230064237.09E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11109904780rs7111498CTrs7111498230064236.09E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11113336172rs11601054GArs11601054230064237.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11113355736rs6589377GArs6589377230064232.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11113364647rs4245150GTrs4245150230064232.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11113364803rs4938021CTrs4938021230064232.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11113365084rs4936275CTrs4936275230064233.14E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11113388674rs4245154AGrs4245154230064239.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11114087467rs397461CTrs397461230064232.42E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11114718070rs4938144TCrs4938144230064236.78E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11116517591rs1240769TGrs1240769230064232.19E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11117716453rs1145223TCrs1145223230064232.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11119751585rs895649AGrs895649230064235.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11119948566rs4938769CTrs4938769230064239.95E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11121115206rs6589865CTrs6589865230064239.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11121120755rs1893248CTrs1893248230064236.09E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11121121448rs7928669TCrs7928669230064234.49E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11121121501rs7942167GArs7942167230064236.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11121128543rs4423192TCrs4423192230064231.63E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11121144114rs12363999TCrs12363999230064235.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11121194946rs10892723AGrs10892723230064231.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11121195951rs6589877GTrs6589877230064235.93E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11121204601rs4936613AGrs4936613230064236.00E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11121707866rs472074GArs472074230064236.09E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11121754288rs1219400CArs1219400230064233.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11121760604rs1219396AGrs1219396230064236.79E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11122101556rs640786GArs640786230064239.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11122579404rs17126767CTrs17126767230064234.31E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11123370595rs3016473GArs3016473230064234.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11126953493rs715364CTrs715364230064236.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11128333215rs12146687TCrs12146687230064237.43E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11129315586rs3019793AGrs3019793230064238.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11129456444rs2087889ATrs2087889230064239.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11129459840rs12787230TGrs12787230230064236.55E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11129461016rs11822830AGrs11822830230064233.52E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11129461171rs11820646TCrs11820646230064238.79E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11129462233rs745382AGrs745382230064237.90E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11130423305rs2172491CTrs2172491230064236.42E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11131193742rs1793553GTrs1793553230064235.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11131194688rs1540231AGrs1540231230064233.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11131197551rs2511506GArs2511506230064235.09E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11131884441rs2518016TGrs2518016230064231.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11131894864rs566390CTrs566390230064231.13E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11131899407rs4936152CTrs4936152230064232.09E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11131900736rs1939717TCrs1939717230064233.16E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11131901748rs11222869AGrs11222869230064232.16E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11131901805rs948039AGrs948039230064231.81E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11131902177rs2018361CArs2018361230064237.85E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11131912523rs579984GArs579984230064231.28E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11131912780rs484096ACrs484096230064232.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11131921698rs1793640TGrs1793640230064234.95E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11131926198rs1793630TCrs1793630230064235.94E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11131933341rs1015055CTrs1015055230064233.50E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11131935236rs1790171TCrs1790171230064233.86E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11131935628rs1626583CTrs1626583230064236.99E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11131954147rs1790181ACrs1790181230064234.13E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11132136885rs10894526CTrs10894526230064236.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11134274676rs1866769AGrs1866769230064238.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11134350107rs11223858CTrs11223858230064234.71E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
11134403389rs11223888CTrs11223888230064236.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
121064438rs10849605TCrs10849605228996536.00E-07NA1.08[1.04-1.11]up to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
123360946rs12371422GA,C,Trs12371422230064239.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
123985224rs7973859AGrs7973859230064238.02E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
123987473rs2109112TCrs2109112230064235.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
126056450rs3809241GTrs3809241230064237.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
126058736rs933408TGrs933408230064239.19E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
127455597rs7137120AGrs7137120230064236.07E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
127465941rs7294678GArs7294678230064235.14E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1210928951rs1444211AGrs1444211230064233.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1211975532rs2710287TCrs2710287230064238.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1212035282rs11054481CGrs11054481230064236.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1212037081rs2071163GArs2071163230064233.07E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1213424929rs4578488CTrs4578488230064235.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1213485340rs9651864GArs9651864230064233.36E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1213984598rs11612353AGrs11612353230064235.07E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1214125734rs1421106GTrs1421106230064232.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1214426092rs16909808GTrs16909808230064234.21E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1214707128rs7296684CTrs7296684230064233.43E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1216364884rs11056825AGrs11056825230064238.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1217423964rs7314782CTrs7314782230064239.88E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1217450756rs2942578CTrs2942578230064236.60E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1217505513rs2971177CTrs2971177230064234.87E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1217508277rs1532521TGrs1532521230064234.63E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1220182733rs2579206TArs2579206230064236.21E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1220186390rs2248385AGrs2248385230064238.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1221654407rs1061627GArs1061627230064237.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1221654831rs1060126GTrs1060126230064235.53E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1221728345rs10505873TCrs10505873230064237.19E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1224199202rs7966115CTrs7966115230064237.36E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1227843923rs1010094AGrs1010094230064234.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1227845174rs10734762CGrs10734762230064233.88E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1230458263rs1731494GArs1731494230064237.88E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1231127160rs7971358AGrs7971358230064236.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1231128016rs4931395GArs4931395230064233.65E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1234078575rs694088CArs694088230064238.25E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1240547750rs11564122GArs11564122230064237.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1240551073rs7959787CTrs7959787230064232.21E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1240569777rs11564116CTrs11564116230064237.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1241614599rs12367762GTrs12367762230064236.38E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1243825415rs2201465GTrs2201465230064235.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1243980459rs405615GArs405615230064231.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1247179557rs180433TCrs180433230064232.31E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1247179574rs180434CTrs180434230064237.43E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1248853239rs2956467GCrs2956467217253085.46E-14NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyG
1252504038rs2360644GArs2360644230064235.77E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1254352836rs2120295AGrs2120295230064232.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1261909374rs11174055ACrs11174055230064236.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1262325370rs851903CTrs851903230064235.53E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1265291294rs1445442GArs1445442230064239.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1265905668rs11175792TCrs11175792230064232.50E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1265912521rs7300729ACrs7300729230064234.86E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1265917188rs1532326AGrs1532326230064233.21E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1268841276rs1154818GArs1154818230064237.37E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1273439648rs7960235GArs7960235230064231.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1273442495rs1400142CTrs1400142230064231.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1273497747rs1878121CTrs1878121230064237.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1279387804rs17046168CTrs17046168230064234.81E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1287905878rs12424042GArs12424042230064238.81E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1289504012rs3926062GArs3926062230064234.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1291252492rs10745532GCrs10745532230064239.48E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1291444445rs10859101CArs10859101230064239.63E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1291532325rs9971900GTrs9971900230064239.49E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1291540103rs3138288TA,Crs3138288230064239.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1291547030rs3138262AGrs3138262230064239.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1291565343rs3138191GArs3138191230064233.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1293349126rs12368715CArs12368715230064235.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1294006434rs11107127TCrs11107127230064231.16E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1296204253rs1561092TCrs1561092230064236.46E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1296222187rs7310140GArs7310140230064234.89E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1296434880rs2540482CTrs2540482196543039.48E-06NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1296438319rs2660844ACrs2660844230064235.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1296459342rs759394CArs759394230064233.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1296471864rs2540457TGrs2540457230064232.37E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1297919052rs7962117AGrs7962117230064238.31E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1297959792rs10860219AGrs10860219230064232.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1297970138rs11109114AGrs11109114230064239.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
12108696850rs11113808CTrs11113808230064234.00E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
12108697894rs4964243TCrs4964243230064239.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
12108805152rs2673743GArs2673743230064231.77E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
12109568797rs16939972TCrs16939972230064236.93E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
12110645829rs17619763GArs17619763230064233.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
12110712212rs6606683TGrs6606683230064234.35E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
12110766767rs17187412AGrs17187412230064233.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
12111102627rs17625767TGrs17625767230064234.50E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
12114660658rs1920562TCrs1920562230064231.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
12115504520rs35503AGrs35503230064233.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
12117342165rs7980519GArs7980519230064234.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
12119529695rs11609302CTrs11609302230064234.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
12119532430rs7314453TCrs7314453230064237.49E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
12120488636rs5028648GArs5028648230064237.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
12120513625rs3852585TCrs3852585230064233.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
12120540290rs3852587ACrs3852587230064238.07E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
12125071643rs1726263CTrs1726263230064234.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
12127992426rs7295355TCrs7295355230064234.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
12129773186rs12315751TCrs12315751230064238.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
12129783438rs10744409GArs10744409230064236.46E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
12130395730rs12297883TArs12297883230064232.78E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
12130395910rs12317807CTrs12317807230064237.89E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
12131517793rs13377643TGrs13377643230064233.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1323320655rs9510315GTrs9510315230064233.90E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1323350341rs12428099GCrs12428099230064239.76E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1324071322rs17390122AGrs17390122230064232.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1324128199rs17078934CTrs17078934230064237.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1324289783rs2861539AGrs2861539217253085.70E-05NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyC
1324289849rs12867512GArs12867512217253085.20E-05NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyG
1324290267rs11617518CTrs11617518217253084.60E-05NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyT,C
1324290621rs9580741TCrs9580741217253084.00E-05NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyT
1324291878rs745068TGrs745068217253084.00E-05NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyT
1324291972rs745069TCrs745069217253081.90E-05NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyT
1324292701rs2840252ATrs2840252217253088.10E-05NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyT
1324293053rs9553037TCrs9553037217253082.60E-05NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyT
1324293859rs753955AGrs753955217253082.00E-12NA1.18[1.13-1.24]2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs753955-GResearch Support, Non-U.S. Gov'tComparative StudyT
1324294105rs753954GArs753954217253083.00E-05NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyC
1324678732rs9511057TGrs9511057230064233.36E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1326559034rs2031351CTrs2031351230064234.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1328674026rs7998462AGrs7998462189787872.94E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1329898086rs7326604CTrs7326604230064236.36E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1330295287rs7321919TCrs7321919230064239.94E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1330488370rs11617065GArs11617065230064239.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1330494759rs2039951CGrs2039951230064237.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1332869864rs56084662GArs56084662248803421.88E-15(All lung cancer)2.01[1.69-2.38]3,442 European ancestry adenocarcinoma cases; 3,275 European ancestry squamous cell carcinoma cases; 4,631 cases; up to 15,861 controlsNOPOP(20492)European(6717)ALL(27209)NOPOP(20492)EUR(6717)ALL(27209)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs56084662-AResearch Support, N.I.H., Extramural
1332869864rs56084662GArs56084662248803424.12E-17(Squamous cell carcinoma)2.95[2.29-3.81]3,442 European ancestry adenocarcinoma cases; 3,275 European ancestry squamous cell carcinoma cases; 4,631 cases; up to 15,861 controlsNOPOP(20492)European(6717)ALL(27209)NOPOP(20492)EUR(6717)ALL(27209)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs56084662-AResearch Support, N.I.H., Extramural
1332972626rs11571833ATrs11571833248803422.00E-19(All lung cancer)1.83[1.61-2.09] 3,442 European ancestry adenocarcinoma cases; 3,275 European ancestry squamous cell carcinoma cases; 4,631 cases; up to 15,861 controlsNOPOP(20492)European(6717)ALL(27209)NOPOP(20492)EUR(6717)ALL(27209)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs11571833-TResearch Support, N.I.H., Extramural
1332972626rs11571833ATrs11571833248803424.66E-04(Adenocarcinoma)1.47[1.19-1.82]3,442 European ancestry adenocarcinoma cases; 3,275 European ancestry squamous cell carcinoma cases; 4,631 cases; up to 15,861 controlsNOPOP(20492)European(6717)ALL(27209)NOPOP(20492)EUR(6717)ALL(27209)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs11571833-TResearch Support, N.I.H., Extramural
1332972626rs11571833ATrs11571833248803425.00E-20(Squamous cell carcinoma)2.47[2.03-3.00] 3,442 European ancestry adenocarcinoma cases; 3,275 European ancestry squamous cell carcinoma cases; 4,631 cases; up to 15,861 controlsNOPOP(20492)European(6717)ALL(27209)NOPOP(20492)EUR(6717)ALL(27209)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs11571833-TResearch Support, N.I.H., Extramural
1336712330rs1328650GTrs1328650230064237.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1338479710rs17056817CTrs17056817230064238.79E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1338596233rs12429115GArs12429115230064232.98E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1338928976rs9888482ACrs9888482230064233.19E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1341081310rs17199729AGrs17199729230064236.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1341958476rs4558307GArs4558307230064232.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1345358131rs9567479ACrs9567479230064231.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1346484940rs2573286TCrs2573286230064233.96E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1347826159rs6561362CTrs6561362230064232.64E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1347829134rs7998555TArs7998555230064233.16E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1350286218rs1407440TCrs1407440230064231.99E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1350290990rs1407441TCrs1407441230064234.87E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1350296026rs9535310TCrs9535310230064232.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1350313345rs9316474CArs9316474230064234.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1350443418rs7332385CTrs7332385230064232.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1356459234rs2645920TCrs2645920230064239.86E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1358480590rs9537854TCrs9537854230064237.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1362070819rs2329317CArs2329317230064231.30E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1362074306rs17059944CArs17059944230064231.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1362077426rs12427905TArs12427905230064231.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1363551022rs1512883CTrs1512883230064239.75E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1363636680rs9564006TCrs9564006230064237.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1363728981rs9317289CTrs9317289230064235.01E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1363785757rs9564010TCrs9564010230064235.42E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1367728051rs9599192CTrs9599192230064235.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1369564539rs9529473TArs9529473230064236.27E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1369565834rs9529475TCrs9529475230064236.27E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1372583058rs9542806GArs9542806230064238.25E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1372598561rs2810131ACrs2810131230064233.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1372603001rs4884983TCrs4884983230064234.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1372610261rs4883903AGrs4883903230064237.33E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1372668634rs1033981ACrs1033981230064236.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1372672154rs1326683AGrs1326683230064234.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1372672465rs1409571CArs1409571230064233.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1373083051rs7981532CTrs7981532230064234.60E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1373083414rs7982249CTrs7982249230064236.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1373957681rs6562760AGrs6562760230064234.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1373962520rs9600121AGrs9600121230064239.65E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1373964519rs8002929AGrs8002929230064239.65E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1375835859rs9543882TCrs9543882230064233.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1378392656rs9544609CArs9544609230064232.25E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1378409534rs1041620GArs1041620230064238.32E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1378899157rs2243409AGrs2243409230064235.35E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1385546562rs1537994TCrs1537994230064239.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1388484780rs953758TGrs953758230064238.86E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1388496806rs7992197AGrs7992197230064237.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1388807658rs7334500GTrs7334500230064235.13E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1388874373rs16967807GArs16967807230064232.42E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1388877803rs16967900CTrs16967900230064234.66E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1390505140rs9515642AGrs9515642189787876.97E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1392445229rs2352028CTrs2352028203047036.00E-06NA1.46[1.26-1.70] 377 cases; 377 matched controlsNOPOP(754)ALL(754)NOPOP(754)ALL(754)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs2352028-AResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
1396999480rs1925111AGrs1925111230064239.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1397127709rs6491294GCrs6491294230064237.01E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
13100786748rs9300589CTrs9300589230064235.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
13100830307rs4772269AGrs4772269230064236.22E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
13100878484rs9582378AGrs9582378230064239.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
13102306889rs9554815TArs9554815230064239.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
13102778025rs7339421TCrs7339421230064238.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
13103065062rs17690152TGrs17690152230064233.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
13103715668rs9514093ACrs9514093230064238.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
13103718824rs16961281GArs16961281230064233.37E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
13107012212rs7995709CTrs7995709230064233.19E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
13108937452rs12583006TArs12583006230064236.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
13108937833rs11069727AGrs11069727230064235.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
13108939705rs12428930ACrs12428930230064234.52E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
13108943034rs2893321AGrs2893321230064232.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
13109002358rs11069734CTrs11069734230064238.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
13109351962rs17389027TCrs17389027230064237.72E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1421526044rs12435011TCrs12435011230064231.71E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1422535262rs8022660GArs8022660230064232.88E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1423308986rs762052AGrs762052230064231.77E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1424022182rs12886523CTrs12886523230064231.01E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1424024026rs35309020GArs35309020230064231.19E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1424025340rs28403575CTrs28403575230064232.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1424026493rs34015250AGrs34015250230064236.53E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1424306364rs1958299TArs1958299230064238.22E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1424718515rs2229463GArs2229463230064232.32E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1424931234rs12890665AGrs12890665230064231.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1424934910rs12892792AGrs12892792230064238.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1424980311rs1956918GArs1956918230064235.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1425339449rs854342CTrs854342230064234.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1429373283rs4462524AGrs4462524230064237.29E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1429373308rs1956595CTrs1956595230064231.49E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1432842189rs11156740GArs11156740230064239.32E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1433205501rs2300831AGrs2300831230064238.86E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1433206507rs17440692TCrs17440692230064235.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1433221482rs1955504TCrs1955504183857382.00E-05NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1437435295rs17177982GArs17177982230064239.94E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1437444794rs8003131TCrs8003131230064235.22E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1437445831rs10483481GCrs10483481230064234.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1437446359rs9322971AGrs9322971230064233.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1441953160rs9323049TArs9323049230064237.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1441953762rs12884090AGrs12884090230064237.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1441959784rs7140726GCrs7140726230064237.98E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1444445910rs10141817CTrs10141817230064238.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1447461203rs17560594TCrs17560594230064235.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1447467145rs17641214TCrs17641214230064235.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1447499386rs10135113ACrs10135113230064239.66E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1448034860rs2416095TGrs2416095230064231.13E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1448045792rs12891099GArs12891099230064239.00E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1448049641rs12894376TCrs12894376230064239.00E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1448460210rs11622479GCrs11622479230064235.99E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1449952834rs8008323AGrs8008323230064235.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1451144660rs7159861AGrs7159861230064239.00E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1452365774rs1316298AGrs1316298246582837.00E-06NA1.41[1.20-1.61]1,506 Han Chinese ancestry smoker cases; 825 Han Chinese ancestry non-smoker cases; 1,309 Han Chinese ancestry smoker controls; 1,768 Han Chinese ancestry non-smoker controlsHan Chinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancer (smoking interaction)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerNANANANALung cancerrs1316298-TResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tComparative Study
1453192357rs2884343TCrs2884343230064234.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1454098459rs7149928AGrs7149928230064239.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1457459136rs2345838CTrs2345838230064233.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1457791313rs8021868CGrs8021868230064234.65E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1461957000rs17098533GTrs17098533230064236.86E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1461958290rs17098542CTrs17098542230064233.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1461984737rs3751295TArs3751295230064237.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1471290125rs7157405CTrs7157405230064238.39E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1472434531rs17105032GTrs17105032230064239.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1472456227rs2238276CTrs2238276230064233.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1472456913rs1860105GArs1860105230064239.93E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1472457365rs2238275TGrs2238275230064233.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1472458188rs2238274GArs2238274230064238.61E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1472462381rs11623535GArs11623535230064232.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1472464107rs4354860CTrs4354860230064233.88E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1472464262rs4899412TCrs4899412230064233.88E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1472466149rs11158927GCrs11158927230064234.36E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1473754746rs17126584GArs17126584230064237.98E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1474035671rs11545737AGrs11545737230064235.49E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1476049334rs8181959GArs8181959230064234.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1477726733rs888060CTrs888060230064239.15E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1478608741rs10483891CTrs10483891189787901.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1480189374rs12586263GArs12586263230064232.37E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1480190556rs7158292CArs7158292230064232.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1480192862rs12589656CTrs12589656230064232.81E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1480327082rs2293847TCrs2293847230064234.29E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1480346011rs993920GTrs993920230064238.63E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1481026314rs10138951TCrs10138951230064239.16E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1482922925rs1198416GArs1198416230064236.78E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1483941267rs4904117GArs4904117230064233.78E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1485116699rs13285529TCrs13285529230064236.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1485116699rs36179278TAATA,TGrs13285529230064236.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1486895654rs7157820GArs7157820230064239.29E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1489974582rs4900000TCrs4900000230064232.33E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1490119626rs2761355TCrs2761355230064238.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1491263159rs11629240CTrs11629240230064233.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1491563816rs10438207AGrs10438207230064232.14E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1491590988rs4900070AGrs4900070230064238.75E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1491705188rs933528GArs933528230064236.81E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1491708195rs2540879CTrs2540879230064235.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1491711471rs2540875AGrs2540875230064239.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1492365051rs2430363GArs2430363230064231.02E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1495049228rs10484047GArs10484047230064232.28E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1495312660rs1243500GTrs1243500230064233.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1495478823rs2353567TCrs2353567230064236.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1495480924rs7147709AGrs7147709230064236.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1495876466rs12892702CArs12892702230064231.29E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1495881221rs12882488CTrs12882488230064231.79E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1497886219rs10137783TCrs10137783230064234.16E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1497887489rs3912371GCrs3912371230064234.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1498174479rs7159075CTrs7159075230064236.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1498177573rs10149128CTrs10149128230064237.31E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
14101713910rs915378TCrs915378230064232.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1524940793rs12102021GCrs12102021230064236.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1526692455rs6576576GArs6576576230064231.64E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1526818362rs8030011GArs8030011230064236.11E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1526833362rs8024723GArs8024723230064235.96E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1526865535rs1897356AGrs1897356230064235.58E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1526865632rs17117177CArs17117177230064233.25E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1526867109rs17117178TCrs17117178230064234.73E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1526886154rs7173713CTrs7173713230064238.00E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1531357138rs919001AGrs919001230064239.09E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1531377573rs12441329CTrs12441329230064233.94E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1531749336rs12592342TCrs12592342230064233.30E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1532229483rs11071406TCrs11071406230064232.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1532230940rs7177058GCrs7177058230064234.43E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1532237709rs6494074GArs6494074230064234.16E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1532345139rs11071512TCrs11071512230064238.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1533843336rs1529849AGrs1529849230064237.29E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1533871487rs2643365TCrs2643365230064233.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1535981314rs6495794GArs6495794230064236.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1536751845rs2467364CTrs2467364230064236.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1536891254rs2602923TCrs2602923230064237.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1537177687rs16964247GArs16964247230064239.14E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1537215855rs837134GArs837134230064237.43E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1543247567rs16957284TCrs16957284230064239.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1543554226rs504417AGrs504417196543033.11E-06NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1543557549rs11853991AGrs11853991196543033.61E-06NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1543559231rs748404TCrs748404196543031.00E-06NA1.15[1.09-1.20] 1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1547093850rs1918662GArs1918662230064237.21E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1549771796rs12901446GTrs12901446230064238.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1549771796rs552340379GTTTTTTGrs12901446230064238.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1549771796rs56097665GTGrs12901446230064238.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1549961386rs2202713CTrs2202713230064239.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1549990209rs16962755CGrs16962755230064233.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1553061156rs2440327TCrs2440327230064233.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1554967609rs4774702GA,Crs4774702230064238.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1555382590rs473758GArs473758230064233.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1555408307rs564719ATrs564719230064234.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1555411860rs16975962GArs16975962230064237.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1557697029rs12909509GArs12909509230064235.77E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1557697075rs12909385CTrs12909385230064232.65E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1561536422rs8029174CArs8029174230064233.15E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1561566215rs4775378AGrs4775378230064235.03E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1563288730rs12437471TCrs12437471230064232.09E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1563653479rs8041909TCrs8041909230064237.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1565101007rs7176023TCrs7176023230064232.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1567155069rs4589502CTrs4589502246582834.00E-06NA1.55[1.29-1.87]1,506 Han Chinese ancestry smoker cases; 825 Han Chinese ancestry non-smoker cases; 1,309 Han Chinese ancestry smoker controls; 1,768 Han Chinese ancestry non-smoker controlsHan Chinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancer (smoking interaction)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerNANANANALung cancerrs4589502-TResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tComparative Study
1567341810rs12911494CTrs12911494230064239.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1567359883rs4776338TCrs4776338230064234.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1567361308rs7162912TGrs7162912230064233.53E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1567361774rs12904944GArs12904944230064238.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1567363283rs10518705TGrs10518705230064238.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1567365622rs10518707AGrs10518707230064236.79E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1567370445rs12901499GArs12901499230064237.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1568270380rs338344GArs338344230064236.61E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1568976882rs8033246GArs8033246230064238.07E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1569008251rs12443134AGrs12443134230064235.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1569008315rs12915581CTrs12915581230064236.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1577747869rs937237TCrs937237230064236.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1577777632rs7119CTrs7119230064234.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1577803660rs8040318ACrs8040318230064235.00E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1577809150rs12902896ACrs12902896230064237.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1577833625rs11630540GArs11630540230064235.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1577837982rs12909292GTrs12909292230064239.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1577849191rs12902898TCrs12902898230064235.31E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1577850146rs12917044CTrs12917044230064232.35E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1577850184rs12917431GCrs12917431230064233.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1578507316rs11629576GArs11629576230064236.77E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1578509542rs8037412TArs8037412230064239.15E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1578546189rs11633014TCrs11633014230064239.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1578712699rs4887053AC,Trs4887053189787875.60E-10NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578712699rs4887053AC,Trs4887053196543035.94E-11NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578712699rs4887053AC,Trs4887053228996532.60E-20NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1578724469rs1394371CTrs1394371189787874.30E-10NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578724469rs1394371CTrs1394371189787904.00E-08NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1578724469rs1394371CTrs1394371196543031.27E-09NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578724469rs1394371CTrs1394371228996531.20E-28NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1578742754rs10519198CArs10519198228996532.60E-08NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1578745707rs2656069CTrs2656069228996532.00E-08NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1578789488rs13180CTrs13180189787906.00E-07NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1578789488rs13180CTrs13180196543037.12E-10NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578789488rs13180CTrs13180228996539.30E-20NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1578792527rs1062980TCrs1062980196543032.35E-10NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578792527rs1062980TCrs1062980228996532.50E-04NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1578806023rs8034191TCrs8034191183856763.00E-18NA1.3[1.15-1.47]1,154 cases; 1,137 controlsNOPOP(2291)ALL(2291)NOPOP(2291)ALL(2291)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs8034191-GResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
1578806023rs8034191TCrs8034191183857385.00E-20NA1.3[1.23-1.37]1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs8034191-CResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
1578806023rs8034191TCrs8034191187808721.00E-08 1.38[1.17-1.64] 194 cases; 219 controlsNOPOP(413)ALL(413)NOPOP(413)ALL(413)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs8034191-GResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
1578806023rs8034191TCrs8034191189787874.03E-19NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578806023rs8034191TCrs8034191189787903.00E-15NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
1578806023rs8034191TCrs8034191196543033.00E-26NA1.29[1.23-1.35]1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578806023rs8034191TCrs8034191228996539.50E-59NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1578825917rs3885951AGrs3885951228996532.20E-05NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1578826948rs2036534TCrs2036534189787879.81E-14NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578826948rs2036534TCrs2036534189787905.00E-06NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
1578826948rs2036534TCrs2036534196543032.23E-12NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578826948rs2036534TCrs2036534228996533.30E-25NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1578865893rs6495306GArs6495306228996531.80E-09NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1578871288rs680244TCrs680244228996537.20E-10NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1578888400rs578776GArs578776196543038.83E-11NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578888400rs578776GArs578776228996531.90E-09NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1578891627rs12910984GArs12910984196543031.71E-14NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578891627rs12910984GArs12910984228996531.10E-16NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1578894339rs1051730GArs1051730183856761.33E-09NANANA1,154 cases; 1,137 controlsNOPOP(2291)ALL(2291)NOPOP(2291)ALL(2291)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1578894339rs1051730GArs1051730183857385.40E-09NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1578894339rs1051730GArs1051730189787872.83E-19NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578894339rs1051730GArs1051730189787901.00E-15NA1.35[1.25-1.45]2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs1051730-AResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1578894339rs1051730GArs1051730196543039.60E-14NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578894339rs1051730GArs1051730228996532.20E-63NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1578896547rs938682GArs938682196543037.11E-15NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578896547rs938682GArs938682228996531.00E-16NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1578898723rs12914385CTrs12914385196543033.19E-16NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578898723rs12914385CTrs12914385228996532.80E-28NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1578908032rs8042374AGrs8042374189787878.00E-12NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578908032rs8042374AGrs8042374196543032.70E-15NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578908032rs8042374AGrs8042374228996531.10E-16NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1578915245rs6495309CTrs6495309189787871.85E-13NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578915245rs6495309CTrs6495309189787905.00E-06NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1578915245rs6495309CTrs6495309196543031.93E-14NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578915245rs6495309CTrs6495309228996531.10E-32NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1578926018rs950776TCrs950776228996537.00E-09NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1578929372rs12441998GArs12441998196543032.06E-10NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578929372rs12441998GArs12441998228996532.60E-15NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1578930510rs1316971AGrs1316971196543037.53E-10NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578930510rs1316971AGrs1316971228996531.90E-14NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1578946633rs12594247CTrs12594247189787878.42E-07NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578946633rs12594247CTrs12594247196543031.47E-06NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578946633rs12594247CTrs12594247228996531.80E-14NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1578953785rs17487514CTrs17487514228996531.90E-10NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1578956806rs1996371TCrs1996371189787876.01E-09NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578956806rs1996371TCrs1996371189787906.00E-08NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
1578956806rs1996371TCrs1996371196543034.84E-08NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578956806rs1996371TCrs1996371228996531.10E-11NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1578960529rs6495314ACrs6495314189787874.16E-09NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578960529rs6495314ACrs6495314189787908.00E-08NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
1578960529rs6495314ACrs6495314196543034.33E-08NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578960529rs6495314ACrs6495314228996532.20E-32NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1578974545rs8038920AGrs8038920228996534.00E-12NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1578978364rs4887077CTrs4887077189787877.89E-09NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578978364rs4887077CTrs4887077189787903.00E-07NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1578978364rs4887077CTrs4887077196543036.85E-08NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578978364rs4887077CTrs4887077228996532.40E-17NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1578983559rs11638372CTrs11638372189787877.23E-09NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578983559rs11638372CTrs11638372189787904.00E-07NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1578983559rs11638372CTrs11638372196543035.93E-08NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1578983559rs11638372CTrs11638372228996535.00E-31NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1579006442rs11072793GArs11072793228996537.80E-09NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1579019610rs3813565GTrs3813565196543031.40E-08NANANA1,952 European ancestry cases; 1,438 European ancestry controlsEuropean(3390)ALL(3390)EUR(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1579019610rs3813565GTrs3813565228996533.40E-17NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1579111093rs4380028CTrs4380028228996536.20E-09NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1579128499rs4539564GArs4539564228996531.80E-09NANANAup to 14,900 European ancestry cases; up to 29,485 European ancestry controlsEuropean(44385)ALL(44385)EUR(44385)ALL(44385)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Meta-Analysis
1581109594rs2055713AGrs2055713230064232.29E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1581130887rs25431GArs25431230064236.35E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1581385552rs2683260TGrs2683260230064238.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1581391411rs1509559GArs1509559230064235.71E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1581391713rs1509560TGrs1509560230064235.71E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1582103939rs7170175CTrs7170175230064239.35E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1582107103rs4778652TGrs4778652230064232.25E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1584135138rs9920377GArs9920377230064236.37E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1587449130rs4426325AGrs4426325230064236.39E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1591921234rs4586406TCrs4586406230064238.36E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1592602314rs8032656GCrs8032656230064236.28E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1593577383rs1978877TCrs1978877230064239.38E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1593584615rs7164440GArs7164440230064233.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1593877257rs16947830AGrs16947830230064237.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1597018475rs7168357TCrs7168357230064238.42E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1598208220rs289471TCrs289471230064233.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1598750737rs11633447CTrs11633447230064237.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1598774993rs11247163AGrs11247163230064233.33E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1599256570rs3803476AGrs3803476230064238.48E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1599263801rs11857366AGrs11857366230064232.79E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1599287375rs12908437TCrs12908437230064235.18E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1599289638rs2137683CGrs2137683230064233.20E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1599292805rs7166999ACrs7166999230064234.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1599293056rs6598542GArs6598542230064231.07E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1599294355rs12898337TCrs12898337230064232.08E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1599294452rs12898502TCrs12898502230064233.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1599295570rs4966024GArs4966024230064231.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1599836804rs12592075GArs12592075230064236.63E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1599838020rs12913897AGrs12913897230064237.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1599839408rs8041923TCrs8041923230064237.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
15100007996rs7171291GArs7171291230064231.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
15100008392rs4965245CTrs4965245230064235.62E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
15100009396rs1561860GCrs1561860230064236.50E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
15100009490rs1561861GTrs1561861230064237.17E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
15100786271rs4533267AGrs4533267230064233.13E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
15101242690rs1002941GArs1002941183857384.70E-05NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
15101251719rs184234TCrs184234230064231.00E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
15101253557rs304115GArs304115230064231.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
161109435rs2467440CTrs2467440230064233.22E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
161109518rs2056992ACrs2056992230064231.09E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
161135403rs17135170AGrs17135170230064233.63E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
165001380rs9635542AGrs9635542226377434.00E-06NANANA1,154 European ancestry cases; 1,137 European ancestry controlsEuropean(2291)ALL(2291)EUR(2291)ALL(2291)Lung cancer-asbestos exposure interactionHPOID:0010616Lung fibromaDOID:1324lung cancerD001195AsbestosisNANALung cancerrs9635542-GResearch Support, N.I.H., ExtramuralANA
165559149rs13337426CTrs13337426230064235.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
166417933rs12446308AGrs12446308194146792.88E-08Lung cancer (non-small cell lung cancer), survival in early stageNANA100 samplesNOPOP(100)ALL(100)NOPOP(100)ALL(100)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAMulticenter StudyResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
166846271rs12921548TCrs12921548230064231.07E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
166875404rs7190693CTrs7190693230064233.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
167468729rs7190503AGrs7190503230064239.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
167664875rs9929993CTrs9929993230064235.52E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
168415921rs29605CTrs29605230064237.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
168853060rs1273433ATrs1273433230064232.49E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
169303318rs11647231AGrs11647231230064237.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
169306667rs10500367GArs10500367230064231.33E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
169312782rs2941318GArs2941318230064237.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
169335318rs8045112ACrs8045112230064232.21E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
169336618rs2314293AGrs2314293230064232.38E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
169341096rs959228GArs959228230064238.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
169354756rs907021CTrs907021230064238.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
169356311rs7190139TGrs7190139230064238.39E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
169748201rs170290TCrs170290230064231.50E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1612119676rs8050827TGrs8050827230064236.30E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1612760767rs1713478AGrs1713478230064234.38E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1615754468rs8061376GTrs8061376230064237.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1615758906rs7184854TCrs7184854230064234.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1615761433rs4781679CGrs4781679230064234.73E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1616965532rs9936071GArs9936071230064238.73E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1619188256rs9673444CTrs9673444230064234.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1625784598rs11862584TGrs11862584230064235.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1625784898rs11074721TCrs11074721230064237.05E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1625784920rs12443577CGrs12443577230064235.76E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1626347780rs4787367TGrs4787367230064239.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1626352382rs7202468CTrs7202468230064235.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1629036915rs4077347GArs4077347230064235.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1629101402rs252272CArs252272230064231.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1629833714rs1057452GArs1057452230064233.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1629877301rs12917823GTrs12917823230064238.27E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1629885447rs4787483AGrs4787483230064234.72E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1629906546rs4787484CTrs4787484230064231.00E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1629910725rs7498372AGrs7498372230064238.18E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1629911260rs7189550GArs7189550230064234.61E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1649504166rs4785310ACrs4785310189787876.07E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1652913327rs8061856AGrs8061856230064239.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1654211135rs7190251TArs7190251230064238.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1656704125rs2062545GArs2062545230064237.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1657149645rs2305699CArs2305699230064234.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1658664602rs37037AGrs37037230064235.31E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1658973967rs12927800TGrs12927800230064238.21E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1658974871rs1992113AGrs1992113230064236.75E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1668219969rs9932414AGrs9932414230064236.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1668353983rs7190070CTrs7190070230064236.50E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1668381516rs7190134GArs7190134230064239.62E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1668566787rs8048966GArs8048966230064232.15E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1673065656rs4788692TCrs4788692230064231.02E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1673525237rs825842GArs825842230064237.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1673536221rs825851GTrs825851230064233.75E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1673542760rs825836GArs825836230064234.93E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1674360929rs4888213GArs4888213230064238.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1674702254rs4448975GArs4448975230064233.60E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1674702430rs4395097CTrs4395097230064234.38E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1675224733rs4479268ACrs4479268230064236.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1675230638rs1019537TCrs1019537230064236.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1675230739rs1019539TCrs1019539230064236.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1675254966rs8048956GCrs8048956230064239.78E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1676130755rs1423858CTrs1423858230064234.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1676389134rs17766740GTrs17766740230064238.61E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1676393741rs17699214TCrs17699214230064234.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1676404556rs7193350CTrs7193350230064238.28E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1677111576rs284939GArs284939230064238.29E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1677112564rs285001TGrs285001230064232.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1677177128rs4243134CTrs4243134230064232.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1677177737rs4555168CArs4555168230064231.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1679562141rs10514459CTrs10514459230064238.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1679699967rs1364339GArs1364339230064237.86E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1679702573rs4888041TArs4888041230064237.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1680947996rs1981868GArs1981868230064235.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1680952299rs9319558ATrs9319558230064233.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1680953051rs7187344GArs7187344230064235.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1681359825rs2216768GArs2216768230064231.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1681512821rs2927324CTrs2927324230064239.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1683438394rs11647148CTrs11647148230064236.51E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1683446304rs17286565AGrs17286565230064232.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1683453851rs10514573AGrs10514573230064236.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1683725371rs7200481CTrs7200481230064239.16E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1684785672rs4783057GArs4783057230064233.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1684786250rs6564074CArs6564074230064231.93E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1684959707rs11863338CGrs11863338230064239.63E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1684959942rs11863425CArs11863425230064237.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1684966561rs13334795CTrs13334795230064236.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1684977997rs4783101GArs4783101230064232.86E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1685364315rs8047149CTrs8047149230064238.39E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1686018861rs6540239TCrs6540239230064236.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1686822348rs7199746CArs7199746230064235.89E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1686825472rs4843460CTrs4843460230064239.50E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1686825963rs11640979CTrs11640979230064238.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1686827339rs13337840AGrs13337840230064234.38E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1686828158rs2059287CArs2059287230064234.06E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1687556088rs11645728AGrs11645728230064238.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1687570851rs9922687TCrs9922687230064235.22E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1687581198rs2334207TGrs2334207230064239.68E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1687642073rs1864152ACrs1864152230064234.14E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1688072574rs12102841CGrs12102841230064235.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1688110422rs7499959CGrs7499959230064232.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1688993580rs1808448CTrs1808448230064233.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
171145506rs28655569GTrs28655569230064233.33E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
171151592rs28603687TCrs28603687230064235.19E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
173569913rs222757GTrs222757230064236.48E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
173786907rs758642GArs758642230064234.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
174214005rs17764251GArs17764251230064231.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
174649785rs7223183AGrs7223183230064234.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
174657034rs754814CTrs754814230064232.01E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
175571881rs9892702GCrs9892702230064236.61E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
175982293rs7210943GArs7210943230064232.60E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
176163555rs1872235ATrs1872235230064239.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
176163894rs1872236ACrs1872236230064237.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
176175260rs8078518TCrs8078518230064237.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
176179929rs1077009TCrs1077009230064239.30E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
178016013rs3027213ACrs3027213230064232.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
179002267rs9899718TCrs9899718230064235.99E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
179582214rs6503238TCrs6503238230064231.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
179590319rs7220651TGrs7220651230064234.37E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
179590409rs16958589TCrs16958589230064237.79E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
179601871rs8078327GArs8078327230064235.21E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1711460264rs2874641AGrs2874641230064235.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1712615971rs7210857GTrs7210857230064238.36E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1713208676rs10521215GCrs10521215230064238.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1713767150rs11649927AGrs11649927230064235.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1714604769rs11653737TCrs11653737230064233.19E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1726327892rs4239214GArs4239214230064238.29E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1731609815rs9891803CTrs9891803230064238.38E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1731623326rs9915774GArs9915774230064231.49E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1731626855rs2346689GArs2346689230064238.09E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1731633201rs9303662CTrs9303662230064233.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1731636912rs10432046GTrs10432046230064235.98E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1731639502rs1391077CTrs1391077230064235.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1731647041rs12449358TArs12449358230064238.81E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1731654683rs320629CTrs320629230064238.37E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1731656804rs1504575AGrs1504575230064236.89E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1731665328rs320637CTrs320637230064239.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1739569918rs7214766GArs7214766230064236.94E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1740767786rs7220074GArs7220074230064231.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1742064987rs9895585ACrs9895585230064239.00E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1748289070rs2586502CArs2586502230064231.00E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (docetaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1755197914rs3095505GCrs3095505230064237.36E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1756162496rs11079337CArs11079337230064235.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1756226845rs17740678ATrs17740678230064233.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1756242230rs2052085CTrs2052085230064235.62E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1756473259rs9889419TCrs9889419230064233.43E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1756485358rs1476596AGrs1476596230064238.77E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1756492800rs3744093TCrs3744093230064233.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1756501420rs2429369AGrs2429369230064238.53E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1756585872rs3744108GCrs3744108230064234.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1756608465rs4793952CTrs4793952230064232.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1756660279rs8071916AGrs8071916230064239.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1756663842rs9907940AGrs9907940230064236.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1756734695rs1631237AGrs1631237230064235.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1756951474rs12944948AGrs12944948230064239.49E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1756990099rs1588322TCrs1588322230064236.32E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1757010225rs8071280TCrs8071280230064239.49E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1757064167rs6503890AGrs6503890230064239.16E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1758828402rs11655927GArs11655927230064237.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1758828449rs8076615CA,G,Trs8076615230064238.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1758837937rs8078216CTrs8078216230064236.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1764197259rs7225197AGrs7225197230064238.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1765898809rs7216064GArs7216064231436017.00E-06NA1.16[1.09-1.25]5,510 East Asian ancestry cases; 4,544 East Asian ancestry controlsEast Asian(10054)ALL(10054)ASN(10054)ALL(10054)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs7216064-AResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, N.I.H., Intramural
1766903236rs4147994GArs4147994230064233.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1769364682rs17178928GArs17178928230064233.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1769367311rs7221046ACrs7221046230064233.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1769371040rs4239152TCrs4239152230064232.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1769371095rs4239153GTrs4239153230064234.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1769372864rs2190707TGrs2190707230064237.63E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1769379760rs10512565AGrs10512565230064235.61E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1769380081rs10512566CArs10512566230064235.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1769380906rs11077561CTrs11077561230064236.40E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1769382599rs8080955GCrs8080955230064239.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1769385117rs11653885CG,Trs11653885230064233.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1771035613rs1552846TArs1552846230064236.19E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1773328989rs16967789GArs16967789230064237.48E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1773407381rs16967866TGrs16967866230064235.65E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1776479367rs9900319GArs9900319230064233.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1776870618rs9916773CArs9916773230064233.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1777285677rs9898469GArs9898469230064237.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1779254903rs7212762TCrs7212762230064235.71E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1780449676rs6502114GArs6502114230064233.75E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1780937305rs9898649TCrs9898649230064236.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
18155566rs4797876CTrs4797876230064237.64E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
18272535rs11080970GTrs11080970230064238.52E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
18905125rs1893154AGrs1893154230064232.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
182866490rs8086883TCrs8086883230064238.03E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
182874156rs583523GArs583523230064238.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
184084386rs11663122TGrs11663122230064232.14E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
184161831rs7232189CTrs7232189230064234.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
184394577rs7244876AGrs7244876230064233.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
185560258rs1785394TC,Grs1785394230064234.62E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
188355048rs7226445ACrs7226445230064238.77E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
188356825rs8087223GArs8087223230064236.46E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
188823577rs16954325CTrs16954325230064236.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
188824239rs12960677ACrs12960677230064239.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
189882587rs513186TCrs513186230064234.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1811168361rs4629032TGrs4629032230064235.37E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1813642721rs12326169TCrs12326169230064236.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1813830371rs1298527GArs1298527230064232.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1821773097rs7242469CTrs7242469230064239.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1822135044rs1791261GTrs1791261230064231.90E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1822135116rs1791510CTrs1791510230064235.64E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1822136569rs12954803AGrs12954803230064238.00E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (docetaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1822137454rs1945150GTrs1945150230064239.35E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1822142090rs11659943AGrs11659943230064233.15E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1824994052rs1105237GTrs1105237230064237.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1825001111rs16943614CTrs16943614230064232.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1825007624rs16943627CTrs16943627230064234.25E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1826457167rs1401191CTrs1401191230064236.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1826465206rs1464217AGrs1464217230064237.02E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1826467370rs4800889GArs4800889230064235.00E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1826563494rs11877588GTrs11877588230064237.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1828367748rs2591119GArs2591119230064233.19E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1828367893rs2591118CTrs2591118230064232.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1828368036rs1943536GArs1943536230064235.42E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1828370223rs2591117TArs2591117230064231.96E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1828370584rs2591116TArs2591116230064231.96E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1828384725rs4547414GArs4547414230064237.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1828391012rs2733119TArs2733119230064231.65E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1828392489rs9966361CA,Grs9966361230064233.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1828394375rs2733156CTrs2733156230064231.52E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1828628256rs10502557TGrs10502557230064235.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1832312652rs899828TGrs899828230064238.09E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1833679581rs1944323GCrs1944323230064239.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1837682827rs752216TCrs752216230064231.98E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1838731837rs17769226TCrs17769226230064235.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1838733962rs10502752GTrs10502752230064232.22E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1838735059rs17769347AGrs17769347230064231.78E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1838735952rs16974138GCrs16974138230064232.25E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1838736742rs17696757TCrs17696757230064237.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1839370967rs17657594CTrs17657594230064238.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1842748365rs8089498AGrs8089498230064239.37E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1842972154rs9807288CGrs9807288230064232.86E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1842974182rs1362838AGrs1362838230064236.73E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1842982959rs2612561CTrs2612561230064235.07E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1842988088rs17823562CArs17823562230064231.01E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1842988330rs17750770TArs17750770230064231.03E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1842990753rs7230301TGrs7230301230064231.36E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1842990931rs7242620AGrs7242620230064235.32E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1842998976rs4622609AGrs4622609230064237.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1843411190rs477397CArs477397230064233.31E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1844919327rs1893784TCrs1893784194146796.85E-04Lung cancer (non-small cell lung cancer), survival in early stageNANA100 samplesNOPOP(100)ALL(100)NOPOP(100)ALL(100)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAMulticenter StudyResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1845564962rs4072059GCrs4072059230064234.43E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1845577201rs8089034CTrs8089034230064239.42E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1845579276rs7244057ACrs7244057230064239.78E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1845591325rs3935039CTrs3935039230064237.03E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1845779667rs12967400AGrs12967400230064233.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1845786206rs1944586AGrs1944586230064233.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1845794555rs17744700CTrs17744700230064236.61E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1845815417rs1944582AGrs1944582230064234.00E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (docetaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1846528270rs698611CArs698611230064232.88E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1847818688rs9961704CTrs9961704230064233.54E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1847840555rs4939626TCrs4939626230064235.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1847967166rs9964613GArs9964613230064232.61E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1848331553rs2849233TCrs2849233230064235.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1851010902rs8082807ACrs8082807230064237.78E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1851129489rs894274AGrs894274230064233.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1852715175rs9955009TCrs9955009230064237.76E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1853531732rs8092776GArs8092776230064232.43E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1856363908rs12455229ACrs12455229230064236.35E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1858474850rs9956748CArs9956748230064237.53E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1861163925rs1396782TCrs1396782230064238.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1863302058rs4941345AGrs4941345189787906.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
1865120212rs4471801GArs4471801230064238.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1865148334rs12955986AGrs12955986230064236.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1865179829rs2279269GArs2279269230064238.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1865423581rs9953346AGrs9953346230064239.07E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1866393240rs17079623CTrs17079623230064236.94E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1872213416rs2346064TCrs2346064230064236.98E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1872452702rs547335CTrs547335230064231.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1872525280rs12956238GArs12956238230064235.32E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1872538424rs966123TCrs966123230064231.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1872540401rs2042703CTrs2042703230064232.21E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1873528080rs2612366TCrs2612366230064234.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1873528162rs1017747CTrs1017747230064234.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1875634258rs9973133TCrs9973133230064239.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
192334538rs10413189CTrs10413189230064238.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
192441106rs4807265GArs4807265230064235.89E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
192451266rs4806851GArs4806851230064232.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
194984588rs33938520CTrs33938520230064238.79E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
194995926rs11880464CTrs11880464230064232.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
195041049rs11878982CTrs11878982230064233.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
197840356rs653488TCrs653488230064233.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
198121369rs1129763CTrs1129763230064239.63E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
198512940rs17160491TGrs17160491230064232.60E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
198516278rs17160495ATrs17160495230064233.09E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
198552273rs2277987AGrs2277987230064235.96E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
198587782rs10408143TCrs10408143230064235.60E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1911297434rs11880312GArs11880312230064238.87E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1911497104rs318720TGrs318720230064233.32E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1915797409rs645827TArs645827230064236.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1915798394rs631193AGrs631193230064233.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1915799130rs627753AGrs627753230064239.37E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1915799343rs616514GTrs616514230064234.76E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1915799366rs677903GArs677903230064232.81E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1915800153rs583946CTrs583946230064236.16E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1915800729rs597012CGrs597012230064233.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1915802751rs626580CArs626580230064237.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1915807212rs596252TGrs596252230064238.50E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1915808890rs624512GArs624512230064239.13E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1915809248rs610354AGrs610354230064239.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1916425503rs501537GArs501537230064233.02E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1916426889rs429294CTrs429294230064239.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1916609453rs8108300GArs8108300230064231.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1916611978rs728116TCrs728116230064237.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1916612365rs7251978GArs7251978230064237.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1916613476rs6512116CArs6512116230064237.71E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1916614665rs12459711TCrs12459711230064237.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1916616420rs8109218ACrs8109218230064236.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1916637009rs10416645TCrs10416645230064238.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1919883691rs248940AGrs248940230064239.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924060980rs8113266CArs8113266230064234.43E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924061144rs8113608GArs8113608230064232.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924066956rs11670289CTrs11670289230064237.44E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924080807rs10418417TCrs10418417230064237.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924112777rs10420981CTrs10420981230064238.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924152735rs10402888ACrs10402888230064234.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924168088rs7250712ATrs7250712230064231.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924168558rs7254714GArs7254714230064231.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924176996rs4313914AGrs4313914230064238.71E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924181822rs4635459TCrs4635459230064237.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924217064rs8104657GTrs8104657230064237.28E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924222786rs7260598AGrs7260598230064236.00E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924225576rs6511680TCrs6511680230064237.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924238451rs10414075AGrs10414075230064233.15E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924240905rs17304569CTrs17304569230064237.76E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924276353rs4416149GTrs4416149230064234.23E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924282231rs10420762GArs10420762230064234.29E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924282272rs8110507GA,C,Trs8110507230064236.64E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924300721rs4932745TGrs4932745230064233.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924322822rs7260280TGrs7260280230064235.67E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924340502rs9305015GArs9305015230064233.30E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924346024rs10500223AGrs10500223230064232.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924346532rs2278443TCrs2278443230064235.32E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924348925rs7508396ACrs7508396230064235.35E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924354312rs17620029TCrs17620029230064232.63E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924355493rs11668609GCrs11668609230064233.00E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (docetaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924356307rs10500224AGrs10500224230064234.02E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924358391rs8100720ACrs8100720230064235.32E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924368053rs985196AGrs985196230064232.77E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924368149rs17000162GArs17000162230064232.89E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924374419rs10405242TCrs10405242230064231.21E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924374857rs17000660ACrs17000660230064232.23E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924378197rs7253132ACrs7253132230064231.50E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924446469rs4045101TCrs4045101230064233.89E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924455963rs1830180AGrs1830180230064235.32E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924457120rs2255598AGrs2255598230064235.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924461655rs1852408TCrs1852408230064231.33E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1924487350rs8189856AGrs8189856230064236.69E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1931340752rs17545624AGrs17545624230064239.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1931367508rs7359991CTrs7359991230064235.01E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1931375761rs12978650AGrs12978650230064239.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1933035849rs1862214GCrs1862214165498204.00E-04Lung cancer in current smokersNANA322 German male smoking lung cancer patients; 273 German healthy smoking controlsGerman(595)ALL(595)EUR(595)ALL(595)Lung cancer, smokers with versus smokers withoutHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerNANANANALung cancerNAResearch Support, Non-U.S. Gov'tCNA
1939813853rs8108034TGrs8108034230064232.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1945256947rs2927457GArs2927457230064236.05E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1945854919rs13181TGrs13181231081459.00E-07NANANA914 European ancestry non-small cell lung cancer cases; 860 European ancestry controlsEuropean(1774)ALL(1774)EUR(1774)ALL(1774)Lung Cancer (DNA repair capacity)HPOID:0003254HPOID:0100526Abnormality of DNA repairNeoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsNANALung cancerrs13181-CResearch Support, N.I.H., Extramural
1946025388rs2301284GArs2301284230064234.56E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1950502912rs3786673CTrs3786673230064237.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1950803403rs1078446AGrs1078446230064233.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1952947667rs2561012GArs2561012230064236.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1952949568rs2561018GArs2561018230064238.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1952949680rs2608543CTrs2608543230064238.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1953554240rs7259688TCrs7259688183857384.90E-06NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1954604822rs10423754TCrs10423754230064239.00E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (docetaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1954605278rs8111677CTrs8111677230064236.06E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1954606405rs254259TCrs254259230064231.46E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1954609170rs254256AGrs254256230064235.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1954611287rs621147GArs621147230064232.01E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1954622488rs10418693CTrs10418693230064232.36E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1954658001rs1055234CGrs1055234230064236.77E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1954709328rs17273267TCrs17273267230064232.77E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1954711981rs11666543GArs11666543230064235.01E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1955017416rs6509880TCrs6509880230064234.30E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1956996595rs17273407CGrs17273407230064237.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1957002137rs877394AGrs877394230064234.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1957006853rs10426952AGrs10426952230064234.39E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1957686211rs8106506GArs8106506230064238.77E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1957686804rs740400CTrs740400230064234.07E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
1958784732rs12462307TCrs12462307230064237.29E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
20849993rs16994418CGrs16994418230064232.87E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
20851769rs1411192GArs1411192230064232.86E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
20853435rs1888087TGrs1888087230064232.35E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
20857271rs882806TCrs882806230064238.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
201658258rs6034368CTrs6034368194146791.38E-04Lung cancer (non-small cell lung cancer), survival in early stageNANA100 samplesNOPOP(100)ALL(100)NOPOP(100)ALL(100)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAMulticenter StudyResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
204285532rs3859666AGrs3859666230064235.61E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
205707548rs6085256CTrs6085256230064239.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
208787329rs1997752GArs1997752230064235.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
208795984rs16995282AGrs16995282230064232.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
208968642rs4813881ATrs4813881230064239.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
208978063rs6108228TGrs6108228230064236.89E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
209645420rs2423395GArs2423395230064238.32E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
209664539rs2143256GTrs2143256230064236.26E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2015251031rs453349GArs453349230064231.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2015608581rs956506GArs956506230064237.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2015790136rs6135546GArs6135546230064238.00E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2016003406rs6080100TCrs6080100183857382.80E-05NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
2016024095rs12625514CTrs12625514230064238.21E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2016510024rs6080286TCrs6080286230064237.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2016513316rs17674942TA,Crs17674942230064235.79E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2016517950rs6075068CGrs6075068230064234.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2016528914rs6075069CTrs6075069230064233.63E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2016536414rs6044112CTrs6044112230064237.00E-07NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (docetaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2016859716rs17763056TCrs17763056230064238.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2018366623rs17733134GArs17733134230064232.46E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2019055731rs1033815GArs1033815230064236.25E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2019241680rs4814837CTrs4814837230064239.98E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2019245723rs6081555GTrs6081555230064238.36E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2020070642rs6081870AGrs6081870230064239.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2031813134rs4911305CTrs4911305230064237.50E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2032780822rs6059711CTrs6059711230064234.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2040008482rs6102391TCrs6102391230064236.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2041981482rs4812699CTrs4812699230064234.29E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2042364734rs285198GArs285198230064231.42E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2042371095rs370971GArs370971230064234.01E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2042375432rs880064GArs880064230064235.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2042382106rs6017164GArs6017164230064238.89E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2042390973rs6073190CTrs6073190230064234.01E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2043311088rs4812849ACrs4812849230064237.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2045600280rs13041757GArs13041757194146796.08E-06Lung cancer (non-small cell lung cancer), survival in early stageNANA100 samplesNOPOP(100)ALL(100)NOPOP(100)ALL(100)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAMulticenter StudyResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
2048664874rs6125878TGrs6125878230064231.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2050171340rs17801923AGrs17801923230064235.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2050556670rs2869621AGrs2869621183857382.90E-05NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
2051259176rs856411TCrs856411230064233.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2051263369rs865608GArs865608230064237.42E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2051653799rs6013611GCrs6013611230064234.01E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2051670372rs6091627TGrs6091627230064238.31E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2051909682rs6022377GArs6022377230064233.48E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2051911199rs6013656GArs6013656230064232.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2051914724rs4811423AGrs4811423230064231.14E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2052827268rs1418926TGrs1418926230064238.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2052855872rs6013938GArs6013938230064236.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2052868443rs6097867ATrs6097867230064238.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2053355127rs6127270CArs6127270230064232.15E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2053382213rs6014161CArs6014161230064233.98E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2053384031rs6023583TCrs6023583230064233.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2053398823rs6023594TGrs6023594230064239.01E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2054839794rs4811685TCrs4811685230064238.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2055895429rs6014975TCrs6014975231081456.24E-05NANANA914 European ancestry non-small cell lung cancer cases; 860 European ancestry controlsEuropean(1774)ALL(1774)EUR(1774)ALL(1774)Lung Cancer (DNA repair capacity)HPOID:0003254HPOID:0100526Abnormality of DNA repairNeoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsNANALung cancerNAResearch Support, N.I.H., Extramural
2056064267rs6099656TCrs6099656230064237.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2056232583rs927171CArs927171230064234.19E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2056946001rs6064647AGrs6064647230064237.52E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2058908464rs6100868GArs6100868230064232.40E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2058951673rs16983858AGrs16983858230064238.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2059755640rs817691CTrs817691230064236.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2059757223rs817697CArs817697230064236.75E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2059834206rs6101282GArs6101282230064231.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2059834496rs6101283GArs6101283230064231.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2059836389rs6101284AGrs6101284230064233.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2110979098rs240446ACrs240446230064236.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2114945115rs7281173TCrs7281173230064238.93E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2115372509rs1297083CTrs1297083230064239.21E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2116229925rs2822964CTrs2822964230064237.64E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2116241868rs2822965TCrs2822965230064239.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2120363475rs2825256TArs2825256230064239.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2122341051rs2826625GArs2826625230064235.85E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2124691977rs2828056TCrs2828056230064239.03E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2124764752rs2828104CArs2828104230064231.52E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2125884428rs2186435AGrs2186435230064233.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2126674476rs2829689CTrs2829689230064235.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2126692371rs7283848CArs7283848230064236.35E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2126694924rs2829700TGrs2829700230064239.38E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2126699109rs2829702AGrs2829702230064235.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2126699228rs2829703AGrs2829703230064235.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2127833284rs191997TArs191997230064234.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2128113180rs2830448GTrs2830448230064232.31E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2128124166rs2830457AGrs2830457230064236.02E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2128127680rs2212815CTrs2212815230064236.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2128614871rs1477717CTrs1477717230064235.64E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2128876415rs2830987TGrs2830987230064233.02E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2128877292rs2830988CTrs2830988230064235.27E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2128883017rs1987950CArs1987950230064235.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2128886568rs2830991GCrs2830991230064233.84E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2128888680rs2830992ACrs2830992230064233.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2129440312rs2831451TCrs2831451230064237.73E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2130058933rs8129139GTrs8129139230064234.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2130060546rs982279TCrs982279230064232.40E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2130061531rs2205423GCrs2205423230064239.30E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2130063749rs4817242AGrs4817242230064234.61E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2130071603rs4817244AGrs4817244230064232.21E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2130072448rs7276179CTrs7276179230064234.80E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2130072918rs4816322AGrs4816322230064233.60E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2130075486rs9305380ACrs9305380230064232.69E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2130075897rs2831965GCrs2831965230064232.40E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2130076432rs9980601TGrs9980601230064233.53E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2130076780rs2831966ACrs2831966230064233.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2130093105rs2831980GCrs2831980230064237.39E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2130099405rs2409318TCrs2409318230064235.99E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2130136868rs2832067GArs2832067230064238.75E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2130239378rs4817258CTrs4817258230064233.24E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2130244170rs8134005GArs8134005230064236.83E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2130252088rs2205449TArs2205449230064236.69E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2130252562rs2254160AGrs2254160230064235.72E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2130274908rs2776227GArs2776227230064232.68E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2130277054rs2142374AGrs2142374230064234.61E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2130280016rs2832137ATrs2832137230064231.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2130281420rs2472209CTrs2472209230064239.94E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2130520085rs8129616GArs8129616230064236.79E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2130527999rs2251087CTrs2251087230064232.31E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2130531705rs2776252GArs2776252230064231.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2132957765rs2833459AGrs2833459230064239.60E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2133426886rs6517072CTrs6517072230064231.98E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2133427852rs2833626AGrs2833626230064233.00E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2135124253rs2834255AGrs2834255230064232.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2136453837rs2242900AGrs2242900189787903.00E-05NANANA2,971 cases; 3,746 controlsNOPOP(6717)ALL(6717)NOPOP(6717)ALL(6717)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
2138140659rs7275269GCrs7275269230064238.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2139991146rs16996589AGrs16996589230064235.95E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2139991893rs2836574AGrs2836574230064238.39E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2141041821rs2837111CTrs2837111230064234.51E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2141387324rs2837378CTrs2837378189787871.40E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
2141622294rs2837534TCrs2837534230064231.34E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2141624622rs2837536CTrs2837536230064238.36E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2142711678rs424513TGrs424513230064239.05E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2143275495rs915832AGrs915832230064237.00E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2143285426rs11203189AGrs11203189230064236.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2143285513rs11203190TCrs11203190230064236.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2143286352rs2839398CGrs2839398230064234.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2144022258rs1788421GArs1788421230064238.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2144731138rs504022TGrs504022189787876.18E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
2146319417rs2838729AGrs2838729230064238.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2146646264rs1051385TCrs1051385189787879.90E-05NANANA1,952 cases; 1,438 controlsNOPOP(3390)ALL(3390)NOPOP(3390)ALL(3390)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
2146820082rs9637198CTrs9637198230064235.17E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2147787002rs6518289TCrs6518289230064235.61E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2217989378rs1296757CTrs1296757230064239.95E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2220982876rs5759632CTrs5759632230064236.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2220983592rs596235TCrs596235230064236.70E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2220990057rs661440TCrs661440230064236.77E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2220991062rs580204TCrs580204230064239.93E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2224117916rs2267029AGrs2267029230064236.40E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2224129005rs2073387TGrs2073387230064236.40E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2224133570rs2073390GArs2073390230064232.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2224134394rs5760022TCrs5760022230064236.40E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2224158315rs738800CArs738800230064238.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2227048858rs16982543TCrs16982543230064233.51E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2227049032rs16982551AGrs16982551230064231.97E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2227049119rs16982554AGrs16982554230064234.53E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2228166402rs5997301CGrs5997301230064238.49E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2229121087rs17879961AGrs17879961248803421.00E-13(Squamous cell carcinoma)2.63[2.04-3.33] 3,442 European ancestry adenocarcinoma cases; 3,275 European ancestry squamous cell carcinoma cases; 4,631 cases; up to 15,861 controlsNOPOP(20492)European(6717)ALL(27209)NOPOP(20492)EUR(6717)ALL(27209)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs17879961-AResearch Support, N.I.H., Extramural
2229121087rs17879961AGrs17879961248803423.00E-11(All lung cancer)1.67[1.43-1.92] 3,442 European ancestry adenocarcinoma cases; 3,275 European ancestry squamous cell carcinoma cases; 4,631 cases; up to 15,861 controlsNOPOP(20492)European(6717)ALL(27209)NOPOP(20492)EUR(6717)ALL(27209)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs17879961-AResearch Support, N.I.H., Extramural
2230193548rs2349225ATrs2349225217253083.40E-06NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyT
2230211512rs36578AGrs36578217253087.30E-06NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyG
2230223991rs1076137AGrs1076137217253083.40E-05NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyG
2230229399rs3958025CG,Trs3958025217253083.30E-05NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyG
2230233446rs5752968AGrs5752968217253083.30E-05NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyG
2230250312rs5752972ATrs5752972230064239.89E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2230253256rs4993442GTrs4993442217253081.50E-06NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyT
2230261219rs9625870AGrs9625870230064233.78E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2230288625rs9625874AGrs9625874217253081.00E-06NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyA
2230300112rs3887275CGrs3887275217253082.40E-07NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyC
2230304234rs8136147CTrs8136147217253082.40E-07NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyC
2230308780rs4823063GCrs4823063217253089.20E-07NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyG
2230328070rs36590TCrs36590217253082.10E-07NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyC
2230334382rs36594CTrs36594217253082.10E-07NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyT
2230337586rs36600TCrs36600217253086.00E-13NA1.29[1.20-1.38]2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerrs36600-AResearch Support, Non-U.S. Gov'tComparative StudyC
2230340138rs36604CArs36604217253089.20E-07NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyC
2230340356rs36605ATrs36605217253082.20E-07NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyT
2230340410rs36606ATrs36606217253089.60E-07NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyT
2230344457rs200426271TTGrs36609217253082.20E-07NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyG
2230344457rs36609TGrs36609217253082.20E-07NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyG
2230348652rs737904ATrs737904217253081.10E-06NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyT
2230350532rs5763634TCrs5763634217253081.10E-06NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyC
2230353252rs57003371AAT,ATTrs5763640217253081.10E-06NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyT
2230353252rs5763640ATrs5763640217253081.10E-06NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyT
2230355676rs5763644GArs5763644217253081.10E-06NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyA
2230361881rs2051764GArs2051764217253082.50E-07NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyA
2230368384rs4239932TGrs4239932217253088.30E-07NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyG
2230383262rs2017677GCrs2017677217253082.10E-07NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyC
2230388758rs737909TGrs737909217253082.10E-07NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyG
2230390990rs3788423TCrs3788423217253081.50E-07NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyC
2230391281rs2412963GArs2412963217253081.50E-07NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyA
2230422865rs41172TCrs41172217253081.50E-09NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyT
2230429115rs28257AGrs28257217253086.50E-08NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyT
2230432137rs41175TCrs41175217253081.40E-09NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyT
2230440533rs41178GArs41178217253081.40E-09NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyG
2230441677rs41179AGrs41179217253081.40E-09NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyA
2230448399rs193473AGrs193473217253083.70E-08NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyA
2230474216rs8141404CTrs8141404217253084.70E-08NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyC
2230493918rs7510705AGrs7510705217253083.00E-09NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyA
2230500958rs9625919GTrs9625919217253084.70E-08NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyG
2230503171rs6006356GArs6006356217253084.70E-05NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyA
2230504207rs718772AGrs718772217253089.80E-08NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyA
2230512128rs4337577GCrs4337577217253084.90E-09NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyG
2230512414rs4239933CGrs4239933217253087.50E-08NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyC
2230521770rs11090598AGrs11090598217253081.00E-07NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyA
2230537526rs5997579TCrs5997579217253089.20E-05NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyC
2230546245rs9620953CTrs9620953217253081.30E-07NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyC
2230555216rs9625933GArs9625933217253082.30E-08NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyG
2230562239rs8141765CArs8141765217253081.90E-08NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyC
2230562987rs8138286ACrs8138286217253081.90E-08NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyA
2230570443rs1978083CGrs1978083217253082.00E-09NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyC
2230575812rs12167333CTrs12167333217253083.00E-09NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyC
2230592487rs713875CGrs713875217253089.70E-06NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyC
2230597810rs9614157AGrs9614157217253085.90E-11NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyA
2230597880rs9614158AGrs9614158217253083.20E-10NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyA
2230598552rs17728461CGrs17728461217253085.90E-11NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyC
2230599596rs2023683GArs2023683217253083.20E-10NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyNA
2230601243rs9614159GArs9614159217253082.00E-10NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyG
2230604102rs9614162GArs9614162217253089.60E-11NANANA2,331 Chinese ancestry cases; 3,077 Chinese ancestry controlsChinese(5408)ALL(5408)ASN(5408)ALL(5408)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, Non-U.S. Gov'tComparative StudyG
2230843495rs4820848GArs4820848230064232.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2230846623rs5753152AGrs5753152230064235.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2230854663rs4820851GArs4820851230064235.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2230857373rs2240345ACrs2240345230064235.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2230857448rs5749104AGrs5749104230064238.62E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2230861640rs2412986CTrs2412986230064235.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2230862763rs757663CTrs757663230064235.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2230862839rs5753161AGrs5753161230064235.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2230986350rs5753220TCrs5753220230064235.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2233932624rs5754597AGrs5754597230064238.78E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2234166139rs28374TCrs28374230064231.50E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2234196508rs5749665TCrs5749665230064232.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2234197367rs5754679TCrs5754679230064235.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2234202284rs5754682CTrs5754682230064238.99E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2234213356rs2227023TCrs2227023230064232.46E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2234832523rs13055293GTrs13055293230064237.93E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235131614rs9622012CGrs9622012230064236.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235558414rs134300AGrs134300230064231.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235559579rs2413305AGrs2413305230064235.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235559695rs2413306GArs2413306230064231.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235560386rs6518933GArs6518933230064231.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235571497rs134381TCrs134381230064233.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235580096rs134409AGrs134409230064234.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235580597rs134410TCrs134410230064231.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235583297rs134415AGrs134415230064232.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235587480rs134426AGrs134426230064231.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235588600rs134430CArs134430230064231.54E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235590706rs3752596GArs3752596230064236.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235591035rs134434GArs134434230064238.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235647722rs4820187AGrs4820187230064239.08E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235652241rs2092029CTrs2092029230064233.36E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235653473rs5755674CTrs5755674230064232.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235658225rs4820189AGrs4820189230064232.64E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235664941rs2235148TCrs2235148230064233.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235667486rs12485178GArs12485178230064237.16E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235669441rs4821387AGrs4821387230064236.30E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235669809rs760513CTrs760513230064233.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235672843rs2235150TGrs2235150230064231.89E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235675537rs5755683GArs5755683230064232.75E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235684059rs741996CTrs741996230064232.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235690179rs1474557TCrs1474557230064234.02E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235690183rs1474558AGrs1474558230064232.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235690532rs4821392AGrs4821392230064233.13E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235694295rs138726AGrs138726230064232.30E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235699883rs138744CTrs138744230064232.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235703128rs138764TCrs138764230064231.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2235711098rs138777AGrs138777230064234.45E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2236989327rs926543TGrs926543230064238.30E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2238832512rs196074GArs196074230064236.35E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2241908405rs9611602TCrs9611602230064237.19E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2241981957rs5996039AGrs5996039230064233.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2241995335rs8139993TCrs8139993230064233.11E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2242015765rs5751129CTrs5751129230064239.47E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2242127999rs2064189TCrs2064189230064235.14E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2242128097rs5751144GArs5751144230064235.14E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2242177453rs4822050GCrs4822050230064233.28E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2242178441rs126092GArs126092230064238.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2242210985rs139568TCrs139568230064232.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2242276742rs2228314GCrs2228314230064237.55E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2243814457rs2180154CArs2180154230064232.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2249020407rs7292688CTrs7292688230064238.72E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2249597489rs11913533TCrs11913533230064239.68E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2249684418rs7290877GArs7290877230064238.35E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2250072755rs2012378CTrs2012378230064235.84E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2250085456rs6009820CTrs6009820230064239.18E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2250085731rs6009822GArs6009822230064237.42E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2250086373rs6009824GArs6009824230064235.73E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2250614476rs5771204TCrs5771204230064237.66E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2250644177rs6010202GArs6010202230064234.89E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2250651839rs5771104GArs5771104230064234.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2250652427rs11703673CTrs11703673230064237.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
2250886220rs5770980TCrs5770980230064238.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X4645454rs7055613CTrs7055613230064238.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X7439290rs5979755GTrs5979755230064236.30E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X7458596rs7885520ATrs7885520230064232.33E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X7458791rs7884299GArs7884299230064237.57E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X7470499rs2130835ACrs2130835230064233.00E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X7483102rs980816ACrs980816230064231.41E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X12435321rs6639176GArs6639176230064239.02E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X12497256rs5934006CTrs5934006230064234.15E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X12825639rs17256004TCrs17256004230064234.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X15100744rs17216148TCrs17216148230064239.94E-05NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X15727977rs5936023GArs5936023230064236.39E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X22760288rs5970876ACrs5970876230064232.49E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X22856079rs5926097AGrs5926097230064239.40E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X23626268rs7876326GCrs7876326230064234.40E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X23626473rs5970594TArs5970594230064233.20E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X23626983rs6627955TCrs6627955230064239.12E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X23637116rs4375154AGrs4375154230064239.94E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X28853204rs5943559AGrs5943559230064233.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X28872079rs4893555GArs4893555230064232.98E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X28872608rs4893599AGrs4893599230064232.98E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X29087721rs5985950GArs5985950230064232.90E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X29507021rs1534965AGrs1534965230064238.65E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X29507158rs1040463AGrs1040463230064237.61E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X31337537rs5972370GTrs5972370230064234.93E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X31337695rs5972371GCrs5972371230064234.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X31339102rs5972373AGrs5972373230064239.94E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X33269759rs2064265TArs2064265230064238.45E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X40097231rs2939568ACrs2939568230064232.01E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X40160929rs869829AGrs869829230064238.74E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X40193013rs2948486TGrs2948486230064239.03E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X40197541rs3008962GArs3008962230064237.77E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X69102019rs1202987CTrs1202987230064239.23E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X83619032rs5922971AGrs5922971230064236.91E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X83631474rs2092545AGrs2092545230064238.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X83673619rs6623023CTrs6623023230064232.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X85577260rs5968890GTrs5968890230064232.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X89263367rs5941420ATrs5941420230064237.86E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X89267763rs5941421GArs5941421230064236.98E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X93351801rs5983343GArs5983343183857383.20E-05NANANA1,926 cases; 2,522 controlsNOPOP(4448)ALL(4448)NOPOP(4448)ALL(4448)Lung cancerHPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD008175Lung NeoplasmsEFOID:0001071lung carcinomaLung cancerNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
X100666836rs3027575TCrs3027575230064238.29E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X104064869rs17347021GArs17347021230064235.10E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X109968387rs197023TCrs197023230064237.67E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X121243084rs5957888TCrs5957888230064234.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X122595498rs5956545GTrs5956545230064235.25E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X122971560rs9698139CTrs9698139230064239.54E-06NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X131659975rs726107TGrs726107230064235.02E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X135961796rs7891017CGrs7891017230064236.04E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X136110849rs1201465CTrs1201465230064236.82E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X138117409rs10521792AGrs10521792230064232.00E-07NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X138559569rs4396035CTrs4396035230064238.83E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X141086165rs17323604AGrs17323604230064235.42E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X141086626rs1534907ACrs1534907230064234.33E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X141232285rs2223404AGrs2223404230064236.05E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X141233946rs6636623ACrs6636623230064235.31E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X141952197rs991072ACrs991072230064232.35E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X144600329rs5965863CGrs5965863230064237.92E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X144673082rs5965871ATrs5965871230064232.59E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X144888977rs1009776GTrs1009776230064233.13E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X144983236rs7058595AGrs7058595230064236.44E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X144984818rs12851264AGrs12851264230064235.24E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X144984988rs12851714ACrs12851714230064233.58E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X145002875rs7050282GArs7050282230064238.06E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X145004093rs905089CTrs905089230064234.33E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X145004153rs2385424CTrs2385424230064234.02E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
X153540977rs17174296AGrs17174296230064238.19E-04NANANA96 African American lymphoblastoid cell lines; 96 European ancestry lymphoblastoid cell lines; 96 Han Chinese lymphoblastoid cell linesHan Chinese(96)European(96)African American(96)ALL(288)ASN(96)AFR(96)EUR(96)ALL(288)Response to taxane treatment (placlitaxel)HPOID:0100526Neoplasm of the lungsDOID:1324lung cancerD043823TaxoidsNANALung cancer
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Chemical(Total Drugs:0)
(Waiting for update.)
FDA approved drug and dosage information(Total Drugs:0)
(Waiting for update.)
FDA labeling changes(Total Drugs:0)
(Waiting for update.)